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9Preface
The European population is ageing rapidly: its median age is the highest in the 
world. The topic of ageing has received significant attention in recent years, 
as is evident in the multiple international reports on ageing published during 
the last five years and the existence of at least eight active working groups on 
ageing at the EU level.
The SAPEA Working Group on Transforming the Future of Ageing aims to 
provide a scientific perspective to address the question of what policies at the 
EU level could support the member states in their response to the current and 
future opportunities and challenges posed by ageing.
In this project, SAPEA assembled a large multi-disciplinary working group, 
with world-leading expertise in the biomedical, human, social and engineering 
sciences. The Federation of European Academies of Medicine network led 
the project. The resulting report reflects not only the outstanding knowledge 
of the experts, but also their exemplary commitment to the voluntary task 
of collaborating in an interdisciplinary way and bringing the best and latest 
scientific knowledge into evidence-based policymaking.
The report aims to make a unique contribution from a broad public health 
standpoint to a complex topic in a way that complements other related 
resources, thereby providing evidence-based science advice for the highest 
policy level in Europe. In particular, the working group has made a conscious 
effort not to duplicate the same aspects of ageing covered in existing reports. 
Likewise, by adopting a multi-disciplinary approach in the present report, 
the working group has distinguished itself from other EU ageing-related 
10
initiatives. These include the European Innovative partnership for Active 
and Healthy Ageing, Horizon 2020 projects in response to identified societal 
challenges posed by ageing, and the EU health programme managed by DG 
Santé focusing on healthy ageing, as well as existing networks funded by the 
EU, such as Innovation, Futurage, Mopact, Nestpar, and SHARE . The choice 
of topics covered in this report, or excluded, is based upon the expressed 
interest of policymakers throughout the scoping process, e.g. health, social 
affairs, employment, and technology.
SAPEA is an integral part of the European Commission’s Scientific Advice 
Mechanism (SAM). This Evidence Review Report is presented to the European 
Group of Chief Scientific Advisors, informing their Scientific Opinion which 
will be published later in 2019. Both this report and the Scientific Opinion 
are delivered directly to the College of Commissioners, and will be used 
for planning and policymaking. By such means, the best available science, 
distilled and analysed by the leading experts in Europe, should have a direct 
and tangible impact on decisions taken by the European Commission which 
influences the lives of some 500 million people across our continent.
Professor George Griffin
President of FEAM
Professor Jean-Pierre Michel
SAPEA working group chair
Professor Sierd Cloetingh
Chair of SAPEA Board
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Executive summary
This Evidence Review Report examines how public health aimed at protecting and improving the 
health of people and their communities can improve the prospects of current and future ageing 
of EU citizens.
In 2016, there were 98 million people in the European Union (EU) aged 65 years or older, 
compared with 80 million children aged below 16 years. Taking into consideration that the life 
expectancy of the next generation of older adults is likely to surpass that of their parents, it 
becomes absolutely necessary to foresee and plan for the challenges that they will face. The 
two combined strategies are:
  promoting healthy lifestyles over the life course, as well as detecting and modifying early and 
mid-life risk factors of impaired function and chronic diseases, in order to delay age-related 
disability;
  providing more appropriate health and social care for the aged EU population by offering 
integrated and holistic care in all-age community and health care facilities.
Both of the aforementioned approaches must bear in mind that:
  technology will not only transform entire population attitudes toward life but will also 
revolutionise care delivery systems
  whatever the impact of technology, an adequate number of skilled health care professionals 
is absolutely essential
1 The present report understands ageing as an opportunity for both individuals and 
society as a whole.
At the individual level, the ageing process is extremely heterogeneous, as huge social 
and cultural variations have a significant impact on the quality of ageing. However, ageing 
is usually preferred over early death, as it gives people a second, third and even fourth 
chance at life and provides multiple opportunities for personal fulfilment. This should 
not be overlooked but rather celebrated, as ageing represents a continuing chance to 
redefine oneself during life.
At the societal level, rapid changing societal structures, such as smaller and more 
fragmented family units, the co-development of age discrimination and health inequities, 
and the emergence of new geriatric syndromes and longer periods of disability, greatly 
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allows for increased productivity, greater work expertise and intergenerational exchanges 
of material and non-material goods (e.g. education and experience), thus forming bonds 
between young and old generations.
2 Four main principles guided the thinking and writing of the present report.
  The updated definition of “healthy ageing” proposed by the first World Health 
Organisation report on Ageing and Health (2015) was chosen as the reference to 
drive the public health interventions proposed therein: “the process of developing 
and maintaining the functional ability that enables wellbeing in older age”. Functional 
ability depends on the interaction between “intrinsic capacity, the composite of all 
physical and mental capacities, and the specific life environment of each individual”. 
Indeed, this global concept of functional ageing depends on socioeconomic factors 
and psychological condition.
  The concept of the life course approach, which includes studying the natural 
history of the growth, maintenance and decline in physical and mental (cognitive and 
emotional) capacities over the life course, as well as the onset and development of 
chronic diseases, clinical disorders, and their preclinical intermediate outcomes. The 
purpose of a life course approach is to identify opportunities throughout life to reduce 
the risk of chronic clinical conditions and age-related disability.
  The belief that age is just a number and, where possible, should not be used to 
categorise individuals. Once again, the high heterogeneity in aged populations 
should be acknowledged. The report challenges ageism and adultism stereotypes 
and prejudices and promotes intergenerational contact and education. Moreover, 
antidiscriminatory laws, regulations and public health policy options should specially 
prohibit age and gender discrimination, using human rights arguments.
  The internalisation of costs and benefits as an essential part of health and social 
care policy. Without this, it is impossible to truly assess the impact of policy changes 
in light of financial resources applied. While the current report does not explicitly 
analyse the financial aspects of care, the idea of costs constrained is a current thread.
3 The report gathers evidence from longitudinal studies on physical and social exposures 
during gestation, childhood, adolescence and adult life that may have long-term 
effects on the ageing process. Such exposures may impair or protect capacity and 
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increase or decrease risk of disease, operating through behavioural, psychosocial and 
biomedical pathways.
First, common risk factors related to broad ageing outcomes are reviewed, such as 
physical and cognitive performance, as well as disability and mortality. Then, major organ 
functions and diseases most commonly disturbing the ageing process are explored. 
Among these, obesity, diabetes, cardio-, neuro-, and nephro-vascular functions and 
diseases, musculoskeletal disorders and cognitive ability function and dementias emerge 
as the focus of prevention strategies.
The choice of these major individual functions is linked to:
  growing evidence that environments that adversely affect physical, cognitive and 
emotional development are associated with a higher risk of disease development, 
impaired functional capacity and earlier mortality;
  strong evidence that socioeconomic position and social isolation are key determinants 
of health and ageing. Lower socioeconomic position in childhood and adulthood and 
a lack of social interaction are associated with all-cause mortality, cardio-metabolic 
and respiratory impairments and diseases, as well as reduced physical and cognitive 
performance;
  strong evidence that lifetime health behaviours, such as being a non-smoker, 
consuming little or no alcohol and being physically active, considerably improve the 
prospect of healthy ageing. Sedentary lifestyles have been associated with various 
adverse indicators of physical function and cardiovascular health and earlier mortality. 
These health behaviours begin in adolescence and are partly determined by earlier 
factors, including social background, education, and access to resources;
  growing scientific evidence of common cellular hallmark pathways of ageing and age-
related diseases. Identifying these pathways will provide new ways of monitoring the 
quality of ageing as well as personalised interventions.
4 Innovative health promotion and early and midlife preventive strategies may enable 
younger generations to enjoy healthy ageing in the future.
To achieve this, an increased awareness is needed of how certain risk factors for age-
related functional decline are modifiable by lifestyle choices at all life stages. In line with 
the WHO concept of healthy ageing, the present report proposes three broad strategies 
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course:
  the first is to build physical and cognitive capacities or to enhance reserve so that 
maximum potential is reached by early adulthood (until approximately 30 years of 
age);
  the second is to maintain function and delay the onset and pace of functional decline 
and disease during adult life (from approximately 30 to 50 years of age);
  the third is to slow the rate of decline or disease progression in older adults (beyond 
approximately 50 years of age).
Transforming the ageing process of young and middle-aged EU citizens requires cross-
sectorial actions at both the societal and individual level. For each of the organ functions 
and associated diseases, the report provides careful analysis of possible health promotion 
and preventive strategies and targeted interventions, starting with education.
5 Lifelong health promotion and disease prevention play crucial roles.
Health promotion enables people to increase control over their own health. It covers a 
wide range of social and environmental interventions that are designed to benefit and 
protect the health and quality of life of individuals by addressing and preventing the 
root causes of illness. Good governance in health and a strong implication of cities in 
promoting health literacy campaigns aim to enable populations to improve their health 
by adopting healthy lifestyles and behaviours. As different strategies may be better 
suited to different life stages, carefully choosing the type and timing of health promotion 
campaigns may improve effectiveness.
Opportunities for lifelong population- and individual-based health promotion strategies 
are available in different settings:
  schools (e.g. promoting health literacy);
  workplaces (engageing companies and employers in maintaining health);
  general practices (e.g., social prescribing, lifetime vaccination).
Disease prevention differs from health promotion because it focuses on specific 
efforts aimed at reducing the development and severity of chronic diseases and other 
morbidities by targeting specific risk factors. The report focuses on:
  Biological and functional biomarker age scores continue to be developed and refined 
to identify those at risk of functional decline due to advanced biological or functional 
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age rather than chronological age. For example, a biomarker of accelerated ageing 
that suggests that a risk of being metabolically compromised should help tailor 
individual care.
  In parallel, innovative technologies (m-health), such as lifelong tracking of health, 
record changes in intrinsic capacities or monitor real-time exposure to risk (for 
example, level of physical activity), which may help identify individuals with 
accelerated functional decline at an earlier stage and motivate them to modify their 
lifestyles or behaviours.
6 All-age communities enable older people to feel secure and to go about their daily 
life comfortably. The present report stresses that architects, urban planners, experts in 
mobility and ergonomics, social care experts and geriatricians must cooperate to achieve 
all-age communities. Consequently, special efforts must be made to drive attractive and 
well-funded projects involving all relevant stakeholders working together to support a 
greater integration of older people in society.
7 Favouring ageing in the home is a high priority. Training and supporting informal carers 
(usually partners, family members or friends) is essential for maintaining care supply, but 
so is ensuring the wellbeing of care receivers and carers. In order to prevent burnout in 
informal care, it is important to offer (affordable and available) formal care alternatives 
for all socioeconomic groups, thereby enabling an adequate care mix, to facilitate the 
balance among care, work and leisure, and to reduce the care burden for all parties 
involved. The interoperability of these human agents, incorporating home visits and 
new home technology, should be considered in the context of the ‘Internet of Things’. 
Moreover, to favour ageing in the home, the report stresses the possible positive impact 
of expanding health insurance coverage to include professional care, as well as the 
potential role of municipal subsidies.
8 Creating all-age health care facilities (hospital settings and long-term care institutions). 
The present report stresses the need for the evidence-based design of health care 
facilities as age-inclusive urban places strongly integrated in the neighbourhoods and 
communities they serve, and for proposed changes in facility design, where appropriate. 
Pragmatic, holistic and transdisciplinary sustainable design increases the effectiveness 
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workers, which in turn, leads to an overall enhance health care quality.
This report insists also on the fact that, regardless of institutional structures, health care 
management is essential. Appropriate care for older adults requires:
Avoiding emergency visits and hospital admissions, as suggested by this report, by 
employing an integrated geriatric care model. The development of an interoperable 
universal medical record universal medical record for all EU member states will greatly 
assist in determining which care pathway will fit best with patient needs (clinical, 
functional or social). A ”one-site,-one-stop model” will prove essential for the diagnosis 
and regular follow-up of patients suffering from disabling health conditions, such as 
frailty, musculo-skeletal disorders, falls, heart failure and mental/cognitive disturbances.
  Reducing the length of hospital stays, as well as readmissions. To reach these 
goals, in addition to the aforementioned universal medical chart, older inpatients 
need a comprehensive geriatric assessment to help identify medical, social, 
economic and environmental problems at hospital admission. In multimorbid older 
patients with poly-medication, comprehensive geriatric assessment will allow for 
establishing realistic prognoses and help interdisciplinary teams better coordinate 
the care required, start or accurately stop appropriate treatments, and propose 
personalised nutrition supplementation and effective rehabilitation. This approach 
will avoid or decrease adverse drug effects as well as hospital-acquired side-effects 
and infections. Moreover, the number of transfers from hospitals to long-term care 
institutions will be reduced. Once again, the unique universal chart will allow a careful 
follow-up of patient trajectory and immediately alert health care professionals in 
charge to intervene adequately.
  Providing appropriate long-term care (at home, assisted living arrangements or 
shelter housing and nursing homes). Long-term care is typically addressed to older 
people with decreased levels of functional, mental and physical capability, as well 
as increased support needs. To establish all-age long-term care environments and 
increase residents’ satisfaction with the care received, this report insists on leadership 
committed to addressing ageism, the use of evidence-based care in favour of 
advanced care planning and the identification of surrogate decision markers including 
regular evaluation. By adopting an all-age long-term care approach, staff members 
may better handle support services with different perspectives and measurable 
outcomes: preventive, supportive, disease managerial and rehabilitative care (allowing 
for de-institutionalisation), but also palliative and terminal care.
  Addressing the specific needs of older people as they near the end of life. Eighty 
percentage of deaths occur among older people. Beyond its main goals of extending 
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and preserving life, palliative medicine and care, including pain relief and end-of-life 
symptom control, must be promoted widely. Traditionally offered to patients with 
cancer, palliative care has been extended to long-term care facilities and dementia 
units. Unfortunately, evidence suggests that people with dementia too often have 
unmet needs, have underdiagnosed and undertreated pain and are subjected to 
burdensome and futile care plans. This report insists on the fact that palliative care 
should be offered to everyone in all care settings and not limited to the final days of 
life.
  Tackling the problem of elder abuse in all settings. One in six adults over 60 years 
of age suffers from elder abuse (psychological, financial, neglect, physical or sexual), 
independent of whether in institutional or community living. This report highlights the 
need for urgent action to tackle the problem by identifying situations where abuse is 
suspected to take place, continuously fighting against ageist stereotypes and insisting 
on respect for human rights at all ages.
9 Technology will both impact individual and population ageing and revolutionise 
health care delivery.
Among the expected technological advances for the ageing population, we note:
  Physical health and social and cognitive health applications have started to appear, 
making it very likely that smartphone-based m-health will play an increasingly 
important role in lifelong tracking of health. By providing regular advice, alerts and 
recommendations, the mobile applications will allow supporting positive changes in 
lifestyle behaviours and preventing age-related disease/disability.
  Universal design and smart home technology will also favour ageing in the home 
by providing increased security, safety, help in daily living activities, and social 
connectedness. Moreover, the rapid development of assistive robots will facilitate 
ageing in the home and at-home care delivery.
  Prescribed devices and apps may provide information to support clinical decision-
making and accelerate hospital discharge.
  Care technologies will ease the lifelong follow-up of health and chronic clinical 
conditions and functional abilities through remote monitoring, at-home physical 
rehabilitation, brain training and control of medications compliance.
  Technology will also transform diagnostic and surgical procedures. Applications of 
machine learning algorithms (artificial intelligence, or AI) in the field of ageing research 
offer enormous possibilities. Such methods applied to data, acquired at a single time 
point or longitudinally, can be employed to generate predictors of disease and identify 
19
S
U
M
M
A
R
Y moments for early intervention. AI-derived biomarkers of ageing enable a holistic 
view of biological processes and allow for the development of new methods to build 
causal models, extracting the most important features and identifying biological 
targets, thereby favouring drug discovery.
Although technology offers fantastic promise for facilitating healthy ageing, practical 
applications are currently limited for multiple reasons:
  Acceptance. Technology uptake varies substantially among older individuals, 
influenced by affordability, ease of use and functionality of devices, as well as 
personal preferences, knowledge and concerns over data privacy. Moreover, 
developing technical solutions for home monitoring requires consideration of both 
care receivers and care providers (formal or informal), who may not be sufficiently 
trained in this domain.
  Global efficiency & proven outcomes. Some remote health care monitoring models 
have shown clear benefits for patients with chronic diseases, while others have not 
been able to demonstrate significant improvements. There are still several obstacles 
to achieving widespread use: economical sustainable reimbursement systems, 
interoperability between electronic health record systems, and technological capacity 
to accommodate bandwidth-heavy telemedicine programs in smaller hospitals, clinics 
and in the home.
  Standardisation. Developing standards in this area will need strong liaisons and 
collaborations with regulatory agencies to fully standardise data from wearable 
devices, as well as the transmission, processing and storage of data generated from 
the home.
  Funding. Reimbursement for equipment varies across EU member states. More 
expensive equipment is funded on a means-tested basis and according to local 
funding criteria. These items can be provided directly and free of charge to patients, 
or, if approved, purchased through personal budgets granted by local councils.
However, none of these current obstacles will stop the development and use of 
technology. A rapidly growing number of wearable devices for medical use has arisen, 
due to the prevalence of smartphones, the surge in the use of connected devices known 
as the Internet of Things, the portability of wearable devices and the increasing costs 
of health care. The advantage of this consumer market is that the cost of devices will 
continue to decrease while the devices become more technically advanced. Prescribing 
devices and apps that may provide information to support clinical decision-making and 
accelerate hospital discharge is an area of promise.
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Regarding the use of advanced technology, the challenge posed to acute care in 
hospitals, but also to long-term care of older adults at home, is the development of 
processes to ensure the assessment of data from smart devices for validity; consent 
to access data must be appropriately acquired and data storage correctly managed 
(including consideration of whether these data carry implications for the electronic health 
record system).
10 However technology advances, an adequate number of skilled health care 
professionals will be absolutely essential. The aforementioned strategies for 
transforming the future of ageing depend, at the same time, on the care needs of the 
population, the organisation of health services and the quality and preparedness of the 
health workforce. Without coordinated efforts among ministries of education, health, 
finances and labour, a shortage of skilled health care workers will remain a daunting 
problem. Improving the health of the population, health services and health education 
should be seen as an investment rather than a cost.
Altogether, the 51 countries of Europe currently suffer from a lack of 1 million health 
care workers (physicians, nurses, midwives, associate and allied health professionals, 
care workers and carers). Without urgent, coordinated educational initiatives and 
attractive human resources policies, the lack of health workers in Europe will reach 
4.1 million by 2030.
In this context, the current health care workforce crisis in the EU is due, in part, to the fact 
that:
  the workforce itself is ageing and suffers from an annual rate of attrition reaching 10%;
  the needs and demands of the increasing older population are rapidly changing;
  the health services provided need to adopt more efficient planning, hiring and 
management procedures in a world embracing a technological revolution.
Keeping in mind the close relationship between health workforce size and global health 
outcomes, the report insists on the urgently needed efforts to build and retain a strong 
and skilled health workforce and to match its supply to population care needs, current 
and future.
Education will play a major role in transforming ageing into an opportunity for 
all. Enhancing health education from primary school to adulthood is indispensable. 
Identifying middle school students who later may be candidates for entering the health 
workforce may be one method to attract greater numbers of health care workers. 
Enhancing and improving workforce training (knowledge, skills and attitudes) to make 
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physicians, nurses, associate and allied professionals, adopting interactive teaching, using 
mannequins to teach technical care gestures, and employing information communication 
technology (for example, blended teaching, serious games, multidisciplinary virtual 
scenarios and virtual reality).
Human resource policies needs to attract and retain health care workers and allow for 
lifelong learning tied to an attractive career ladder and opportunities for advancement. 
Furthermore, it must not be forgotten that developing and promoting a strong health 
care workforce not only leads to improved quality of care, but also serves as an excellent 
stimulus for economic development.
In summary, ageing is part of the life course and may be associated with health challenges, but 
also opportunities. A broad spectrum of individual and societal measures, including education, 
are required to facilitate best ageing.
22
S
U
M
M
A
R
Y
General overview
The exceptional increase in life expectancy in Europe, which rose from 45 years in 1840 to 85 
years in 2000, is one of the most remarkable indicators of progress in modern development 
(Oeppen & Vaupel, 2002):
Figure 1. Record of female life expectancy from 1840 to the present (Oeppen and Vaupel, 2002). The dashed red 
lines denote projections of female life expectancy in Japan by the United Nations in 1986, 1990 and 2001.
Europe, at the forefront of this demographic transition, now enters a stage characterised by low 
fertility and low mortality. After the collapse of the communist regimes in Central and Eastern 
Europe around 1990, there was a big and sudden drop in fertility, from 2.1 to 1.3 children per 
woman. According to Eurostat, the fertility rate is now slightly higher, around 1.7 (Eurostat, 2019a). 
Consequently, in 2016, there were 98 million people in the European Union aged 65 years or 
older, compared with 80 million children aged 16 or younger (Eurostat, 2018h). Projections show 
that this trend is currently only halfway through and will reach its peak around 2040-2050.
  The percentage of adults aged over 65 years will increase from 19.5% in 2016 to 29.5% of the 
global EU27 population;
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EU27 population.
Thus, the ageing of European populations and their individual care have become topics of 
utmost importance for all EU policymakers.
Over the past few years, this situation has prompted a very large number of reports on ageing-
related challenges, in particular, the economic impact of delayed retirement age, labour 
participation, the “silver economy”, health care and long-term care expenditures, migration flows, 
and pensions. In this complex array of reports, the present Evidence Review Report reflects 
a conscious decision to focus essentially on individual health and social care from a broad 
scientific perspective on public health. The main goal of this approach is to emphasise the fact 
that each individual is an active player in his or her own ageing process and makes conscious 
and unconscious decisions that pave the way for healthy or unhealthy ageing.
However, this focus on individual health and social care does not mean that the present report 
ignores the fact that ageing must be considered in a holistic way, representing an opportunity for 
both individuals and society as a whole (Gonzales, Matz-Costa, & Morrow-Howell, 2015).
  At the individual level, for most, ageing is much preferred over early death, as it allows 
people to realise their potential, achieve personal fulfilment, and bring stability to their family 
and surroundings using their insight and problem-solving abilities. Moreover, additional 
healthier years of life enable older adults to remain engaged in the economy as taxpayers 
and active consumers (Davey & Glasgow, 2006). This approach to ageing contrasts with 
outdated negative stereotypes of elderly citizens and celebrates age as a continuing chance 
to redefine oneself over the life course. However, the ageing population is not homogenous; 
there are huge social, economic and cultural variations that have a significant impact on 
ageing and need to be properly considered.
  At the societal level, ageing allows for increased productivity, greater professional expertise, 
and the growing global longevity economy, including the intergenerational exchange of both 
material and non-material items (education, experience, know-how, etc.) (Gurven & Schniter, 
2010), which forms lasting bonds between generations (Albertini, 2016).
In order to tackle the ambitious task of producing an Evidence Review Report on ageing and 
health from a medical standpoint, which was underrepresented in previous publications, 
twenty-three working group members and twenty-seven additional external contributors from 
different disciplines — geriatric medicine, gerontology, epidemiology, psychology, sociology and 
technology, as well as architecture, economics, engineering and law — worked as a team for 
nine months. Sharing the belief that close collaboration and dialogue among researchers, health 
care providers, and policymakers is absolutely essential, the participants in the present report 
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25
S
U
M
M
A
R
Y worked toward the goal of providing the most scientifically solid arguments to EU policymakers 
in order to answer the following questions:
  What measures are needed to enable health care systems to face the challenges posed by 
the current generation of older adults?
  How can public health policy best organise efficient prevention, control and treatment of 
early and midlife risk factors, to ensure that people have good functional ability when they 
enter old age?
Two sub-questions evolve from these questions, namely:
  What public policies can facilitate the taking up of innovative technologies, including 
software and communication tools, by older adults and health care institutions, in order to 
meet the challenges and opportunities posed by an ageing society?
  What is needed to build and sustain an appropriately skilled workforce in the coming 
decades for the optimum organisation of health systems and for the delivery of quality health 
and social care to older adults?
OVERVIEW OF CHAPTER 1
Chapter 1 of this Evidence Review Report provides current demographics and updated 
prospects, explains the choice of the WHO definition of “healthy ageing” and its focus on 
combating ageism.
The term “healthy ageing” first appeared in scientific literature in 2006 (Swedish National Institute 
of Public Health, 2006). It was preceded by “successful ageing” five decades earlier (Havighurst, 
1961) and, more recently, by “active ageing” (WHO, 2002) and “active healthy ageing” (European 
Commission & European Committee of the Regions, 2011).
In 2015, after a careful analysis of the aforementioned terms, the first WHO report on ageing 
and health proposed the new term “healthy ageing” as “more than just the absence of disease” 
(as Margaret Chan, former director-general of the WHO, put it) but rather “the process of 
developing and maintaining the functional ability that enables wellbeing in older age” (WHO, 
2015b). Functional ability depends on the interaction between “intrinsic capacity, the composite 
of all physical and mental capacities, and the specific life environment of each individual” (WHO, 
2015b).
Social and behavioural scientists severely criticise the term “healthy ageing” for its strong 
medical and biomedical connotations. However, in order to maintain the focus of the present 
Evidence Review Report on functional ageing, it was decided that this term properly stressed 
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the importance of physical, mental and cognitive daily functioning in performing specific tasks, 
including self-care activities in different life environments, in order to fulfil the current and future 
care needs of the ageing EU population.
Ageism — discriminatory attitudes and behaviours toward older adults — is perhaps the clearest 
example of how changing societal values have contributed to the projection of negative 
images of ageing and older adults. In both subtle and obvious ways, ageism is manifested by 
individuals, communities, institutions, and entire governments. As explained in the recent AGE 
Platform Europe Position on Structural Ageism, the systematic stereotyping of ageing and older 
people has enabled society and its institutions to “sustain ageist attitudes, actions or language 
in laws, policies, practices or culture”, as seen in “upper age limits, the inadequate provision of 
services for the needs of older people, the failure to take situations, experiences or aspirations 
of individuals into account when making decisions or allocating resources, or the segregation 
of people in later life due to a lack of real choice to remain active in their communities” (AGE 
Platform Europe, 2016). Women are particularly vulnerable to ageist policies, especially in terms 
of elder abuse (see page 186) but also inadequate pensions, which are often penalised by 
career breaks taken in order to assume care responsibilities.
The lack of positive models of ageing and older adults must be effectively addressed now to 
prevent the situation from exacerbation for an ageing society. Furthermore, it is a sign of much 
more serious underlying societal issues.
OVERVIEW OF CHAPTER 2
Chapter 2 of the report presents the life course perspective used to address healthy ageing.
The life course approach taken in this report builds on the concept of functional ageing by 
studying the natural history of the growth, maintenance and decline in physical and mental 
(cognitive and emotional) capacities across the whole life. It summarises what is known about 
biological mechanisms of ageing at the cellular and molecular levels, which operate from the 
beginning of life. Biological age may prove more useful than chronological age in identifying 
health care needs and may help to tackle the ageism that exists within societies. The life course 
approach examines the long-term effects of physical and social exposures during gestation, 
childhood, adolescence and adult life that act independently or interactively to impair or protect 
capacity and increase or decrease disease risk (Kuh, Ben Shlomo, 2004; Kuh, Cooper, Hardy, 
Richards, & Ben Shlomo, 2014a). The large heterogeneity in the ageing process encourages 
scientists to investigate functional change and disease development over the life course and 
whether associations between risk factors and ageing outcomes change with chronological 
or biological age. The life course approach attempts to better understand the interconnected 
biomedical, behavioural and socioeconomic pathways involved in the development of age-
related disability and to intervene early in life to pave the way for a positive life course trajectory.
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chronic diseases and disability over the life course:
  to build physical and cognitive capacities and thus enhance reserves so that maximum 
potential is reached by early adulthood;
  to delay the onset and pace of functional decline and disease during midlife;
  to slow the rate of decline or disease progression in late adulthood.
In the face of a daunting burden of disease, multimorbidity and disability, individuals and society 
should be made aware that it is seldom too late to intervene or too early to prevent chronic 
diseases and age-related disability.
OVERVIEW OF CHAPTER 3
Chapter 3 of the report deals with concrete and practical issues facing current health and 
social care for older citizens in the European Union. Its major concern is how to develop and 
optimise integrated health and social care in both the community and in acute and long-term 
care facilities. The frequency of chronic diseases, geriatric syndrome, multimorbidity and their 
functional impact on daily living activities are surveyed.
The special needs of older adults necessitate the sustainable development of environments 
and communities designed for all ages, to better engage them in the life and development of 
the society as a whole. In this context, mobility and driving are main issues currently witnessing 
innovations such as the rapid development of self-driven vehicles.
Ageing in people’s private homes needs to be favoured to better respond to the clear wishes of 
the aged population which, moreover, promote active economic involvement as encouraged by 
policymakers. Stronger support for informal carers as well as reinforcement of community health 
professionals is urgently needed. Technology in the home is a valuable care support tool, whose 
development, entailing public and private partnerships, has only just begun.
In parallel, a radical transformation of care facilities is needed. The development of hospitals for 
all ages and long-term care facilities conceived as a whole and integrated into the community 
provides promise for easing and increasing care delivery quality and security.
Indeed, even if care structures are modernised, care management and delivery must also be 
revamped. Medical structures for all ages will benefit from the expertise of geriatricians in care 
design:
  Reduction of emergency visits and avoidance of hospital admissions will benefit integrated 
care, including the implementation of universal health and social records. Early identification 
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of sarcopenia and frailty will avoid one of the most frequent causes of emergency visits: falls 
in older adults.
  Decreasing the length of hospital stays and readmission rates also depends on the 
implementation of transborder universal electronic health and social records in all EU 
countries. Moreover, the systematic application of a comprehensive geriatric assessment of 
all admitted older patients will allow for easier identification of the potential problems they 
face, including medical (malnutrition, inappropriate drug prescriptions), functional (disability, 
loss of autonomy) and social (loneliness, financial difficulty).
  Strict hygiene control, identification of shared care goals in collaboration with patients, 
fixed date for treatment evaluation and adjusted interventions (medication review, early 
rehabilitation) appear essential for effective and secure hospital care and control (reduction 
of acquired hospital admission), as well as for shorter hospital stays.
  Indeed, the integrated care system, including both universal health and social care records 
and a systematic comprehensive geriatric assessment of older patients, will allow the rate of 
nursing home admissions to be reduced.
  Long-term care, provided either at home or institutions for all ages (residences or nursing 
homes), must favour resident wellbeing while favouring de-institutionalisation and 
developing a palliative care culture.
OVERVIEW OF CHAPTER 4
In Chapter 4, technology advances are highlighted to complement the previous sections of the 
report.
Information communication technology increasingly empowers and engages EU citizens in 
health self-management, as exemplified by wearable sensors and m-health; assists older 
people living at home, offering them security, safety and help in daily functioning; and facilitates 
communication with family members, friends and communities. A unique electronic medical 
chart interoperable in all EU countries, telemonitoring, and integrated diagnostic and data 
science could help transform health services, from diagnostics to care delivery and rehabilitative 
processes, and benefit from robotic assistance. However, these quickly developing technologies 
raise innumerable questions regarding acceptance, privacy, regulation, and certification, as well 
as proven outcomes, reimbursement and health economics.
OVERVIEW OF CHAPTER 5
Chapter 5 focuses on the health and social care workforce in relation to all the previous sections 
of the Evidence Review Report. At the EU level, there is currently a lack of one million health 
and social care professionals. Prospects for 2030 are alarming, with an expected deficit of 
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EU level along ministries of health, education, labour and finances, in order to overcome the 
health care workforce crisis and to better cope with the current and future needs of the EU 
population. Indeed, basic and health education appear essential to improve not only the health 
behaviours of the general population, but also the knowledge, skills and attitudes of the health 
care workforce. A more positive and attractive perception of ageing needs to include innovative 
training initiatives aimed at future health care professionals; use information communication 
technology; favour transversal and multidisciplinary training scenarios; and adapt professional 
teaching activities to virtual reality. However, these efforts will not prove effective without 
human resources policy changes, including tempting recruitment, lifelong education, regular 
recertifications and the establishment of career ladders and incentives.
OVERVIEW OF CHAPTER 6
Finally, Chapter 6 summarises the science-based proposals for policy emerging from the report, 
enabling policymakers to select the most appropriate ones and prioritise public health decisions 
that favour functional ageing for the greatest number of ageing and older EU citizens.
Policy options
Throughout this report, specific policy options are highlighted in orange.
Orange icons highlight policy options proposed for the European Union itself; EU 
member states; and research and academia.
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Chapter 1. Transforming challenges 
into opportunities
DEMOGRAPHIC CHANGES IN THE EU: TRENDS 
AND PREDICTIONS
The global context
Sweeping changes have taken place across European society, particularly over the last century, 
changing the paradigm of ageing. The basic structures underlying business, education, tax 
distribution and social benefits, family units, places of residence, communication and even 
leisure have experienced fast and profound changes. Taking into consideration that the life 
expectancy of the next generation of older people is likely to surpass that of their parents, it 
becomes absolutely necessary to foresee and plan for the problems that they will face. This 
section sets out the demographic framework behind these changes and sets the stage for 
understanding the ageing process in Europe.
The 20th century witnessed a stunning demographic change worldwide. At the beginning of 
the 20th century, the world population measured 1.6 billion inhabitants, compared to 7.3 billion 
today. The pace of world population growth rate has accelerated dramatically since 1950. 
Around 1976, world population growth reached its peak of 2.1 per cent per annum, after which it 
slowly started to decelerate to 1.5 per cent today, which still means a doubling of the size of the 
world population over 46 years. This long-term growth path of the human population has been 
described as the first demographic transition, an almost universal pattern worldwide, but with 
different timing and intensity across regions and countries.
The demographic transition may be characterised by three distinct phases: an initial phase of 
very low population growth, as a result of high mortality and high fertility; followed by a fast 
growth phase of declining mortality levels, but still high fertility levels; and a third phase of slow 
growth again when fertility dropped to low values.
  Europe has clearly been a frontrunner in this transition and has reached the third stage of low 
population growth. The EU28 has even reached the stage of zero population growth, and the 
population is projected to decline in the 21st century; world population growth, although still 
high, is also decelerating (Figure 3).
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  North America and Australia have also reached the third stage of the transition, but for these 
regions the impact of migration as an additional growth component in the past has been 
higher.
  Latin America and Asia have followed much later and are still in the second phase of rapid 
population growth, but the growth rate is decelerating and before the end of the 21st century 
they will also reach the third stage.
  The trend in Africa is slower. It has experienced the fastest drops in mortality worldwide, but 
fertility has only recently started to decrease.
As a result of these developments, the share of the EU28 countries in the world population has 
dropped considerably, from 14 per cent in 1950 to 6.8 per cent today, and it is anticipated to 
drop to 4 per cent in 2060. The current size of the world population is 7.6 billion and will grow to 
9 billion in 2040 and 10.2 billion in 2060.
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Figure 3. EU28 (left axis) and world (right axis) population, 1950–2060. Sources: Eurostat (2019); United Nations 
(2017).
The changing impact of natural increase and migration
Without migration as a growth component, the population of the EU28 would start to decrease 
as of now. Natural increase (births minus deaths) is around zero at present and will decrease 
steadily in the coming decades (Figure 4). Net migration has reached historically high levels in 
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recent years, but in the baseline Eurostat projections1 it is assumed that it will remain structurally 
at about 1 million individuals per year during the coming decades. As a result of this positive 
migration component, the EU28 population will continue to grow from its current level of 
508 million to an estimated 529 million in 2045, but will start to decrease thereafter. Compared to 
world population growth, this is a very low growth rate. Population growth is also very unevenly 
distributed across the EU28, with a strong decline in Eastern European countries (Bulgaria, 
Romania), and small growth in Northern and Western Europe. There is also a strong divide 
between rural and urban areas, with population decline and ageing going hand-in-hand in most 
European rural regions.
Since the 1960s, Europe has been a continent of structural immigration. Over time, the motives of 
migrants, as well as their origins, have become more diverse. As a result, Europe has become a 
multi-ethnic society, which adds to the diversity in demographic behaviour, but also to significant 
integration and inequality challenges as well as increasing societal tensions. Currently 11.2 
percent of the EU28 population is foreign-born, up from 9.8 per cent in 2010, of which a large 
minority is from other EU countries.
Ageing and migration are related. First, migration is viewed by some as the ‘solution’ to the 
ageing process, since it adds numbers to the working-age population (United Nations, 2001). 
Given the sheer numbers required, this solution can at best be partial. Second, migration could 
help to mitigate the labour shortages in the care sector for older adults (WHO, 2006b). Finally, 
ageing is becoming an issue in many migrant populations as well (Fokkema & Nedelcu, 2017).
1 Unless otherwise specified, all projections in this section refer to the Eurostat population projections that use the population 
from 1 January 2015 as a baseline (Eurostat, 2019b).
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Figure 4. Natural population increase and net migration in EU28, 1950–2060. Sources: Eurostat (2019); United 
Nations (2017).
The root cause of population ageing: baby boom and bust
One of the most profound changes in Europe’s demography, and a key factor behind ageing, 
has been the stark drop in fertility during the 1960s and 1970s (Figure 5). Many countries in 
Europe experienced a baby boom after World War II, leading to large post-war generations 
and high population growth. This post-war surge in fertility temporarily interrupted the longer-
term decline in fertility, as described in the first demographic transition in many countries. In the 
1950s, the European total fertility rate, i.e. the average number of children a woman has during 
her lifetime, was 2.66, but values above 3 were no exception, such as Poland (3.6), Slovakia (3.5), 
Ireland (3.4), Portugal (3.1), and the Netherlands (3.1). This baby boom was followed by a baby 
bust, although in Eastern Europe this occurred somewhat later. This sudden transition has been 
labelled the ‘Second Demographic Transition’ (Lesthaeghe, 2014; Van De Kaa, 1987).
A key factor behind the Second Demographic Transition was the introduction of the 
contraceptive pill, which allowed women to postpone childbirth. In 1950, the average age for 
having the first child in Europe was 22.8 years. This increased to 28.7 years in 2015, with the 
highest values for Spain (30.4 years) and Italy (30.6 years) (Eurostat, 2015).
The Second Demographic Transition fits in the larger picture of changing cultural values in 
Europe (Van De Kaa, 1987). Rising incomes, as well as educational expansion for the post-
war generations, allowed them to develop a lifestyle different from that of their parents, 
characterised by greater freedom and individuality.
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The pattern in Eastern Europe developed somewhat differently. In the Communist era, women 
were expected to combine a working career with motherhood, which resulted in a much more 
moderate drop in fertility, from 2.9 in 1950 to 2.2 in 1970. A second big and sudden drop in fertility 
(from 2.1 to 1.3) occurred after the collapse of the Communist regimes around 1990.
The Eurostat baseline population projection foresees that the average number of children of 
future European generations will be slightly higher, around 1.7 children per woman. This is the 
consequence of reaching the end of postponing childbearing age, which will have an upward 
effect on the (period) value of the total fertility rate (Bongaarts & Feeney, 1998).
The structural drop in fertility is well illustrated by the change in the size of the respective 
birth cohorts since 1945. The baby boom generation (those born between 1945 and 1975) was 
217 million persons. Their children’s generation (1975–2005) was 170 million. According to the 
current Eurostat projections, the following two generations (2005–2035 and 2035–2065) will 
be 148 million and 139 million respectively. This will impact upon the potential for provision of 
informal care, especially for those without children who are in need of care (Agree & Glaser, 
2009).
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Figure 5. Total fertility rate in Europe, 1950–2090. Sources: Eurostat (2019); United Nations (2017).
Living longer
The exceptional increase in life expectancy in Europe since the middle of the 19th century is 
one of the most remarkable indicators of progress in human development. Oeppen and Vaupel 
(2002) have shown that maximum life span worldwide since 1850 has increased by 2.5 years 
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per decade. This increase can be explained by the epidemiological transition (Omran, 2005), 
which describes how mortality has decreased since the end of the 18th century, as a result of 
overcoming death caused by:
  phase 1: pestilence and famine (which took place in Europe largely before 1850)
  phase 2: pandemics (in Europe in the latter half of the 19th and first half of the 20th century)
  phase 3: degenerative and man-made diseases (since 1950), which may be further 
subdivided into diminishing cardiovascular diseases in the 1960s and 1970s, and the age of 
controlling ageing-related diseases since the 1980s (Barrett et al., 1998).
For most of this time, European countries (especially Sweden and France) were the frontrunners 
in highest life expectancy, but since the middle of the 1980s Japan has taken the lead. 
Nevertheless, European countries in general have an impressive record in this respect. Figure 6 
shows that, since 1950, life expectancy at birth increased from 67 to almost 83 years for females, 
an increase of more than 15 years, or 2.4 years per decade, and from 63 to almost 77 years 
for males, which is an improvement of almost 15 years, or 2.2 years per decade. The gender 
gap widened in the 1970s due to a stagnation of the increase among males which was largely 
caused by the smoking epidemic (Janssen et al., 2007; Vallin & Meslé, 2004).
According to Eurostat projections, the children and grandchildren of baby boomers are expected 
to live even longer than their parents and grandparents. Currently, life expectancy is 77.7 years 
for men and 84.3 for women. The next generation may expect to see about another five years 
added to their lives. According to Eurostat projections, life expectancy in the EU28 for males is 
expected to increase by 7.2 years to 84.9 between 2015 and 2060, 4.9 years of which (or 68 per 
cent) will be after 65 years of age. For women the values show a 6.2-year increase, with 4.7 years 
(or 75 per cent) due to improvements in survival after age 65.
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Figure 6. Life expectancy at birth in the EU28, 1950–2060. Sources: Eurostat (2019); United Nations (2017).
Differences among countries within Europe diminished until the 1970s, mainly because of 
catching up of infectious disease control in Eastern Europe (Mackenbach, 2013). The trend has 
reversed since then, again due to the diverging path of Eastern Europe. Northern, Southern and 
Western Europe have converged as a result of better controlling man-made diseases such as 
cardiovascular diseases and breast cancer; the development of an extensive health care system; 
and accident prevention (Figure 8). Eastern European life expectancy stagnated or decreased 
since the 1960s, only to show an increase after 2000.
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Figure 7. Life expectancy in four European regions and Europe as a whole, 1950–2015. Source: United Nations 
(2017).
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Economic and social gradients in life expectancy
The main driver behind the demographic and epidemiological transitions is modernisation, 
which is indicated by economic development and education. There is a clear linear relationship 
between economic development (as indicated e.g. by GDP per capita) and life expectancy. As 
seen in Figure 8, a difference of €10 000 in GDP per capita between countries corresponds to a 
difference of 0.5 years in life expectancy.
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Figure 8. Gross Domestic Product versus life expectancy at birth in the EU28 (excluding Luxemburg), 2000–2015. 
Source: Eurostat (2018b; 2018d).
In some countries, the next generation of older adults represents the first to have completed 
compulsory health education integrated in the school curriculum, as well as to have the highest 
rate ever of successful completion of basic primary and secondary education. This will have 
profound effects on their health status. Figure 9 demonstrates the role of education in improving 
health. Moving up from basic education to mid-level education results in an increase in life 
expectancy of about four years. Having completed the highest educational levels adds another 
2.5 years to life. These figures are evidence of the potential of education for primary prevention 
of disease and disability.
Nevertheless, innovative educational programmes are necessary to target at-risk groups more 
effectively, as detrimental habits are often adopted regardless of exposure to basic and health 
education. Exploring ways of integrating concepts from emerging fields such as m-health and 
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personalised medicine into education programmes in a way that is attractive, user-friendly, and 
more directed toward specific groups could help harness the potential of these programmes.
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Figure 9. Life expectancy at birth by educational level in the EU28, 2007–2016. Source: Eurostat (2018c). 
Explanation of educational levels: Level 0–2: Less than primary, primary and lower secondary education; 
level 3–4: Upper secondary and post-secondary non-tertiary education; level 5–8: tertiary education.
Healthy life expectancy
An important question concerning healthy life expectancy is how the extra years of life are spent 
(largely beyond 65 years). Are the extra years healthy years or years with disability, with severe 
consequences for health care budgets?
Table 1 provides some recent evidence at the European level. For females, on average 64.2 
years of life are spent in good health, and 19.4 years (almost a quarter of the lifetime) with some 
disability (2016). Males, although they live on average more than five years less, spend five years 
less in poor health, which means that the extra years lived for females are almost all spent in 
poor health. This is called the ‘female–male health survival paradox’ (Oksuzyan et al., 2008). The 
time trend is positive, for both sexes: the life years gained between 2010 and 2016 are all in good 
health, and the unhealthy years have even decreased in absolute terms.
Healthy life expectancy has an even stronger gradient with socioeconomic status than mortality. 
People with low income and low educational attainment not only live shorter lives, but also more 
years of their lives are spent unhealthy and with functional limitations (Stringhini et al., 2018).
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Females Males
Life 
expectancy
Healthy 
years
Unhealthy 
years
Life 
expectancy
Healthy
years
Unhealthy 
years
2010 82.8 62.6 20.2 76.9 61.8 15.1
2016 83.6 64.2 19.4 78.2 63.5 14.7
Change  +0.8  +1.6 –0.8 +1.3 +1.7 –0.4
Table 1. EU 28 life expectancy at birth, healthy life expectancy at birth, and unhealthy years in 2010 and in 2016 
(Eurostat, 2018a, 2018b).
Old age dependency ratios
The post-war generation started to move into retirement around 2010. Due to the size of this 
generation, this has resulted in a stark increase in the percentage of retirees since then. Added 
to this development is the extension of the length of life, leading to the older cohorts taking up 
an even larger share of the population.
The number of people aged 65+ to people in the working age range (20–65 years) is called the 
old age dependency ratio, and is expressed per 100 persons of working age. This number has 
increased significantly, from 16 in 1950 to 21 in 1980 and to 28 at present (Figure 10). It will further 
increase until the level of 50 around 2050, and remain stable thereafter, which will mark the end 
of the ageing transition in Europe.2
The child dependency ratio is the ratio of dependent people aged 0–14 to those typically in the 
labour force (the productive part aged 15–64). Used to measure the pressure on the productive 
population, it dropped from 59 children per 100 persons of working age in 1950, to 52 in 1980, 
and to 33 now. It will decrease further to 25 and stabilise at levels below 30 thereafter.
As the combined result of both these developments, the demographic pressure (i.e. the sum 
of old-age dependency ratio and child dependency ratio) has decreased since 1950, and is 
currently at its lowest point, to increase again in the future to about 80 around 2050. Whereas it 
was mostly due to the number of children in the past, it is now the number of older adults that 
make up almost half of the demographic weight. Obviously, it concerns the same generations: 
the young of the past are the older people of today (Figure 10).
Not only is the proportion of the 65+ age group increasing over time, but, after 2030, it is primarily 
the 85+ age group that will grow in proportion and number. This means that the ageing process 
will represent a double challenge for society, as the demand for health services increases while 
the available supply decreases. Informal health care is an important resource for this age group, 
which is to a large extent provided by those in the age group 50-74 (see Chapter 4). The oldest 
2 The use of ‘dependency ratios’ has been criticised as ageist; see page 53 for further discussion.
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old support ratio is the number of 50–74-year-olds for each person aged 85+ (Robine et al., 
2007). Currently there are 12 persons aged 50–74 for each person aged 85+, but in 2040 there 
will be only 6 persons, and in 2060 this number will have further dropped to 4. Undoubtedly, 
therefore, the future resources for informal caregiving to those in need of it will diminish and 
alternative solutions will need to be developed.
Fortunately, future generations of older adults will be more highly educated than previous 
generations (Commission/EACEA/Eurydice, 2019; Koucký et al., 2010). As a consequence of 
this, on the one hand, the incidence of dementia will be delayed, and on the other hand more 
highly educated people are in general more familiar with digital technologies and internet-
based applications. It is thus likely that many of them will be avid users of ICT tools developed 
to assist them with their future health and social care needs, to substitute for the reduced 
resources for informal care from family and friends. In addition, robotics and artificial intelligence 
have emerged as areas where innovation could lead to the greatest impact on assistance and 
monitoring of the older adults.
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Figure 10. Old age (65+ vs 20–64) and child (0-19 vs 20-64) dependency ratios and demographic pressure (the sum 
of old age and child dependency ratios) in Europe, 1950–2080. Sources: Eurostat (2019); United Nations 
(2017). Note that the age ranges used in this figure are slightly different from those discussed in the 
preceding text.
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Concluding remarks
Europe’s demography has changed significantly in the last century. It has reached the last stage 
of the first demographic transition and gone through the second demographic transition, with the 
result that its population is now stagnating, and would even decrease without migration. Fertility 
levels have dropped to below replacement levels and, at the same time, life expectancy has 
surged. European citizens are getting older than ever before, but at the same time they spend 
a significant share of their lives with disability. The population diversity in health and mortality is 
important, in terms of geographical, educational, income and ethnic background.
A stabilising population is an ageing population, and again Europe is globally at the forefront of 
these developments. A negative replacement fertility level in an affluent society such as Europe 
will almost automatically need a significant migration influx, as indeed indicated by projections. 
Ageing and migration are therefore the two most pressing demographic and societal issues 
for some time to come, but ageing is by far the more significant of the two, in terms of its 
consequences for wellbeing and sustainability of society, as reflected in social, economic, and 
ecological concerns.
Future projections show that the demographic transition previously described is, at present, 
only halfway through and will peak around 2040–2045. At the European level, the process of 
population ageing, defined as an increase in the share of older adults, will come to an end 
around 2050, with three out of ten persons being over 65 years of age by then. Moreover, after 
2030 the double load of ageing will become manifest, as currently older adults will have reached 
the age at which disability typically appears.
Policy option
It would be beneficial to take greater account of data on demographic trends to 
inform policymaking. The data highlights certain challenges that governments face 
and allows the targeting of appropriate issues for policy actions.
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1A. THE EUROPEAN HEALTH LANDSCAPE IN 
TRANSITION
Demographic transition
The European health landscape is gradually adjusting to the challenges and opportunities posed 
by the demographic transition. Longevity is rising steadily, albeit at a slower pace than in the 
past half century, and fertility rates are at historically low levels. Jointly, these trends give rise to 
an increasing share of individuals aged 65 and over, leading to an old-age dependency ratio of 
55.9 in 2050 (OECD, 2017b). With the advance in life expectancy gradually levelling off, healthy 
life expectancy is gaining more traction as a concept and policy objective. Indeed, while women 
in the EU are currently expected to live for 83.6 years and men for 78.2 years, their healthy life 
expectancy is 19.4 years shorter for women and 14.7 years shorter for men (Eurostat, 2018a). 
Closing this health gap in life expectancy is one of the key challenges for the years to come.
Epidemiological transition
Together with the demographic transition, the European health landscape is confronted with 
a new phase in the epidemiological transition, with an ever-increasing burden of chronic non-
communicable diseases such as cancer, cardiovascular disease, chronic and obstructive 
pulmonary disease and dementia (James et al., 2018). Ever more frequently, we observe 
individuals afflicted with multiple chronic conditions (Barnett et al., 2012), which leads to potential 
problems with polypharmacy when individuals are confronted with multiple (prescription) 
medicines to combat and manage a host of different conditions. As the interaction between 
many different medicines is hard to ascertain, each patient’s reaction to his or her combination of 
medicines is a matter of significant uncertainty (Guthrie et al., 2015).
Importantly, the origins of many chronic conditions can be traced back to life course 
socioeconomic, environmental and lifestyle factors. This implies that prevention strategies aimed 
at promoting healthy lifestyles and a reduction of environmental risk factors can potentially 
lead to a mitigation of the current and future burden of chronic diseases. In spite of its name, 
prevention does not, however, end with the prevention of disease. Indeed, a healthy lifestyle 
and environment can not only prevent disease but also limit disease progression and enhance 
treatment success. Therefore, to deal with the epidemiological transition, we should aim for a 
symbiotic relationship between prevention, cure and care (Bauer et al., 2014).
While the brunt of chronic conditions affects older adults, school age and working populations 
are confronted with a larger (relative) burden of mental health problems such as anxiety and 
depression (Whiteford et al., 2013). Given the early onset of these problems, they tend to have 
a composite effect over the life-cycle leading to a large loss of income and wellbeing, both for 
44
Tra
n
sfo
rm
in
g
 ch
a
lle
n
g
e
s in
to
 o
p
p
o
rtu
n
itie
s
C
H
A
P
T
E
R
 1
the individual and for society as a whole (Knapp et al., 2011). Indeed, mental health problems 
in adolescence may lead to lower school performance, then in early adulthood may lead to 
absenteeism or presenteeism which limit career progression and finally cause early retirement 
(Koenen et al., 2013). As such, the costs of mental health problems manifest themselves mainly in 
the non-medical domain. The early onset of mental health problems also implies that effective 
prevention interventions aimed at children and adolescents can potentially generate very large 
benefits for individuals and society at large (Angelini et al., 2018).
Health inequalities
The demographic and epidemiological transitions are not uniformly felt across different 
socioeconomic groups. Indeed, the extant literature shows that individuals in lower 
socioeconomic groups tend to have worse health outcomes than individuals in higher 
socioeconomic groups (Stringhini et al., 2017). While the causality between health outcomes 
and socioeconomic status is complex and multi-directional, a growing body of literature 
acknowledges that adverse socioeconomic conditions in childhood are causally related to a 
variety of adverse health outcomes later in life (van den Berg & Lindeboom, 2014). Ongoing 
and future research should shed more light on the mechanisms — in particular modifiable 
mechanisms — by which socioeconomic conditions early in life affect health outcomes later in 
life (Almond et al., 2017). These mechanisms can be part of a prevention policy agenda aimed at 
mitigating the impact of adverse early life conditions on health outcomes over the life-cycle.
While much of the literature, and policy, focuses on understanding and mitigating differences in 
health outcomes between socioeconomic groups, health outcomes also differ quite substantially 
within socioeconomic groups (Ferrer & Palmer, 2004). These differences reveal that there are 
individuals in lower socioeconomic groups who do very well in terms of health outcomes and, 
simultaneously, there are individuals in higher socioeconomic groups who are actually quite 
unhealthy. Potentially, these differences within groups give rise to policy anchors that are 
more promising than those derived from differences between socioeconomic groups. After 
all, identifying why certain individuals seem to be ‘immune’ — in both a positive and a negative 
sense — to their environment may hold the key to designing laws, policies and interventions that 
can improve health and wellbeing in all socioeconomic groups.
In the near future, health differences between groups are likely to widen due to the interplay 
between the demographic and epidemiological transitions. Indeed, with chronic diseases 
manifesting themselves mainly later in life, as well as an increasing share of older adults in 
society and a higher prevalence of chronic diseases among lower socioeconomic groups, the 
observed average gap in health outcomes between groups will be more pronounced. Potentially, 
this will have consequences for the sustainability of the health care system that rests on a large 
degree of solidarity between sick and healthy individuals. To counter the widening gap in health 
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outcomes, preventive interventions early in life should be supplemented with interventions at 
each point of the life-cycle to mitigate and maybe even ameliorate the health impact of adverse 
socioeconomic conditions.
Health clusters
While prevention, cure and care tend to be organised quite differently and separately from each 
other in most European countries, sustainability of the European health landscape calls for a 
deeper integration between prevention, cure and care, particularly in primary care (Linde-Feucht 
& Coulouris, 2012). To achieve this integration, it serves to organise health in regional clusters 
around, for instance, the referral area of tertiary care centres. In general, individuals within such 
a cluster will enjoy the lion’s share, if not all, of the cure and care that they receive over their life-
cycle from a provider within the cluster. Within these regional health clusters, policy and practice 
in prevention, cure and care can coordinate and plan the provision of health with different 
degrees of formality, and knowledge development can be facilitated by closely aligning the 
clusters with knowledge institutes in translational networks so as to improve the quality of 
prevention, cure and care (Ogilvie et al., 2009).
Health clusters will interact intensively with other clusters in their own country — for instance, in 
the case of treatment of rare or complex diseases — but also with clusters in adjacent countries. 
While citizens of the European Union have the right to use health care in a country of their 
choice, only very few individuals are aware of this right, let alone use it (European Commission, 
2016). Nevertheless, 150 million individuals live in a border region and could potentially gain from 
being able to use health care infrastructure in a bordering country. With (human) resources in 
health being increasingly scarce, efficient joint use of infrastructure in border regions seems like 
a straightforward strategy to increase capacity.
Concluding remarks
The epidemiological transition will increase the burden in:
  Non-communicable diseases (e.g., cancer, cardiovascular disease, chronic and obstructive 
pulmonary disease and dementia) in the older population
  Mental health problems (e.g., anxiety and depression) in school age and working populations
These medical conditions will lead to a large loss of income and wellbeing, both for the 
individuals and for society as a whole.
Causality between poor socioeconomic status and health outcomes is complex and multi-
directional; adverse socioeconomic conditions in childhood are causally related to a variety of 
adverse health outcomes later in life.
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Integration of prevention, cure and care will lead to increasing public health knowledge and 
higher quality of care.
Policy options
To counter the widening gap in health outcomes, comprehensive preventive 
interventions early in life should be complemented with interventions at each point 
of the life cycle (midlife is a period of particular importance).
Good policymaking would be supported by European collaboration to assess 
common challenges in ageing and gathering best practice in policies that have been 
effectively used to tackle them.
1B. APPRECIATING AGEING AS AN OPPORTUNITY
Whatever, the trends of the demographic and epidemiologic transitions (sections A and B), 
the present report stems from the understanding that ageing itself is an opportunity for the 
individual and society.
Ageing opens opportunities at the individual level
As the French entertainer Maurice Chevalier put it, “old age isn’t so bad when you consider the 
alternative”. Everyone (or the great majority) wants to grow old, given that the alternative is to die 
young.
Ageing allows for people to have a second, third and even fourth chance in life. Today, more 
than ever, older people have opportunities to have a second or third career (Ahn et al., 2017), a 
second, third or fourth relationship (Koren, 2011), and multiple diverse opportunities for lifelong 
learning (Narushima, 2008). This should not be overlooked, but rather celebrated as an ongoing 
prospect to redefine oneself over the life course, realise one’s human potential, achieve personal 
fulfilment and bring stability to one’s family and surroundings using insight and problem-
solving abilities. In old age, people are more likely to have time, wisdom and experience that 
can allow them to fulfil and explore their potential (Etezadi & Pushkar, 2013; Glueck & Bluck, 
2018). Moreover, research has shown that older adults who feel that their time in this world 
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is shortening are more attuned to positive aspects of their lives and experience less of the 
emotional turmoil which characterises younger age groups (Mather & Carstensen, 2005).
These processes could potentially serve as opportunities to come to terms with challenging 
experiences in one’s past. Opportunities for intergenerational relationships, not only with children 
but also with grandchildren, which many times serve as a chance to repair old family wounds, 
are additional benefits that may come with age (Burn & Szoeke, 2015; Gunderson & Carr, 2016). 
So is the opportunity to contribute to society and to exchange knowledge, skills and abilities with 
younger generations and each other (June & Andreoletti, 2018; Murayama et al., 2015; Zhang, 
2018). Older adults also benefit from the fact that normative expectations on them are more 
lenient, unlike other age groups that have to obey predefined roles and norms, which allows 
older people to redefine themselves.
However, the ageing population is not homogenous; there are huge social, economic and 
cultural variations that have a significant impact on ageing and need to be carefully considered.
Ageing as an opportunity at the societal level
Old age also has a tremendous potential for society at large (Gonzales et al., 2015). Specifically, 
given declining numbers of younger European employees, older people could potentially take 
on more productive roles in the workforce (Walker, 2019). Older people can be experienced 
workers who have time on their hands and are known to be highly reliable and devoted to 
their work (Walker, 2019). Moreover, society at large can capitalise on older adults’ wisdom 
and experience, and benefit from a lifelong perspective that allows for the dissemination 
and continuation of tradition and customs to the younger generations (Schniter, 2009). Older 
people provide a comprehensive perspective which incorporates lifelong experiences and 
knowledge (Walker, 2019), and exchange both material and non-material commodities with 
the younger generations (Gurven & Schniter, 2010). Specifically, research has shown that the 
transfer of financial commodities is more likely to go from old to young, who often support their 
adult children for many years after adolescence and early adulthood (Attias-Donfut et al., 2005). 
Moreover, older people also provide assistance in various tasks such as grandparenting or 
housing, for instance, that are not always financially quantified, yet have a tremendous value to 
both older adults, their adult children and grandchildren (Albertini et al., 2007).
However, the opportunities for intergenerational solidarity do not only go one way. Older adults 
also allow for intergenerational exchanges to go from young to old (Albertini, 2016; Albertini et al., 
2007). Such exchanges have the potential to create a more inclusive and compassionate society, 
which encourages empathy and understanding towards others, even if they do not contribute 
in active and productive ways, as not all older adults can or wish to stay productive members in 
society (Walker, 2019).
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Concluding remarks
At the individual level, ageing offers more freedom, facilitates personal fulfilment and choices 
of a second or third chance in life. With wisdom, more experience and time and less emotional 
turmoil, old adults can enjoy more leisure, do more shopping, travel longer or increase their 
lifelong learning or sponsoring big natural causes. Ageing can also favour intergenerational 
relationships and society contributions.
At the societal level, individual ageing allows for productive roles and disseminates experiences 
and knowledge, as well as traditions and customs, to the younger generations. Transfers of 
financial or non-material commodities are extremely frequent and appreciated. Such exchanges 
encourage empathy and understanding of others.
Policy options
There should be a greater recognition of the value that older people contribute to 
the economy and society. Effective policy can leverage that contribution to a greater 
extent, rather than just viewing ageing as a negative process and a drain on finances.
1C. REVISITING THE CONCEPT OF HEALTHY 
AGEING
In 2018, more than 3500 scientific papers were published in peer-reviewed journals on 
“successful ageing” (N=473) and “healthy ageing” (N=3064) (PubMed). The main problem faced by 
the readers of this prolific literature is the confusion surrounding the exact meaning of these two 
terms qualifying the ageing process: “successful” and “healthy” (Michel & Sadana, 2017; Sadana 
& Michel, 2019).
Defining successful, active and health ageing
While the benefits of preserving and maintaining health during later life are self-evident, over the 
last seven decades, the numerous attempts to conceive and define the ageing process across 
the life span has been impressively diverse. The approaches to the concept of ageing have 
evolved from the disengagement theory promoted in 1961 and towards a positive gerontology 
approach in the late 1980s, with a stronger focus on social participation (Rowe & Kahn, 1987).
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Disengagement theory 
(1961)
Desire and ability of older people to disengage from 
active life in order to prepare themselves for death
Cummings
Successful ageing 
(1963)
Having inner feelings of happiness and satisfaction with 
one’s present and past life
Havighurst
Index of activities of 
daily living (ADL) (1963)
Systematic approach to measuring physical performance 
in a population of older or chronically ill persons
Katz
Ageing successfully 
(1972)
Coping style: prior ability to adapt, and expectations of life, 
as well as income, health, social interactions, freedoms, 
and constraints. Personality adds also complexity to the 
definition of successful ageing
Neugarten
Successful ageing 
(1987; 1998)
Interplay between social engagement with life, health, 
and functioning for a positive ageing experience (low 
probability of disease and disease-related disability)
Rowe
Active ageing (2002) The process of optimising opportunities for health, 
participation and security, in order to enhance quality of 
life as people age
WHO
Healthy ageing (2006) Optimising opportunities for good health, so that older 
people can take on an active role in society and enjoy 
independence and a high quality of life
Swedish 
National 
Institute of 
Public Health
Healthy and active 
ageing (2011)
The process of optimising opportunities for health to 
enhance quality of life as people age and grow old
European 
Commission
Healthy ageing (2015) Healthy ageing is more than just the absence of disease; 
it is the process of developing and maintaining functional 
ability, needed for wellbeing in older age
WHO
Table 2. Brief history of the ageing concept. For more information and references, see Michel & Sadana (2017).
Since the 1980s, three definitions stand out in terms of their measurement criteria as most 
commonly used in scientific literature (Michel & Sadana, 2017):
  The term active ageing promoted by WHO in 2002 was enthusiastically received and 
immediately followed by proposals to create an Active Ageing Index (Oxley, 2009; Zaidi et al., 
2013).
  The term active and healthy ageing, introduced by the EU in 2011, which was developed 
by the European Innovation Partnership on Active and Healthy Ageing (2019), became the 
object of numerous and high-quality working group reports (Bousquet et al., 2017; Malva & 
Bousquet, 2016). This attractive definition combines multiple psychological, social, economic 
and medical approaches to optimising health and to enhancing quality of life as people age. 
Its ultimate aim is to extend healthy living for two additional years for all European citizens by 
2020.
  The 2015 WHO definition of healthy ageing (WHO, 2015b) represents a welcome balance 
between the adaptive processes that ageing adults undergo over the life course to modify 
their goals in the face of functional decline, and objective measurements to maintain or 
restore their functioning within the limits of researchers’ predetermined cut-offs. “Intrinsic 
capacity” is the composite of all physical and mental activities of an individual. Functional 
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ability depends on the interaction between “intrinsic capacity” and the specific life 
environment of each individual” (WHO, 2015b).
The different conceptual approaches
Among this flood of papers, Kusumastutia et al. (2016) have made a major contribution to the 
current understanding of these concepts by reviewing all papers on successful ageing written 
from 1902 to 2015 (Kusumastuti et al., 2016) and visualising outcomes using timeline-based 
citation patterns, thus differentiating between two distinct citation networks:
  The first, known as the Havighurst cluster, contained 1146 publications and 3946 citation links 
and focused on successful ageing from the perspective of older people themselves. Across 
the lifespan, the Havighurst cluster highlighted the importance of the adaptive processes 
that adults undergo to modify their goals in the face of age-related losses (e.g. death of the 
spouse, children, divorce, retirement, loss of job).
  The second, known as the Katz cluster, had 609 publications and 1682 citation links. It 
viewed successful ageing primarily from the perspective of objective measurements as 
determined by researchers. According to this view, to be successful, older people have to 
maintain their functional ability within the limits of researchers’ predetermined cut-offs.
Two extensive reviews have made an inventory of all individual measurements used to assess 
the ageing process in a total of 78 longitudinal studies (N= 28; Deep CA et al 2006 and N = 50 Lu 
W et al 2018).
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Security
Environment and finances
Social productive management
Disbility/ADL/IADL
Cognitive function
Presence of illness
Health behaviours
Self-perceived health
Longevity
Personality
Psychological wellbeing
Social wellbeing
Global life satisfaction/wellbeing
Self-rated successful ageing 2006 (N = 28)
2018 (N = 50)
Figure 11. Comparison of the criteria for successful/healthy ageing, used in the 28 longitudinal studies analysed by 
Depp and Jeste (2006) and the 50 different longitudinal studies analysed by Lu W et al. (2018). Figure by 
Michel (2019).
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Figure 11 shows how difficult it is to compare the results of longitudinal studies using so many 
various subjective and objective measurements, formulated differently from one study to 
another.
  Preservation of health as well as physical and cognitive functions appears essential.
  Evidence indicates that subjective aspects such as psychological and social wellbeing are 
also important to the individual.
  Environment and finances are not considered in the top priorities of individuals participating 
in this review analysis, while it is known that health inequities between high- and low-
resource settings (Hanson et al., 2016) generally interfere greatly in health outcomes over the 
lifespan. However, with some exceptions (Kuh et al., 2014b), health inequities have been too 
often forgotten in research.
  Security is a new emerging topic, not already used in 2006.
The choice of the 2015 definition of “healthy ageing” for this report
In light of the various above concepts, terms and definitions, it is important to explain briefly why 
the present report adopts the 2015 WHO definition of healthy ageing, which corresponds to a 
realistic and pragmatic concept of healthy ageing.
  Functional abilities across ageing merge individual determinants of health and roles played 
by the individual life environment.
  Functional ageing is the best possible approach to address ageing across the life course, 
understanding the importance of acquiring the most important functional abilities at a young 
age and preserving them during the lifespan. Complementary to health promotion, mid-life 
identification of risk factors will allow targeting individualised prevention strategies to avoid or 
delay chronic diseases and age-related disability (Michel, 2019).
  The new definition of “healthy ageing” involves reshaping health care delivery systems from 
a disease-centred practice to a more integrated concept of care from birth to very advanced 
age.
  Moreover, the general biomedical approach used in this report fits best with the latest 
functional approach to ageing.
It could be argued that this functional approach to ageing is too restricted because it does 
not integrate “active and healthy ageing”, participation in society, paid or voluntary work after 
retirement, recreational outdoors activities or capacity-building. These multiple criteria were not 
frequently used in longitudinal studies published before 2018.
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Concluding remarks
The functional approach to ageing has been chosen for this report as it considers both the 
various individual determinants of health and the surrounding life circumstances of each 
individual and their interactions.
Functional ageing is the best possible approach to address ageing across the life course, 
knowing the importance of acquiring the most important functional abilities at a young age and 
preserving them during the whole life. This approach can support the policy objective for citizens 
to live healthier as well as longer.
1D. LIFE COURSE APPROACH
A growing trend over the last twenty years is the increasing use of the life course approach to 
health and ageing, which has multidisciplinary roots and incorporates the developmental origins 
and social determinants of adult function and disease (Ben-Shlomo et al., 2016; Kuh et al., 2014a). 
Various strategic and policy documents on ageing also cite a life course perspective (see for 
example Walker, 2019; WHO, 2002).
The life course approach taken in this report builds on the WHO concept of healthy ageing by 
studying the natural history of the growth, maintenance and decline in physical and mental 
(cognitive and emotional) capacities across the lifespan, as well as the onset and development 
of chronic diseases, clinical disorders, and their preclinical intermediate stages (Kuh, 2019). It 
examines the long-term effects of physical and social exposures during gestation, childhood, 
adolescence and adult life that act independently or interactively to impair or protect capacity 
and increase or decrease disease risk (Kuh & Ben Shlomo, 2004).
The purpose of a life course approach is to identify opportunities at different life stages for 
promoting healthy ageing and reducing the risks of future disability and dependence.  
The life course approach offers an opportunity to understand better the interconnected lifelong 
biomedical, behavioural and socioeconomic pathways involved in the development of age-
related disability and to intervene earlier in life for a healthier life course trajectory. Innovative 
health promotion and early preventive strategies may enable younger European generations 
to have a healthier old age in the future and to be aware that some risk factors for age-related 
functional decline are modifiable by lifestyle choices at all life stages.
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Policy options
It should be recognised that ageing is a continuous process from conception. A life 
course approach can identify opportunities at different life stages for promoting 
healthy ageing and reducing the risks of future disability and dependence.
1E. FIGHTING AGAINST ALL TYPES OF AGE 
DISCRIMINATION
Ageism
Ageism is defined by the World Health Organisation as stereotypes, prejudice, and discrimination 
towards people because of their age. It is manifested in the way we think, feel and act towards 
age and ageing (Officer & de la Fuente-Núñez, 2018). Ageism can be both negative (e.g., not 
hiring a person for a job because of his or her age) and positive (e.g., giving up your seat to a 
person who looks old) and can be directed towards people of any age group (Ayalon & Tesch-
Römer, 2018), as both young (Rachel Gordon, 2007) and old (Kite & Wagner, 2002) people in 
society experience ageism.
Ageism is the most prevalent type of “ism” in society (compared with sexism and racism), 
reported by one in three Europeans (Ayalon, 2014). Although not all of us are members of 
a minority group, all of us, if we are lucky, will become old and thus have the likelihood of 
experiencing ageism. The report focuses primarily on the negative manifestations of ageism 
directed towards older people because of their negative impact on older people and on society 
at large.
Ageism impacts all aspects of our lives and is manifested at the cultural and institutional level, at 
the family and relational level, and at the individual level (Ayalon & Tesch-Römer, 2018). At the 
cultural and institutional level, ageism determines what policies and legislation are developed, 
for example defining premature death as occurring prior to the age of 70 (Lloyd-Sherlock et 
al., 2015), using constructs such as the dependency ratio, which assumes that all people over 
the age of 60 are dependent (Angus & Reeve, 2006; see page 40 for more explanation), and 
imposing a mandatory retirement age (Dennis & Thomas, 2007), which forces older people to 
become dependent on their life savings and old age pension.
Ageism is particularly prevalent in the health care system (Wyman et al., 2018). Research 
has shown that older adults are less likely to receive optimal treatment (Peake et al., 2003), 
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more likely to be approached using “elder talk” (Schroyen et al., 2018), and more likely to be 
offered medical interventions even for social conditions (Gewirtz-Meydan & Ayalon, 2017). 
Moreover, older adults are less likely to be given the opportunity to enrol in clinical trials, even 
for conditions which are more prevalent in old age, such as stroke (Hadbavna & O’Neill, 2013), 
dementia (Banzi et al., 2016) or diabetes (Cruz-Jentoft et al., 2013). The negative effects of 
ageism also contribute to the shortage of health and social care workers willing to work with 
older adults (Ouchida & Lachs, 2015) and to the high prevalence of negative attitudes towards 
older adults reported by health care professionals (Higashi et al., 2012; Higgins et al., 2007; Liu 
et al., 2013). Furthermore, ageism affects the long-term care services available to older adults, 
who as consumers often experience paternalistic treatment which disregards their autonomy 
(Shippee, 2009). Moreover, elder abuse may be justified or precipitated by views of old people 
as incapable and dependent (Phelan, 2008) and by views of abuse towards old people as being 
less severe than abuse towards young people (Yechezkel & Ayalon, 2013).
Ageism is also manifested in the built environment, where we see a separation between 
younger and older population groups in the configuration of public space (Ayalon, 2015; Noon & 
Ayalon, 2018). This results in the marginalisation and social isolation of older adults (Vitman et al., 
2014).
An important social arena that reflects the depth and explicit negative expression of ageism 
is the workforce (Stypińska & Nikander, 2018). In the workforce, ageism is manifested in the 
mandatory retirement age which is enacted in many European countries despite laws that 
prohibit workforce discrimination based on age (e.g., the EU Equal Treatment Directives). 
Moreover, research has shown that older people have a harder time finding a job and are likely 
to be the first employees to be laid off due to economic considerations (Radović-Marković, 2013).
At the individual level, many old people have already internalised negative perceptions towards 
their own ageing, and this affects both physical and mental health. Research has shown that 
older adults who think negatively about their own ageing are likely to die 7.5 years before those 
who think more positively about their ageing (Levy et al., 2002). Moreover, those older adults 
who hold more negative attitudes towards their own ageing are more likely to have physical 
impairments (Levy, 2003), falls (Ayalon, 2016), deteriorated cognitive functioning (Levy, 1996), 
and to recover more slowly from disability (Levy et al., 2012). Ageism also affects the mental 
health of older adults (Wurm & Benyamini, 2014) and the social interactions of older adults with 
their peers, with those older adults who report more anxiety about their own ageing process also 
reporting higher levels of loneliness (Ayalon, 2018).
The negative effects of ageism are often amplified when in combination with other 
disadvantages (Potter et al., 2018). This is because it is almost never age alone, but age in 
interaction with multiple other disadvantages, which results in inferior treatment and social 
standing in society (Krekula et al., 2018). For instance, the interaction between old age 
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appearance and gender makes women particularly vulnerable to become invisible in society 
(Walkner et al., 2018). Meanwhile, the interaction between old age and minority status may 
make some older minorities particularly susceptible to poor health and disability (Vasquez et 
al., 2018), whereas the interaction between old age and migration status places some people 
at a social, economic and health disadvantage which cannot be accounted for by old age alone 
(Dolberg et al., 2018).
Adultism
“Adultism” describes the power that older generations have over younger generations. The 
negative effects of ageism on younger people have two main sources:
  First, from early on, young children internalise negative perceptions towards old people 
(Teater & Chonody, 2017). Although these negative perceptions may not have a direct effect 
on their childhood and early adulthood, when people age, the beliefs and attitudes they have 
internalised throughout their lives impact their ageing process (Levy, 2009). The effects of 
ageism do not end here, though.
  Although under-researched, there is some evidence to show that children and young adults 
are also subjected to ageist attitudes and practices by older generations. The negative 
effects of ageism on younger generations have been documented in several large-scale 
social surveys that have shown that younger people, more than older people, report 
exposure to discrimination based on age (Ayalon, 2014; Kessler et al., 1999). Research in the 
European Social Survey shows that public feelings towards older people are less negative 
than those towards younger people (Ayalon, 2013). Young people mainly report ageism in the 
workplace (Horhota et al., 2018). The experiences of ageism are not only subjective, but also 
have a strong objective basis. Young people are particularly affected during an economic 
downturn, when they experience very high rates of unemployment (Caliendo & Schmidl, 
2016). Moreover, there is a general negative tone which characterises the discussion around 
younger generations (e.g., describing the millennials as the “me generation”) (Beal, 2016).
The intersectionality of ageism towards young people (Kelan, 2014) should also be noted 
as young women, people of colour and young people of lower socioeconomic status are 
particularly disadvantaged in our society. Although we still lack rigorous research to document 
the impact of these negative experiences on younger people’s health and wellbeing, there is no 
doubt that ageism is prominent in their life and thus should be challenged.
Concluding remarks
Age discrimination is more prevalent in society than sexism or racism, concerning one in three 
European citizens. Age discrimination can be both negative (e.g., not hiring a person for a job 
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because of his or her age) and positive (e.g., giving your seat to a person who looks old) and can 
be directed towards old people (ageism) or young persons (adultism).
Age discrimination impacts all aspects of our lives and is manifested both at the individual 
level, at the family and relational level, and at the cultural and institutional level. Indeed, fighting 
against age discrimination implies actions at different levels in society, including laws and 
regulations at both national and European levels.
Policy options
Age is just a number and therefore it should not be used to categorise individuals. 
There is a high heterogeneity in older age that should be acknowledged. Arbitrary 
categorisation simply based on chronological age should is discriminatory and thus 
should be avoided.
The existing legislation to prevent age discrimination at work, the EU Employment 
Equality Directive and the national legislations that implement it, cover age 
discrimination in the workplace but there is a gap in measures to ensure equal 
treatment outside of the workplace. An approach based on human rights and social 
rights could be beneficial.
1F. INTEGRATION OF SOCIAL AND HEALTH CARE 
SYSTEMS
Integration of social and health care systems is essential to adapt to the demographic transition. 
Social security systems are fundamental instruments to insure against major lifetime risks. They 
insure against:
  risk of large health expenses (health insurance)
  costs of care in old age (long-term care insurance)
  risks of income losses due to unemployment (unemployment insurance), work disability 
(disability insurance) and old age (public pension systems).
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These elements have interactions both on the individual and on the macro level (Börsch-Supan 
et al., 2016). For example, older individuals may claim unemployment or disability insurance 
benefits as a substitute for early retirement benefits.
The distinction between health insurance and long-term care insurance is often blurred. As 
spending on public pension benefits increases, it will be harder to finance additional health care 
services through health insurance or long-term care services through long-term care insurance. 
Ageing puts financial pressures on all social security systems.
Social insurance systems vary dramatically across EU member states (OECD, 2017b). Benefits 
may be generous or only partial; they may be financed by general taxes or dedicated 
contributions; they may be pay-as-you-go financed or fully funded. These three fundamental 
characteristics, explained in the following paragraphs, influence the interconnections and 
discrepancies between health care and other social systems.
Generosity of social benefits
If social benefits are generous, population ageing has large crowding-out effects in the sense 
that large expenses in one subsystem (e.g. public pensions) diminish the ability to increase 
expenses in another subsystem (e.g. health insurance).
One possible policy response to population ageing is therefore to make insurance partial. In 
public pensions, this means reducing social security benefits and making households save 
more instead, for instance via private and occupational pensions. In health insurance, this means 
increasing co-payments and excluding certain health care services, for example dentistry. Long-
term care insurance is typically partial: it may finance only professional help (unlike Germany, 
where also help by relatives is covered) and it may only pay a certain percentage of the costs 
involved.
Method of financing
Financial ‘crowding-out’ at the macro level (e.g., the government of a country) is largest if social 
systems are tax-financed, since there is direct competition among alternative uses of tax 
revenues.
If social expenses are financed by dedicated contributions, such crowding-out is more subtle 
on the individual level of households and companies. For households, higher contributions 
create a larger gap between gross and net income and reduce their consumption possibilities. 
For a far-sighted household, this may not matter too much, since the contributions will finance 
consumption (public pensions) or cover expenses (health insurance) in old age. For less forward-
looking households, contributions simply cut into their budget. If contributions to social systems 
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are shared between employers and employees (present in many countries and referred to as 
social partnership systems), employers may insist on a certain threshold of total contributions, as 
is currently the case in France and Germany, for example. Thus, raising the contribution rate to 
public pensions will crowd out a rise in health insurance contributions.
Pay-as-you-go financing vs full funding
The distinction between pay-as-you-go financing versus fully funding is also important for the 
interconnections between social systems. Pay-as-you-go financing means that the younger 
generation pays the benefits of the older generation, while in fully funded systems, one 
generation saves when young and uses these savings later for consumption when older.
Population ageing thus puts a lot of pressure on pay-as-you-go systems, since the benefits for 
an increasing number of older people must be financed by fewer and fewer younger people. In 
a funded system, financing happens within a single generation such that population ageing does 
not directly affect other generations, except for feedback on the macro level such as a reduced 
interest rate due to ageing (Börsch-Supan et al., 2002). Countries in which old-age income is 
largely funded via occupational pensions, for instance (the UK, the Netherlands, Denmark) will 
therefore face less crowding-out of health and long-term care expenses than countries with 
generous pay-as-you-go public pension systems (Germany, France, Italy).
Interconnections may also exist on an administrative level. Some countries, such as the US, have 
health insurance that is largely employer-based. Retirement then necessitates a switch of health 
insurance. Whether this switch is beneficial or not greatly affects the choice of retirement age 
(Coile & Gruber, 2001). Within a social partnership-financed health care system, somebody has to 
step in after retirement for the part of the contributions that was formerly paid by the employer. 
If not (as in the UK), it creates discontinuities. In many countries, the public pension system steps 
in and becomes the sponsor of health and long-term insurance (e.g., Austria and Germany). 
Changes in the earliest, statutory or mandatory retirement age of a country’s public pension 
system have implications for the finances of this country’s health insurance system. In some 
countries (e.g., Germany), providing long-term care to a relative is counted towards pension 
benefits. This may become a major expense item as population ageing accelerates.
Needs at the EU and member state levels
The typical silo approach to public policy — where public pensions belong to the ministry of 
employment and social affairs, while health and long-term care insurance is regulated by the 
ministry of health — may lead to unwanted fiscal effects, since the interconnections have been 
ignored. Reforms which are beneficial from a public pension sustainability point of view, like 
increasing the retirement age, may have unexpected negative side-effects on health insurance 
coverage, and vice versa. This also holds for expenditure projections, which need to include all 
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interrelated social systems. At the EU level, the  Directorate for Economic and Financial Affairs 
has carefully avoided this silo trap.
Moreover, the design of reforms in one social subsystem needs to take account of the effects on 
the other subsystems. Effects may be financial, as already pointed out; they may also be more 
subtle, in terms of health outcomes. There is an emerging literature on the effects of retirement 
on cognitive and physical health (Adam et al., 2007; Bonsang et al., 2012; Börsch-Supan & 
Schuth, 2014; Rohwedder & Willis, 2010). Raising the retirement age seems to increase cognition 
because active individuals keep their memory abilities longer than passive ones. It seems to 
decrease physical health, especially in physically demanding occupations, while the effect 
appears to be the opposite for office workers and similar occupations (Calvo et al., 2013; Coe et 
al., 2012); Sustainability reforms, such as the increase of the statutory retirement age, may thus 
be beneficial for a pension system’s finances but may harm the finances of the health insurance 
system.
Concluding remarks
A final lesson is to be careful that costs and benefits are sufficiently internalised. That is, 
additional costs to another subsystem should be carried by the subsystem that initiated the 
reform. Examples abound in non-universal health care systems. The benefits of preventive 
health care interventions are often long-term.
If individuals switch their health insurance provider during life, the first insurance provider carries 
the costs of prevention or early intervention, but the second provider enjoys the benefits of a 
lower incidence rate. This reduces the incentive to provide prevention. A case in point is diabetes, 
where early interventions only pay off in the long run. Other examples are salient for the many 
interactions between health insurance and long-term care insurance.
Policy option
Policymakers commonly attempt to reform and integrate health and social care 
systems. Strategies and financing must recognise that benefits are often derived 
long term; for example, prevention and health campaigns can take decades to 
pay off, but may have profound impacts. Costs and benefits need to be sufficiently 
internalised: that is, additional costs and benefits should be borne by the subsystem 
that initiates or drives the reform.
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Chapter 2. Addressing the health 
challenges of ageing across the life 
course
INTRODUCTION
This part of the report describes the major health challenges and opportunities for healthy 
ageing that should be addressed to ensure that younger generations of European citizens 
improve their chances of a healthy old age. It updates the scientific evidence to support three 
broad public health strategies based on a life course perspective:
  To build physical and cognitive capacities and enhance reserve so that maximum potential is 
reached by early adulthood (approximately until 30 years of age).
  To maintain capacities and delay the onset of diseases during midlife (approximately 30–50 
years of age).
  To slow the rate of functional decline or disease progression at more mature ages and adapt 
the environment to maintain functional ability, independence and quality of life.
Evidence for these strategies comes from a broad range of multidisciplinary scientific advances, 
from the biomechanisms of ageing that underlie many aspects of functional ageing and age-
related diseases, the focus of section A; through to common global and life course determinants 
of mortality and other broad ageing outcomes, the focus of B. Section C then builds on this basic 
science and global context by focusing on specific intrinsic capacities and associated diseases, 
identifying temporal trends and the early and midlife risk factors. Population-based and 
individual-based strategies for health promotion and disease prevention are the focus of section 
D: as many risk factors (such as poor socioeconomic conditions, smoking, obesity and inactivity) 
have been found to be common within a wide range of functional domains, strategies with the 
potential to influence multiple rather than single outcomes may be particularly effective.
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Figure 12. Public health strategies for functional ageing from a life course perspective.
2A. BIOLOGICAL RESEARCH INTO 
DETERMINANTS, MECHANISMS AND 
MODULATIONS OF THE AGEING PROCESS
Lifespan and longevity
During the last 200 years, average human life expectancy has doubled in most developed 
countries (Oeppen & Vaupel, 2002) due to improved hygiene, nutrition and medical care. The 
increased lifespan originally started with reduced child mortality and reduced morbidity and 
chronic disease in adulthood (Fogel & Costa, 1997). Although the increased lifespan was not 
paralleled by a health span increase, in the oldest old it did gradually associate with increased 
physical and cognitive functioning in successive birth cohorts (Christensen et al., 2013).
Not all individuals profit equally from these societal accomplishments. Due to variation in 
lifestyles, geography, socioeconomic position and so on, there is a large variability in the ageing 
rate, morbidity patterns and age at death of individuals. In addition to the environmental hazards, 
genes play a role in susceptibility to disease and intrinsic capacity to survive to old age. However, 
the influence of genes on the variation in age at death of individuals in populations is generally 
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very low (12–25%) (Kaplanis et al., 2018; Skytthe et al., 2003), except for families in which many 
family members reach exceptionally high ages (i.e. belong to the 1–10% longest lived of a birth 
cohort) (van den Berg et al., 2017; van den Berg et al., 2019). Members of these long-living 
families illustrate the holistic nature of healthy ageing. They have a lifelong survival advantage 
compared to their birth cohort, and a lower risk of coronary artery disease, cancer and type 2 
diabetes (Terry et al., 2004; Westendorp et al., 2009). In middle and old age, they express better 
immune and metabolic health than other individuals of the same age in the general population 
(Ash et al., 2015; Deelen et al., 2016) and they show compression of late-life morbidity (Andersen 
et al., 2012; Christensen et al., 2008). In addition to exceptional longevity running in families, 
in which for example the APOE and FOXO3A genes play a role, (Partridge et al., 2018), this 
phenomenon is also observed in the ‘Blue Zones’ of the world (Okinawa in Japan, part of Sardinia 
in Italy, etc.,) where the environment and lifestyle appear to contribute to survival into advanced 
age (Poulain et al., 2013).
Genetic influences on age-related human diseases are much more prominent than on lifespan. 
Using large collaborative genome-wide association studies (Fuchsberger et al., 2016), numerous 
locations in the genome and polygenic risk scores were identified that associate with increased 
susceptibility to specific age-related diseases (such as dementia, diabetes, osteoporosis and 
cardiovascular events) or the corresponding risk factors (blood pressure, serum glucose or 
cholesterol, bone mineral density) summarised in the GWAS catalogue (2017). For most diseases 
and traits, functional genomic studies are required to understand how specific genetic variation 
at the identified genomic locations and genes influences the age-related traits.
The ageing process
Calendar age is the major risk factor for the onset and progression of virtually all common 
diseases affecting the general population of the Western world today (Rae et al., 2010), 
suggesting that common processes of ageing are involved in the aetiology of many diseases. 
The ageing process is characterised by a progressive and systemic loss of function at the 
cellular, tissue and organismal level, thus affecting the general capacity for maintaining bodily 
homeostasis (Kirkwood & Austad, 2000). The biomedical field of ageing research aims to identify 
causal determinants that maintain and modulate intrinsic capacity and bodily homeostasis 
(resilience) during ageing. Most advanced are the insights into cellular determinants that 
emerged from studies into lifespan regulation in animal species and cellular models. Hallmark 
mechanisms (Lopez-Otin et al., 2013) that seem most relevant for human biological ageing 
(Partridge et al., 2018) include cellular senescence, changes in serum factors, stem cell 
exhaustion, accumulation of damaged proteins and genomic instability (cleared by proteostasis 
and DNA repair mechanisms), nutrient sensing (cellular response to nutrients), mitochondrial 
dysfunction (or energy homeostasis in general), and epigenetic dysregulation. The causal 
relationship of these hallmarks to the physiology of ageing has been demonstrated especially in 
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animal models so far, but these mechanisms are clearly also at play in human long-living families 
and age-related diseases (Partridge et al., 2018).
The influence of genetics 
on the age at death of 
individuals is very low (12–25%)
But some families exhibit 
extreme old age due to their 
genetic makeup (1–10% longest 
lived in a birth cohort)
Genetic studies identified 
genes that increase 
susceptibility to age-
related diseases & mortality 
(dementia, diabetes, osteoporosis & 
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Figure 13. Gene—environmental interactions determine lifespan and susceptibility for age-related disease.
Modulating the ageing process
Two lines of evidence strongly suggest that a reduction in the length and severity of the period 
of disease (compression of morbidity) is physiologically feasible. First, there is the long life and 
compression of late-life morbidity in centenarians (Andersen et al., 2012; Christensen et al., 2008). 
Second, the ageing process across yeast, nematode worms, fruit flies and mice was shown 
to be remarkably malleable through the hallmark mechanisms mentioned above. Genetic, 
environmental and pharmacological interventions can extend lifespan, ameliorate the loss of 
function and diseases of ageing and, in some cases, compress late-life morbidity (Fontana, 2017; 
Kenyon, 2010).
The challenge for future research is to gain a better understanding of the genetic and 
environmental determinants of human lifespan and health span, and to translate the results of 
discoveries in model organisms into health improvements for ageing humans. In the first place, 
this requires an improvement of biological age indication. At older ages, calendar age is not very 
informative on the holistic health status or intrinsic capacity of individuals. Biomarkers of the 
ageing process (often referred to as biological age indicators) ideally reflect the physiological 
state of the systems that form a common denominator to the risk of multiple age-related 
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diseases. Such whole-system indicators need to be an early reflection of deficits and/or decline 
in intrinsic capacity. Multiple biomarkers of ageing have been generated, based on organ 
functions (Levine et al., 2013) or molecular age changes (Horvath, 2013; Toledo et al., 2015). The 
increased understanding of human ageing and joint efforts on analysis of multiomics and other 
big data needs to be translated to well defined, standardised and feasible biomarkers to provide 
scores that monitor individual ageing trajectories that can be used for risk assessment and 
personalised interventions in human and model systems, and to monitor the individual and often 
heterogeneous response to interventions.
The opportunities to better fit what works for whom are often represented as ‘4P research’:
  improving prediction tools
  preventive methods and interventions
  personalised solutions
  participation of citizens to assure that the health and quality of life outcome is relevant to the 
person.
Interventions now and in the future
Preventive interventions to slow down human ageing have resulted in reductions in 
hypertension, diabetes and brain atrophy, improved cognitive performance, and reduction in 
mortality due to cancer and cardiovascular disease. These have all been achieved by alterations 
to lifestyle. Specific diets such as the plant-based Mediterranean diet (Estruch et al., 2018; Toledo 
et al., 2015), exercise (Penedo & Dahn, 2005), the two combined (Heilbronn et al., 2006), cognitive 
training and vascular risk management (Ngandu et al., 2015), caloric restriction (Most et al., 2017), 
intermittent fasting (Mattson et al., 2017) and supplementation of vitamin D (Laird et al., 2018) 
have all been reported as effective for specific conditions. Responses to these interventions 
usually show marked individual variation, and it may become possible to target them to those 
individuals who will benefit most when robust biomarkers become available.
However, compliance with lifestyle-based interventions is quite a challenge. One might envision 
a more pharmacological approach to slow down ageing based on the results of animal models, 
for example by testing whether existing drugs used to treat single age-related diseases also 
prevent multimorbidity (secondary prevention). For instance, the licensed drug sirolimus 
(rapamycin) inhibits mTOR complex 1, part of the nutrient-hallmark and stress-sensing network, 
and can extend lifespan in model organisms including mice, where it improves many, but not 
all, aspects of health during ageing, and protects against cancer (Johnson et al., 2013). As in 
old mice, the poor immune response of older humans to immunisation against influenza can 
be enhanced by pre-treatment with the related drug everolimus (Mannick et al., 2014). The 
antidiabetic drugs metformin and acarbose can also extend lifespan in laboratory animals and 
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are currently registered for clinical trials against ageing itself, which has not previously been 
recognised as a valid target (Barzilai et al., 2016; Espeland et al., 2017).
Another intervention is presented by the selective removal of senescent cells from tissues to 
restore homeostasis. In mice, this increases health span and lifespan (Childs et al., 2017; Jeon 
et al., 2017). The first human trials have already started, such as the treatment of osteoarthritis, 
glaucoma and treatment prior to kidney transplantation (van Willigenburg et al., 2018).
Finally, the ‘microbiome’ (the microorganisms present in the gut) is increasingly implicated in 
the health of the gut itself and of other organs during ageing (Clark & Walker, 2018; Kundu et 
al., 2017). The composition of the human gut microbiome shows marked individual variation and 
is labile to many environmental factors, including habitual diet, (O’Toole & Jeffery, 2015). The 
microbiome can beneficially be modulated by nutrition and faecal transplantation.
Linking life course cohort studies and interventions
‘Individualised health’ entails focusing on individual responses to interventions and life course 
trajectories, i.e., zooming in on the biological, psychological, and social factors that determine 
individual characteristics over time, which can be more closely observed in the rich life course 
cohort studies, taking gender, age and cultural effects into account. The individual physiological 
history will result in “responders” and “poor or non-responders” to medical and lifestyle 
interventions, which can be observed in such experimental studies, but these are rarely linked 
to the understanding of heterogeneity that may come from observational (cohort) studies. Along 
these lines, it is important to broaden the understanding of the phenotypic characteristics that 
render every individual unique.
It is important to explore how calendar age, which is the classic way of determining age in the 
biomedical and clinical domain, can be complemented by novel ways of determining biological 
age. Both may be very different from an individual’s understanding and experience of age. This 
can help to explain varied outcomes among older people exposed to the same intervention. 
In the future, average values for groups will be less important than individual responses, and 
individualised health will have a major impact on the understanding of the trajectories of ageing 
and life course exposures.
The emerging evidence from basic research as well as intervention studies show that human 
longevity can be extended, and that health span can be increased to prevent or delay several 
age-related diseases.
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Concluding remarks
Calendar age is the major risk factor for the onset and progression of virtually all common 
diseases, suggesting that common processes of ageing are involved in the aetiology of many 
diseases.
Responses to preventive interventions usually show marked individual variation and it may 
become possible to target them to those individuals who will benefit most when robust 
biomarkers become available
Policy option
There is a gap in 4P research (prediction tools; preventive methods and 
interventions; personalised solutions including biomarkers; and participation of 
citizens). Improved research in this area will allow more understanding of what works 
for whom, leading to a more efficient and effective tailored approach.
2B. IDENTIFYING AND ACTING ON GLOBAL AND 
LIFE COURSE DETERMINANTS OF AGEING
In this section, we complement the consideration of lifelong mechanisms that underlie the 
biology of ageing (see section A) by acknowledging how the macro physical and social 
environments can affect healthy ageing (see Figure 14). To illustrate the influence of the macro 
physical environment, we have selected three widely acknowledged global environmental 
challenges: climate change, environmental pollution and antimicrobial resistance.
The macro social environment includes social and cultural norms, demographic change, 
changing political and economic conditions (e.g. globalisation, growth in income and wealth 
inequalities) and government policies and regulations (including health and social care 
spending). These challenges at the macro level require societal responses at the multinational 
and national level, and have been addressed by other reports (EEAC, 2018a, 2018b; European 
Commission, 2018c; PricewaterhouseCoopers International, 2018). There is clear evidence that 
life expectancy improves with economic development, although less is known about why some 
countries do better than would be expected from their economic status (Baum et al., 2018). 
There is increasing evidence that countries with a high level of social spending, or a higher 
ratio of social to health spending, have a higher life expectancy than countries with lower social 
spending (Rubin et al., 2016; van den Heuvel & Olaroiu, 2017).
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Here, we focus on the ways in which the macro environment impacts healthy ageing by 
influencing the lives of individuals within each birth cohort through living conditions, social 
relationships, health and social service provision, developmental and educational opportunities 
and lifetime behaviours. Their interrelationships over the life course are illustrated in Figure 
14, and their effects on healthy ageing may be modified by genes, gender and ethnicity. In this 
section, we briefly review the evidence which examines how these individual factors influence 
broad ageing outcomes such as mortality, disability and composite indicators of healthy ageing. 
Risk factors for specific intrinsic capacities and age-related diseases are considered in section C.
Examples of global challenges in the macro physical environment
Climate change and environmental pollution
Earth system changes, including rising temperatures and sea levels, ocean acidification, and 
changes in precipitation, are considered to be a consequence of increased atmospheric 
concentrations of carbon dioxide, directly related to the spike in greenhouse gas emissions 
from human activities following the industrial revolution. These activities are also responsible 
for generating increased pollutants found in air, land, and water. An assessment of current and 
projected impacts of climate change in Europe has recently been published (European Energy 
Agency, 2018b).
Climate change and environmental pollution may adversely affect health in a number of ways, 
including:
  heat stress and reduced work capacity due to heat-related disorders
  asthma and other respiratory disorders
  infectious diseases such as vector- and water-borne diseases
  undernutrition and growth stunting linked to reduced crop production
  increased food systems and food insecurity
  even mental health disorders, including depression and post-traumatic stress disorder 
associated with climate-related disasters and displacement (Patz et al., 2014).
In this sense, older adults are more highly represented among the groups at a higher risk of 
suffering heat-related disorders, along with those living in poverty, social isolation, or with mental 
illness (Bouchama et al., 2007).
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Figure 14. Impact of macro environment on health and ageing within each birth cohort, over the life course.
Air pollution is of particular relevance to healthy ageing (European Energy Agency, 2018a). 
Exposure to particulate matter air pollution is associated with chronic diseases such as 
cardiovascular morbidity and mortality (Brook et al., 2010) and there is increasing interest in its 
effects on biomarkers of ageing such as telomere length and the epigenome (Cohen et al., 2017). 
Older adults are likely to be particularly susceptible to air pollution. Cognitive outcomes, via 
pathways linked to respiratory and cardiovascular diseases, may also be affected. Clifford et al. 
(2016) conducted a review including 31 studies and found evidence to support a negative impact 
of pollutants (mostly derived from traffic-related exposures) to impaired cognitive development 
in early life, and cognitive decline in later life.
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There is widespread exposure of children to air pollution worldwide, harming their health and 
development which may have long-term effects on ageing outcomes (WHO, 2018b).
Endocrine-disrupting chemicals (EDCs) and potential EDCs are threats to lifelong health. 
They are mostly man-made, found in various materials such as pesticides, metals, additives 
or contaminants in food, and personal care products. EDCs may be associated with altered 
reproductive function in males and females, increased incidence of breast cancer, abnormal 
growth patterns and neurodevelopmental delays in children, as well as changes in immune 
function (Bergman et al., 2013). EDCs are increasingly recognised as a risk factor for obesity and 
diabetes, especially in early life (WHO, 2014).
Coordinated efforts involving governments, private enterprises, NGOs and individuals across the 
globe are required to act on climate change and environmental pollution. Two main strategies to 
reduce the adverse effects of climate change and environmental pollution on health are primary 
prevention, corresponding to mitigation or reduced carbon emissions, and secondary prevention, 
corresponding to adaptation or public health preparedness for potential threats (European 
Energy Agency, 2018a, 2018b; Patz et al., 2014).
Antimicrobial resistance
The modern developed world has been made keenly aware of its dependency on effective 
treatment for bacterial infections with the rise of antibiotic-resistant strains (for example, 
rise of carbapenem-resistant Enterobacteriaceae), with the widespread use of antibiotics in 
hospitals, communities and livestock as the suspected culprit (Laxminarayan et al., 2013). The 
consequences for human health of antimicrobial resistance are significant, translating into longer 
recovery times from illnesses, higher mortality rates, increased treatment costs, and serious 
limitations to interventions that require the effective prevention of infections. It is calculated 
that approximately 25,000 people die in Europe each year from bacterial infections that fail to 
respond to antibiotics (ECDC/EMEA Joint Working Group, 2009), a situation that prompted the 
creation of the European Surveillance of Antimicrobial Consumption Network (European Centre 
for Disease Prevention and Control, 2019). Furthermore, the worldwide situation is expected 
to worsen for the next generation of older adults: deaths from antimicrobial resistance are 
projected to rise from 700,000 in 2015 to up to 10 million per year in 2050 (O’Neill, 2016).
While a less-than-rational use of antibiotics by hospitals and individuals has contributed to the 
problem, antibiotic use in animals is viewed as a major driver of the crisis of antibiotic resistance. 
This is especially true regarding antimicrobials administered to livestock, not just for veterinary 
use, but for growth promotion, a practice commonly used in Europe since the 1940s in response 
to the demands of industrial food production (Laxminarayan et al., 2013), until the European 
Commission banned their use for growth promotion in 2006. A relationship was established 
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between the use of antibiotics in animal husbandry and antibiotic resistance in humans and 
livestock (for example, against Escherichia coli, Salmonella sp. and Campylobachter sp.).
Here again, coordinated efforts involving governments, private enterprises, NGOs and individuals 
across the globe are required to act on the threat of antimicrobial resistance. The ‘One Health’ 
approach, promoted as a response to this global health challenge, is defined by the World 
Health Organisation, as “designing and implementing programmes, policies, legislation and 
research in which multiple sectors communicate and work together to achieve better public 
health outcomes”. In simpler terms, it views the health of people, animals and the environment 
as all interconnected, reflected in policy options spanning sectors such as health, agriculture and 
food. In 2015, WHO announced its Global Action Plan on antimicrobial resistance in veterinary 
medicine, with two main objectives: 1. a prudent and rational use of antibiotics, with antibiotics 
selected from those not of critical importance; and 2. the development of more effective and 
targeted antibiotics (WHO, 2015c). These measures apply not only to farm animals, but also pets, 
as resistances of some bacterial species (E. coli) can also be found in domestic dogs and cats 
(Van Cleven et al., 2018).
The Committee for Veterinary Medicine of the European Medicines Agency has adopted a 
five-year strategic plan (2016-2020) on the availability of effective antibiotics against important 
infectious diseases while minimising risks both for humans and animals (European Medicines 
Agency, 2015).
Vaccination in both animals and humans is seen as one of the most effective ways of preventing 
diseases and reducing the use of antibiotics to treat them, thereby lessening the threat of 
antimicrobial resistance. As a contribution to the global actions in this area, in April 2015, the 
Office International des Epizooties (OIE) convened an ad hoc Group on Prioritisation of Diseases 
for which vaccines could reduce antimicrobial use in animals. Animal diseases for which 
availability and use of vaccines could reduce the call on antimicrobial agents were identified 
and recommendations were made to better target research programmes for new or improved 
vaccines (Epizooties, 2015). As for veterinary medicine, practitioners and governments have to 
contend with pseudo-scientific arguments and so-called individual liberties supporters, who 
often hamper efforts for widespread vaccinations to prevent infection. Vaccination policies for 
humans, especially children and older adults, are discussed later in this chapter (page 193).
Advancements in the development of new antibiotics, along with a strengthened academia-
industry interface and new business models, are all needed to provide global solutions 
(Laxminarayan et al., 2013). Increased prevention and biosecurity through hygiene and 
vaccination are required worldwide to help lessen the burden of antimicrobial resistance.
Similarly, antifungal resistance has emerged as a new health challenge for the next generation 
of older adults, as the Global Action Fund for Fungal Infections estimates that 1.6 billion deaths 
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a year are linked to fungal infections, especially Crypotococcus, Pneumocystis, Aspergillus and 
Candida sp. Furthermore, Aspergillus bronchopneumonias have been found to provoke severe 
asthma, especially in immunosupressed individuals, such as older adults, HIV patients and those 
undergoing chemotherapy or organ transplantation. As with antibiotics, in many cases, a balance 
between “access to” and “excess of” antifungals is a tricky balance to achieve, prompting 
officials in public health and agriculture to investigate potential alternatives. However, to date no 
preventive measures have been adopted.
While regulatory guidelines for reasonable antimicrobial and antifungal use have been 
issued by international organisations in addition to WHO, including the OIE and the UN Food 
and Agriculture Organisation (FAO), the development of global solutions to fight resistance 
falls mostly on the shoulders of research institutions, requiring partnerships among different 
stakeholders in different sectors and countries. In short, antimicrobial resistance will present an 
important threat to healthy ageing unless coordinated worldwide efforts are successful.
The macro environment
Risk factors for adult health and ageing are strongly influenced by the macro environment.
Lifetime living conditions, social relationships and educational attainment
Socioeconomic position (SEP), whether assessed by occupation, education, income or wealth, is 
a commonly-used indicator of living conditions and an established distal determinant of health 
and ageing. There is strong evidence that lower adult SEP is associated with all-cause mortality, 
cardiometabolic and respiratory diseases, and physical and cognitive performance (Chapko et 
al., 2018; Galobardes et al., 2006; Petrovic et al., 2018; Stringhini et al., 2017). A recent systematic 
review of 114 articles showed that smoking, alcohol consumption, physical activity and dietary 
patterns account for a considerable part of the socioeconomic gradient in all-cause mortality 
and cardio-metabolic outcomes, more so in Northern Europe than in Central or Southern Europe 
(Petrovic et al., 2018). For quality of life, there are somewhat conflicting results, though social 
mobility appeared to be a determinant of better quality of life (Niedzwiedz et al., 2012). There 
is growing evidence that childhood SEP is also associated with many of these adult outcomes, 
such as cardiovascular disease (Galobardes et al., 2006) and muscle strength and physical 
performance (Birnie et al., 2011), but the mediating factors have not yet been systematically 
reviewed.
The rise in inequalities in earnings and household income in the EU and other OECD countries 
over the past three decades and the accumulation of disadvantage across life are likely to lead 
to increased health and economic inequalities in old age for younger generations unless action is 
taken (OECD, 2017c).In Europe, relative inequalities in mortality by educational level have almost 
universally increased over the past decades (Mackenbach, 2013; Mackenbach et al., 2018).
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Multiple aspects of social relationships, including social isolation or lack of social interaction 
are associated with cardiovascular disease, cognitive decline and an increased risk of incident 
dementia (Gow & Mortensen, 2016; Kuiper et al., 2015; Kuiper et al., 2016; Valtorta et al., 2016). 
Work stress has been one of the main occupational psychosocial characteristics examined. 
There is reasonable evidence of an association with cardiovascular outcomes (Sara et al., 2018). 
Those exposed to high levels of mentally challenging work tasks, work demands, or job control 
had higher levels of cognitive function in mid and late life, but the associations with cognitive 
decline were conflicting (Gow et al., 2014; Nexø et al., 2016).
Lifetime health behaviours and life habits
The evidence is well established that behaviours such as smoking, physical inactivity, poor 
nutrition and heavy alcohol consumption have adverse effects on ageing outcomes. Strategies 
required to promote health behaviours are both societal and individual. Health behaviours are 
often initiated in adolescence and are partly determined by earlier factors, including social 
background, education, and access to resources. So, as well as being important mediators 
linking adult SEP to ageing, they are also likely to be important mediators within a casual chain 
linking factors in early life to later life outcomes.
In two recent and related systematic reviews (Daskalopoulou et al., 2017; Daskalopoulou et al., 
2018), being a non-smoker or former smoker and being more physically active considerably 
increased the odds of healthy ageing, variously defined but encompassing aspects of 
health status, physical function, cognitive and mental health. A positive association between 
“limited” alcohol consumption and healthy ageing was observed, though the authors note that 
standardisation across studies from different countries can be difficult (Daskalopoulou et al., 
2018). A very large combined analysis of individual-participant data from 83 prospective studies 
recently concluded that risk thresholds for alcohol consumption in regard to all-cause mortality 
and cardiovascular disease are lower than previously assessed (Wood et al., 2018). Sedentary 
lifestyles have been associated with earlier mortality and various adverse indicators of physical 
function and cardiovascular health (de Rezende et al., 2014; Wirth et al., 2017). It is estimated that 
physical inactivity is responsible for 6–10% of coronary heart disease, Type 2 diabetes, breast 
and colon cancers (Lee et al., 2012). Unhealthy diets and obesity are key risk factors for ageing 
and age-related diseases. It is increasingly recognised that they coexist and interact with climate 
change, and that joined up global strategies on sustainable food systems are required to tackle 
them (Swinburn et al.; Willett et al., 2019), as well as strategies designed to change individual 
behaviours.
Recent systematic reviews have provided evidence of associations between a Mediterranean 
diet and global cognition in healthy older adults (Loughrey et al., 2017), and between various 
indicators of healthy diets and higher quality of life (Govindaraju et al., 2018), better cognition and 
mental health (Milte & McNaughton, 2016), and a lower risk of frailty (Lorenzo-Lopez et al., 2017).
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There is evidence that higher BMI raises the risk for 20 chronic conditions that generally increase 
with age: ischemic heart disease, ischemic stroke, haemorrhagic stroke, hypertensive heart 
disease, diabetes mellitus, chronic kidney disease, oesophageal cancer, colon and rectum 
cancer, liver cancer, gallbladder and biliary tract cancer, pancreatic cancer, breast cancer, 
uterine cancer, ovarian cancer, kidney cancer, thyroid cancer, leukaemia, knee osteoarthritis, hip 
osteoarthritis, and lower back pain (GBD 2015 Obesity Collaborators et al., 2017). Some of these 
risks may be exacerbated by an earlier age of onset or a greater duration of overweight and 
obesity, which are increasingly experienced by younger birth cohorts. More than half of European 
adults are overweight or obese (Legler et al., 2015). The prevalence of obesity among children 
is particularly high in southern European countries, with 15% of them being overweight or obese 
in Greece, Italy, Portugal and Spain (Legler et al., 2015). A life course approach is important, 
as children who are obese are more likely to remain so as adults, with consequences for 
morbidities, quality of life and health care costs throughout life, and there is good evidence that 
foetal and infant undernutrition are risk factors for obesity throughout the life course (Swinburn 
et al.).
Physical, cognitive and emotional development
Increasing evidence has linked indicators of adverse physical, cognitive and emotional 
development to poorer adult health and ageing outcomes, including an increased risk of chronic 
diseases. For example, in regards to physical growth, there are sufficient data from longitudinal 
studies to undertake systematic reviews and meta-analyses showing that low birth weight (a 
crude indicator of an adverse prenatal environment) is associated with higher risks of earlier 
mortality (Risnes et al., 2011), ischaemic heart disease (Huxley et al., 2007), diabetes (Whincup 
et al., 2008), and poor muscle strength (Dodds et al., 2012), whereas associations with blood 
pressure are modest (Huxley et al., 2002) and with cholesterol were weak (Huxley et al., 2004).
In terms of postnatal growth, shorter adult height is associated with mortality from cardiovascular 
disease and COPD whereas taller height is associated with mortality from several cancers 
(The Emerging Risk Factors Collaboration, 2012). Shorter height, particularly shorter leg length, 
is an indicator of adverse early life risk exposures, and is consistent with the evidence linking 
low childhood SEP to later life outcomes. Data on heights and weights through childhood and 
adolescence have been used to study growth patterns in relation to cardiovascular disease and 
its risk factors, osteoarthritis, bone density and fractures (Ben-Shlomo et al., 2016), although 
systematic reviews are not common because there are few studies on each outcome, and the 
analysis and interpretation of these data are more complex. However, the data generally show 
that linear growth in the first few years of life is beneficial for later life ageing outcomes. The 
current research focus in the developmental origins of adult disease is on understanding the 
underlying biological mechanisms that link prenatal and postnatal exposures to adult health and 
ageing (Hanson & Gluckman, 2014).
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A parallel field of research area has linked childhood characteristics such as lower cognitive 
ability with a range of health outcomes, from all-cause mortality (Calvin et al., 2011), 
cardiovascular and respiratory disease to physical functioning and reproductive ageing (see the 
next section). It is an ongoing and policy-relevant debate whether these associations are due to 
poorer childhood cognitive ability being a mediator of early adversity or neurodevelopmental 
delay, or a determinant of subsequent educational attainment, socioeconomic position 
and other life chances. A related research field has demonstrated how indicators of 
emotional development and early psychosocial adversity relate to adult mental health and 
psychopathology (Rutter et al., 2006). It is challenging to test whether different adversities 
operate through social, behavioural or biological pathways (Ferrucci et al., 2016; Rutter, 2012). 
These pathways are increasingly being investigated in younger cohorts with more precisely 
assessed exposures and stress responses.
Concluding remarks
In briefly introducing some of the global environmental health challenges and some of the 
lifetime risk factors that are common to many aspects of healthy ageing and age-related 
diseases, the current section sought to illustrate the range of factors that are modifiable, at an 
individual or societal level, and across the life course. While most risk factors are examined 
separately, risk factors often cluster or co-occur. Thus, health promotion and preventive 
strategies need to be assessed for their effectiveness on multiple rather than single outcomes, or 
targeted towards risk factors or protective factors that have a wide breadth of effect.
Policy option
Many risk factors (such as poor socioeconomic conditions, smoking, obesity 
and inactivity) have been found to be common within a wide range of diseases. 
Strategies with the potential to influence multiple rather than single outcomes may 
be particularly effective.
A “health in all policies” approach may support policymakers to better tackle the 
negative impacts of disparate policy fields including education, climate change, 
environmental pollution, food and nutrition, endocrine disrupting chemicals and 
antimicrobial resistance.
Fiscal and regulatory policies that facilitate tobacco control and promote healthy 
diets would target and manage risk factors for CVD and cancer, for example.
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2C. IDENTIFYING AND ACTING ON EARLY AND 
MIDLIFE RISK FACTORS FOR FUNCTIONAL 
AGEING AND AGE-RELATED DISEASES
A life course approach to promote healthy ageing and to prevent or slow down functional 
decline requires an understanding of early and midlife influences on, and trends in, functional 
ageing and age-related diseases.
This section is divided into subsections focusing on different intrinsic capacities (immune, 
metabolic, cardiovascular, respiratory, musculoskeletal, cognitive, psychological and sensory 
function) and their associated diseases and cancers. Within each section, drawing on systematic 
reviews where available, each health challenge is summarised by describing what is known 
about how capacities change and age-related diseases emerge across life, their health 
consequences, and their early and midlife risk and protective factors. Are there trends over time 
reported in the evidence — trends between generations, variations by gender, socioeconomic, 
or cultural groups — which EU policymakers need to take into account when developing public 
health strategies, in addition to population ageing?
The biological mechanisms underlying ageing, and some of the common lifetime determinants 
of ageing, were described in the preceding two sections. Here, the focus is on evidence about 
factors associated with characteristics of individuals and the social and physical environment in 
early and midlife that influence specific capacities and associated diseases. In the next section 
(2d, page 113), we consider the public health promotion and preventive disease strategies that 
evidence reveals may be most effective at each life stage, to reduce risks and build protection 
from the biological to the societal level.
Diabetes and metabolic function
Diabetes is a chronic disease characterised by high levels of glucose in the blood. With ageing, 
diabetes occurs either because the pancreas stops producing insulin (type 1 diabetes), or, more 
often, through a combination of the pancreas having reduced ability to produce insulin alongside 
the body becoming resistant to its action (type 2 diabetes).
The International Diabetes Federation estimates that in the whole of Europe in 2017, 8.8% 
(7.0–12.0%) of adults (20–79 years) are diagnosed with diabetes, corresponding to 58 million 
inhabitants. Their 2045 projections suggest that this prevalence will rise to 10.2%, or 66.7 million 
people (International Diabetes Federation, 2017). In addition, each year 28,200 children are newly 
diagnosed with type 1 diabetes.
Adverse trajectories of metabolic function, including obesity and elevated levels of glucose and 
triglycerides, precede the diagnosis of type 2 diabetes up to 20 years or more (Hulsegge et al., 
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2017; Malmstrom et al., 2018) and contribute to the development of cardiovascular disease and 
other morbidities. Fasting and postload glucose levels have been found to increase with age 
from early adulthood to old age, with a suggestion of a sharp increase in the rate of increase in 
glucose and insulin from approximately 60 years of age, probably driven by age-related weight 
gains and declines in physical activity (Hardy et al., 2015).
There is considerable variation among European countries in the proportion of the population 
with diabetes (from <1% to almost 10%) and the numbers have been rising over time (Figure 
15) (Wilkins et al., 2017). People with diabetes are at greater risk of developing cardiovascular 
diseases such as myocardial infarction, heart failure, and stroke if the disease is left undiagnosed 
or poorly controlled. They often have other cardiovascular risk factors, including hypertension 
and dyslipidaemia. Although treatment goals for people with prediabetes are the same as for 
the general population, increased vigilance is warranted to identify and treat these and other 
cardiovascular risk factors (e.g., smoking).
Figure 15. Prevalence of diabetes in Europe by country (International Diabetes Federation, 2017).
With ageing, people with diabetes also have higher risks for sight loss, foot and leg amputation 
due to damage to nerves and blood vessels, and chronic kidney disease eventually requiring 
dialysis or transplantation. Cognitive decline is greater and more common in diabetics than 
in non-diabetics. Research has shown that the disorders of cognition are underestimated in 
individuals with diabetes (Cukierman et al., 2005); there is a significant relationship between a 
long-term increase in blood glucose level and lower scores of various tests evaluating cognitive 
function (Cukierman-Yaffe et al., 2009). The mechanisms involved in these cognitive alterations 
are poorly studied and could involve hyperglycaemia and glycaemic fluctuations with severe 
hypoglycaemia, macrovascular ischemic cerebral lesions and microangiopathy, insulin-
resistance and chronic (Buysschaert et al., 2015). An increase in dementia risk associated with 
severe hypoglycaemia due to anti-diabetic treatment has been found in patients with diabetes. 
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Therefore, this evidence supports that strategies which target interventions aiming to prevent 
obesity and diabetes, and their morbidities, are major ways for favouring healthy ageing.
Figure 16. Prevalence (%) of diabetes in Europe by age and sex, 2017 (International Diabetes Federation, 2017).
In Europe in 2017, the global related health care expenditures of adults (20–79 years) with 
diabetes was substantial. The health expenditure of EU member states allocated to prevent 
and treat diabetes and its complications was estimated to be in the order of $166 billion in 2017 
(International Diabetes Federation, 2017), with a mean expenditure per person with diabetes of 
$3122. Over one quarter of this health expenditure was spent on treating elevated blood glucose, 
another quarter on treating long-term complications of diabetes, and the remainder on additional 
general medical care. People with diabetes also have a lower probability to be employed, and, 
when they are employed, have more days of sick leave and earn less. The growing direct and 
indirect costs related to diabetes reinforce the need for effective preventive actions and the 
provision of quality care to effectively manage diabetes and its complications (OECD/EU, 2016).
Risk factors and prevention
Type 2 diabetes is largely preventable. Numerous lifestyle factors, such as being overweight 
or obese, alcohol intake and inactivity are modifiable, and alterations here can also help to 
reduce complications associated with diabetes (American Diabetes Association, 2017). The long 
window of elevated metabolic risk factors before a diabetes diagnosis provides opportunities for 
prevention (Hulsegge et al., 2017; Malmstrom et al., 2018).
In older population groups of EU countries, people with a lower level of education are more than 
twice as likely to report having diabetes as those with a higher level of education. Research in 
this area has found that people with lower levels of education often have poorer nutrition and 
are more likely to be obese, which are important risk factors for diabetes (American Diabetes 
Association, 2018). Low socioeconomic level is associated with higher use of junk food, and the 
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unreliable availability of food has been shown to increase the risk for obesity and diabetes by a 
factor of two or three, with their morbidity consequences (Hill et al., 2013).
Challenge: Preventing or postponing type II diabetes
C
ro
ss
-s
e
ct
o
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l a
ct
io
n
s
Education   Form or mobilise responsible partners, care providers, teachers, etc.
  Train in use of available technologies for obese and at risk patients
Individual behaviour   Reduce caloric intake (favouring Mediterranean diet, 
monounsaturated fat, avoiding sugar-sweetened beverages)
  Physical activity (150 minutes per week)
  No smoking
Possible targeted 
prevention
  Diabetes prevention programme
  Identify and control early and midlife risk factors of obesity and 
cardio-metabolic diseases
  Regular medical follow-up and appropriate targeted advice
Technology   Importance of information technology (m-health)
  Identify health issues
  Monitor glycemic levels using available technology
  Ease treatment
  Ensure careful follow-up of global health conditions
Society   Proactively regulate agro-industry, business, goods distribution, 
advertisement campaigns
  Tax super-sweetened beverages
  Town planning
  Control of endocrine disruptors
Table 3. Challenge: preventing or postponing type II diabetes.
Endocrine-disrupting chemicals are mostly man-made, and found in various materials such as 
pesticides, metals, additives or contaminants in food, and personal care products. Exposure to 
these chemicals is increasingly recognised as a contributor to obesity and diabetes, mainly in 
early life and independent of diet and physical activity (Legler et al., 2015). For example, prenatal 
exposure to bisphenol A is associated with an increased risk of childhood obesity, and exposure 
to phthalate is associated with an increased risk of obesity and diabetes (Legler et al., 2015).
The peri-conceptional period and time of early embryonic development are now known to be 
key windows and a determinant of future chronic disease in adults. Suboptimal maternal and 
paternal nutrition, and maternal under- or over-nutrition and obesity, can increase the offspring’s 
risk of obesity, type 2 diabetes and cardiovascular disease into adulthood by way of metabolic 
imprinting, i.e. types of epigenetic cellular and metabolic mechanisms that happen very early 
on in development of life, but only reveal their effects later (Fleming et al., 2018; Hanson & 
Gluckman, 2014; Simeoni & Barker, 2009).
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Cardio-, neuro- and nephro-vascular diseases and vascular function
Cardiovascular disease
Despite steady declines in cardiovascular disease (CVD) mortality rates over the last 40 years, 
heart disease and stroke remain the first and fifth leading causes of death respectively in most 
high-income countries, and their associated mortality rates have recently begun to plateau in 
the general population and even increase in some sub-groups (Wall et al., 2018). However, given 
population ageing and CVDs’ association with ageing, the global burden of CVD is expected to 
continue to rise; premature deaths will increase from 5.9 million to 7.8 million between 2013 and 
2025 if current risk factors for CVD do not change (National Academies of Sciences et al., 2017).
At age 45, estimates of lifetime risk for total CVD (including fatal and nonfatal coronary heart 
disease, all forms of stroke, congestive heart failure, and other CVD deaths) were 60% for 
men and 56% for women (Wilkins et al., 2012). These estimates were based on data from US 
community-based cohorts between 1964 and 2008 only, as similar data for the EU are not 
available. By midlife, subclinical atherosclerosis is already highly prevalent, and was shown 
to affect 63% of the population (71% men, 48% women) in a large Spanish group study of 
asymptomatic subjects between the ages of 40 and 54 (Fernandez-Friera et al., 2015).
Favourable EU trends in CVD are not only related to changes in risk factor exposures (see 
below) but also to improvements in risk factor management and treatment, leading to mortality 
declines that were earlier and greater than declines in incidence (Bhatnagar et al., 2016; Mensah 
et al., 2017). Of current concern are the consequences of CVD and CV risk for physical and 
cognitive capacity and frailty (Forman et al., 2018; Melzer et al., 2018; Samieri et al., 2018). Also 
of importance are the persisting socioeconomic inequalities observed in CVD mortality and 
morbidity, based on child as well as adult socioeconomic indicators (Galobardes et al., 2008).
Atrial fibrillation is the most common sustained cardiac arrhythmia in humans, affecting more 
than 30 million people globally. Its association with complex, resource-intensive medical 
conditions such as stroke, heart failure and dementia means it will have profound impacts across 
existing health care structures.
Stroke
Stroke ranks second after ischemic heart disease as a cause of lost disability-adjusted life-
years in high-income countries, and as a cause of death worldwide. The rate of new strokes and 
stroke deaths, when adjusting for age, has decreased over the last two decades in all European 
countries (Wilkins et al., 2018). However, the number of strokes is set to rise because the 
proportion of Europeans over 70 is increasing. The projections indicate that, between 2015 and 
2035, there will be a 34% increase in total number of stroke events in the EU and a 32% increase 
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in disability-adjusted life years lost in the same period. In the EU, the total cost of stroke in 2015 
was calculated as €45 billion. 44% of this amount, €20 billion, was caused by direct health care 
costs: 72% of direct health care costs were for in-hospital care and 7% for drugs (Stevens et al., 
2017).
In Western societies, about 80% of strokes are caused by focal cerebral ischemia due to arterial 
occlusion, and the remaining 20% are caused by haemorrhages (van der Worp & van Gijn, 2007). 
Atherosclerosis (leading to thromboembolism or local occlusion) and cardio embolism (usually 
secondary to atrial fibrillation) are the leading causes of brain ischemia. Ischemic brain injury is 
thought to result from a cascade of events from energy depletion to cell death. The likelihood of 
a poor outcome after stroke increases with increasing age, with the coexistence of diseases such 
as ischemic heart disease and diabetes mellitus, and with increasing size of the infarct (van der 
Worp & van Gijn, 2007).
Stroke is preventable, but public knowledge about the risk factors for stroke is low. The 
proportion of the population with one or more risk factors for stroke is significant. High blood 
pressure, the most important risk factor for stroke, is significantly under-treated. The proportion 
of people with known high blood pressure who achieve adequate blood pressure control is 
well below 50%. Atrial fibrillation, another important risk factor, is often not diagnosed until after 
a stroke event, or not treated according to widely available national evidence-based guidelines 
(Stevens et al., 2017; Wilkins et al., 2017).
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Challenge: Preventing or postponing cardio-, neuro- and nephro-vascular diseases and functions
C
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Education   School education and workplace lifelong learning on coherent and 
comprehensive life habits
Individual behaviour   Individual choice, family influence, cultural and ethnic groups, 
workplace
  Adolescence is a vulnerable period for uptake of smoking, drinking 
alcohol, stopping sports, and spending too much time on screens
Possible targeted 
prevention
  Detect and control arterial hypertension lifelong
  Empower primary care professionals to prevent and reduce harmful 
use of alcohol, tobacco and junk food
  Regularly control weight/glycemic/cholesterol and establish total 
cardiovascular risk estimation
  Maintain healthy lifestyle changes
  Drink fresh water
  150 minutes a week of moderate intensity physical activity
Technology   e-health stimulating programs
  m-health self-management of physical activity, blood pressure, 
cardiac rhythm, functional ability
Society   Unhealthy food, tobacco and alcohol: media and educational 
campaigns, consumer-friendly labelling, marketing limitations, 
increased taxes
  Subsidise the cost of healthier foods
  Ban smoking in public places
  Implement countermeasures against drink driving
Table 4. Challenge: Preventing or postponing cardio-, neuro- and nephro-vascular diseases and functions
Nephro-vascular disease
Nephro-vascular disease refers to chronic kidney disease (CKD) in diabetes mellitus (both type 
1 and type 2), which represents a microvascular complication, and CKD secondary to systemic 
arterial hypertension, which represents both a microvascular and macrovascular complication. 
The prevalence and associated economic and social burden of CKD is rising worldwide, with 
the fastest growth occurring in low- and middle-income countries (LMICs) (Levin et al., 2017). 
CKD is associated with impaired quality of life and reduced life expectancy at all ages. It 
represents an independent risk factor for cardiovascular disease and is associated with excess 
risk of other conditions such as diabetes, infections and cancer (Levin et al., 2017). The number 
of drug side-effects is much more important in older patients with CKD (Gallieni & Cancarini, 
2014). Despite a global prevalence as high as 10–15% (Hill et al., 2016), CKD is not included in 
most non-communicable diseases priority lists, and few countries have explicit policies or public 
programmes aimed at CKD prevention and control (Levin et al., 2017).
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Risk factors and prevention
The key risk factors for CVD are well known: elevated blood pressure and cholesterol, diabetes, 
smoking, heavy alcohol use, obesity and high sodium intake. Maintenance of optimal levels in the 
first four of these risk factors in middle age was associated with substantially longer morbidity-
free survival (Wilkins et al., 2012). Compared with participants with at least two major risk factors, 
those with an optimal risk factor profile lived up to 14 years longer free of total CVD. The positive 
relationship between regular physical activity and cardiovascular health is also well established 
according to the latest US guidelines (Piercy & Troiano, 2018):
  Decreased incidence of cardiovascular disease, including stroke and heart failure
  Decreased cardiovascular disease mortality
  Reduced blood pressure (in people with normal blood pressure, prehypertension and 
hypertension)
  Decreased incidence of hypertension
  Weight loss, especially when combined with dietary changes to reduce calorie intake
  Prevention of weight regain after weight loss
  Reduced or slowed weight gain over time
  Decreased incidence of type 2 diabetes mellitus (includes those at any body weight)
  Decreased risk of adverse lipid profile
Somewhat less well known is the importance of these risk factors from an early age. Based on a 
review of life course trajectories in blood pressure, lipids and glucose, Lawlor and Hardy (2014) 
conclude that higher blood pressure, LDL-cholesterol, and fasting glucose in adolescence and 
early adulthood are associated with adverse cardio-metabolic events in older age, independent 
of these risk factors in adulthood. Moreover, blood pressure, body mass index (BMI) and 
glycaemic control measures in childhood, adolescence and early adulthood, and subsequent 
longitudinal trajectories of blood pressure and BMI, are predictive of future abnormalities in 
cardiac structure and function (Ghosh et al., 2014). Therefore, understanding underlying ‘normal’ 
or ‘healthy’ life course trajectories and the characteristics that drive deviations from such 
trajectories offer potential for early prevention and for identifying means of preventing future 
disease (Hardy et al., 2015). Furthermore, the Developmental Origins of Health and Disease 
concept has received strong evidential support, suggesting that poor developmental experience 
(in utero and in the early postnatal period) can increase the risk of non-communicable diseases 
in later life, including cardiovascular and metabolic comorbidities, such as hypertension, obesity, 
and type 2 diabetes (Hanson & Gluckman, 2014; Turkeshi et al., 2015).
In people with no known vascular disease, the main risk factors for both ischemic and 
haemorrhagic stroke are age, hypertension, diabetes, current cigarette smoking and male 
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sex (Baigent et al., 2009). Female-specific characteristics increasing stroke risk include any 
hypertensive disorder in pregnancy (HDP) for ischemic stroke; late menopause and gestational 
hypertension for haemorrhagic stroke; and oophorectomy, HDP, preterm delivery, and stillbirth 
for any stroke (Poorthuis et al., 2016). Hysterectomy is possibly protective against any stroke. 
Male-specific characteristics that increase stroke risk include medical androgen deprivation 
therapy for ischemic and any stroke, and erectile dysfunction for any stroke (Poorthuis et al., 
2016).
Diabetes mellitus and hypertension are the dominant global risk factors for CKD. Obesity is 
closely linked to diabetes and hypertension and might also predispose people to CKD. Good 
management of diabetes, hypertension, and excess body weight reduces the risk of CKD and 
improves outcomes in patients with CKD (Levin et al., 2017). In the MRC National Survey of Health 
and Development, being overweight throughout early life or becoming overweight in early 
adulthood was found to be associated with CKD in later life (Silverwood et al., 2013a; Silverwood 
et al., 2013b). Thus, reducing or preventing overweight in early life or early adulthood may 
considerably reduce the burden of CKD in the population (Silverwood et al., 2013a; Silverwood et 
al., 2013b).
The ongoing epidemic of obesity results in people becoming overweight at earlier ages (in 
early adult life, and more recently in adolescence and childhood), and this leads to a substantial 
increase in exposure to metabolic abnormalities associated with overweight and obesity, which 
could have important consequences for CKD as well as for CVD (Tirosh et al., 2011).
Given the limited therapeutic options to reduce the risk of atherothrombotic events and 
progression to renal replacement therapy (and high cost of the latter) (Levin et al., 2017), 
preventing or delaying the onset of CKD appears as a high priority for reducing the economic 
and social burden of CKD in future older people.
Pulmonary function and chronic respiratory diseases
Lung health is intimately associated with good health in older adults. Breathing difficulties 
and poor blood gas exchange are key determinants of poor metabolic health, leading to 
physiological inefficiencies, susceptibility to the onset or fast progression of diseases, and poor 
physical and mental performance (Goodwin et al., 2006). Pulmonary function is an independent 
predictor of mortality in old people: in very old adults, low forced expiratory volume (FEV1) is a 
short-term predictor of all-cause mortality, hospitalisation and decline in physical and mental 
functioning independently of age, smoking status, chronic lung disease and other multimorbidity 
(Turkeshi et al., 2015).
The lung grows until puberty and matures until it reaches its maximum function at 20–25 years of 
age (Janssens et al., 1999). Lung function then declines progressively with age as a consequence 
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of structural and physiological changes of the lung and immunosenescence (Bowdish, 2018). 
There are structural changes in the lung, the chest wall and respiratory muscles over time 
(Miller, 2010). The nine hallmarks of ageing (Lopez-Otin et al., 2013) are all involved in the ageing 
lung (Meiners et al., 2015): genomic instability, telomere attrition, epigenetic alterations, loss 
of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, 
altered intercellular communication and stem cell exhaustion.
Chronic respiratory diseases (CRDs) are chronic diseases of the airways and other structures 
of the lungs. They represent a model of non-communicable disease across the life course. 
CRDs affect over one billion people in the world (WHO, 2007b). CRDs are the fourth leading 
cause of death (WHO, 2012) and a major cause of burden (GBD 2015 Mortality and Causes of 
Death Collaborators, 2016). Major preventable CRDs include chronic obstructive pulmonary 
disease (COPD), asthma and respiratory allergies, and occupational lung diseases. The burden 
of preventable CRD has major adverse effects on the quality of life and disability of affected 
individuals; they cause premature death and create large adverse and underappreciated 
economic effects on families, communities and societies in general. The prevalence of some 
CRDs, such as COPD and pulmonary fibrosis, sharply increases with age. In this section we focus 
on COPD and asthma, as they represent the greatest burden.
COPD is a major public health problem and will remain a challenge for the future. It affects 5–10% 
of European adults aged over 40, with a higher prevalence in men than women (European Lung 
White Book, 2019). Globally, over 4 million people die from COPD annually (Figure 17). COPD is a 
heterogeneous disease with various clinical presentations. It is characterised by abnormal tissue 
repair, resulting in (small) airways disease and emphysema, and by persistent airflow limitation, 
which is usually progressive and associated with an enhanced chronic inflammatory response in 
airways and lungs to noxious particles and gases (Barnes et al., 2015).
COPD is a major source of physical and social disability (Liu et al., 2014), and of frailty. Physical 
disability stems from exercise-induced dyspnea (shortness of breath), muscular deconditioning, 
and other factors that have a major impact on the quality of life of the patients (Rasekaba et al., 
2009). Many individuals with COPD have a low body weight associated with impaired pulmonary 
status, reduced diaphragmatic mass, lower exercise capacity and higher mortality than those 
who are adequately nourished (Ferreira et al., 2012a). Up to 15% of patients with stable COPD 
have sarcopenia (loss of skeletal muscle mass), which impairs function and health status (Jones 
et al., 2015). Severity of COPD can be assessed by gait speed, which captures many of the 
multi-systemic effects of COPD (Ilgin et al., 2011), and correlates with age, clinical symptoms, 
pulmonary functions and quality of life scores.
Asthma is defined as an airflow obstruction that is reversible, spontaneously or after treatment. 
Inflammation of the airways and non-specific bronchial hyperreactivity are features of asthma 
(Boulet et al., 2015). Asthma and allergic diseases often occur in early childhood and persist 
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across the life cycle (Samoliński et al., 2012). Asthma is a global health problem affecting over 
300 million people worldwide. Patients from all countries, all ethnic groups, and all ages suffer 
from asthma. The prevalence of asthma can be higher than 20% of the population in some age 
groups. Asthma affects social life, sleep, school and work. Long-standing asthma can cause 
disability and COPD. Various social and economic effects are associated with asthma, including 
absenteeism and presenteeism (Fletcher et al., 2015).
Long-term prognosis of patients with characteristics of both COPD and asthma (asthma–
COPD overlap) is poor and seems to be affected by the age of recognition of asthma, being 
worst in those with late asthma onset (after 40 years of age). Such patients should be followed 
up closely to prevent fast lung function decline and exacerbations (Lange et al., 2016).
Risk factors and prevention
The airways are constantly exposed to the outside environment, which impacts lung structure 
and function and thus determines lung health. A life course approach is therefore essential to 
prevent and control CRDs in order to promote healthy ageing (Bousquet et al., 2015). As with 
diabetes and obesity, factors across life from the prenatal period onwards influence CRDs. 
Factors that affect lung growth during pregnancy and early childhood may increase the risk 
for COPD (Vestbo et al., 2013). Major early-life risk factors for later respiratory disease include 
abnormal antenatal lung growth, low birthweight, prematurity and bronchopulmonary dysplasia, 
passive smoke exposure and viral infections. The links between such early life events and 
subsequent risk of disease in adulthood are accumulating (Allinson et al., 2017).
Figure 17. Mortality rate for COPD (age-standardised rate per 100,000) (European Lung White Book, 2019). 
Reproduced with permission of the European Respiratory Society.
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Ageing is a major risk factor for CRDs (Meiners et al., 2015). For COPD, there is accumulating 
evidence that ageing hallmarks are prominent features (Barnes, 2017; Brandsma et al., 2017). 
Worldwide, the most common risk factors for COPD are tobacco smoking, indoor and outdoor air 
pollution (Cohen et al., 2017), and occupational exposures to vapour, dust, gas or fumes (Caillaud 
et al., 2012). Low socioeconomic status also increases the risk of developing COPD. Bronchitis, 
airway hyper-responsiveness and asthma accelerate decline in FEV1 independent of exposures 
(Vestbo & Lange, 2016).
Challenge: Preserving respiratory function until very old age
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Education   Basic education starting at school
  Lifelong health literacy
Individual behaviour   No smoking
  No exposure to polluted air and toxins
  Limit and control occupational exposure
  Physical activity
  Healthy nutrition
Possible targeted 
prevention
  Identify and control earliest risk factors in life: antenatal conditions; 
birth weight; prematurity; growth; childhood allergy; viral infections; 
smoking and pollution exposure
  Identify and manage midlife pre-frailty and frailty
Technology   Mobile health app providing allergen and toxin alerts
  Detect the first symptoms
  Reduce acute and chronic respiratory diseases
  Evidence-based care and better treatment adherence
Society   Sustainably control noxious particles and gases, indoor and outdoor 
pollution
  Improve socioeconomic status of population at risk
Table 5. Challenge: Preserving respiratory function until very old age
For asthma, the role of ageing is not sufficiently well understood and needs more studies 
considering different phenotypes, environmental risk factors and multimorbidity.
COPD impact is expected to rise globally in the future, partly due to continued exposure to 
COPD risk factors and partly due to ageing (Barnes et al., 2015). Strategies should be considered 
to reduce exposure to CRD risk factors, especially smoking; to use gait speed as a functional 
capacity indicator; and to provide sustainable models for preventing CRDs and promoting good 
lung health.
Musculoskeletal and physical function, and related diseases
Maintaining musculoskeletal function for the maximal period of time, and preventing 
musculoskeletal disorders, are important aspects of healthy ageing, enabling people to remain 
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active and independent for longer (Cooper et al., 2014) and reducing the risk of common 
clinical conditions such as back pain, osteoporosis, sarcopenia (muscle weakness), falls and 
osteoarthritis. In Europe, musculoskeletal disorders rank second in their contribution to loss of 
disability-adjusted life years (Figure 18) (Wilkins et al., 2017).
The musculoskeletal system underpins the individual’s intrinsic capacity to maintain mobility 
and other aspects of physical function needed to undertake the physical tasks of daily living, 
although other body systems also contribute. Physical function tests are good indicators of 
such intrinsic capacity. Hand grip strength, which relates directly to upper body function, is a 
commonly used indicator of overall muscle strength, while tests of walking speed, chair rises, 
and standing balance are good indicators of lower body function (Cooper et al., 2014).
Figure 18. Disability-adjusted life years lost by cause. 2015 data for the EU (Wilkins et al., 2017).
Low bone mineral density is a major risk factor for osteoporosis and fractures, commonly at the 
hip, spine and wrist. Low grip strength has been recently recommended as the key criterion 
for defining sarcopenia, confirmed by an assessment of muscle mass and severity defined by 
poor walking speed (Cruz-Jentoft et al., 2019). Hip and knee osteoarthritis are major causes 
of disability (expected to become the 4th leading cause of disability by 2020 (Runhaar & 
Zhang, 2018). Weaker grip, slower walking and chair rise speed, and shorter balance times are 
associated with future morbidity, disability, falls, and mortality across populations of different 
ages, ethnicities and income levels (Cooper et al., 2011; Cooper et al., 2010; den Ouden et al., 2011; 
Kim et al., 2017).
At a population level, musculoskeletal and physical function develop during childhood and 
adolescence, reach a peak or plateau in early adulthood and then decline with age (Dodds et al., 
2014; Ferrucci et al., 2016; Gabel et al., 2018; Nahhas et al., 2010). There is an accelerated decline 
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in strength and physical function by the end of the seventh decade and in bone mass after 
menopause (Dodds et al., 2014; Ferrucci et al., 2016; Nahhas et al., 2010). The clinical sequelae 
(osteoporosis and fracture, sarcopenia, osteoarthritis and falls) all show an increase with age, with 
the exception of back pain, which may peak in midlife (Hoy et al., 2012). By midlife, osteoarthritis 
is already a burden, particularly for women (Litwic et al., 2013). With population ageing, numbers 
affected will inevitably rise, and increasing obesity and sedentary lifestyles from early life will 
increase numbers further.
Women generally have lower levels of musculoskeletal and physical function and are more at 
risk of all the common clinical sequelae. The main ethnic differences are in fracture risk, with 
white Caucasian groups being most at risk compared with black African groups, and Asians 
having an intermediate risk (Cauley et al., 2014).
Risk factors and prevention
  Socioeconomic status: A lifetime of socioeconomic disadvantage is associated with lower 
muscle strength and physical function, and their age-related decline (Birnie et al., 2011; 
Stringhini et al., 2017), and greater functional consequences of fractures (Truong et al., 2018).
  Lifetime body size: Greater adiposity is a major determinant of knee and hip osteoarthritis 
(Blagojevic et al., 2010) and earlier onset of adiposity may increase the risk further (Wills et 
al., 2012). Greater adiposity is also a risk factor for reduced physical function, particularly 
when it coexists with sarcopenia or low muscle strength (Hardy et al., 2013). The relationship 
of adiposity with bone mineral density (BMD) and fracture risk is site-specific (Compston et 
al., 2014). Poorer prenatal growth (indexed by lower birthweight) is associated with weaker 
grip throughout life, independent of adult body size (Dodds et al., 2012), and with lower bone 
size during adulthood (Baird et al., 2011). Puberty is an important period for bone growth and 
mineral accrual, with 20–30% of an individual’s total body bone mineral accrued during the 
pubertal growth spurt. Later puberty and/or peak height velocity have been associated with 
lower BMD, osteoporosis and fracture risk (Bonjour & Chevalley, 2014; Day et al., 2015; Kuh & 
Ben-Shlomo, 2016).
  Lifetime health behaviours: Adult physical inactivity and sedentary lifestyles are risk factors 
for lower levels of BMD (Bolam et al., 2013), muscle strength and physical function (Ferreira 
et al., 2012b; Shaw et al., 2017). Higher childhood levels of physical activity are formative for 
later muscle and bone strength (Gordon et al., 2017), and in adult life can play an important 
role in rehabilitation and recovery of muscle mass. Smoking, high alcohol consumption and 
a diet lacking in protein, calcium or vitamin D are risk factors for peak bone mass (Gordon 
et al., 2017) and later bone loss (Al-Bashaireh et al., 2018). Overall, an unhealthy lifestyle is 
associated with decline in strength (Cooper et al., 2016) and with physical function (Robinson 
et al., 2013).
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  Health status: The associations between depressive symptoms and musculoskeletal 
and physical function from midlife onwards are probably bidirectional (Mezuk et al., 2012; 
Schweiger et al., 2016). Lower levels of childhood and adult cognition are associated with 
subsequent lower levels of grip strength and physical function (Clouston et al., 2013; Cooper 
et al., 2017), indicating that neurodevelopmental and neurodegenerative processes are 
involved.
  Cardiovascular disease: Those with CVDs or high cardiovascular risk scores subsequently 
have worse physical function (Forman et al., 2017; Hamer et al., 2010; Windham et al., 2017), 
bone loss and fractures (den Uyl et al., 2011), and more incident falls, hospitalisations with 
fragility fractures, and osteoarthritis (Melzer et al., 2018). Poor metabolic health affects 
osteoarthritis by the mechanical burden due to overweight and through independent 
metabolic mechanisms. Higher levels of inflammation are associated with weaker muscle 
strength, poorer physical function and faster decline (Anton et al., 2015; Newman et al., 
2016). Hormonal dysregulation, particularly of the hypothalamic-pituitary-adrenal and 
hypothalamic–pituitary–gonadal axes, is an underlying biological mechanism of ageing 
affecting physical function (Anton et al., 2015), and hormonal changes accompanying the 
menopause in women increase the loss of BMD and risk of hip fracture (Banks et al., 2009).
In summary, given the evidence, the promotion of musculoskeletal and physical function needs 
to start early in life (Cooper et al., 2014; Gordon et al., 2017) and continue across life. In the 
following sections, this report aims to offer public health strategies which seek to optimise peak 
function by early adulthood, and monitor change and encourage healthy lifestyles and body 
weight throughout life, with the aim of delaying the onset or progression of functional decline 
and disorders (Deary et al., 2009). Such strategies will have multifaceted consequences that cut 
across different domains of age-related pathophysiological changes.
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Challenge: Improve physical function, prevent or postpone musculoskeletal disorders
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Education   For parents and health professionals: Improve health literacy about 
prenatal and prepubertal growth, later puberty and hormonal 
dysregulation in children
  For children: Educate in role of exercise, sports and appropriate 
nutrition
Individual behaviour   No smoking
  No or low alcohol intake
  Physical exercise
  Healthy diet
  Regular low-intensity sun exposure
Possible targeted 
prevention
  Medically prescribe physical exercise and high-protein diet
  Address obesity and sedentary lifestyle
  Ensure adequate calcium intake and vitamin D supplement if 
needed
  Manage cardio-metabolic health and mood
  Stimulate cognitive activity
Technology   Everyday technology for mental stimulation
  Mobile health app to monitor physical function
  Stimulate adequate and diverse physical activity every day
Society   Promote sports and exercise at all ages
  Provide easy access to sports facilities and green spaces
  Integrate this policy within health-friendly and ageing-friendly 
communities
Table 6. Challenge: Improve physical function, prevent or postpone musculoskeletal disorders
Cognitive function and dementias
Dementia is a 21st-century epidemic. The World Alzheimer Report (Alzheimer’s Disease 
International, 2015) estimates that 131 million people will be living with dementia in the year 
2050, up from 47 million in 2015. The increase in life expectancy means that the overall number 
of people with dementia, and therefore its societal impact, will increase dramatically in the 
coming decades. Emerging evidence suggests that the age-specific incidence of dementia is 
declining in high-income countries, thought to be due to better control of cardiovascular risk 
factors and improved education and living standards (Chene et al., 2015; Langa, 2015; Larson 
et al., 2013; Matthews et al., 2013). This trend is observed in European studies (Qiu et al., 2013). 
However, dementia continues to increase in rapidly industrialising countries due to increased 
cardiovascular risk factors and rates of smoking, obesity, and metabolic diseases (Prince et al., 
2016).
Alzheimer’s disease (AD) is the most common cause of dementia, accounting for up to 70% of 
all dementia cases. The research paradigm that dominates thinking in AD revolves around the 
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amyloid cascade hypothesis, where the overproduction or poor clearance of amyloid-beta is 
thought to trigger a cascade of changes that lead to neuronal injury and loss (Glenner & Wong, 
1984; Hardy & Selkoe, 2002). Considerable financial and intellectual investment has led to better 
understanding of the sequence of changes in imageing and cerebrospinal fluid biomarkers (Jack 
et al., 2013).
However, pharmaceutical interventions to modify the course of disease have met with 
limited success, and the failure rate of drug trials is greater than for any other chronic disease 
(Cummings et al., 2014). Several authors have highlighted inconsistencies in the evidence to 
support the amyloid hypothesis (Morris et al., 2014). Reduced cerebral blood flow, hypoxia, and 
blood–brain barrier dysfunction may be initiators of neurodegenerative changes independently 
and/or prior to deposition of amyloid beta (Zlokovic, 2011). Furthermore, the pathophysiological 
process of AD and related dementias is thought to begin as long as 20 years prior to emergence 
of clinical symptoms of dementia (Bateman et al., 2012; Jack et al., 2013; Nelson et al., 2009; 
Sperling et al., 2011; Villemagne et al., 2013), highlighting the importance of a life course approach 
to dementia and cognitive function.
The life course approach proposes that interactions between genes and environmental factors 
drive cognitive development to a peak or plateau in early adulthood, and determine the onset 
and rate of functional decline and in some cases the clinical expression of dementia (see 
Figure 19) (Whalley et al., 2006). There are age-related changes in cognitive abilities that, while 
associated with age, are not necessarily markers of an underlying disease process. In general, 
cognitive abilities show characteristic changes with increasing age, though the trajectories of 
change differ from person to person (both the timing of change and the extent to which these 
are experienced) (Hertzog et al., 2008). Those individual differences in cognitive development 
and in the degree of age-related cognitive decline help to identify the potential risk and 
protective factors which, when modified, might enhance cognitive reserve and delay the onset 
and progression of cognitive decline and dementia. A one-year delay in dementia onset is 
projected to lead to 9.2 million fewer cases worldwide by 2050 (Brookmeyer et al., 2007).
Risk factors and prevention
A range of social, psychological and neurobiological processes and factors shape cognitive 
maturation and ageing, along with pathogenesis common to many dementia syndromes. The 
case for understanding cognitive development in childhood is tied to tremendous cognitive 
plasticity early in life. It is urgent to assess how neurocognitive development in infancy 
and childhood is impacted by changes in social and family structure, as well as physical, 
environmental and other psychosocial factors.
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Figure 19. Life course model of cognitive health.
Better cognitive performance in young adulthood has salience for late-life outcomes due to the 
protective effect of ‘reserve’ — the capacity to offset the detrimental effect of neuropathology 
later in life. Recent findings highlight the role of lifestyle factors (Gow & Mortensen, 2016; Gow 
et al., 2017; Sabia et al., 2014; Sabia et al., 2012), metabolic (Sabia et al., 2014; Singh-Manoux et 
al., 2012; Tuligenga et al., 2014), cardiovascular (Kaffashian et al., 2013a; Kaffashian et al., 2013b; 
Kaffashian et al., 2011) and inflammatory (Singh-Manoux et al., 2014) risk factors for cognitive 
ageing trajectories.
In regard to dementia, a number of factors are often cited as potentially associated with an 
increased or decreased risk, although there are differences in the approach used. We describe 
the current evidence, separating out the approach of a priori risk factors from those based on 
reviews of the literature.
Three major studies in the last decade have identified risk factors for dementia from a literature 
review, and then used the prevalence of each risk factor and the strength of its association to 
provide population-based estimates of attributable risk (the a priori approach) (Barnes & Yaffe, 
2011; Livingston et al., 2017; Norton et al., 2014). Seven potentially modifiable risk factors — 
diabetes, midlife hypertension, midlife obesity, insufficient physical activity, depression, smoking, 
and low educational attainment — may account for about one third of Alzheimer’s cases in 
the US and Europe (Winblad et al., 2016). The same analysis indicated that even a modest 10% 
reduction in each of these risk factors could reduce the prevalence of Alzheimer’s disease in 
93
C
H
A
P
T
E
R
 2
A
g
e
in
g
 a
cr
o
ss
 t
h
e
 li
fe
 c
o
u
rs
e
these regions by about 8% by 2050. The latest study by Livingston et al. (2017) calculated the 
population-attributable fraction associated with risk factors from across the life course: poor 
education in early life (before approximately 18 years of age), hypertension, obesity, and hearing 
loss in midlife (approximately 45–65 years of age), and smoking, depression, physical inactivity, 
social isolation, and diabetes in later life (after approximately 65 years of age). Their results 
suggest that around 35% of dementia is attributable to a combination of these nine risk factors:
  Young age (approximately <18 years)
  Low education in early life
  Midlife (approximately 45–65 years)
  Hypertension
  Obesity
  Hearing loss
  Later life (approximately >65 years)
  Smoking
  Depression
  Physical activity
  Social isolation
  Diabetes
There have also been four major reviews of the literature over the last ten years (Baumgart et al., 
2015; Kane et al., 2017; National Academies of Sciences, 2017; Winblad et al., 2016). The extensive 
review by Winblad et al. (2016) reiterated the multifactorial nature of dementia, highlighting the 
interplay between genetic susceptibility and environmental factors across the lifespan. The 
authors presented a long list of risk and protective factors but cautioned that the evidence to 
support the factors listed is variable, and the relevance of several proposed factors is open to 
debate. The most pronounced risk factors are advancing age and carrying one or two APOE ɛ4 
alleles.
The National Institute of Ageing of the US National Institutes of Health (NIH) asked the US 
National Academies of Sciences, Engineering and Medicine to convene a committee to 
examine the state of knowledge about what works in preventing or slowing cognitive decline 
and dementia (Brookmeyer et al., 2007). The goal was to use the recommendations for 
communicating with the public. The systematic review highlighted significant methodological 
shortcomings in the evidence. Based on this body of evidence, the committee identified three 
classes of interventions — cognitive training, blood pressure management for people with 
hypertension, and increased physical activity — as being supported by modest but inconclusive 
evidence at present. This strength of evidence did not, in the committee’s judgement, warrant 
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aggressive public health campaigns at the present time. The report also noted that evidence 
should be strengthened on the following categories of interventions, alone or in combination, for 
which there is currently insufficient evidence to determine their effectiveness:
  new anti-dementia treatments
  diabetes treatment
  depression treatment
  dietary interventions
  lipid-lowering treatment/statins
  sleep quality interventions
  social engagement interventions
  vitamin B12 plus folic acid supplementation
The review by Kane et al. (2017) assessed evidence for interventions aimed at preventing or 
delaying the onset of age-related cognitive decline, mild cognitive impairment, or clinical 
Alzheimer’s-type dementia. 263 eligible studies were identified and the authors report finding 
“no high-strength evidence for the effectiveness of any intervention” to delay or prevent these 
outcomes. The study reported finding moderate-strength evidence that cognitive training 
improved performance in the trained cognitive domains, but not in domains not trained. Evidence 
of an effect on dementia incidence was weak. There was a mix of positive and negative findings 
for different outcomes, all of low strength, for physical activity, antihypertensives, nonsteroidal 
anti-inflammatory drugs (NSAIDs), B vitamins, nutraceuticals, and multimodal interventions. 
Signals seem more promising for physical activity and vitamin B12 plus folic acid. This review also 
highlighted widespread methodological problems in the available literature.
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Challenge: Building reserve, preventing or postponing cognitive decline
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Education   Lifelong education: improving cognitive ability, boosting cognitive 
performance life
Individual behaviour   Physical activity
  Mediterranean diet
  No obesity
  No smoking
  Socially and mentally stimulating activities
  Avoid head trauma
  Light to moderate alcohol consumption
Possible targeted 
prevention
Moderate but inconsistent evidence for efficacy of management through:
  Cognitive training
  Targeting and controlling cardio-metabolic risk factors
  Increasing physical exercise
Insufficient evidence for effects of:
  New statin treatments (anti-dementia, anti-diabetes, anti-depression, 
lipid-lowering)
  Interventions related to diet, sleep quality, social engagement
  Vitamin B12 and folic acid supplementation
Technology   Mobile health app to detect cognitive decline and ease early 
diagnosis
  Biomarkers or companion diagnosis
  Precision medicine?
Society   Reduce loneliness and combat ageism
  Favour social integration
  Promote age-friendly communities and stimulating leisure activities
  Enhance research activities on brain health
Table 7. Challenge: Building reserve, preventing or postponing cognitive decline.
In assessing the evidence, however, others have noted that the evidence for some factors 
is now sufficiently strong to justify action (Baumgart et al., 2015). For example, Kannel et al. 
(1976) summarised the risk and protective factors as having strong, moderate, lower or unclear 
evidence for dementia and for cognitive decline. In terms of increased risk of dementia, they 
concluded that the strongest evidence was available for traumatic brain injury, with moderate 
evidence for obesity and hypertension in midlife, smoking and diabetes as risk factors, while 
years of education appeared to lower risk (strong evidence) with the benefit of physical activity 
being moderately supported. In terms of cognitive decline, they suggested that there was strong 
evidence for traumatic brain injury, obesity and hypertension in midlife, smoking and diabetes as 
risk factors, while years of education and physical activity were protective (Kannel et al., 1976).
There are key gaps in understanding the role of risk factors for cognitive decline and dementia 
and for many other aspects of functional decline and age-related diseases. First, much of the 
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evidence on risk factors for dementia comes from studies on adults aged 65+ at recruitment, and 
uses one-off measures of risk factors with subsequent tracking of dementia. When risk factors 
are assessed once in older cohorts and the follow-up is short, the estimates necessarily include 
the effects of reverse causation, i.e. the effect of preclinical dementia on risk factors. Lack of 
consideration for the long preclinical phase of Alzheimer’s disease is the primary explanation for 
inconsistency in findings. Issues of reverse causation are also relevant to cognitive decline not 
associated with dementia. Second, while there is considerable consensus on the importance 
of midlife cardio-metabolic factors, they have not been examined systematically, particularly 
in relation to age of exposure, threshold levels, and changes over time. ‘Midlife’ remains poorly 
characterised in studies, and few have undertaken research on critical time windows for 
exposures (midlife vs. late-life). The exceptions are recent findings on obesity and hypertension 
that suggest that exposure at age 50 but not at age 70 increases risk for dementia. In addition, 
many cardio-metabolic factors may carry risk for dementia below the threshold established 
for cardiovascular disease; thus, thresholds established for cardiovascular disease may not 
transpose directly to cognitive dysfunction.
In summary, the consistently explored risk factors for dementia include diabetes, hypertension, 
obesity, smoking, and low educational level. Taken together, these analyses suggest that such 
factors might account for about one third of dementia incidence, and therefore that these 
factors should be among the targets for intervention as they also drive CVD and CKD; these are 
considered further in following sections.
Psychological function and mental disorders
Mental disorders are one of the most important public health challenges in the European region, 
whether measured by prevalence, burden of disease or disability (WHO, 2015a). One of the 
most common mental disorders is depression, which has a lifetime prevalence of 9% among 
European adult men and 17% among European adult women (WHO, 2016d). The economic costs 
associated with depression amounted to €136.3 billion in the European Economic Area in 2007, 
€99.3 billion from reduced productivity and €37 from billion health care costs (McDaid & Park, 
2011).
A survey of fourteen European centres using the EURO-D depression scale in 21,724 subjects 
aged 65 years or more found consistent differences in prevalence across centres that could not 
be explained by demographic differences; consistently higher rates were found with increasing 
age, female gender and by widowhood and separation (Prince et al., 1999). A further study 
of the prevalence of depressive symptoms and syndromes in 10 centres in the SHARE study 
found higher rates in the Latin ethno-lingual group of countries, especially symptoms related to 
motivation. They also found that women scored higher on affective suffering and older people 
and those with impaired verbal fluency scored higher on motivation (Castro-Costa et al., 2007).
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Common mental disorders (CMDs), largely anxiety and depressive disorders, are associated 
with age. In the UK, the Adult Psychiatric Morbidity Survey (McManus et al., 2016) showed that 
working-age people were twice as likely to have CMDs as those aged 65 and over. Between 16 
and 64, the proportion remained around 17%–18%, but among those aged 65 and over the rate 
was much lower (10.2% of 65 to 74-year-olds and 8.1% of those aged 75 and over). Both men and 
women experienced a tailing off of CMDs in later life. This pattern was similar, although even 
more pronounced, in rates of severe symptoms.
Since the previous APMS in 2007 (NHS Digital, 2009), there were increases in CMDs in late 
midlife men and women (aged 55 to 64). This continued an upward trend observed in midlife 
women since 1993, whereas the longer-term trend in men was less clear. Those in late life have 
also seen a steep increase in rates of reported lifetime self-harm. Men in this age group have 
the highest rates of registered suicide and have been identified as a priority group in England’s 
National Suicide Prevention Strategy. There have also been increases in rates of severe CMDs 
in women aged 55 to 64 (from 5.5% to 9.3%), and for men aged 55 to 64 (from 5.7% to 9.1%) 
(McManus et al., 2016). Overall, and for men, the recent change in rates of severe CMDs between 
2007 and 2014 in 55–64-year-olds was statistically significant. This increase may relate to people 
of this age being particularly vulnerable at time of economic recession (Frasquilho et al., 2016). 
One interpretation of this may be that the recession, which began in 2008, has had more of an 
impact on the mental health of adults approaching retirement than of those who had already 
reached retirement age.
Among older adults, disability has been associated with increased risk of depression (Prince et 
al., 1997b). In a recent study, once disability had been taken into account, somatic disease did 
not contribute independently to variance in depression (Verhaak et al., 2014). The association was 
stronger for those aged 60–69 years than for those older than 70 years. In particular, disability 
in participation, self-care and social activities contributed to increased risk of depression. It is 
also possible that the causal association may work in the opposite direction: depression may 
contribute to a deterioration in physical capacity, an inverse association has been found in 
NHANES between depression and hand grip strength (Brooks et al., 2018). Poor self-rated health 
and depression have been found to be the strongest predictors of needing assistance in one or 
more activities of daily living in a Norwegian cohort study (Storeng et al., 2018). There is a robust 
prospective relationship between depression and incident frailty; frailty and depression can be 
difficult to separate in advanced old age (Vaughan et al., 2015).
Risk factors and prevention
Social disadvantage in childhood is associated with a higher risk of major depression in 
adulthood adjusting for childhood sociodemographic factors, family history of mental illness and 
adult social position (Gilman et al., 2002). Exposure to adversity in childhood, especially physical 
and sexual abuse, is a predictor of both depressive and anxiety disorders in young adulthood and 
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mid-life (Clark et al., 2010); part of this may be mediated through changes in HPA axis function. 
Deficits in social support and life events, especially involving personal illness, bereavement and 
theft have been associated with an increased risk of depression in older adults; loneliness was 
also strongly related to depression in the older people in a London-based community sample 
(Prince et al., 1997a). Perceived social isolation and loneliness are major risk factors for mental 
illness in later life (Ong et al., 2016). High levels of support from spouses, and better social 
network integration in men and support from friends and children in both sexes was protective 
against depression in prospective analyses from the TILDA Study (Santini et al., 2016). A high level 
of social strain from children was a risk factor for depression in women. Loneliness mediated 
these associations. Interventions based on attachment theory can be used to combat loneliness 
and improve self-esteem, coping and problem-solving abilities (Loboprabhu & Molinari, 2012). 
Elder abuse has been reduced in a randomised controlled trial by an educational intervention 
mediated through increased social support, self-efficacy and health promoting behaviours 
(Estebsari et al., 2018). Support for carers of the elderly who suffer high levels of stress and 
depression resulting from the burden of caring, may also help to sustain caring for longer.
Work is generally beneficial for health, and retirement or premature exit from the workforce may 
reduce sources of social support as well as the financial benefits of working, which may influence 
psychological health in older adults. Psychological ill-health in childhood and adulthood predicts 
earlier exit from the workforce (Clark et al., 2017), and reduced physical and cognitive capability 
in midlife may reduce the likelihood of having bridge employment following retirement, which 
may cushion the impact of retirement and provide benefits to psychological health (Stafford 
et al., 2017). In the same way, volunteering after retirement may have beneficial effects on 
psychological health in older people (Tabassum et al., 2016). Thus, extending working lives, if the 
working conditions are good, may help to prevent depression in older people.
Physical activity has been shown to protect against the emergence of depression in both older 
and younger people in a review of 49 prospective studies (Schuch et al., 2018). Moreover, 
physical activity may also prevent depression in people with chronic disease (Seo & Chao, 2018). 
Alcohol and drug misuse are health problems currently in older adults (Wang & Andrade, 2013). 
Alcohol use disorders in older adults are risk factors for dementia and depression; prevention 
of drinking relapse is often more successful in older than younger patients (Caputo et al., 2012). 
Insomnia is a risk factor for depression in the old adults and interventions to improve sleep could 
have a positive effect on mental health (Gooneratne & Vitiello, 2014).
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Challenge: Preventing or postponing mental disorders
C
ro
ss
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ct
o
ra
l a
ct
io
n
s
Education   Fight all forms of discrimination
  Learn and respect human rights
  Promote resilience and mental fitness at school and in the workplace
Individual behaviour   Continued physical activity
  Build social networks
  Work and late retirement are beneficial if working conditions are 
good
  Volunteer engagement in various social activities
Possible targeted 
prevention
  Strong support of family and friends
  Improve self-esteem
  Improve quality of sleep
  Fight against drinking relapse
  Competitive memory training
  Reminiscence group meetings
Technology   Support self-help with interactive and engaging programs over 
the internet or on mobile devices: scalability, low cost, privacy, less 
stigma, ease of use
Society   Enhance working conditions
  Fight inequality
  Universal prevention programme for avoiding isolation and 
loneliness
  Accessible and affordable community mental health services
  Support carers of older adults (who can suffer high stress levels and 
depression from the care burden)
Table 8. Challenge: preventing or postponing mental disorders
A systematic review of different non-pharmacological interventions for depression in older 
people found that cognitive behaviour therapy, competitive memory training, reminiscence 
group therapy, problem-adaptation therapy, and problem-solving therapy were all effective in 
reducing depressive symptoms (Apostolo et al., 2015). Prevention of suicide in older adults is 
largely focused on identifying and treating depression and decreasing social isolation (Lapierre 
et al., 2011). Further strategies might include engaging family and community, keeping in touch 
with isolated adults by telephone or other communication devices, restricting means for suicide, 
and educating physicians about suicide risk in older adults.
There is a need for more studies linking early and midlife risk and protective factors to 
psychological health in old age, and more intervention studies that focus on both the 
psychosocial and clinical aspects of depression simultaneously. There is also a need for studies 
with an emphasis on understanding the mechanisms of how psychosocial and behavioural risk 
factors affect health, for example, the effects of loneliness on psychological health (Ong et al., 
2016).
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In summary, interventions to reduce social isolation and loneliness, increase social support, 
support carers, extend meaningful work, maintain physical activity, reduce alcohol intake and 
maintain healthy sleep may all help to prevent psychological disorders in older people.
Sensory function and associated diseases
Vision, hearing and balance play major roles in our daily life. With age, these sensory systems 
tend to lose function, not only because of the biology of ageing but also through independent 
mechanisms unique to each of them (Gadkaree et al., 2016). In other words, sensory decline 
is an inevitable physiological process that is aggravated by some specific aetiologic factors. 
The impact of such declines is of utmost importance for individuals and societies due to their 
physical, cognitive and socioeconomic consequences.
Vision
There is rapid eye growth before the age of two years and, by ten years, axial growth of the eye 
has reached almost adult size (Williams et al., 2018). Myopia is the most common eye disease 
and is often diagnosed in childhood. The earlier onset of myopia is associated with greater 
severity and increased complications in adult life (Williams et al., 2018). The prevalence of mild 
or moderate myopia has increased across Western and Northern Europe in successive birth 
cohorts, and is one of the few health challenges that are more likely to affect those with higher 
educational and occupational levels (Williams et al., 2015). This increased prevalence will result in 
more visual impairment in middle-aged and older adults, with economic, social and health care 
consequences.
Starting around the fourth decade, structural changes affect the retina and peripheral nerve 
fibers: loss of cones and rods, reduction of pupil diameter, senile myosis, slowing of the 
pupillary reflex, yellowing of the crystalline lens, etc. These alterations impair several system 
functions, including field of view, acuity, colour discrimination, contrast sensitivity at high 
spatial frequencies, depth and motion perception, and visual processing speed. The main 
causes of moderate or severe vision impairment in European adults aged 50 years or older 
are uncorrected refractive error (just under 50%) followed by cataracts, age-related macular 
degeneration and glaucoma (Flaxman et al., 2017).
Impaired accommodation is the most sensitive and earliest index of age-related vision 
impairment. This has a significant impact on daily living, including mobility-based activities 
and quality of life (Peres et al., 2017; Crews et al., 2017). A large body of evidence suggests 
that diminished visual information, whatever its cause, is associated with increased risk of falls, 
depression and anxiety (Heesterbeek et al., 2017; Kempen et al., 2014), and may affect vision-
dependent cognitive outcomes (Clemons et al., 2006). Some studies (Albers et al., 2015; Rizzo et 
al., 2000) suggested that individuals with advanced age-related macular degeneration have a 
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greater two-year risk of developing Alzheimer’s disease than those with better vision. Conversely, 
deficits in visual cognition in Alzheimer’s patients have been widely reported. Finally, some 
studies have shown that visual stimulus enhancement has a positive impact on many aspects of 
the functional impairments experienced by patients with Alzheimer’s disease (Cronin-Golomb et 
al., 2007).
Risk factors and prevention
The increase in myopia prevalence has encouraged research into the factors that could reduce 
its development and progression during childhood (Rahi et al., 2011; Williams et al., 2018). Early-
life factors associated with myopia risk, assessed in adult life (Rahi et al., 2011) include higher 
maternal education, paternal social class, lower birth weight adjusted for gestational age, 
maternal smoking in early pregnancy, higher cognitive ability, more near-work activities, playing 
less sport, greater height and lower body mass index in childhood. A recent study of twins 
assessed in adolescence replicated some of these associations, and additionally found that early 
schooling and playing computer games were associated with excess risk, while parental fertility 
treatment was associated with lower risk (Williams et al., 2018). The authors of both studies 
concluded that early-life factors influence ocular growth trajectories, and further studies are 
warranted. A third study found that reported exposure to childhood febrile illnesses was also 
associated with myopia but the scientific reasons for this were unclear (Guggenheim & Williams, 
2016).
Four main pathologies have particularly significant impact on decreased vision, even by midlife, 
and require treatment: chronic glaucoma, retinopathy, cataract, and age-related macular 
degeneration. The main protective factor is a systematic midlife ophthalmologic examination 
that could detect these four eye diseases, acquired or genetic with late revelation, liable to 
exacerbate the adverse effects of ageing. This is further considered in the following sections.
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Challenge: Preventing or postponing sensory impairments
C
ro
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s
Education   Educate on consequences of unprotected sun exposure
  Educate on consequences of hearing trauma from daily acoustic 
exposure (headphones, earphones)
  Educate on consequences of sedentary behaviour
Individual behaviour   Vision: No UV exposure, avoid progressive glasses and lenses
  Hearing: Avoid hearing trauma, use hearing protection
  Balance: Physical activity, structurally safe surroundings
Possible targeted 
prevention
  Treat and control general diseases such as cardio-metabolic 
conditions
  Vision: Midlife assessment (fundus and visual field)
  Hearing: Midlife audiology evaluation, no ototoxic drug use, early use 
of hearing aids
  Balance: Midlife tests (up and go; unipodal stance); comprehensive 
asessment after fall; family and environment counselling
Technology   Vision: artificial retina, bionic eye
  Hearing: hearing aid technology is constantly improving
  Balance: wearable sensors to control balance and prevent falls
Society   Campaigns to stress the importance of lifelong protection of 
sensory ability (loss of sensory ability is a major cause of age-related 
disability, loneliness and poor wellbeing)
Table 9. Challenge: Preventing or postponing sensory impairments
Alongside these specific ophthalmologic pathologies, each requiring specific treatment, 
preventive measures should address the general and environmental risk factors of visual 
impairment (Arné et al., 2013). From midlife, disadvantaged social position was strongly 
associated with poorer visual function in the UK Biobank study (Cumberland & Rahi, 2016). High 
blood pressure, diabetes, sedentary lifestyle and obesity aggravate the process of ageing and 
increase the risk of eye stroke. Diabetic status is a strong risk factor for retinopathy since it 
develops in nearly all individuals who have type I diabetes with more than 15 years’ progression, 
and in 50–80% of type II diabetic patients after 20 years (Klein et al., 1984; Stéphan et al., 2014; 
Toth et al., 2017). Prolonged excessive use of psychotropic drugs or antidepressants also 
aggravates ageing processes and is a leading cause of dry eye. Alcohol abuse and smoking are 
known to induce optic neuropathy. Ultraviolet radiation exposure leads to phototoxicity (Arné et 
al., 2013). Oxidative stress has been implicated in the development of cataracts but there is no 
evidence from randomised controlled trials that beta-carotene, vitamin C or vitamin E prevent or 
slow down the progression of age-related cataract (Mathew et al., 2012). For some pathologies, 
such as age-related macular degeneration, there are genetic as well as environmental origins 
(Lechanteur et al., 2015).
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Hearing
Hearing loss in children is relatively uncommon, and only about 4% of those with hearing loss 
(in the US) are under 18 years old (Russ et al., 2018). However, detecting impairment early may 
reduce future cognitive deficits (Kennedy et al., 2015). The cumulative prevalence of hearing loss 
rises sharply with age. Age-related hearing loss, known as presbycusis, has high prevalence, 
doubling with each successive age decade, with onset beginning around the 40s or 50s and 
affecting over two-thirds of adults aged over 70 years. It is the third most prevalent chronic 
medical condition after osteoarthritis and hypertension, and has major, although underestimated, 
socioeconomic and medical implications as it increases the risk of physical and cognitive decline 
as well as affecting working ability (Lin et al., 2013; Bozic et al., 2017). The lack of European studies 
of hearing loss at different ages is a knowledge gap (Roth et al., 2011).
Clinically, the most common and earliest complaint in age-related hearing loss is difficulty in 
understanding speech, especially in the presence of background noise (the ‘cocktail party 
effect’). This symptom is due to poor frequency resolution of sounds by an impaired cochlea, 
and to higher-level cognitive factors. Impaired communication leads to socio-familial isolation, 
withdrawal, depression (Pronk et al., 2011; Gates et al., 2002). A major issue in this regard is 
that hearing loss in older adults may incur a long-term risk of dementia (Gates et al., 2002; 
Dartigues & Feart, 2011; Ray et al., 2018), with a shared neuropathologic aetiology including 
synaptic alterations in central pathways, deficits in central auditory processing that in turn affect 
executive functions, and auditory difficulties requiring greater cognitive resources to process 
auditory perception, to the detriment of other cognitive processes such as working memory. 
Conversely, recent studies have suggested that patients with normal cognitive function carrying 
the APOEɛ4 allele, the most robust genetic risk allele for Alzheimer’s disease, show significantly 
more severe presbycusis than non-carriers (Albers et al., 2015). A convincing argument for a 
relationship between presbycusis and dementia was provided by a recent study suggesting that 
early rehabilitation by hearing aids postpones onset of dementia; this finding awaits replication 
(Amieva et al., 2015).
Risk factors and prevention
As in other sensory systems, presbycusis involves both intrinsic and extrinsic factors (Gates 
& Mills, 2005; Schuknecht, 1974). Intrinsic factors include structural and genetic components. 
Structurally, inner and outer hair cells are post-mitotic cells unable to multiply and any loss, 
whatever its cause, is irreversible, leaving a “dead zone” in the organ of Corti. From a genetic 
perspective, three genes are considered as susceptibility genes for presbycusis, suggesting that 
systematic genetic screening could provide an epidemiologic picture and lead to preventive 
measures (Ibrahim et al., 2018; Vozzi et al., 2014; Plevova et al., 2017).
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Extrinsic factors comprise two main aetiologies. First, drugs may cause hearing loss, 
disequilibrium or tinnitus (Hawkins, 1973). Their action mechanism is not fully elucidated, but at 
least partly involves individual genetic susceptibility. Second, chronic acoustic trauma is a well-
recognised factor of early hearing loss. It is well established that individuals in occupations with 
work-related noise exposure (such as artillerymen, musicians, road workers and DJs) or who 
take part in certain leisure activities (such as hunting, clay-pigeon shooting, concert-going) have 
a greater risk of hearing loss (Honeth et al., 2015; Medina-Garin et al., 2016; Money et al., 2011; 
Schink et al., 2014). It is impossible to overstate the dangers of the prolonged or too loud daily 
acoustic exposure suffered (or actively sought) by adolescents and young adults from their 
frequent use of headphones and earphones. Exposure to higher noise levels means that people 
now lose their hearing earlier in life than in the past (WHO, 2013). Beyond prolonged or excessive 
noise exposure, childhood risk factors for hearing loss include exposure to viral or bacterial 
infections during pregnancy and birth delivery (e.g. rubella) or childhood (such as measles, 
mumps and meningitis and chronic otitis media) (WHO, 2013). A life course approach to hearing 
health is now being actively promoted (Davis et al., 2016).
Medical factors, such as diabetes mellitus (Martikainen et al., 2013), atherosclerosis and viral 
infection may have exacerbating effects. Whatever the factors involved, the final result is 
intracellular accumulation of free radicals, a well-known cause of (sensory) cell death.
Midlife prevention of age-related hearing decline is founded on careful protection of a limited 
auditory cell stock that is sadly sensitive to environmental aggression. It is mainly based on the 
management of the above extrinsic factors. This is considered further in the following sections.
Balance ability
Balance disorder is becoming a major issue in developed countries (Barin & Dodson, 2011; 
Salzman, 2010; Tran Ba Huy, 2011; Harun et al., 2015), firstly because prevalence increases 
steadily with age, affecting a quarter to a third of the population older than 65 years and about 
half of those older than 85. Secondly, over and above the everyday nuisance, it is a major risk 
factor for iterative falls, with their devastating physical and financial consequences: 30% of 
adults older than 65 years fall at least once a year, and about 50% fall again, leading to hospital 
admission, restricted mobility, loss of independence and a financial burden averaging $20 billion 
per year in the US. During midlife, there is a sharp increase in the prevalence of falls, based on 
evidence from British, Irish, Dutch and Australian cohort studies. The prevalence of falls over the 
preceding year increased from 8.7% in 40–44-year-olds to 29.9% in 60–64-year-olds in women, 
and from 14.7% in 45 to 49 year olds to 15.7% in 60–64-year-olds in men (Peeters et al., 2018). 
Midlife may be a sensitive life stage for preventive interventions.
Balance in humans involves a complex system including three peripheral sensory systems 
(vestibular, visual and proprioceptive), and central structures integrating peripheral sensory input 
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and transmitting appropriate commands to a select group of skeletal, oculomotor and somatic 
muscles. The outcome of this system should be an automatic, unconscious and instantaneous 
corporal response to spatial modifications accompanying movement, i.e., to stabilise posture and 
gaze.
With age, the whole balance system undergoes degenerative changes (Rosenhall & Rubin, 1975). 
In the vestibule, loss of hair cells, disintegration of otoconia, decrease in the number of primary 
vestibular neurons and shrinkage of vestibular nuclei have been extensively documented and 
attributed partly to microvascular changes. At the same time, the decline of visual performance 
described above limits visual preponderance, which increases with age, older adults increasingly 
relying on the visual system to stabilise their posture. Similarly, ageing of the muscles, joints 
and tendons impairs proprioceptive system performance. In addition, reduction in strength and 
contraction speed, along with fatigability of skeletal, somatic and oculomotor muscles, delays 
the reaction to postural disturbance. At the same time, the central structures (cerebellum, 
brainstem and cortical structures), which integrate and stratify all these peripheral sensory inputs, 
show progressive and irreversible changes, including demyelination and neuronal degeneration 
(Barin & Dodson, 2011; Salzman, 2010).
Age-related dizziness (also known as presbystasis) induces a variety of symptoms and signs. 
Firstly, difficulty walking, slower gait speed and shorter step length are universally reported by 
older individuals subject to dizziness. Secondly, constant fear of falling, anxiety, feeling unsafe 
and lightheadedness constitute a heavy emotional burden that comes with vestibular loss, 
restricting daily activities and causing social isolation. Thirdly, emerging literature suggests that 
difficulties in concentration and memory, leading to cognitive impairment, are associated with 
loss of balance (Barin & Dodson, 2011; Salzman, 2010; Tran Ba Huy, 2011; Harun et al., 2015).
Risk factors and prevention
Peripheral vestibular disorders, including benign peripheral paroxysmal vertigo, Menière’s 
disease, vestibular neuritis, ototoxic insult or any type of otologic pathology, may aggravate or 
decompensate a precarious and ageing balance system (Strupp & Brandt, 2013). Overweight, 
diabetes, atherosclerosis, cardiovascular diseases, osteoporosis, recent anaesthesia or 
confinement to bed may affect balance, from which older adults do not readily recover. The 
effects of sedatives, antidepressants, hypnotics, diuretics and anti-hypertensives can cumulate 
and directly impair residual physical capacity including balance; such iatrogenic effects are too 
often overlooked yet all too frequent.
Immediate environmental hazards that contribute to disorientation and increase the risk of 
falling are irregular flooring at home (rugs and carpets, steps, paving), insufficient lighting, 
and unsuitable footwear (such as high heels, foam soles absorbing proprioceptive sensation). 
More broadly, familial and social isolation can influence the risk of losing balance ability and 
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falls. These risks are also higher in those who have depressive symptoms (Anstey et al., 2008) 
and poorer cognitive function (Blodgett et al., 2018; Kuh et al., 2009; Tabbarah et al., 2002) and 
socioeconomic conditions throughout life (Syddall et al., 2009) (Birnie et al., 2011), Physical 
exercise, particularly structured exercise or strength training, has been associated with better 
balance ability and reduced falls risk in a number of RCTs (see for example (Okubo et al., 2017). 
Cognitive interventions also improve components of balance (Li et al., 2010), as does interactive 
dual training, which targets both cognitive and physical processes (Fraser et al., 2016; Schoene et 
al., 2015).
Prevention strategies of balance disorder and of its dramatic consequence, falls, have become a 
timely consideration in today’s health care landscape (Khanuja et al., 2018). It includes analysis of 
the patient’s environment and lifestyle, and thorough multidisciplinary screening for risk factors 
that worsen the deleterious side-effects of ageing (Barin & Dodson, 2011; Tran Ba Huy, 2011; 
Harun et al., 2015).
A physical examination to investigate the various systems involved in the maintenance of balance 
should include otoneurologic, ophthalmologic, neurologic and orthopaedic examinations and 
a general check-up; and a geriatric assessment after a first fall. These are considered in the 
following sections.
Immune function, immunosenescence and infectious diseases
The immune system of the newborn is immature and protection against infections is provided 
by antibodies in the mother’s milk, hence the importance of breastfeeding. The ability of the 
immune system to recognise, resist and remember specific pathogen exposure develops rapidly 
and is essentially complete by puberty. The adult therefore relies to a great extent on immune 
memory of common pathogens (or nowadays their counterparts in vaccines) encountered during 
childhood, and retains a set of so-called T cells that have not yet responded to an infectious 
agent (these are known as “naïve”). Naïve T cells are produced in the bone marrow, but require 
‘processing’ in the thymus to achieve maturity. The thymus gland is very active in infancy and 
childhood, but almost absent in adulthood, so the production of naïve T cells is minimal in 
later life and absent in most people at old age. Adaptive immune memory acquired in early 
life is potentially maintained for a lifetime; however, the increase in life expectancy means that 
immune memory deterioration may make older adults more susceptible to pathogens that they 
have previously experienced as well as more susceptible to those that are new.
Current research is focusing on ways of dealing with the biological limitations of waning immune 
memory; the dysregulated interactions of components of the immune system with each other 
and with different organ systems in older individuals; and ensuring that new exposures can be 
combatted by the remaining naïve cells in older adults. There is little evidence that any of these 
phenomena are markedly different in different ethnic groups or among sexes, and therefore 
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interventions would be expected to be homogeneous across these groups. However, there is 
a great deal of inter-individual variation even within closely similar populations that will require 
personalised interventions. Some of this variation could be due to differences in gut microbiota, 
which are strongly influenced by ageing and diet.
Thus, infectious diseases in older adults are both more frequent and more severe than in 
younger adults, and older adults are more likely to respond poorly both to newly-encountered 
antigens and antigens re-encountered either as vaccines or live pathogens. Improved 
understanding of the mechanisms responsible for decreased immune competence is 
urgently required to reconstitute appropriate protective immunity. Older adults are particularly 
susceptible to newly-emerging or newly-encountered pathogens, and persistent herpes viruses 
such as Varicella Zoster (VZV) and Cytomegalovirus (CMV) also reactivate more frequently than 
in the young. These observations suggest some degree of immune compromise, which may be 
reflected in the distribution of immune cells and antibodies in the peripheral blood. There is a 
great deal of heterogeneity in disease susceptibility and response to vaccination in humans, and 
therefore it is essential to establish sets of immune biomarkers that reflect immune competence 
of the individual in this context. The use of such “immune signatures” to predict responsiveness 
to vaccination and susceptibility to infectious disease would allow better selection of prophylaxis 
and treatment options in older adults. Also, novel compounds are being developed to enhance 
the response of older adults to treatment (Mannick et al., 2014). Limited longitudinal studies 
of free-living human populations suggest that it is possible to establish individual immune 
signatures with predictive power for frailty and mortality. The definition of these biomarkers and 
their clinical correlates requires further research, preferably in longitudinal intervention studies to 
allow biomarkers to be aligned with clinical outcomes (Bertram et al., 2014). Immune signatures 
may differ according to birth cohort and country, creating a challenge for assessing immune 
ageing trajectories and their impact on morbidity and mortality (Pawelec, 2019).
Acute infections clearly also remain problematic in older people, especially viruses like influenza 
and pneumococcal pneumonia. Both are major public health problems (see Figure 20 and Figure 
21). Influenza vaccine responses are poor, and older adults respond less well than younger adults 
to seasonal influenza vaccination; existing infections such as CMV may exacerbate the poor 
response. Despite respiratory disease caused by Streptococcus pneumoniae (S. pneumoniae) 
resulting in much morbidity and mortality, pneumococcal polysaccharide vaccines (PPVs) are 
less well investigated in the ageing context than influenza and their ability to prevent disease 
and death in older people is not clear. There is an opportunity to establish predictive immune 
biomarkers, taking CMV into account from the beginning.
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Figure 20. Deaths from pneumonia in the EU (Eurostat).
With increasing mobility of ever-older people, responding to travel vaccines against pathogens 
such as Yellow Fever or West Nile Virus to which the individual has not yet been exposed 
poses a challenge. This is because these travel vaccines rely on the responsiveness of the very 
small number of aged naïve B and T cells still present. For example, there is currently some 
controversy concerning the wisdom of giving older adults the live attenuated Yellow Fever 
vaccine due to their perceived immune-compromised state. Given the variability between 
individuals, it would be very valuable also here to establish an immune signature that would be 
diagnostic for protective response capacity. Another increasingly important challenge is the re-
emergence of tuberculosis, especially in poorer and more socioeconomically deprived areas. 
This is particularly important given the rapid acquisition of resistance to antibiotics, which is 
clearly a major problem in all areas of infectious disease policy worldwide.
Prevention
The key factor is the protection afforded by the development of and adherence to vaccination 
schedules. The use of antibiotics or antiviral agents is less effective and more dangerous. A life 
course approach to vaccination has been recommended (Michel et al., 2009; Esposito et al., 2016; 
Centre, 2017). In childhood, parents need to fully take up the available vaccines for infectious 
agents for their children in order to establish immune memory in a safe and controlled manner. 
Older adults would benefit from the development of prophylactic vaccines for pathogens for 
which there is no vaccine yet, and for more effective therapeutic vaccines against agents that the 
patient is already infected with, especially if they can be tailored to immune signatures.
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Figure 21. Deaths from influenza (including swine flu) in the EU (Eurostat).
Cancers
The natural history of cancer is explained by the accumulation of sub-critical events at molecular 
level, leading to critical mass of mutations (Martincorena & Campbell, 2015). Thus, the increasing 
rate of cancer according to age is polynomial or exponential. A small shift in the curve, by 
reducing the rate of acquired mutations, would potentially be an effective preventive strategy, 
assuming that cancers could be delayed by around 20 years. This could be achieved with 
intervention on external risks such as lifestyle (Wu et al., 2016).
Data from the WHO mortality database shows that, in the EU, all cancers accounted for 30% of 
total deaths of men and 23% of total deaths in women at all ages in 2012 (Malvezzi et al., 2018). At 
35–64 years, all cancers accounted for 35% of total deaths in men and 51% deaths in women. For 
men, lung cancer was the most common cancer (11%); for women it was breast cancer (11%) and 
lung cancer (10%). Between 1970 and 2012, overall cancer mortality rates declined for women 
and have been declining since 1988 for men. All cancers have shown decreases in mortality 
rates, albeit in variable amounts and timing, with the exceptions of pancreatic cancer and lung 
cancer (in women) (Malvezzi et al., 2018). For some cancers, such as stomach cancer and breast 
cancer, declines were predominantly seen in successive cohorts; declines in other cancers were 
due to both period and cohort effects, or predominantly to period effects (Malvezzi et al., 2018).
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The EU cancer mortality trends contrast with incidence trends that still show increasing 
incidence rates for certain cancer sites such as thyroid, liver and kidney cancer (Ferlay et al., 
2018). There are also strong regional variations in cancer incidence rates; variations are three- to 
four-fold in men and even greater in women (The Cancer Atlas, 2019; Ferlay et al., 2018). Current 
incidence and trends over 50 years reflect the different stages of the tobacco smoking epidemic 
in men and women from different countries. In most European countries, lung cancer rates in 
men are generally stable or decreasing, while they are still increasing in women. Overall, the 
number of cases is going up because of population ageing: In 2013, 2.8% of the EU population 
had cancer, with a slightly higher prevalence for women (2.9%) than for men (2.7%).
This difference in incidence and mortality rates means that more people are surviving cancer, 
and research is now highlighting the consequences of survival for patient reported outcomes, 
such as quality of life and the costs of health care (Smith et al., 2016). In Savage et al (2015), the 
average cost of cancer treatment was £3036 between 1995 and 1999; then at £20,233 between 
2005 and 2009; and then at £ 35,383 between 2010 and 2014. The costs are still increasing, 
leading to the concept of financial toxicity (Zafar, 2016). Finding effective ways to prevent 
cancers will bring the biggest benefit for individuals and help to stem the rising costs of cancer 
treatments.
Cure rates vary by cancer site, which has implications for prevention priorities. For example, 
prevention is particularly important for lung cancers that have a cure rate of only 25%. Other 
cure rates are much higher — for example, for thyroid cancer it is 90% (De Angelis et al., 2014). 
Due to the increasing rate of cure (Torre et al., 2015), prevention of a second cancer needs 
to be considered. Interestingly, there is cross-fertilisation between prevention and care: diet 
and physical activity used to belong to the preventive field but are now used for increasing 
therapeutic efficacy (Schmid & Leitzmann, 2014). Conversely, drugs like Tamoxifen used as 
adjuvant therapy for breast cancer may be used (in the USA at least) for primary prevention 
(Robidoux et al., 1998).
Risk factors and prevention
Increasing longevity is a major risk factor for cancers and the majority of cancer occurs in older 
adults (Fitzmaurice et al., 2015). However, cancer in midlife is a common cause of death (see 
above) and the years of lost life are inevitably higher (Brustugun et al., 2014).
Adult lifestyle makes an important contribution to the development of many cancers (Ferlay 
et al., 2013; Steliarova-Foucher et al., 2015; Ferlay et al., 2018). For example, the risk of common 
cancers such as lung cancer and breast cancer are modifiable by changes in lifestyle, with 
expected reductions of 20% and 80% respectively (Blot & Tarone, 2015). The population 
attributable fraction for cancers related to three main risk factors tobacco, overweight and 
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alcohol is close to 20% (30% in men and 10% in women) in an Australian cohort (Arriaga et al., 
2017).
Challenge: Preventing or postponing cancer onset
C
ro
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Education   Lifelong health education on genetic background and 
corresponding susceptibility to toxic exposures, endocrine disruptors 
and individual behaviours
Individual behaviour   Control behavioural and lifestyle factors: obesity, alcohol, tobacco, 
sedentary lifestyle
  Control environmental risks: radiation, viruses, chemical and toxic 
agents
  Individual’s values, preferences and priorities in life
Possible targeted 
prevention
  Risk assessment: risky life conditions, occupation and family history
  Modifiable rissk: environment control
  HPV & vaccines to prevent virus-induced cancers
  Use classical anti-cancer medication for pharmaco-prevention
  Systematically genotype tumours (precision medicine)
Technology   Prevent some cancers through everyday technology: e.g. fridge use 
to decrease incidence of gastric cancers
  Mobile health app for primary prevention, currently mainly used in 
secondary prevention e.g. pulmonary cancer
Society   Sustainably control known and emerging risks: toxic particles, gases, 
viruses
  Monitor health impacts of indoor and outdoor pollution
  Screen for cancers (breast, colorectal, uterine cervix)
  Improve socioeconomic status of at-risk and ill populations
Table 10. Challenge: Preventing or postponing cancer onset
Other, less important risk factors are occupational (for certain cancers, such as mesothelioma 
caused by asbestos or leukaemia caused by benzene), social and environmental (e.g radiation 
and chemical exposures and viruses) (Collaborators, 2017). Absolute or relative constitutional 
genetic factors appear not to be important in terms of population attributable fraction, because 
few persons are in the higher risk categories. However, in the future, it is likely that more persons 
will be identified who have a somewhat increased genetic risk.
It should also be recognised that the risk of some cancers, such as cervical cancer, stomach 
cancer and breast cancer, are increased by exposures earlier in the life course. Examples 
include:
  exposure to HPV infection increasing the risk of cervical cancer
  exposure to Helicobacter pylori increasing the risk of stomach cancer
  exposure to diethylstilboestrol in utero raising the risk of breast and pancreatic cancers in 
exposed female offspring (Troisi et al., 2017)
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  having breastfed reducing breast cancer risk (Weiss et al., 1997)
Less modifiable are reproductive factors associated with risk of breast cancer, such as early 
menarche age, null parity, late age at first live birth, a long reproductive interval index, and long 
contraceptive use duration (Al-Ajmi et al., 2018). It has been estimated that an early first live birth, 
lower reproductive interval index and increased number of children can contribute to a breast 
cancer risk reduction of up to 50% (Al-Ajmi et al., 2018); however, this creates an ethical dilemma 
between the availability of risk reduction (improving health) and individual and societal values.
Overall, cancer prevention in the EU will benefit most from a risk factor-based approach 
mainly focused on tobacco, weight control, increasing physical activity and reducing alcohol 
consumption. This is considered further in this report, along with more targeted approaches 
based on age (e.g. HPV vaccinations before sexual relationships) or for specific groups which are 
at increased risk genetically, occupationally, or in some other way.
Policy options
Lifelong self-tracking of health can support citizens’ engagement. Health care 
professionals could analyse the data collected to identify risk factors and symptoms 
of age-related disease as early as possible. Innovative technologies that capture 
changes in intrinsic capacities or monitor real-time exposure to risk (such as the 
level of functioning) may help to motivate individuals and to identify those with 
accelerated decline at an earlier stage.
The burden on society of the most common age-related diseases is growing due 
to many factors including demographic change. While specific policy actions are 
rightly taken on specific diseases, (for example, cancers, cardiovascular disease 
and diabetes), addressing the commonalities and determinants of all age-related 
diseases can be effective. This is especially important in terms of identifying and 
acting on early and midlife risk factors.
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There are key knowledge gaps in understanding the role of risk factors for cognitive 
decline and dementia and for many other aspects of functional decline and age-
related diseases.
2D. OPPORTUNITIES FOR HEALTHY AGEING: 
REINFORCING HEALTH PROMOTION AND 
TARGETED PREVENTIVE STRATEGIES
This section explores health promotion and targeted prevention strategies that the Working 
Group considers essential in midlife or earlier in the life course to improve the chance of healthy 
ageing in later life. The short timescale of this report limited comprehensive assessment (e.g. 
systematic review of intervention studies) of these strategies and so largely reflects assessment 
based on the experience of the Working Group experts. Health promotion consists of social 
and environmental interventions, such as health literacy campaigns, with the aim of enabling 
populations to gain more control over their health and improve it by adopting healthy lifestyle 
behaviours. Targeted prevention consists of strategies that focus on individuals or groups at 
highest risk of functional decline and specific age-related diseases (WHO, 2015b). Many of 
these age-related diseases share biological mechanisms and common risk factors, such as 
poorer socioeconomic conditions, lower educational level, physical inactivity, smoking, obesity, 
diabetes, hypertension and depression. Thus, tackling these risk factors may prove to be most 
efficient. For example, CVD prevention will also benefit cognitive and physical function.
Biological and functional biomarker age scores are increasingly being developed and refined 
to identify those most at risk because their biological or functional ages are older than their 
chronological age, and to facilitate targeted prevention. For example, an accelerated biomarker 
age may identify individuals who are metabolically compromised, or have been adversely 
affected by aggressive medical treatments, and should help tailor individual care.
The life course approach highlights when health promotion or targeted prevention may 
be most effective, as different strategies may work best at different life stages. In regard to 
targeting cardio-vascular health, for example, different phases of life require different strategies 
(Fuster, 2015). Compliance may be linked to an increasing sense of urgency as people age 
chronologically, functionally and biologically.
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To structure what preventive strategies are best for whom, and when and how to motivate 
groups of individuals, the 4P framework (Flores et al., 2013) is helpful:
  Predictive: Identification of individual risks of developing certain diseases and functional 
inabilities based on the person’s genetic profile and other personal information
  Preventive: Methods and treatments to avoid, reduce and monitor the risk of developing 
certain diseases
  Personalised: Clinical interventions based on the unique genetic, medical and environmental 
characteristics of each patient-citizen, and genomic profile of his or her diseases
  Participatory: Citizens are fully engaged in personal health management
Especially in the second half of life, due to the diverse nature of the ageing process, personal 
profiles (recorded by quantitative biomarkers other than genetics; i.e. the metabolome, gut 
microbiome, proteome) may have major impact on health, and interact with many smaller 
genetic influences.
In this section, strategies for health promotion and targeted prevention are grouped under four 
sub-headings:
  lifelong population-based strategies (population or individual based);
  strategies that encourage a healthy start to life (0–30 years);
  strategies for adults (30–50 years) that maintain capacities, restore function and delay 
disease onset;
  strategies for mature adults (over 50 years) for restoring capacity and functional ability, 
slowing the rate of functional decline and delaying disease onset and progression.
We use these broad age ranges with a cautionary note, as chronological age ranges may have 
little correspondence with biological and functional ageing. As further research refines indicators 
of biological and functional age, these may be increasingly used to identify the best individual-
based approaches to healthy ageing.
Lifelong strategies for healthy ageing
  Enact health and social policies to combat poverty and social inequalities at all life stages 
so that all European citizens have equal opportunities to age healthily. Many of the ageing 
outcomes are strongly socially patterned, with generally poorer outcomes associated with 
lower economic status (Centers for Disease Control and Prevention, 2016).
  Regulate environmental exposures, including air pollution and endocrine-disrupting 
chemicals, and work and leisure-related noise pollution.
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  Adopt fiscal and regulatory approaches that facilitate tobacco control and healthy 
diets to reduce intake of sugar sweetened drinks and salty manufactured foods. These 
approaches are among the most effective means to curb the burden of metabolic disorders, 
cardiovascular diseases and cancers (WHO, 2019).
  Create sustainable health and social care systems for health promotion, targeted 
prevention and integrated care at all life stages. Screening programmes are essential for 
the early detection of disease, thereby reducing its burden. Targeted programmes for familial, 
geographic and ethnic risks raise awareness among potential at-risk groups and assist in the 
primary prevention of disease.
  Promote lifelong learning and skills development. Formal education in most countries 
often ends by the age of 24 years, and may end much sooner. With people living and 
working longer, investment in lifelong learning and skills development, and work-based 
educational and training programmes, can extend productive lives (Chen et al., 2018a). 
Broader engagement of older people in society, both in the workforce and through 
volunteering, can also be financially advantageous. These measures provide economic 
benefits directly through labour force participation, but also indirectly by improving health 
and cognitive function, and facilitate societal cohesion through a shared sense of purpose 
(Chen et al., 2018a). In a recent multidimensional analysis of countries’ adaptation to societal 
ageing, which included a new Ageing Society Index, the high performance of the United 
States in the domain of productivity and engagement was considered to reflect the highest 
labour force participation rates at older ages, high effective retirement age, and high rates 
of volunteerism. These findings were likely driven by low unemployment rates and the 
adoption of flexibility in work hours and pension eligibility rules to reduce constraints to 
continued employment. In contrast, in Europe, 78% of people aged 55 years and above stop 
working altogether, citing the lack of opportunities for gradual retirement by reducing work 
hours (Eurobarometer, 2012). This multidimensional Ageing Society Index (Chen et al., 2018a) 
shows the needed shift from focusing on individuals and their immediate environments to 
a strategy that ensures that each society is successfully adapting to population ageing. Any 
‘new’ index has to characterise a society as cohesive, with minimal tension and competition 
between generations and major sex or racial subgroups, productive with opportunities for 
effective engagement both within and outside the workforce, healthy, equitable, and secure 
(Macarthur Foundation Research Network on an Ageing Society, 2010). Importantly, all of 
these domains are mutable with effective public policies. The resulting index, which takes a 
broad view of ageing, builds on but does not duplicate prior efforts such as the Active Ageing 
Index (Zaidi et al., 2013).
  Adopt health promotion and health literacy programmes for the whole population. These 
should cover, for example, precise information on the risks of UV exposure for vision and 
skin health and improve public understanding of the risk and protective factors for chronic 
diseases such as dementia. Evidence suggests that people can identify a range of risk factors 
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for chronic diseases, such as dementia (Roberts et al., 2014; Vaportzis & Gow, 2018), but that 
there may be a disconnect between knowledge and behaviour (Vaportzis & Gow, 2018). As 
such, recommendations for improving public health education about risk factors may need 
to be combined with more specific actions at the individual level to support and enable 
behaviour change.
  Create a lifelong self-tracking tool to monitor health and to empower and engage all 
EU citizens in health management. Health booklets are already used to monitor growth 
and development in children. This concept should be extended to the whole of life and 
encompass parameters of adult health. The technology to enable lifelong tracking now 
appears possible. This proposal is elaborated in Chapter 4, page 190.
Strategies that encourage a healthy start to life (approximately 0–30 years)
These strategies focus on parents, infants, children, adolescents and young adults, covering the 
period from conception, through growth and development to maturity.
  Improve preconception care. Societal advice on and greater provision of preconception 
care, benefiting young adults and their offspring (Fleming et al., 2018).
  Create programmes for infants, children and adolescents that promote healthy ageing 
through education, safe lifestyles and behaviours, as recommended by the recent WHO 
report (WHO, 2015b). The optimal period to motivate behaviour in favour of health may be as 
early as 3–5 years (Fuster, 2015). Good practice models include the Spanish ‘Salud Integral’ 
programme, a comprehensive health model for schools (Penalvo et al., 2015).
  Adopt prenatal and postnatal strategies for optimal growth and development of intrinsic 
capacity. This includes strategies to maximise cardio-metabolic, respiratory, musculoskeletal 
and cognitive potential in early life. For example, the importance of maximising peak bone 
mass is acknowledged (Gordon et al., 2017) and estimates suggest that 50% of chronic 
obstructive pulmonary disease is due to poor lung function from early life (Lange et al., 2015).
  Monitor early development for identification of children and families at risk of unhealthy 
ageing. This includes children with particularly low physical, cognitive, sensory and emotional 
capacities for more targeted approaches. Monitoring by parents and the health care system 
could benefit from m-health innovations (see Chapter 4, page 190).
  Establish immune memory in a safe and controlled environment. There should be a strong 
focus on maintaining effective immunity via a “life course vaccination programme” (Michel et 
al., 2017). It is of paramount importance that available vaccines for infectious agents are fully 
taken up by parents and grandparents; too often they are not completely vaccinated and 
thus can transmit infectious diseases to their young children (this is the case for pertussis and 
Streptococcus pneumoniae).
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  Avoid radiation and follow the protective regulatory rules when exposed to radiation (x-ray, 
gamma ray, radioactivity and natural radiations) and radon gas.
Strategies for adults (approximately 30–50 years) that maintain capacities as 
long as possible after maturity, restore function and delay disease onset
  Monitor functional change, sub-clinical disease markers and behavioural risk factors 
in individuals. The aim is to detect accelerated age-related decline and the early onset of 
disease rather than waiting for a critical clinical threshold to be reached. Such monitoring 
should include a simple examination of balance disorders (where necessary, screening 
for risk factors and comorbidities and recommending simple daily activities such as one-
leg stance to improve balance). Monitoring could take place at the primary care level and 
be informed by self-managed life course health trackers that would also build scientific 
knowledge. Innovative technologies that capture changes in intrinsic capacities or monitor 
real-time exposure to risk (such as the level of physical activity) may help to motivate 
individuals and to identify those with accelerated decline at an earlier stage (see Chapter 4, 
page 190).
  Information on whether clinical thresholds for certain risk factors can be applied to all ages 
and ethnicities and both sexes is often lacking. Further research is needed to establish 
meaningful thresholds for the various population sub-groups.
  Primary screening of certain conditions, such as breast cancer and colorectal cancer, starts 
in this phase (e.g. stool samples collected and analysed for colorectal cancer) (Binefa et al., 
2016).
  Introduce preventive, lifestyle and tailored interventions (depending on susceptibilities) 
for at-risk groups, and secondary cancer prevention. Good examples of effective lifestyle 
interventions are the Diabetes Prevention Programme (Centers for Disease Control and 
Prevention, 2018) and the million Hearts 2022 programme (US Department of Health and 
Human Services, 2017) for preventing cardiovascular disease in the US. Million Hearts 
2022, a 5-year initiative, was launched in 2017 by the US Department of Health and Human 
Services to accelerate the implementation of effective strategies to improve cardiovascular 
health (Wall et al., 2018). During 2017–2021, Million Hearts 2022 priorities are to keep adults 
healthy through community-based strategies that reduce combustible tobacco use, sodium 
intake and physical inactivity, as well as optimising health care for those with and at risk 
for cardiovascular disease through clinical strategies that improve appropriate aspirin use, 
blood pressure control, cholesterol management, and tobacco cessation (Wall et al., 2018). 
Lifestyle intervention trials, particularly those involving physical activity, have generally 
shown improvement in muscle strength and physical function such as walking speed in older 
adults (Anton et al., 2015; Fielding et al., 2017; Cruz-Jentoft et al., 2014). However, there is wide 
individual variation in the benefits of physical activity that needs to be better understood, and 
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in the benefits of combining dietary and exercise interventions. To move forward with primary 
prevention, more information is needed about the effects of dietary interventions, especially 
dietary restriction, on healthy and overweight adults (Anton et al., 2015).
  Screen and reduce cardio-metabolic risk factors, benefiting not just cardiovascular disease 
but also cognition and brain health and physical function (Forman et al., 2017). Cardiovascular 
trials should include musculoskeletal and physical function as additional outcome measures.
  Maintaining cognitive capacity for longer during adulthood may be possible through 
lifelong learning, work complexity, high team responsibility and volunteer engagement 
(Valenzuela & Sachdev, 2006). It may also be through cognitive training, combining smart 
technologies, or non-invasive brain stimulation (Anton et al., 2015), which may have benefits 
for both cognitive and physical functions.
  Screen for eye disorders. Visual check-ups are important at this life phase. Measurement of 
ocular pressure and visual field monitoring appear to be cost- effective for early diagnosis, 
prevention or treatment (Boodhna & Crabb, 2016). The diagnosis of retinopathy relies on 
fundus examination, which should be systematically performed in adults over 45 years of 
age, especially in patients with diabetes mellitus because of their increased risk. Families at 
risk for age-related macular degeneration should receive genetic counselling in addition to 
preventive measures (Lechanteur et al., 2015).
  Address the adult vaccines gap, as part of a life course vaccination programme in order to 
maintain immunity to infections (including HPV for cervical cancer, if not yet received). The 
anti-vaccine movement represents a barrier to the progress that has been achieved through 
immunisation programmes.
  Perform pharmacological interventions when appropriate. Some are well-established (e.g. 
bisphosphonates, anti-hypertensive medications, statins), while others are more equivocal or 
of limited success. However, pharmacological treatment strategies remain expensive given 
the lifetime incidence of age-related diseases. Non-pharmacological interventions treatment 
(such as physical exercise, intellectual leisure activities and adequate intake of proteins) are 
beneficial alone or as a complement to pharmacological treatment.
  Avoid radiation and follow the protective regulatory rules when exposed to radiation (x-ray, 
gamma ray, radioactivity and natural radiations) and radon gas.
  Tertiary and secondary prevention directed at managing and rehabilitating persons with 
diagnosed diseases. Relatively common at this life stage are diabetes, cardiovascular 
disease, osteoarthritis and cancers.
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Strategies for mature adults (approximately over 50 years) to restore capacity 
or functional ability, slow the rate of functional decline, and delay disease onset 
or progression
  Continue adult strategies for regular monitoring of intrinsic capacities, disease markers 
and the emergence of new risk factors to identify susceptible sub-groups with accelerated 
decline or disease progression. Remaining active and fit is particularly important in this life 
phase.
  Pay more attention to assessing hearing loss, which becomes common in this life phase, 
is a risk factor for cognitive decline, and can cause serious consequences for social life, 
increasing the risk of loneliness. Early prescription of hearing aids can dramatically improve 
functional abilities and wellbeing. At the present time, hearing aids are the only means of 
palliating the decline of auditory function. However, there are many barriers to this solution: 
high cost, inadequate national health and private insurance cover, the inconvenience 
of repeated consultations for fitting and adjustments, and, above all, psychological 
unwillingness to accept reality. From a public health perspective, efforts should be made 
to increase the affordability and accessibility of sound amplifier devices. Education and 
coaching by speech therapists on the use of communication strategies must be undertaken: 
e.g., speaking face-to-face, reducing background noise and speaking more slowly (Mamo et 
al., 2016).
  Provide physical examinations for those with balance problems at risk of falling, to 
investigate the various systems involved in the maintenance of balance.
  Tertiary and secondary prevention directed at managing and rehabilitating persons with 
diagnosed diseases and improving their quality of life. Increasingly common at this life stage 
are dementia, sarcopenia, COPD, and frailty.
  Develop vaccinations to prevent infectious diseases common in older people. As reflected 
in the interests of many companies, there are opportunities for using more effective and 
safe adjuvants or for enhancing vaccine response with pre-treatment, to compensate 
for the lower immune response of older people to vaccines and therefore lower vaccine 
effectiveness. The main public health issue here is to regulate predatory companies selling 
“anti-ageing” and “immune-strengthening” products to the gullible.
  Make sarcopenia and frailty interventions as they arise.
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Policy options
Promotion of healthy ageing needs to start early in life and continue across life, 
monitoring change in function over time, intervening to optimise peak function 
during development and where there is (accelerated) age-related decline, rather 
than waiting for a critical clinical threshold to be reached.
Health promotion programmes should stress that those who exercise, eat a healthy 
diet, maintain a normal weight and do not smoke have a higher level of capacity and 
a lower chance of decline as they grow older.
Member states should implement the most effective strategies for preventing 
obesity and encouraging a range of healthier lifestyles across the whole of life. 
A more equitable balance between health promotion, targeted intervention, and 
treatment is required. The fact that functional ageing is fundamental must be the 
basis for policy, and systematically included in any health and disease evaluation.
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Table 11. Reinforcing health 
promotion for 
current and future 
old generations 
at the individual 
level
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Education
Basic school education
Health literacy
Planetary health education
High technology education
Individual behaviour: healthy lifestyle
Healthy diet (e.g. 
Mediterranean type)
Regular physical activities
Weight control
Reduced calorie intake
Limited or no alcohol
Individual within the life environment
Safe, non-polluted 
environment
Good working conditions
Smoke-free environment
Safe environmental and personal 
acoustic exposure (including 
ototoxic drugs)
UV exposure
Progressive glasses or 
contact lenses
Primary prevention: health promotion
Lifelong self-tracking of 
health
Midlife risk assessment
Careful follow-up of 
appropriate lifestyle advice
Regular medical controls
(continued on opposite page)
Negative impact
(continued from opposite page)
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Table 11. Reinforcing health 
promotion for 
current and future 
old generations 
at the individual 
level
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Targeted prevention
Life course vaccine 
programme (including HPV)
Prevention of malnutrition 
(undernutrition)
Prevention of malnutrition 
(overweight and obesity)
Diabete prevention 
programme
Cardiovascular score (risk 
factors)
Cognitive stimulation and 
training
Pharmacological prevention
Genotyping and precision 
medicine
Technology
e-health user
m-health user
Wearable devices, clothes
New non-invasive 
technology in care
Robots in home care
(continued from opposite page)
Scientific importance of impact (higher to lower)
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Table 12. Reinforcing 
health promotion 
for current 
and future old 
generations at 
the society level
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Society as a whole
Basic lifelong health 
education (starting at primary 
school)
Address poverty and health 
inequalities
Invest in a good start to life 
and build reserve
Combat all forms of 
discrimination (ageism)
Promote age-friendly cities 
and communities
Favour ageing in the home
Promote age-friendly care facilities 
(hospitals and long-term care)
Society and environment
Address risks, known (e.g. air, noise 
pollution) and emerging (e.g. viruses, 
endocrine disruptors, toxin alerts)
Regulate agro-industry
Promote ‘one health’
Society and individual health
Media health advertisement 
campaigns
Adress known risks e.g. too 
salty manufactured food
Taxes on sugar-sweetened 
beverages
Taxes on tobacco
Society and health care systems
Prioritise prevention
Improve care access
Improve care coordination
Scientific importance of impact (higher to lower)
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Chapter 3. Optimising health and 
social care for older EU citizens
INTRODUCTION
The approach to current and future challenges to public health and ageing is underpinned by 
the heterogeneity of ageing, the frequently shared risk factors for different outcomes, and the 
high prevalence of multimorbidity, necessitating a comprehensive multifactorial approach to 
assessment and management of older people.
Whereas many of the problems and challenges detailed in this report are not new, a number of 
features of ageing demography are rapidly changing, such as the magnitude of the problems; 
the rising prevalence of the oldest old; the rapidly changing societal structures such as smaller 
and more fragmented family units; the constituent of the health and social care labour force; the 
impact on pensions; and the rapidly changing cultural landscape in Europe.
The ageing population is not homogenous; significant variations in demographic, social and 
economic characteristics are commonplace. Therefore, when addressing policy issues, this 
heterogeneity and the contribution of social and economic factors to inequalities must be 
prioritised. Recognition of the success of the ageing population is highlighted by the ‘65 is the 
new 55’ approach, which recognises that most of the age-related pressures on health and social 
care systems come from those in later old age, also the fastest growing demographic group.
In this chapter we adopt an ‘out of the silo’ approach, emphasising the common platforms and 
pathways shared by many of the challenges and opportunities of ageing. For example, the 
high prevalence of physical and mental multimorbidity coupled with care and social needs 
necessitates a comprehensive assessment and management strategy rather than individual 
speciality approach. The selected examples of care pathways are modelled on this approach, 
with specifics for individual conditions commonly encountered in the oldest old, e.g. malnutrition, 
frailty, sarcopenia, heart failure, falls and syncope, osteoporosis. The focus is on function, 
independent living and quality of life.
A public health approach is recommended, combining social and health care services and 
budgets for ease of access and reduction in duplication of services, given the frequent overlap 
between health and social care needs. New efficient models of health care provision should 
include social care considerations with internalisation of systems to deliver more efficiency 
i.e. single budget streams for health and social care, and seamless integrated discharge 
arrangements from the hospital sector to the community.
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medication prescriptions to incorporate a holistic approach to therapeutic interventions, 
including access to physical activities and social engagement strategies in addition to traditional 
prescription of medications. The approach extends to interventions and risk factors: for example, 
risk factors for cardiovascular diseases are common to other outcomes such as cognitive 
disorders, falls, mental health and locomotor disorders. Interventions for one system will 
positively influence other systems. For example, physical exercise benefits cardiovascular fitness 
and cardiovascular disorders but also benefits metabolic disorders, mental health, bone health 
and cognition.
Therefore, the overarching care philosophy of the report is person-centred and relational-
centred to ensure a fair, inclusive, sustainable health and social care system for all. It is important 
to appreciate older service users as full individuals rather than individuals being treated for 
particular conditions or sets of needs.
This chapter outlines the health and social status of today’s older people, detailing options 
for solutions which incorporate, in addition to comprehensive care pathways, efficient models 
of service delivery which combine traditional approaches with new technologies and ensure 
functional ageing with as much independence as possible. Where institutional care is necessary, 
this should be in an environment which enhances quality of life as much as possible. Dignity, 
respect and quality of life should extend to end-of-life care.
3A. THE HEALTH CARE CHALLENGES
The health care challenges of today’s older generation are diverse and complex, but they 
are also increasingly controllable, as beneficial interventions are developed, prioritised, and 
implemented not only concerning the individual but also at the level of system change. This is 
important because, while there is a major opportunity from increasing life expectancy, there is an 
associated challenge as healthy life expectancy is not fully keeping pace. There has been a call 
for coordinated action to address this gap (Beard et al., 2016).
The challenges associated with health care include the burden of individual long-term 
conditions that become more prevalent with increasing age — cardiovascular, neurological, 
metabolic, cancers and musculoskeletal disorders (Partridge et al., 2018). Current treatments 
convert many disorders into longer-term conditions. In addition, acute events such as infections 
are still frequent in patients suffering from age-related or treatment-related immune-depression, 
raising concerns about antimicrobial resistance (Giarratano et al., 2018).
Affective disorders including depression and anxiety are also common in later life, may result 
from functional impairment as well as cause it (John et al., 2019), and have a profound adverse 
impact on health as well as quality of life (Ferrari et al., 2013).
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Geriatric syndromes have been referred to as “multifactorial health conditions that occur when 
the accumulated effects of impairments in multiple systems render [an older] person vulnerable 
to situational challenges” (Tinetti et al., 1995). Typically, geriatric syndromes are clinical conditions 
in older people which do not fit into discrete disease categories, including delirium, falls, 
dizziness and urinary incontinence. Newer geriatric syndromes now widely recognised include 
frailty, defined as multi-system impairment associated with increased vulnerability to stressors 
(Clegg et al., 2013), and sarcopenia, the age-related loss of skeletal muscle mass and strength 
(Sayer et al., 2013). These conditions represent multiple organ impairment (Inouye et al., 2007; 
Isaacs, 1992) and are common causes of loss of function.
Comorbidity and multimorbidity, although closely related to geriatric syndromes, are distinct 
clinical entities. Comorbidity is the co-existence of other conditions with an index condition that 
is the specific focus of attention. Multimorbidity is defined as the co-existence of two or more 
chronic conditions (The Academy of Medical Sciences UK, 2018) and the prevalence rises with 
advancing age.
Multimorbidity can be represented by the co-existence of two or more chronic conditions, each 
one of which is either:
  a physical non-communicable disease of long duration, such as a cardiovascular disease or 
cancer;
  a mental health condition of long duration, such as a mood disorder or dementia;
  an infectious disease of long duration, such as HIV or hepatitis C.
Multimorbidity is further defined as the co-existence of several conditions where none is 
considered an index condition that is the specific focus of attention. The most important 
functional issues associated with multimorbidity in old adults are disability and dependency and 
impaired cognition (Maclullich et al., 2013; Mukaetova-Ladinska, 2018).
For older people, multimorbidity is the rule rather than the exception:
  Studies found that hypertension and arthritis are typically the most frequent combination of 
chronic diseases (Walker et al., 2016; Violan et al., 2014; Garin et al. 2016). However, despite 
a high prevalence, these may not be the most burdensome in terms of physical impact and 
quality of life.
  Having concurrent physical and mental health conditions is associated with poorer health-
related quality of life, worse clinical outcomes and increased risk of premature mortality than 
having only physical conditions (Walker et al., 2016; Doherty & Gaughran, 2014).
  Furthermore, a UK study found that the co-existence of depression with another chronic 
condition was associated with increased financial cost per person relative to treating each of 
these conditions independently (Brilleman et al., 2013).
127
C
H
A
P
T
E
R
 3
O
p
ti
m
is
in
g
 h
e
a
lt
h
 a
n
d
 s
o
ci
a
l c
a
re   Increased cost associated with certain combinations of conditions may also be age-
dependent. For example, the same study found that the co-existence of diabetes and stroke 
was associated with increased cost (relative to each condition in isolation) among those aged 
60 years and older. However, the same two conditions were associated with lower cost when 
presenting concurrently in individuals aged below the age of 60.
  Individuals with concurrent neurological or mental health conditions (including dementia, 
depression, anxiety and stroke) exhibited the greatest functional decline over time (Jackson 
et al., 2015).
Figure 22. Number of chronic conditions (CCs) by age group in a representative sample of 2904 patients reported 
by 118 general practitioners throughout Switzerland, and prevalence of multimorbidity in each age group 
(Excoffier et al., 2018).
Recognition of multimorbidity, and application of interventions to tackle all morbidities and 
shared risk factors, are preferred to a single disorder approach in older people (The Academy of 
Medical Sciences UK, 2018). There are a number of challenges in addressing multimorbidity: for 
example, treatment of one condition (i.e. cardiac disease) could raise the risk of a second (e.g., via 
polypharmacy), or one chronic condition could induce another (e.g., depression stemming from 
coping with another chronic condition).
Recognition of mutimorbidities also affords opportunities. For example, conditions may cluster 
within households, and thus identification of common and modifiable risk factors which lead to 
morbidities in multiple household members at different stages in the life course could influence 
the broader trend of health within households through preemptive action against risk factors 
beyond the primary patient.
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While individual combinations of problems vary, the health care needs of most people with 
multimorbidity are similar: namely unconditional, personalised continuity of care from a small 
team of generalists whom they know and trust, linked to specialist and other services and 
resources as required (Barnett et al., 2012; Ong et al., 2016; Teh et al., 2018; Vetrano et al., 2018). 
Unfortunately, older people remain underserved by research on this topic, despite the burden of 
multimorbidity within this group being highest for both the patient and the health care system.
Concluding remarks
Recognition of multimorbidity and application of interventions to tackle all possible morbidities, 
including shared risk factors, is preferred to a single disorder approach in older people.
The major challenge of age-related diseases is functional loss. Health systems largely fail to 
measure function and yet it is the number one concern for patients and carries high care needs.
Continuity of care appears essential.
Policy options
The high prevalence of physical and mental multimorbidity, coupled with care and 
social needs, means that we need a comprehensive assessment and management 
strategy, rather than an individual speciality approach.
It is beneficial to implement comprehensive care pathwaysfficient models of service 
delivery which combine traditional approaches with new technologies and ensure 
functional ageing with as much independence as possible.
The major challenge of age-related diseases is functional loss. Health systems 
largely fail to measure function and yet it is the number one concern for patients and 
carries high care needs.
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re 3B. INTEGRATING AND EXPANDING 
ENVIRONMENTS AND COMMUNITIES FOR 
ALL AGES
Problem area
In its guide to Age Friendly Cities in 2007 (WHO, 2007a), the WHO defined an age-friendly city 
as a place that “encourages active ageing by optimising opportunities for health, participation 
and security in order to enhance quality of life as people age”. In practical terms, an age-friendly 
city adapts its structures and services to be accessible to, and inclusive of, older people with 
varying needs and capacities (Buffel et al., 2018; McCracken & Phillips, 2017; WHO, 2007a). For 
the purposes of this report, we refer as much as possible to an environment “suitable for all ages” 
so that the report does not reify ageism.
Along with recognising older people as contributors to the development of society, and 
advancing health and wellbeing into old age, the drive to ensure “enabling and supportive 
environments” is one of the three priority areas of the Madrid Plan of Action endorsed by the 
UN in 2002 (United Nations, 2002). Based upon a model of human functioning and capabilities 
(WHO, 2015b), the WHO’s recent Global strategy and action plan on ageing and health (2016-
2020) (WHO, 2016b) includes developing age-friendly environments as one of five strategic 
objectives with key actions aimed at fostering older people’s autonomy, enabling older people’s 
engagement, and promoting multi-sectoral action. As a holistic improvement and intervention 
framework, delivery challenges include:
  Addressing in a coherent fashion, the inter-connected, place-based, domains of action 
affecting the experiences of older people living in cities, towns and villages.
  Delivering these actions and innovations within a wider converging framework of regional 
spatial development, addressing additional and competing urban agendas such as 
sustainable cities, smart cities, green cities, healthy cities and creative cities.
First innovative interventions to favour environments and communities for all 
ages
There are now over 700 members of the Global Network on Age-Friendly Cities and 
Communities (GNAFCC) worldwide, working with programmes spanning a broad range of scales 
across national, regional, city, county, municipal and neighbourhood levels (WHO). Innovative 
practices are shared in the Global Network of Age-Friendly Cities and Communities repository, 
aligned with the WHO themes addressing:
  outdoor spaces, the urban built environment and public realm;
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  housing;
  mobility and transportation;
  civic participation and employment;
  social participation and leisure;
  respect, social inclusion and combating ageism;
  communications and information;
  community supports and health services.
Some examples of specific innovations include:
  Extending the timing of green pedestrian traffic lights to accommodate people who walk 
more slowly when crossing roads and streets (Crabtree et al., 2015).
  Installing more and better seating (with backs and arm-rests) along pedestrian routes and in 
parks and public spaces to accommodate people who need to rest more frequently, while 
also encouraging opportunities for greater social engagement (Yücel, 2013).
  The provision and access to toilets in public spaces and ‘away from home’ in publicly 
accessible buildings (Bichard & Hanson, 2009; Bichard & Knight, 2012).
  Rural and community transport to connect people living remotely with amenities and 
services centred in towns and cities (Breen, 2014).
  Liveable cities and neighbourhoods addressing sustainable, intergenerational communities 
that are inclusive, safe and secure for all (American Association of Retired Persons (AARP), 
2018).
Encouraging implementation of innovations
The interdisciplinary and multi-sectoral nature of age-friendly strategies and action plans calls 
for significant levels of collaborative working across local government agencies, health service 
providers, local industry and commerce, civic society organisations and community groups. 
Successful planning and implementation processes are dependent upon the active involvement 
of diverse older people, bringing a cross-section of experiences, priorities, contribution areas and 
a wealth of social capital to the table.
Examples of best practice in implementation include:
  The Irish programme provides support to all 31 county administrations in Ireland, based on 
a model of multi-stakeholder collaboration, older citizen participation and a shared local 
action agenda framed by the WHO guide (Age Friendly Ireland, 2014). This model is scalable 
and is now embedded in the replicable structures of Ireland’s local government economic 
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Ireland’s national planning framework out to 2040 (Government of Ireland, 2018b). As such, 
the age-friendly communities and environments movement has an opportunity to effect a 
paradigm shift in local democracy and participatory governance through fostering a culture 
of engagement, empowerment and co-design that is at once innovative, creative, generative, 
evaluative and sustainable (Bond, 2015). While encouraging implementation takes on 
different forms in response to local contexts, spatial scales, ambitions and partnerships, there 
are some common, cyclical elements to most approaches and practices centred on initial 
assessments, developing commitments and plans of action, delivering on actions, evaluating 
and reporting, updating and recalibrating.
  In New York, the assessment process used a combination of community forums, 
focus groups and interviews to gather citizens’ perspectives and aspirations. This was 
complemented with stakeholder inputs that spanned expert round-tables, Geographic 
Information System population data mapping, information requests, and self-assessments 
by relevant agencies. The result of this assessment process was a plan with 59 initiatives 
spanning community and civic participation, housing, public spaces and transport, and health 
and social services. To support delivery, the age-friendly team developed a series of guides 
and toolkits for architects and urban designers, arts and culture, businesses, colleges and 
universities, parks, pharmacies, transportation and walkability, urban planning, supermarkets 
and for primary care. The strong political commitment from the mayor’s office provides a 
point for convergence of these implementation strands and an integrated environment for 
review and updating. The New York Academy of Medicine (2007) has been an important 
research and innovation partner to the programme.
  In the UK, the Age-Friendly Manchester initiative (Manchester City Council, 2017) adopted 
a similar assessment and co-creation approach. Manchester’s programme is founded on a 
shift from a needs-based to a rights-based approach to inclusive access to the city. Part of 
Manchester’s blueprint for encouraging implementation has been to produce an ‘age-friendly 
charter of rights’ for older people, and to encourage the public, private and NGO sectors to 
make ‘pledges’ or commitments to improve their products or services to make them more 
age-friendly. Advice and guidance are provided to organisations making pledges so that they 
are achievable and measurable, they are specific in relation to deliverables, there is clarity 
about who is responsible, and there is an understanding of how it will contribute to making 
the city age-friendly. Age-Friendly Manchester is supported by the Manchester Institute for 
Collaborative Research on Ageing (2018), where the teams are updating needs and asset 
assessments and exploring new sets of indicators.
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Outside of initiatives anchored by public authorities at national, county, city or municipal levels, 
civic society organisations can play leading roles in encouraging implementation:
  In the USA, the American Association of Retired Persons (2019; founded in 1958) Liveable 
Community’s initiative adopts a three-pronged approach to promoting liveable, age-friendly 
communities through engagement, volunteer education, and as an information resource.
  Across Europe, as an outcome of the European Innovation Partnership on Active and Healthy 
Ageing (2019), and based on the principles of the Dublin Declaration on Age-Friendly Cities 
and Communities in Europe 2013, the Covenant on Demographic Change (2018) is promoting 
actions towards an ‘Age-Friendly Europe’ through a network of regional and local authorities, 
civic society organisations, academic and research organisations, and industry.
  The recent Joint Statement from the Thematic Network on Smart Healthy Age-Friendly 
Environments (2018) addresses the local convergence of age-friendly, smart and healthy 
city drivers, and recognises that the Digital Single Market (European Commission, 2019a), the 
European Pillar on Social Rights (European Commission, 2017), the Sustainable Development 
Goals (United Nations, 2019); the EU Health Strategy (European Commission, 2007), and EU 
Health Policy Platform (European Commission, 2019b) are among many initiatives that must 
be aligned and harmonised to promote and deliver a more inclusive society that can support 
the health and wellbeing of older European citizens in their communities into the next 
decades.
Concluding remarks
Following the UN (2002) Madrid Plan on Ageing (United Nations, 2002) and the WHO (2006a) 
initiative of Age Friendly Cities (WHO, 2006a), great progress has been made in easing the lives 
of older populations in more than 700 cities worldwide. Currently, numerous collaborative and 
innovative initiatives continue to promote more inclusive communities to support the integrated 
and active life of older European citizens in their communities, but further work remains to be 
done.
The policy landscape effecting the implementation of age-friendly environments and 
communities and the achievement of an ‘age-friendly Europe’ is both trans-sectoral and spatially 
hierarchical spanning European, national, regional and city to neighbourhood levels. Several 
common areas for action include:
  Standardisation: Achieve greater harmonisation of standards and guidelines as they affect 
the quality of the built environment particularly in relation to universal design and inclusive 
design spanning housing, the public realm and transportation.
  Trans-sectoral collaboration capacity: Promote regional and inter-regional programmes 
that can strengthen local capacities to build well-functioning multi-agency coalitions that can 
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smart, healthy and age-friendly places.
  Common monitoring and evaluation: Informed by the WHO strategic objective to improve 
measurement, monitoring and research for healthy ageing, promote an evaluative culture 
for the design and implementation of multi-factorial, place-based, age-friendly environment 
innovations, through developing greater consensus on ways to measure, strengthening 
research capacities and incentives, and building and synthesising a ‘place-oriented’ evidence 
base.
  Technology adoption and digital inclusion: Enhance the take-up of technology-oriented 
solutions that empower older people to self-manage health and wellbeing though greater 
awareness, technical interoperability of devices and applications, and more integrated health, 
social and community-based pathways.
  Alignment with global agenda: Improve EU policy alignment with the global sustainable 
development agenda. From the UN to the WHO, and through UN Habitat, there is now 
a range of initiatives where the issue of ageing is considered within a broader human 
rights-based and citizenship-based approach, including combating ageism, which is still 
widespread.
  Data: Improve data for indicators and planning. There is still a lack of consistent, Europe-wide 
high spatial resolution, disaggregated data addressing older age groups, gender, health and 
wellbeing, and economic status that can support planning and community action at local, city 
and sub-regional scales.
  Healthy ageing in all policies: Encourage a cross-sectoral approach that promotes healthy 
ageing in all policies from local to European level, and encourage inter-sectoral responses to 
enhance healthy ageing, enable ageing in place and provide with greater social participation 
opportunities.
Policy options
Local level policy, planning and procurement decisions are critical to delivering age-
friendly communities. National and international political levels can act to provide 
financial and other incentives for smart community design and provide support and 
facilitate the sharing of best practice from communities that have experience of 
making the age-friendly transition.
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There is a knowledge gap concerning the value of social engagement. It is thought 
that referral to non-clinical community and volunteer services may support the 
engagement of citizens, both in their own health and within their community.
3C. EASING MOBILITY AND DRIVING 
CONDITIONS
Mobility and access to transport are essential in order for older adults to retain autonomy, 
maintain physical fitness, stay integrated within their communities, and remain socially engaged. 
The car is the preferred mode of transportation by older people, with an increase in recent 
decades in the number of older adults who have driving licences and access to cars (Hjorthol et 
al., 2010). This is mainly attributable to an increase in the number of older female drivers (DaCoTa, 
2012). By 2030, a quarter of all drivers will be aged 65 years or older (DaCoTa, 2012).
Access to a car has been associated with increased social engagement, quality of life and 
mental health. Driving, in particular, is associated with independence and a sense of control over 
one’s life (Windsor et al., 2007). Conversely, driving cessation appears to increase symptoms 
of depression (Chihuri et al., 2016), cognitive decline (Choi et al., 2014) and functional limitations 
(Shimada et al., 2016). Therefore, older drivers must be supported to continue driving for as long 
as it is safe to do so.
Existing policies for renewing older people’s driving licences differ between EU member states, 
with variable periods of licence renewal and diverse approaches to screening and assessment 
for determining fitness to drive. This is problematic when it comes to assessing the effectiveness 
of these approaches. Common procedures in place include age-based screening, mandatory or 
voluntary assessments and a requirement for medical screening (Polders et al., 2015). Evidence 
is lacking to support any safety benefits for age-based assessments; on the contrary, these 
assessments are is associated with at best neutral outcomes and at worst adverse outcomes for 
older people (CONSOL, 2013). Imposing strict age-related screening likely increases societal and 
personal costs without safety benefits, and may result in premature driving cessation in women 
particularly (Siren & Haustein, 2014). There is evidence to support the effectiveness of alternate 
approaches to licensing regulations, including mandatory in-person licence renewal (Goodwin 
et al., 2015), referral of at-risk drivers (regardless of age) for a more comprehensive and multi-
faceted assessment (Langford et al., 2006), and restricted licensing (Langford & Koppel, 2011). 
In the US, requiring an older driver to renew their licence in person has been associated with 
reduced fatal crash involvement rates for all age groups, with the greatest reduction seen for 
those aged 85 years and older (Goodwin et al., 2015).
135
C
H
A
P
T
E
R
 3
O
p
ti
m
is
in
g
 h
e
a
lt
h
 a
n
d
 s
o
ci
a
l c
a
re Screening and assessment of at-risk drivers, rather than being based on age or presence of 
disease per se, should centre on how functional ability is impacted. Assessments of driving 
fitness should ideally be multifactorial; however, currently a lack of good evidence regarding the 
effectiveness of different screening and testing procedures is hampering the development and 
standardisation of detailed assessments (Polders et al., 2015), therefore a priority should be to 
facilitate further research into the predictors (e.g. sensory, cognitive, psychomotor and medical) 
of non-fitness to drive.
Implementing restructions for older drivers is an approach to licence renewal that has proven 
efficacy and could be combined with comprehensive screening and assessment. These include 
restricting driving to specific times or limiting distance, requiring adaptive vehicle equipment or 
shortening the renewal cycle. Licensing restrictions reduce crash rates (Langford & Koppel, 2011) 
and gradual restrictions may be more acceptable to older adults and help ease the transition 
from full driving to eventual cessation of driving. The role of licensing agencies should include 
helping to ease this transition (Eby et al., 2008).
Evidence from the US and Canada supports the effectiveness of specific driving rehabilitation 
and refresher programmes (Betz et al., 2014; Korner-Bitensky et al., 2010). These comprise off-
road (including education) and on-road components. Driving rehabilitation specialists — typically 
occupational therapists — carry out an assessment of fitness to drive and provide retraining as 
part such courses. However, this is rarely implemented in a standardised manner (Dickerson, 
2013). There are also several barriers limiting uptake by drivers, including cost, lack of public 
awareness about the existence of such schemes, and lack of knowledge or willingness on the 
part of medical professionals to refer older drivers (Betz et al., 2014). Successful implementation 
and good uptake of retraining schemes requires initiatives at a national level to regulate training, 
increase awareness and engage various stakeholders so that incentives can be increased and 
costs can be reduced.
Application and standardisation of non-discriminatory policies and testing procedures across EU 
member states should be a key objective of initiatives in this area. The issue of restrictions on 
rental car hire for older people should also be addressed as part of a uniform policy change, to 
safeguard mobility between Member States and ensure compliance with their laws. Anecdotal 
evidence suggests that rental car policies differ markedly between EU countries, with many 
countries imposing widely varying upper age limits on rental.
Finally, progress in the development of autonomous vehicle technologies over the next few 
decades will benefit older drivers and thereby allow older adults to stay mobile for longer, by 
increasing safety and compensating for a decline in functional abilities. The latter is being 
achieved through the development of increasingly complex and sensitive advanced driver 
assistance systems, with vehicle sensors designed to monitor, for example, the driver’s 
physiological or cognitive state (e.g. detection of drowsiness, distraction). The system can then 
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providing warnings, share control with the driver, or take full control of the car if necessary 
(Sentouh et al., 2014). However, there is currently poor regulation of autonomous vehicles 
and strict protocols must be developed for the testing of such vehicles. These include 
mandatory data reporting by manufacturers where situations have arisen during testing that 
could compromise safety, as well as the development of appropriate safeguards to ensure 
cybersecurity (Claybrook & Kildare, 2018). In addition, despite the rapid advancement of 
autonomous vehicles technologies, the rate of uptake is likely to be limited by the cost of these 
vehicles, at least in the short-to-medium term (Polders et al., 2015).
Concluding remarks
In summary, the key points concerning older drivers in the EU raised here are:
  Non-discriminatory policies should be developed and standardised for:
  screening and assessment approaches for fitness to drive;
  licence renewal processes for older drivers;
  car rentals between EU member states.
  Autonomous vehicles could benefit older drivers by increasing safety and maintaining 
mobility
Policy options
Access to a car has been associated with increased social engagement, quality 
of life and mental health. Therefore, older drivers must be supported to continue 
driving for as long as it is safe to do so.
There is evidence to support the effectiveness of alternate approaches to licensing 
regulations, including mandatory in-person licence renewal; restricted licensing; and 
referral of at-risk drivers (regardless of age), for a more comprehensive and multi-
faceted assessment.
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Ageing at home
Supporting older people to ‘age in place’ is a central concern of ageing policy. Ageing in place 
focuses on providing the necessary resources and assistance to enable older people to live 
with some level of independence at home or in the community for as long as possible, to avoid 
transferring to more costly long-term care or residential facilities (Heumann & Boldy, 1993; 
Horner & Boldy, 2008). As noted by Boldy et al (2011), it is important to distinguish between 
simply ‘staying put’ and ‘ageing in place’, with the latter implying a person is able to make 
an active and evolving decision to stay in their own home or community depending on their 
changing health and social care needs, preferences and available resources.
Ageing in place is generally a preferred option for older people, with a move to long-term care 
or a residential facility viewed as undesirable and an option of last resort (Stones & Gullifer, 
2016; Wiles et al., 2012; Wilson, 2000). A large body of research has established that ageing in 
place affords stability and security and contributes to maintaining a sense of independence, 
self-reliance and empowerment (Coleman et al., 2016; Horner & Boldy, 2008; Stones & Gullifer, 
2016; Wiles et al., 2012). Remaining in a familiar home and community environment may also 
enable people to more successfully adopt strategies for healthy ageing, provided that at least 
a minimum standard of housing quality is maintained and local resources such as transport and 
health care facilities are able to meet individual needs (Rosel, 2003; Sixsmith et al., 2014). Living 
in the community can further contribute to wellbeing and quality of life by helping people retain 
social connections and preserve an active social life (Horner & Boldy, 2008; Wiles et al., 2012). 
Sentimental objects such as photographs and familiar people and places also provide a link 
between the past and the present, fostering a sense of self-identity (Hidalgo & Hernández, 2001; 
Sixsmith et al., 2014; Stones & Gullifer, 2016).
Ageing in place is desirable as it affords opportunities for cost savings. Evidence in general 
shows that more appropriate and less costly care and support can be provided to older people 
who remain at home rather than in a residential facility (Chappell et al., 2004; Grabowski, 2006; 
Heumann & Boldy, 1993). Ageing in place may also offer advantages to service providers, by 
facilitating coordination of multiple care and support services for complex health and social care 
needs and enabling older people to remain more involved in decision making about their own 
care and support (Horner & Boldy, 2008).
Despite affording many benefits, Heumann and Boldy (1993) note that ageing in place 
nevertheless also has the potential to cause “great harm”. For instance, an emphasis on ageing 
in place may encourage older people or their families to make decisions to remain at home 
when care in a residential facility may be necessary and more appropriate (Horner & Boldy, 
2008). Furthermore, assistance from family or friends is often required to enable an older 
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person to remain living at home; delaying a move to institutional care may place a significant 
and unnecessary burden on informal carers (Horner & Boldy, 2008). Remaining at home may 
also result in social isolation and exclusion if appropriate social networks are not available or 
accessible (Horner & Boldy, 2008; Wiles et al., 2012). Additionally, ageing in place policies may 
have negative consequences if they are implemented at the expense of investing in developing 
a high quality long-term care system for those that will eventually need residential care 
(Heumann & Boldy, 1993).
Favouring ageing in the home environment seems to be an obvious win-win for both the health 
care system and the individual. Yet, what often is overlooked is ensuing loneliness in old age for 
those who live alone at home. Loneliness is defined as the subjective experience of distress in 
light of not meeting one’s expectations for the quality or quantity of social relationships (Peplau & 
Perlman, 1982). It is distinguished from ‘aloneness’, which is the objective lack of social relations, 
characterised by social isolation (de Jong Gierveld et al., 2006; Russell et al., 2012).
  Aloneness is particularly high in old age as older adults often experience losses in their social 
environmental. These may include the loss of a spouse, friends or family members (Lopez 
Doblas & Diaz Conde, 2018). Older adults also are more likely to retire and this may result in 
reduced contact with their social network, leading to social isolation and loneliness (Segel-
Karpas et al., 2018). Many older adults also experience physical changes, such as reduced 
mobility or hearing or vision impairments that make social interactions more challenging (Qiu 
et al., 2010).
  Similar to aloneness, loneliness is highly prevalent in old age. But a meta-analysis has found 
a U-shaped association between age and loneliness (Pinquart & Sorensen, 2001). The rates 
of loneliness are high in late adolescence and among the oldest old (Luhmann & Hawkley, 
2016). In a large survey conducted in 25 European countries, the prevalence of loneliness 
ranged between 34% among people over the age of 60 in Ukraine and 3% among those over 
60 living in Denmark (Yang & Victor, 2011). Loneliness is higher in Mediterranean countries 
(10% lonely all of the time in Greece and 8% in France) compared with Northern European 
countries (1% in Switzerland, 2% in Denmark) (Sundstrom et al., 2009). Loneliness has been 
identified as an extreme stressor in later life which impacts health and even mortality (Luo et 
al., 2012).
New forms of care settings need to be developed which are decentralised and more self-
organised by patients and their families, which allow patients to live together in small units and to 
contribute to everyday life routines for as long as possible and experience agency and purpose. 
This form of decentralised care setting is very important also for dementia patients.
The provision of the necessary care and support to facilitate ageing in place varies according 
to national context, contributing to country-specific differences in the number of older people 
living at home and in residential facilities. Data from the Eurostat population and housing census 
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(defined as ‘health care institutions or institutions for retired or elderly persons’) in 2011, with 
this figure reaching 12.6% for individuals aged over 85 years (Eurostat, 2018g). This share varies 
considerably across Member States, with over 20% of the population aged 85 years and over 
living in an institutional facility in Luxembourg, Malta and some parts of France, Germany, the 
Netherlands and Portugal, but this figure falling to below 2% in Bulgaria, Romania and some 
parts of Greece, Spain and Southern Italy (Eurostat, 2018g). Of course, while some of this variation 
is due to insufficient provision of formal long-term care, much will depend on social and cultural 
attitudes towards looking after older people and the ability of populations to provide informal 
care to family and friends.
Home care
Home care, which is defined as delivering personal care and practical support to older people 
living in their own home, is one of several services that are offered to older people assessed 
as needing social care support. It is typically funded by health or social care services. Although 
the range and type of services within the theme of home care varies, it usually encompasses 
personal care (help to wash), support with the activities of daily living and help with essential 
domestic tasks. Home care services typically aid older people to stay independent and remain 
part of social and other activities.
The National Institute for Health and Care Excellence in the UK has a series of guidelines on 
home care. Recommendations include that the care is person-centred; offers support options; 
operates jointly with health and social care; ensures safety and safeguarding for those using 
home care services; and provides training and support for home care workers (National Institute 
for Health and Care Excellence, 2015).
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Home care, 
non-professional 
(family, friends)
Formal health 
care at home 
(professionals)
Formal health 
care in an 
institution 
(professionals)
Figure 23. Age related coverage of dependent population by age and type of care provided and costs, 
aspercentage of the population (http://ec.europa.eu/economy_finance/publications/european_
economy/2015/pdf/ee3_en.pdf) with annotations added for this report.
It is difficult to establish how many older people with health and social care needs receive 
appropriate formal care at home to support ageing in place. This is due to an absence 
of comprehensive data on formal home care provision in many countries and a general 
fragmentation of long-term care funding and organisation that makes it challenging to decipher 
exactly what is spent on different care areas and on different age groups (European Commission, 
2018a). Some insights can, however, be obtained from data from the European Commission’s 
Economic Policy Committee on the distribution of long-term care received by the dependent 
population in Europe. These data suggest that in the EU in 2016, approximately 10% of the 
dependent population aged 65 to 69 with long-term health or social care needs received 
home care, with 10% receiving care in an institutional setting and 30% granted cash benefits to 
purchase their own care or to reimburse informal or formal carers (European Commission, 2018a). 
Receipt of care in institutional settings compared to in the home was higher for those aged 85 to 
89, with 30% receiving home care, 40% care in a residential facility and approximately 70% cash 
benefits. (As explained in the European Commission’s (2018a) ageing report, coverage may be 
above 100%, as some recipients may receive both cash and in-kind benefits.)
Undertaking cross-country comparisons of receipt of care for dependent older adults is 
complicated due to a lack of country-specific data by age group. However, if receipt of long-
term care by all dependent individuals is considered, the majority of which is received by 
individuals aged over 60 years, we see large variations between countries. For instance, while 
over 40% of the dependent population in Belgium, Finland, the Netherlands and Norway receive 
home care, this falls to below 5% in Portugal and Poland (European Commission, 2018a).
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The level of home care resources available to older people living in their own home varies 
significantly from country to country, as does the method of delivering care at home. The level of 
demand from patients for home care also differs significantly across EU member states. Even the 
definition of what exactly constitutes home care differs (Genet et al., 2012). Generally, many types 
of home care services are available but often not very extensively. Relatively extensive services 
are available in Austria, Belgium, Denmark, the United Kingdom, Ireland, Luxembourg, the 
Netherlands, Norway and Sweden. In other countries, considerable needs remain unaddressed 
by formally provided services (Genet et al., 2012).
In order to age in place, older people must to some degree remain free of illness and disability 
or be provided with the necessary care and support to meet their health and social care needs. 
Many countries have therefore introduced initiatives to promote healthy ageing or innovative 
care models to support those with everyday functional limitations.
Actions targeting health promotion and prevention in older people who live in the community 
are increasingly prevalent. These interventions often focus on reducing falls, which are a leading 
cause of health complications and injuries among older people. One of the most successful 
and globally replicated fall prevention interventions is the Otago Exercise Programme from 
New Zealand (Thomas et al., 2010). The programme consists of muscle strengthening and 
balance training delivered by trained professionals in homes or other care settings and much 
research has shown it to be a cost-effective strategy in reducing falls and fall–related injuries, 
particularly for frail older people (Campbell et al., 1999; Campbell et al., 1997; Kyrdalen et al., 
2014; Liu-Ambrose et al., 2008; Thomas et al., 2010). Another leading prevention strategy is the 
promotion of appropriate physical activity for older adults. Some initiatives that have successfully 
promoted physical activity in older populations include community-based exercise programmes, 
prescribing and monitoring of physical activity by primary care physicians or provision of 
pedometers to encourage walking (Croteau et al., 2004; King, 2001; Kolt et al., 2012). Much 
evidence has linked physical activity at older ages to lower hazard of disability and improved 
balance, mobility, cognition and wellbeing (de Vries et al., 2012; Kenfield & Stampfer, 2013).
Home visits are a principal strategy to facilitate ageing in place. A well known and successful 
model for providing home visits for adults with functional limitation is the Buurtzorg 
“neighbourhood care” nursing model that originated in the Netherlands in 2007. Under 
the Buurtzorg model, nurses work in small, self-managed teams to provide both medical 
treatment and social care support, with at least 60% of their time spent with patients (Gray et 
al., 2015; Kreitzer et al., 2015; Monsen & de Blok, 2013). The model supports care integration by 
encouraging nurses to work closely with informal carers and primary care providers as well as 
families and community resources. Evidence shows that care provided under the Buurtzorg 
model is of high quality and has led to fewer hospitalisations, lower number of care hours per 
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participant and lower rates of nursing home admissions compared to usual care (Buurtzorg 
Nederland, 2009; KPMG, 2015).
Satisfaction ratings among patients and nursing staff are also higher than for other home care 
models (Buurtzorg Nederland, 2009; Gray et al., 2015; KPMG, 2015; Monsen & de Blok, 2013). 
This success has seen several countries adopt the Buurtzorg model, including Japan, Norway, 
Sweden, the UK and USA, with adaptations made to meet country-specific needs (Gray et al., 
2015; Kreitzer et al., 2015).
Home care can be delivered by two complementary care networks:
  an informal care network of non-professionals: spouse, family members and friends
  a formal care network of health care professionals (GPs/family doctors, nurses, aid-nurses, 
social workers and so on)
Informal care networks
Informal caregiving is an essential part of care supply all over Europe, and older people in many 
countries prefer to receive help at home from their relatives, especially at early stages of care 
dependency (Mair et al., 2016). Depending on the setting, informal caregiving can heavily affect 
the life of carers with respect to work, family and social networks, as well as their health and 
wellbeing.
The majority of informal carers across Europe are between 55–65 years old (Colombo et al., 
2011), and often in a potential “sandwich position” between older parents and younger children 
and grandchildren in need of support (Grundy & Henretta, 2006). Typically, spouses, adult 
daughters or daughters-in-law are the primary carers. They are often not in paid work (Bauer & 
Sousa-Poza, 2015) and have lower educational attainment (Colombo et al., 2011), and are among 
lower socioeconomic groups (Broese van Groenou et al., 2006). Older childless women (often 
also without partners) tend to compensate for a lack of support in older age by drawing on their 
broader social network and formal carers (Deindl & Brandt, 2017). Moreover, most people with 
dementia live in the community and depend on a family member for assistance (Kneebone & 
Martin, 2003). The National Dementia Strategy for England identifies family carers, 27% of whom 
are spouses in the United Kingdom, as “the most valuable resource for people with dementia”, 
with 600,000 family carers providing £8 billion (€10 billion) per annum of unpaid dementia care 
in the UK alone (Alzheimer’s Society, 2012).
Informal caregiving tasks and intensity also differ significantly between different care settings. 
Female carers provide more hours of care and care for a longer period (Yee & Schulz, 2000), 
spouses (of both sexes) more often provide care without any help from others (Litwin et al., 2014), 
and lower education is linked to more intensive caregiving (Colombo et al., 2011). In Southern 
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Northern Europe, where low-intensity support is much more common (Brandt, 2013).
Figure 24. Support networks of spousal care provider (Windle & Bennett, 2011, reproduced in Donnellan et al., 2017).
For Europe, results regarding physical health of informal carers are mixed, depending on the 
groups, indicators and contexts studied (e.g., Hiel et al., 2015). Informal caregiving for one’s 
spouse seems to be especially detrimental (Pinquart & Sorensen, 2003). Caring for an individual 
with dementia is associated with depression (Schulz et al., 1995), anxiety (Cooper et al., 2007), 
greater risk of hypertension and heart disease, decreased immunity, and higher mortality 
(Mausbach et al., 2007; Schulz & Martire, 2004; Shaw et al., 1999). This psychological morbidity 
has been found to be most strongly associated with the coping strategies used by the carer, as 
well as demographic characteristics of the carer and neuropsychiatric symptoms and illness 
severity in the person with dementia (Cooper et al., 2008). Carers outside the household (often 
daughters) are more likely to be in better health. Care inside the household (mostly partners) is 
related to lower physical health and leads to a decline in mental health (Kaschowitz & Brandt, 
2017).
Pinquart and Sorensen (2003) noted that most studies on informal and family carers centred 
on burden. However, burden is not the full story. While stress, at least initially, is common to 
adversity, carers are not homogeneous (Bonanno, 2004). Some family members might find 
caring entirely burdensome while others might find it life-enhancing; these carers are resilient 
(Windle & Bennett, 2012). Studies have also indicated that carers can identify positive aspects 
of their role (Brodaty & Donkin, 2009) and resilience within a caring role has been shown to be 
linked to factors such as perceived ability to cope, perceived control and social support (Dias et 
al., 2015; Harmell et al., 2011). Carers with higher perceived control, who favour challenge over 
stability, present with fewer depressive symptoms at follow-up (O’Rourke et al., 2010). Gaugler et 
al. (2007) found that high levels of resilience in dementia carers led to significantly less instances 
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of institutionalisation at three-year follow-up. They characterised these resilient carers as more 
accepting of support. However, the type of support is important; support may be detrimental if it 
creates feelings of over-dependence (Ingersoll-Dayton et al., 1997) or if it is not empathic.
Formal home care networks
Formal home care workers are usually classified into two categories (Colombo et al., 2011; OECD/
European Commission, 2013):
  paid nurses and rehabilitation staff such as occupational therapists and physiotherapists that 
provide home health care
  personal carers that provide social care and support to people who need assistance with 
activities of daily living
Delivery and financing of formal home care is therefore often split between health and social 
care depending on the type of service being received.
The formal home care workforce shares many commonalities across European countries. The 
majority of workers are personal carers rather than nurses or other health care staff (OECD, 
2017a; OECD/European Commission, 2013). Home care workers are overwhelmingly women 
(over 80% of the workforce in most countries) of middle age, many of whom work part-time and 
have another job. Foreign-born individuals are also an important source of labour for the formal 
home care workforce (Colombo et al., 2011; OECD, 2017a; OECD/European Commission, 2013). In 
France and Austria, for example, 50% of all formal care workers are foreign-born, while migrants 
account for 70% and 23% of home care help in Greece and the UK, respectively (Colombo et al., 
2011). In general, this work is undervalued and not recognised as skilled labour requiring training 
and qualifications.
In general, formal home care workers are low-skilled. Home care workers on average have 
fewer qualifications than formal care workers in institutions, while long-term care staff overall 
have lower qualifications than other health care workers (Colombo et al., 2011). Although some 
countries have made efforts to formalise training and education for formal home care workers, 
qualifications are often not required or enforced during recruitment, leaving workers in many 
countries under-skilled. As shown by Colombo et al. (2011), fewer than half of home care workers 
in Germany have relevant qualifications, while between 17% and 60% of all long-term care 
workers lack necessary qualifications in Australia, the Netherlands and the US.
Across Europe, formal home care workers are undervalued, salaries are low, working conditions 
are poor and the chance for career progression is limited (Colombo et al., 2011; National Audit 
Office, 2018; OECD/European Commission, 2013). These factors have contributed to low 
job satisfaction and high rates of staff turnover and staff vacancies. The UK, for example, is 
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17 and annual staff turnover of 27.8% (National Audit Office, 2018).
To reverse these trends, Member States have implemented a variety of strategies. In Germany 
and Finland, men and unemployed people respectively have been targeted to become formal 
carers, while salaries for long-term care workers have been significantly increased in Belgium, 
Denmark, France and Luxembourg (Muir, 2016). However, the impact of these initiatives is 
unclear, and it is uncertain if wage rises will be sustainable in the long run given the high labour 
intensiveness of long-term care.
Staff shortages across the region remain and are likely to be exacerbated by rising needs and 
reduced supply of both formal and informal care workers as a result of population ageing. 
If further efforts are not made to address issues related to staff shortages, to improve and 
standardise training and qualifications and to overcome poor working conditions, this will 
ultimately undermine the quality of long-term care that can be delivered in future.
Support for informal carers by health professionals
Support by professionals as well as family and friends can reduce caregiving burden (Verbakel 
et al., 2016), whereas disagreement within the care network increases carer strain (Tolkacheva 
et al., 2011). Carers often reduce their leisure activities, experience more friction in their family 
life (Seltzer & Li, 2000), and see their (non-family) social contacts changing more often (Suitor & 
Pillemer, 1996), leading to shrinking networks (Clay et al., 2008).
Family carers are a vital determinant of positive outcomes for people with dementia. 
For example, having a co-resident carer exerts a 20-fold protective effect on risk of 
institutionalisation (Banerjee et al., 2003). Given that family carers of people with dementia are 
such an important resource, it is important to ensure that their own mental health and quality of 
life is satisfactory. Dementia carers have unique support needs (Roth et al., 2005): they are likely 
to suffer declines in the availability of people to provide informal support over time (Clay et al., 
2008), and disengage from their existing social networks as they devote more time to caring as 
the disease progresses (Han et al., 2014; Hough et al., 2005).
Social exclusion is generally acknowledged as negative and is associated with the experiences 
of marginalised groups such as people with dementia, severe mental illness and informal 
carers. Reducing social exclusion and improving social inclusion are therefore policy priorities in 
countries such as England and Wales — leading to, for instance, the National Dementia Strategy 
for people living with dementia, the National Carers Strategy for unpaid informal carers, and 
strategies for people with mental health disorders.
The wellbeing gap between carers and non-carers is smaller in European countries which offer 
more generous formal care, whereas specific support measures for informal carers do not seem 
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to help to close the gap (Verbakel, 2014). Moreover, spousal carers’ wellbeing is positively linked 
to the regional availability of formal care. Better wellbeing can be traced to higher perceived 
control of carers in regions with more formal care provision (Wagner & Brandt, 2018).
Developing financing models for ageing at home
European countries spent on average 0.6% of their health care expenditures on curative home 
and rehabilitative home care and 3.5% on long-term nursing care at home (Genet et al., 2013). 
Figures on home care within the social care system (mostly domestic aid) are rarely available 
and statistics on private (out-of-pocket) home care expenditure are absent in many countries. 
National governments in most countries have developed a vision on home care, but these are 
neither detailed nor homogenous.
Although home care for health needs is usually funded through public sources or social health 
insurance, users in all countries of Europe are expected to pay for at least some share of their 
formal social home care costs (Costa-Font & Zigante, 2017; Robertson et al., 2014). The proportion 
of care paid for by individuals out-of-pocket is often large, with users commonly means-tested. 
The threshold for receiving financial assistance is frequently high. In England and Italy, for 
instance, co-payments are means-tested, with individuals covering up to 100% of social care 
costs (Costa-Font & Zigante, 2017). Other countries such as Sweden and Spain have introduced 
‘reserved amount’ thresholds to limit co-payments, although individuals may still pay for up to 
80% of long-term care needs, depending on personal financial circumstances (Costa-Font & 
Zigante, 2017; Robertson et al., 2014).
Home care that is not paid out-of-pocket is purchased by the central or local government in tax-
funded systems or through social insurance funds. Home care purchased on behalf of users can 
be delivered in-kind through directly provided services, or through cash-for-care benefits where 
users are given cash to purchase their own social care services. Cash benefits can be provided 
in many forms, such as vouchers (e.g. Finland), home-care grants (e.g. Ireland), direct payments 
(e.g. England) or personal budgets (e.g. Netherlands) (Moran et al., 2013; Timonen et al., 2006). 
Although cash benefits enable users to pay for services and formal care workers directly, they 
can in some cases be used to reimburse informal carers. In most countries, uptake of cash-for-
care benefits remains lower than direct in-kind provision of services (Timonen et al., 2006).
Specific attention should be devoted to the internalisation of costs and benefits in long-term 
care. As a principle, costs should match benefits within the same decision unit, such as a social 
insurance scheme, a government entity or a household. If benefits accrue largely outside the 
institution which bears the costs, there is no incentive for this institution to provide such services. 
Home care provides several examples.
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an incentive to underprovide home care. When professional care is only partially covered, there 
is an incentive to purchase less professional care. Both lead to worse health which will in turn 
generate more health insurance costs. The appropriate policy response is to have the health 
insurance support home care and to increase the coverage of professional care. This example 
also shows that internalisation is a matter of extent. Since home care will also be provided to 
some extent voluntarily as a matter of familial duty and altruism, coverage of costs does not 
need to be 100%. The other extreme, 0%, however, is also unlikely to be the right amount.
Home care is very strenuous. Carers need support (information, professional help, and vacation 
time). Often, such support is provided by social workers who are paid by municipalities. Again, 
costs and benefits are only partially internalised, since the resulting better health of both carer 
and care recipient benefits the health insurance while the municipality bears the costs. Health 
insurance funds should therefore subsidise municipalities. This does not necessarily have to be 
done directly, but could be achieved in a roundabout way, such as with block grants by the state 
or federal government charged to the health insurance, or subsidies to the carer enabling her to 
pay for services for which the municipality then charges a fee.
The European-level umbrella group Eurocarers, which represents informal carers, asserts that 
such care is crucial in health care systems but does not receive the recognition or financial 
support that it deserves:
“Due to demographic factors and developments in medical care and social support an increasing 
number of people require long-term care. Approximately 80% of this care is provided by 
spouses, relatives and friends. Without the work of these unpaid carers, formal care systems 
would be totally unsustainable, and many acute needs would remain unattended to. Yet carers 
receive little recognition for the valuable work they do. Policies to support them, although under 
development in many countries, are still far from adequate.”
(Eurocarers, 2019)
Concluding remarks
The factors that influence the impact of informal care on carers’ wellbeing are dependent on the 
balance between formal and informal support provided, the support setting and type, and the 
availability of long-term care in a country or region.
A mix of informal and formal support is essential for appropriate ageing in place, not only for care 
supply but also for the wellbeing of care receivers and carers. In order to encourage informal 
care, it is important to offer affordable and available support from formal care providers as 
alternatives for all social-economic groups. This enables an adequate care mix, facilitates the 
reconciliation of care, work and leisure, and thus increases care quality and reduces care burden 
for all parties involved.
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Policy options
Health and care professions need to be valued in all respects, starting with better 
education and remuneration, and including proper recognition of the role they play. 
The efforts of those workers on the front line of care are crucial in making the health 
and social care system work for old patients living at home.
3E. DEVELOPING CARE FACILITIES TO SUIT ALL 
AGES
Problem area
With older patients accounting for an increasing proportion of hospital use in terms of outpatient 
visits, inpatient days and hospital discharges, there is a growing need to transform the physical 
design of hospitals so that they can provide a more supportive and therapeutic environment 
for patients, families and staff of all ages. The physical design of hospitals has recognised links 
to patient and staff outcomes in areas such as reduced staff stress and fatigue, increased 
effectiveness in delivering care, improved patient safety, and improved overall health care 
quality (Ulrich et al., 2004).
Studies on the positive impact of the design of the built environment on older people with 
dementia have tended to focus on long-term care settings (Marquardt et al., 2014). These 
highlight the differential impacts that environmental design factors (e.g. sensory ambience, visual 
connectivity, small-scale home-like personalisation and specialist care units) have upon patients’ 
behaviours, cognition, functional abilities in daily activities, wellbeing and quality of life, social 
abilities, orientation and care outcomes. However, it should be noted that due to the medical 
and organisational complexity of hospitals, there are limits to the transferability of some of these 
findings across these settings (Büter, 2014). Future age-friendly hospital design may benefit from 
more systematic guidelines and tools based on the fusion of good inclusive hospital design with 
responsive design characteristics of newer care facilities for people with dementia, informed by 
inclusive principles, innovative practices, and end-user participatory approaches (Hignett, 2012).
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Figure 25. An example of hospital signage from Mercer’s Institute for Successful Ageing, a new (2016) clinical 
research facility at St. James’s Hospital, Dublin. ‘0’ indicates ground floor and the graphics illustrate 
neurovascular services, specialist day hospital, general outpatient clinics, bone health and osteoporosis 
unit, memory clinic, falls and syncope unit and creative life unit.
In its all-age primary health centre guide, the WHO identifies vision, hearing, cognitive function 
and physical changes as areas of reduced functioning where a supportive environment can help 
older people, with or without a disability, to move about more independently, actively, safely and 
securely (WHO, 2008). Areas for sensitive environmental adaptation include lighting, acoustics, 
decor, orientation (signage), mobility (flooring, doors, ramps, stairs and lifts), and furniture and 
fittings. Accessible transport, assistive devices and personal assistance also form part of the 
physical environment domain.
Approaching design holistically is emerging as a common principle. An initial review of age-
friendly hospital literature undertaken in Canada (Huang et al., 2011) suggested that, rather than 
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compartmentalising responses to distinct parts of a hospital, a set of guiding principles should 
be applied to hospitals as a whole, so that all older patients, family members and visitors and 
staff can benefit. St Olav’s Hospital in Trondheim, Norway (Jensø & Haugen, 2004) is a leading 
example of a new breed of hospital which fuses a universal or inclusive design approach with a 
patient-focused care philosophy (Planetree, 2017), seeing the physical environment, technology, 
processes of care, and the emotional, social and behavioural environment as integrated 
elements.
While the development and commissioning of new hospitals can provide unique opportunities 
for innovation, architectural design to make existing hospitals more age-friendly requires 
transdisciplinary working in a complex operational environment, where improvements may 
span retrofit, refurbishment or minor works. Interventions may be as low-cost as labelling, 
signage, painting and art installations, through to high-cost spatial reorganisation and structural 
alterations.
At its core are the needs for:
  A paradigm shift in re-imagining hospitals as age-inclusive urban places intimately related to 
the neighbourhoods and communities they serve
  Patient-group, community, and staff engagement in processes of co-design to inform and 
guide the smooth spatial transformation of hospitals towards more inclusive, empowering 
and age-friendly places.
Innovations and developments
There is a wide range of related, though currently unconnected, programmes and initiatives 
at various levels of maturity that can provide guidance to hospital managers to improve their 
facilities and make them more appropriate to the needs of older patients and their families. 
These include the environmental design aspects for person-centred care (Planetree, 2017), 
innovation for design and dignity and end-of-life care in hospitals (Foundation, 2014), the 
Beaumont Age-Friendly Hospital Framework (Age-friendly Ireland, 2014), and recent work 
applying a universal design approach to achieve dementia-friendly hospitals (Grey T. et al., 2018).
Closely related to the concepts of inclusive design and design for all, universal design is “the 
design and composition of an environment so that it can be accessed, understood and used 
to the greatest extent possible by all people regardless of their age, size, ability or disability” 
(Centre for Excellence in Universal Design, 2014). Addressing design qualities from the urban 
environment to products and services, universal design is based on seven core principles which 
promote:
  equitable use: the design is useful to people with diverse abilities.
151
C
H
A
P
T
E
R
 3
O
p
ti
m
is
in
g
 h
e
a
lt
h
 a
n
d
 s
o
ci
a
l c
a
re   flexibility in use: the design accommodates a wide range of individual preferences and 
abilities.
  simple and intuitive use: use of the design is easy to understand, regardless of the user’s 
experience, knowledge, language skills, or current concentration level.
  perceptible information: the design communicates necessary information effectively to the 
user, regardless of ambient conditions or the user’s sensory abilities.
  tolerance for error: the design minimises hazards and the adverse consequences of 
accidental or unintended actions.
  low physical effort: the design can be used efficiently and comfortably and with a minimum 
of fatigue.
  size and space for approach and use: appropriate size and space is provided for approach, 
reach, manipulation, and use, regardless of user’s body size, posture, or mobility.
Figure 26. An example of hospital signal from Mercer’s Institute for Successful Ageing, a new (2016) clinical research 
facility at St. James’s Hospital, Dublin. Note the large numbering: 2 indicates the second floor. Each floor 
is also colour-coded with bold colours.
The Dementia-friendly Hospital guideline (Grey T. et al., 2018) identifies areas where more 
universal design could contribute to improving the hospital experience of older people with 
dementia across the following spatial hierarchies from the public realm through to private 
spaces and services:
  Experiencing the hospital as a whole, including integration and interface with the community
  Site location, approach and entry to a hospital campus, including transportation
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  Campus layout, including spatial organisation and external circulation
  Building layout(s), including entry, common spaces and services and the tissue of 
connectivity managed through internal horizontal and vertical circulation
  Key internal areas supporting clinical services, inpatient experience, outpatient experience, 
and experience in the emergency department and diagnostic and treatment areas
  Building components and elements, such as furniture, fittings, signage and equipment
  Technology for safety, care delivery, communication, and entertainment; the use of 
therapeutic technologies as part of the care process and assistive technologies to support 
patients, family members and staff
  A people-centred internal environment that softens the institutional setting and makes the 
hospital more welcoming, with careful use of lighting, heating and ventilation, and careful 
acoustic design and use of materials to create a supportive and therapeutic environment
Encouraging implementation of innovations
The transferability, scalability and replicability of evidence-based policies and practices can 
be improved by the application of emerging ‘implementation science’ approaches (Bauer et al., 
2015), where the focus is on fidelity and the challenge of practice adoption or adaptation into 
new situational contexts. In the realm of evidence-based design and design practice change, 
research is action-oriented and pragmatic, and needs to draw on methodologies and techniques 
that are holistic and transdisciplinary, spanning behaviour, health and wellbeing as well as 
site-specific sustainable design and creative practice (Niezabitowska, 2018). The dementia-
friendly hospital innovation guidelines suggest that when exploring universal design across the 
hierarchical spatial levels that reflect a patient’s journey, improvement teams should consider 
the following challenges and issues:
  Engagement and participation: Promote engagement with friends and family, staff and 
community; Provide space and supports for accompanying persons; promote a participatory 
design approach.
  Provide a people-centred environment: Soften the institutional environment; familiar or 
recognisable design that is easily understood and intuitive; facilitate personalisation and 
opportunities to add personal belongings.
  Support patient safety and health: Provide a safe environment through unobtrusive safety 
measures; support diet, nutrition and hydration; support meaningful physical and social 
activities including activities of daily living.
  Balance sensory stimulation: Optimise positive sensory stimulation and minimise negative 
stimulation; provide indoor and outdoor contact with nature, and access to the outdoors.  
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improve spatial cognition; provide good wayfinding that supports navigation; provide good 
visibility and visual access.
  Adequate space to support the needs of a person with dementia: Provide bays or single 
rooms with space for personal belongings and visitors; offer retreat spaces in multi-bed 
wards or communal areas in single-bed wards; provide space and supports for patient 
mobilisation and activities.
  Appropriate use of technology: Use technology appropriately for care delivery, safety, 
therapy, communication, and entertainment.
Since 2012, the European Innovation Partnership on Active and Healthy Ageing has been 
promoting innovation partnership as a means of achieving improved quality of life and health, 
improved health care system and service quality, effectiveness and sustainability, and increased 
innovation and competitiveness (European Innovation Partnership on Active and Healthy Ageing, 
2012). While these types of initiatives are fostering the development, adoption, adaptation and 
application of age-friendly and dementia-friendly design principles and guidelines in housing 
and neighbourhoods throughout Europe, there would be significant value in forming an EU Task 
Group to focus on the pan-European development of age-friendly hospitals. Such an expert 
group could develop a more replicable toolkit and guidance for age-friendly hospital design that 
could be applied across the spectrum of environmental improvements, from easily implemented, 
low cost refits and renovations, through to more radical restructuring and new builds that are 
part of longer-term planning and design processes. Beyond tools and guidelines, such a group 
could drive a harmonised programme of actions to cover awareness, policy alignment, capacity 
and governance.
Concluding remarks
A core set of evidence-based actions should be implemented that aim to reduce harm to older 
adults and avoid unwanted or duplicative care. The main goals of care are to improve residents’ 
health, functional ability and wellbeing. Social cohesion and gender justice for residents, and also 
their formal carers, are major goals.
High-performing care teams need to focus on both measurable and intangible outcomes (such 
as dignity and wellbeing of residents). Rather than focusing on providing care where residents is 
seen primarily as a passive recipient of care, we should foster a community of people (residents 
and staff) that can be more actively engaged in mutually supporting each other.
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Policy options
Improving the design of hospitals and care facilities to make them age-friendly 
supports better outcomes for patients, family and health care workers alike. 
Conscientious design of new facilities, and effective retro-fitting of existing ones, 
does not necessarily have to be expensive it can start with something as simple as 
improved signage.
Strengthen relevant European networks that can promote and foster these on-going 
cultural and spatial transformations in residential and long-term care provision and 
settings, accelerating change throughout Europe.
3F. REDUCING EMERGENCY VISITS AND 
HOSPITAL ADMISSIONS
Older adults make up a greater proportion of all emergency department attendees than younger 
adults. Estimates vary, but the prevalence of adults aged 65 years and older in the emergency 
department is between about 12% and 25% (Fusco et al., 2014; Gruneir et al., 2011; Samaras et al., 
2010). Older adults are also more likely to present with a higher level of emergency and require 
more test use.
  Falls are the main cause of emergency department attendance for older adults, accounting 
for between 15% and 30% of admissions (Samaras et al., 2010).
  It is estimated that delirium affects approximately 10% of older adults in the emergency 
department (McCabe & Kennelly, 2015) and 50% of patients with delirium in the emergency 
department may also have dementia.
  Chest pain and dyspnea are the principal complaints of up to 20% of older adult emergency 
department attendees.
  Adverse drug effects and interactions account for 11% of older adult emergency department 
visits (as compared with between 1% and 4% for younger adults).
  Abdominal pain or infections are the main complaint for up to 13% and 4%, of presentations, 
respectively (Samaras et al., 2010).
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have up to a fivefold greater chance of hospital admission (Legramante et al., 2016; Samaras et 
al., 2010). One review identified several clinical predictors of hospitalisation: falls history in the 
previous 12 months, atrial fibrillation, respiratory disease, cancer and leg ulceration. Increased 
age, male gender, living alone and poor mobility were also predictive of hospitalisation (Lyon et 
al., 2007). Other studies indicate that hospital admission typically occurs when an older person 
is experiencing some sort of crisis due to a combination of factors including exacerbation 
of a chronic condition, change in social circumstance or worsening of symptoms due to 
multimorbidity and frailty (Gjestsen et al., 2018).
Once hospitalised, there is considerable variation in length of stay for older adults, with age being 
the main driver. In the UK, the average length of stay for a person under 65 is approximately 
three days, but it is nine days for patients aged over 65, and as high as eleven days for adults 
aged 85 and older (Imison et al., 2012). Imison and colleagues also identified other patient-based 
factors, such as sex and health status; community resources and hospital-based factors such as 
rural location (accessibility); and internal processes as influencing the likelihood of admission and 
duration of stay (Imison et al., 2012).
In order to reduce emergency visits and hospital admissions, it is necessary to screen, diagnose 
and manage common geriatric syndromes and risk factors for syndromes as early as possible. 
Targeting the most frequent causes of emergency admissions of the older population and 
integrate them into care pathways is probably the best possible practice. For this reason, 
sarcopenia, frailty and falls and their orthopaedic consequences will be analysed, before 
focusing on heart failure care.
Sarcopenia
Sarcopenia is a progressive and generalised skeletal muscle disorder that is associated with 
increased likelihood of adverse outcomes including falls, fractures, physical disability, and 
mortality (Writing Group for the European Working Group on Sarcopenia in Older People 2 et 
al., 2018). Although sarcopenia has long been associated with ageing and older people, the 
development of sarcopenia is now recognised to begin earlier in life (Sayer et al., 2008) and 
to have many contributing causes beyond ageing. Optimal care for people with sarcopenia is 
essential because the condition has high personal, social and economic burdens when untreated 
(Antunes et al., 2017; Mijnarends et al., 2018).
The presence of sarcopenia increases risk for hospitalisation and increases cost of care during 
hospitalisation (Cawthon et al., 2017; Zhang et al., 2018). Incident (acute) sarcopenia during 
hospital stay is relatively common and predictive of adverse outcomes, not only in general 
medical settings, but also in critical care, surgical wards and patients with severe diseases 
(DeAndrade et al., 2018; Martone et al., 2017; Toptas et al., 2018). It is also a relevant predictive 
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factor of adverse outcomes for outpatients (Cawthon et al., 2017; Locquet et al., 2017; Tang et al., 
2018).
Sarcopenia has recently been included the International Classification of Diseases ICD 10 
(Chen et al., 2018b), but it is still far from being part of mainstream clinical practice (Vellas et 
al., 2018; Writing Group for the European Working Group on Sarcopenia in Older People 2 et al., 
2018). Thus, pathways to screen, diagnose, and manage sarcopenia should be implemented in 
hospitals and primary care clinics in the near future, and some countries are already exploring 
how to do it and what the barriers are (Cesari et al., 2016; Falcon & Harris-Love, 2017; Reijnierse et 
al., 2017).
In 2018, a European initiative (European Working Group on Sarcopenia in Older People) 
proposed an algorithm for case-finding and diagnosing sarcopenia in clinical practice. A wide 
implementation of the clinical pathway proposed by these organisations would be a major step 
in reducing disability and other adverse outcomes in old age, and to improve treatment of most 
chronic conditions of adult and older Europeans:
For screening and diagnosis of sarcopenia, the European Working Group on Sarcopenia in Older 
People recommends following the pathway: Find Cases; Assess; Confirm; Severity (FACS).
Find Cases: To identify individuals at risk for sarcopenia, EWGSOP advises use of the SARC-F 
questionnaire or clinical suspicion to find sarcopenia-associated symptoms.
Assess: To assess for evidence of sarcopenia, EWGSOP recommends use of grip strength or a 
chair stand measure with specific cut-off-points for each test. For special cases and for research 
studies, other methods for measurement of strength (knee flexion/extension) can be used.
Confirm: To confirm sarcopenia by detection of low muscle quantity and quality, DXA (dual-
energy X-ray absorptiometry) is advised in clinical practice, and DXA, BIA (bio-impedance 
analysis), CT (computer tomography) or MRI (magnetic resonance imageing) in research studies.
Severity: Severity can be evaluated by performance measures; gait speed, SPPB (Short Physical 
Performance battery), TUG (Time Up and Go test), and 400m walk tests can be used.
(Writing Group for the European Working Group on Sarcopenia in Older People 2 et al., 2018)
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Figure 27. European Working Group on Sarcopenia recommendations (Writing Group for the European Working 
Group on Sarcopenia in Older People 2 et al., 2018). Reproduced by permission of Oxford University Press 
on behalf of the British Geriatrics Society.
Concluding remarks
Sarcopenia is a progressive and generalised skeletal muscle disorder that is associated with 
increased likelihood of adverse outcomes including falls, fractures, physical disability, and 
mortality. A wide implementation of the clinical sarcopenia pathway would be a major step 
in reducing disability and other adverse outcomes in old age, and would improve treatment 
outcomes of most chronic conditions.
Frailty
Although the term “frailty” has often been used to characterise the most weak and dependent 
subset of older adults, the term has evolved in recent years. Frailty is now considered as a 
geriatric syndrome of decreased reserve and resistance to stressors, resulting from cumulative 
declines across multiple physiologic systems, and causing vulnerability to adverse outcomes 
(Fried et al., 2001). This state of increased vulnerability distinguishes frailty from disability, is 
associated with ageing and has been linked to multiple adverse outcomes (incident disability, 
falls, hospitalisation, nursing home admission and mortality) (Vermeiren et al., 2016).
The power of using frailty to predict outcomes, initially described in general geriatric medicine, 
has recently been proven to extend to many other areas of medicine (Apostolo et al., 2017; 
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Handforth et al., 2015; Kim et al., 2016; Moskven et al., 2018; Tse et al., 2017; Wang et al., 2004). 
Although the exact tool to be used to identify frail older people is still controversial (Chang et 
al., 2018), it is becoming clear that characterisation of frailty allows for a better personalisation 
of complex, expensive treatments, reducing adverse outcomes and improving outcomes 
(Huisingh-Scheetz & Walston, 2017; Martin et al., 2018).
In the future, assessment of frailty on admission to hospital, irrespective of the condition or 
the admission department, will have to become standard practice, in order not only to predict 
outcomes, but also to tailor medical and surgical treatment to patient needs and to use 
multidisciplinary interventions to prevent disability as a result of hospitalisation (Sourdet et al., 
2015). Also, detection of frailty may help in anticipating social needs after hospital discharge 
(Subbe et al., 2017). Detection of frailty should start in the emergency department (Elliott et al., 
2017), as there is increasing evidence that such detection and the use of specific pathways for 
old frail patients may improve outcomes (Preston et al., 2018).
Changes should also include adapting the outcome measures used at present to assess the 
effects of hospitalisation by including some outcomes that are better fit to an old, frail population 
(Akpan et al., 2018). The power of using a more personalised frailty to predict outcomes could be 
harnessed to make health care interventions more targeted while understanding hospital and 
care demand to a greater extent in the older population.
Concluding remarks
Frailty is a state of increased vulnerability which has to be distinguished from disability. Frailty 
is associated with ageing and has been link to multiple adverse outcomes (incident disability, 
falls, hospitalisation, nursing home admission and mortality). Detection of frailty should start in 
the emergency department, as there is increasing evidence that such detection and the use of 
specific pathways for older frail patients may improve outcomes.
Falls
Falls in the community
Fall rates increase dramatically with advancing age and are the most common cause of fracture, 
including hip fracture, in older people. The annual prevalence of falls is 25% in 50–64-year-
olds, 33% in 65–74-year-olds, and over 40% in people over 75 years. In one in five of these an 
injury occurs which necessitates hospital care, particularly in non-accidental events (Bhangu 
et al., 2017). Falls and syncope are one of the most common reasons for older people to attend 
the emergency department; across Europe, up to 50% of such patients are admitted to hospital. 
In countries where rigorous care pathways and risk stratification are applied, as few as 10% of 
falling patients are admitted to hospital (Sheldon et al., 2011).
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cause of injuries and impact on social participation, fear of falling and health service utilization 
(Collerton et al., 2012; Peeters et al., 2015; Stel et al., 2004). Falls frequently represent an evolving 
frailty state. If preventive measures are not taken in the immediate future, the numbers of injuries 
caused by falls is projected to be 100% higher by 2030, and related costs are projected to 
increase to unsustainable levels by 2042 (Kannus et al., 2007).
Early detection of modifiable risk factors will prevent falls and hence fractures. The most 
common risk factors are muscle weakness, impaired balance, polypharmacy, visual 
impairment, urinary incontinence and cognitive impairment. More recently, the important role 
of cardiovascular risk factors is recognised (cardiac arrhythmia or hypotension). These falls 
are frequently associated with transient loss of consciousness (syncope). 30% of older people 
who have syncope are unaware of loss of consciousness and present with falls (Parry & Kenny, 
2005). Hence, recent guidelines recommend combined falls and syncope risk stratification and 
management (Brignole et al., 2018; Panel on Prevention of Falls in Older people, 2011).
A comprehensive geriatric assessment includes a focused fall history (history of falls and 
relevant risk factors, medication review); physical examination (gait, balance, mobility, 
neurologic function, muscle strength, cardiovascular status, visual acuity, feet and footwear); 
functional assessment (activities of daily living, patient’s perceived function); and environmental 
assessment (home safety). The cardiovascular status assessment includes a history of prior 
cardiovascular disease, electrocardiogram, and lying and standing blood pressure. If a cardiac 
cause is suspected, further cardiac investigations are necessary. Low risk or intermediate risk 
patients can be assessed in dedicated falls and syncope units as per guidelines (Kenny et al., 
2015). If patients are deemed at high risk, then they may require acute monitoring or hospital 
admission. Much of the assessment and management of falls and syncope can be nurse-led and 
physician supervised and delivered in an outpatient setting (dedicated falls and syncope unit). 
The most important step in risk stratification is to identify all possibly modifiable risk factors, and 
stratify for risk of cardiac event, further falls or syncope or death. Management is multifactorial, 
i.e., in most cases there are multiple possible risk factors for further events. Therefore, a 
multidisciplinary approach is necessary. Same-day assessment of fallers in an equipped facility 
with expertise in management of falls and syncope is the optimum care delivery model (Brignole 
et al., 2018; Kenny et al., 2015). Multiple component interventions reduce the rate of falls 
and risk of falling compared with usual care (Hopewell et al., 2018).
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Figure 28. Care pathway for risk stratification of falls and syncope. Diagram modified from Guidelines by the 
American Geriatric Society 2011 (Panel on Prevention of Falls in Older people, 2011) and the European 
Society of Cardiology 2018 (https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines).
Falls in care facilities and among hospital inpatients
Older people falling in care facilities, such as nursing homes, and hospitals are common events 
that may cause loss of independence, injuries, and sometimes death as a result of injury. 
Assessment and interventions are similar to those for falls in the community, with additional 
interventions for sensors and staff training. Interventions include exercise; reviews of drugs; 
evaluation of environment or assistive technologies including bed or chair alarms or the use of 
special (low/low) beds; social environment interventions that target staff members and changes 
in the organisational system; and knowledge interventions (Cameron et al., 2012; Guirguis-Blake 
et al., 2018). Interventions for falls prevention in hospital in patients is similar to care settings. 
Multifactorial interventions may reduce rate of falls in hospital in patients, although subgroup 
analysis suggests this may apply mostly to a subacute setting (Cameron et al., 2012).
There is moderate quality evidence (4512 participants, 4 studies) that vitamin D supplementation 
probably reduces the rate of falls (RaR 0.72, 95% CI 0.55 to 0.95; I² = 62%), but probably makes 
little or no difference to the risk of falling (RR 0.92, 95% CI 0.76 to 1.12; I² = 42%). The population 
included in these studies had low vitamin D levels. In care homes, vitamin D supplementation 
probably reduces the rate of falls but not the risk of falling. The effect of multifactorial 
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interventions may reduce the rate of falls, although this may apply mostly to a subacute setting 
(Cameron et al., 2012).
Concluding remarks
Fall rates increase dramatically with advancing age (annual prevalence: 40% in persons over 75 
years) and are the most common cause of fracture, including hip fracture, in older adults.
The practice of multifactorial assessment for falls and syncope in a well-equipped facility by a 
trained staff is recommended because more than one possible cause may be present, including 
cognitive assessment, physical performance and cardiovascular assessment. Fall technologies 
should be employed as indicated for risk and fall detection.
Effective interventions for falls in care homes and nursing homes are lacking. Multi-component 
interventions reduce rate and risk of falls in the community.
Osteoporosis and osteoporotic fractures
Low-trauma fractures due to osteoporosis and reduced bone mass are an increasing challenge 
as Europe’s population ages, given that the lifetime fracture risk is 1 in 3 for women and 1 in 5 
for men (Hernlund et al., 2013). Across the 28 EU countries, an estimated 28 million people have 
osteoporosis, yet only about 20% are on appropriate treatment to reduce fracture risk (Hernlund 
et al., 2013). The International Osteoporosis Foundation has recently reported on fragility 
fractures in six European countries (France, Germany, Italy, Spain, Sweden, United Kingdom), 
where there are 2.6 million fractures annually. The associated costs in these countries are 
around €37.5 billion per year (Hernlund et al., 2013; International Osteoporosis Foundation, 2018). 
The projected costs by 2030 are of a 23% increase equating to €47 billion annually, which has 
the potential to cripple economies. Adding to that, the personal cost to the individual, carer strain, 
litigation costs to local authorities and so on will all rise accordingly.
However, this potential can be controlled and potentially reversed if preventive measures are 
taken. In adults at risk of fragility fracture, there is substantial evidence that osteoporosis drugs 
taken for 3–5 years can reduce fracture risk by as much as 70%, yet treatment rates even in 
those who have sustained a fragility fracture are low and appear to be falling (Hernlund et al., 
2013). Reasons are many but adverse media and internet coverage may contribute, with many 
patients and even doctors fearing rare osteoporosis drug side-effects more than fractures (Jha 
et al., 2015). Health care systems in Europe must rise to this challenge, supporting education 
programmes that provide patients and their managing clinicians with balanced information. 
Though web-based fracture risk assessment tools are of proven use in refining fracture risk, 
enabling high-risk patients to be treated on clinical risk alone, there is limited access to bone 
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densitometry scanning in many countries, which hampers good osteoporosis care (Hernlund et 
al., 2013; Kanis et al., 2013; Lems & Raterman, 2017).
Concluding remarks
Osteoporosis affects 28 million people in the EU; only about 20% are on appropriate treatment 
to reduce fracture risk, explaining the burden of fragility fractures. In adults at risk of fragility 
fracture, there is substantial evidence that osteoporosis drugs taken for 3–5 years can reduce 
fracture risk by as much as 70%.
Fracture liaison services
In those who have already sustained a fracture, there are clear benefits from use of well-defined 
clinical care pathways such as ortho-geriatric care of patients with a hip fracture (Giannoulis 
et al., 2016; Neuburger et al., 2015). These pathways reduce mortality after fracture. Pathways 
include attention to the prevention and management of delirium, screening and treatment 
of malnutrition, analysis of drug therapy or pain management, integration of an appropriate 
anaesthesia protocol, shortened delay for surgical procedures and a short rehabilitation circuit 
(Moyet et al., 2018).
A key strategy for an ageing population however is to reduce hip fracture numbers in the first 
place, given the serious morbidity and mortality excess associated with hip fracture (Neuburger 
et al., 2015). At least a third of those with a hip fracture have sustained a prior fragility fracture, so 
an increasing focus is now on ‘fracture liaison services’, which provide a coordinated approach 
to detecting and treating all fragility fracture types (International Osteoporosis Foundation, 2018). 
Carefully-structured services, coupled with falls and syncope services, improve treatment rates 
and reduce fracture numbers and associated costs (Brignole et al., 2018; Panel on Prevention of 
Falls in Older People, 2011; Walters et al., 2017). The positive impact on re-fracture rates, hospital 
length of stay, morbidity and mortality derived from national databases and audits have been 
demonstrated in several countries (Giannoulis et al., 2016; Neuburger et al., 2015).
Governments can influence hip fracture outcomes across Europe by supporting IT infrastructure 
for national databases which allow benchmarking and by rewarding good care via best practice 
tariffs which may improve care at the individual level (Neuburger et al., 2015; Oakley et al., 2017).
Concluding remarks
Setting up fracture liaison services, which provide a coordinated approach to detecting and 
treating all fragility fracture types, will reduce the number of all types of fractures (especially hip 
fractures) throughout Europe and will contribute to reducing disability and health care costs.
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The incidence of heart failure increases with age, with a steep rise from 2% among middle-
aged persons to up to 15% among octogenarians (Lloyd-Jones et al., 2002). Older chronic heart 
failure patients are more often female (50% vs. 35%; P<0.0001) and have higher rates of non-
cardiovascular co-morbidities including chronic renal failure, anaemia and malignancy (Stein et 
al., 2012). In older adults hospitalised for heart failure, cognitive impairment is common (present 
in 47%) but only documented in half of the cases (22.7%) (Dodson et al., 2013).
There are currently clear gaps in delivery of guideline-based care (Cleland et al., 2003; Cowie 
et al., 2014; Ponikowski et al., 2014) and this is particularly true for older patients, for whom 
diagnosis is frequently delayed (All-Party Parliamentary Group on Heart Disease, 2016; Hancock 
et al., 2014) with inconsistent use of key diagnostic tests (Devroey & Van Casteren, 2011) such as 
echocardiogram and ECG.
Older patients leave hospital with substantial needs, no clear post-discharge follow-up to 
ensure adequate medication titration and home care need plans, and inadequate assessment 
of comorbid needs (All-Party Parliamentary Group on Heart Disease, 2016; Donkor et al., 2017; 
Mueller et al., 2017). For example, whereas all patients should see a heart failure specialist within 
two weeks of discharge (Ponikowski et al., 2016), in France, only one third see a cardiologist 
after discharge (Tuppin et al., 2013). Education and support for patients and their families is 
poor (Cancian et al., 2013; Jourdain & Juilliere, 2011) and palliative care and end-of-life care is 
poorly planned (Gadoud et al., 2014). Because of this, heart failure is the most common cause of 
unplanned admission of persons over 65 years (Cowie et al., 2014), whereas application of care 
pathway would achieve a 30% reduction in heart failure admissions.
Concluding remarks
The incidence of heart failure increases with age, with a steep rise from 2% among middle-
aged persons to up to 15% among octogenarians. The best model of care is a heart failure 
management programme: a package of person-centred care, which includes self-management 
support, rehabilitative and preventive care, routine reviews and escalation in the event of 
crisis and heart failure specialist and team working in collaboration with geriatrician at each 
opportunity in the heart failure journey (presentation, diagnosis, hospital discharge, and follow-
up).
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Policy options
Implementing the identified care pathways for frailty, falls and syncope, 
osteoporosis, fracture, and heart failure can reduce the number of emergency visits 
and hospital admissions while contributing to a healthier later life. The care pathways 
are informed by leading medical experts and organisations and based upon high 
levels of in practice experience and process refinement.
The roll-out of Electronic Health Records will enable a greater oversight of a patient’s 
social and health history including co-morbidity, which will boost the ability of health 
care professionals to take more targeted, clinically efficacious and co-ordinated 
interventions.
3G. REDUCING LENGTH OF STAY IN HOSPITAL
The geriatric team’s work consists not only of curing acute diseases and caring for chronic 
diseases, but also avoiding over-long hospital stays which are always deleterious for old 
patients. For this reason, geriatricians increasingly focus their team activities on specific domains, 
which will be explored in the following pages. They include the practice of a comprehensive 
assessment, management of nutrition problems, reduction of polypharmacy and avoidance 
of inappropriate prescriptions, the fight against overuse of antibiotics and hospital-acquired 
infections, without neglecting the importance of early rehabilitation.
Comprehensive geriatric assessment (CGA)
There are a number of prognostics tools, one of which is the Multidimensional Prognostic Index 
(MPI) (Gill et al., 2010). The MPI is the only CGA-based predictive tool using physical, cognitive, 
biological and social measures with good short-term and long-term discrimination and accuracy 
in hospital mortality and length of stay (Pilotto et al., 2008). A recent reflection paper published by 
the European Medicines Agency reported that while a complete evaluation of frailty to support 
its management requires a CGA, which is the ‘gold standard’ in clinical practice, “the MPI is able 
to extract information from CGA to categorise frailty in three subgroups with excellent prognostic 
value” (Committee for Medicinal Products for Human Use, 2018; Pilotto & Martin, 2018).
Despite clinical recommendations to incorporate patients’ prognosis in clinical decisions (Royce 
et al., 2014; Schonberg et al., 2015), a recent observational study demonstrated that several 
barriers may limit the implementation of these recommendations: uncertainty in predicting 
prognosis, difficulty in discussing prognosis, and concern about patients’ reactions (Schoenborn 
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based MPI may be useful to evaluate whether specific treatments are cost-effective in older 
patients according to their individual prognostic profile, e.g. statins in secondary prevention 
of diabetes mellitus (Pilotto et al., 2015) or coronary artery disease (Pilotto et al., 2016b), 
anticoagulants in atrial fibrillation (Pilotto et al., 2016a) and anti-dementia drugs (Pilotto et al., 
2018). Moreover, a study from France demonstrated that MPI was useful to evaluate mortality risk 
among older patients undergoing trans-catheter aortic valve implantation (TAVI) (Bureau et al., 
2017), as subsequently confirmed in a multicentre international survey (Ungar et al., 2018). Very 
recently, a study from Germany reported that the CGA-based MPI was significantly associated 
with use of indicators of health care resources, including grade of care, length of hospital stay 
and discharge allocation (Meyer et al., 2018). The studies suggested that with full access to 
prognostic information derived from CGA-based predictive tools, physicians are better equipped 
to make clinical decisions that are aligned with their patients’ needs in terms of safety and 
efficacy.
Concluding remarks
Comprehensive geriatric assessment (CGA) allows optimising in-hospital clinical plans and 
developing tailored post-discharge care plans according to the real needs of the older 
patient. The implementation of a systematic CGA at hospital for admission of all older patients 
is consistently beneficial for several health outcomes, including decreased length of stay, 
institutionalisation rate, hospital readmission and mortality.
Policy options
Teaching comprehensive geriatric assessment to all health care students and 
professionals is a demanding task and should be included in all academic and non-
academic educational programmes for these students.
The clinical use of self-administered prognostic indices as screening tools, based on 
comprehensive geriatric assessment, should be implemented in clinical practice.
Nutrition care
Ensuring proper nutrition for older adults is vital for encouraging healthier ageing, whether living 
at home, in a health care facility or long-term care setting. Nutritional disorder has a significant 
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impact on health, favouring loss of muscle strength and function, osteoporosis, frailty, fractures 
and exacerbating all geriatric syndromes as well as decreased wellbeing.
The most recent definition of nutritional disorder by the European Society for Clinical Nutrition 
and Metabolism (ESPEN) is illustrated by the figure below:
Nutritional 
disorder
Malnutrition
Starvation-
related 
underweight
Cachexia, 
disease-related 
underweight
Sarcopenia
Frailty
Micronutrient 
abnormalities
Overnutrition
Overweight
Obesity
Figure 29.  Definition of nutritional disorder (derived from Cederholm et al., 2015).
This section of the present report will focus on malnutrition, which was recently preferred to the 
term ‘undernutrition’ by the ESPEN group of experts (Cederholm et al., 2015).
Three scientifically demonstrated facts give support to our focus:
  Malnutrition is often undiagnosed in older adults, either in the home or in acute or chronic 
care settings.
  Malnutrition is commonly not treated.
  Malnutrition is the main cause of multiple and dramatic complications in the older population.
The concept and risk of malnutrition is based on four possible and independent criteria: 
unintentional weight loss, low body mass index, insufficient food intake, and low lean body mass. 
If any one of these criteria exists, it is necessary to perform nutritional assessment followed by 
medical diagnostics to identify the cause(s) of malnutrition.
Many European surveys published in peer review journals from 2010 to 2018 have confirmed that 
malnutrition is frequent in older adults living in very different care settings, including in the home. 
The reported prevalence and risk of malnutrition in older patients living at home is varied and 
high. Nine studies published during the period in question, mainly based on the use of the two 
most common forms of Mini Nutritional Assessment, showed that the prevalence of malnutrition 
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varied from 21% to 58% (Ferrari Bravo et al., 2018; Kiesswetter et al., 2014).
When older adults living at home develop medical conditions or injuries that require 
hospitalisation, they are often found to be malnourished or at risk of malnutrition. A large 
European prevalence study performed at hospital admission revealed that 43.5% of older 
patients were malnourished and 33% at risk of malnutrition (Kaiser et al., 2010). It has also been 
reported that rates of malnutrition increase with age (Imoberdorf et al., 2010).
Malnutrition in hospital inpatients causes a range of adverse outcomes. These include 
a decrease in lean body mass, primarily skeletal muscle mass. Three days of bedrest in 
octogenarian patients provoke a loss of 1 kg of lean mass, which corresponds to a loss of 10% of 
the lower lean leg mass (Paddon-Jones et al., 2006). This causes longer immobility, increased 
risk of falls, a decrease in immune competence and a greater need for help when performing 
daily activities. Malnutrition resulted in a three-fold increase in the rate of Clostridium difficile 
infections in a recent prospective study performed in patients admitted for Clostridium epidemic 
in geriatric medicine wards at three acute hospitals in England (Behar et al., 2017). A meta-
analysis of eight studies (4479 patients) demonstrated the link between vitamin D deficiency at 
a threshold concentration of <20 ng/mL and the risk of Clostridium difficile infection (Furuya-
Kanamori et al., 2017). Reduced concentrations of vitamin D were also found to be associated 
with deterioration in mental health (Kvamme et al., 2011), treatment intolerance (Morley, 2012), 
and modified gastro-intestinal, cardiovascular, renal and respiratory functions, thus slowing down 
the recovery process. Those negative effects have been found to contribute to increased length 
of hospital stay in malnourished patients (p<.001) (Kruizenga et al., 2016). New institutionalisations 
(p.<0.001) and in-hospital mortality (p<.001) also increased (O’Shea et al., 2017; Pavic et al., 2012).
As a result of this downward spiral caused by malnutrition, the total additional costs of managing 
patients with malnutrition have been estimated to be approximately four times higher for 
patients over 60 years of age compared with younger adult patients (Lim et al., 2012).
All older inpatients should be systematically screened at hospital attendance and admission for 
malnutrition. Although numerous screening tools exist, a hi-tech weight/height scale balance 
including a vectorial bio-impedance analysis able to determine body mass index and lean body 
mass (Bosy-Westphal et al., 2013) is currently considered the gold standard for diagnosing 
malnutrition (Cederholm et al., 2015).
Traditional screening or the use of high-tech scales will allow targeting appropriate interventions 
toward at-risk patients. Such interventions include better presentation of meals, increase in 
protein content, compensation for vitamin deficiencies, compensation of oral intakes with 
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fortified snacks or oral nutritional supplements, early mobilisation and rehabilitation. The goal of 
these is to:
  decrease complications
  maintain functional independence
  enhance rehabilitation
  increase quality of life
  reduce length of hospital stays and three-month readmission rates
  delay institutionalisation
  reduce hospital deaths
  cut health care costs
If malnutrition is not diagnosed and treated during hospitalisation, it is worse upon discharge 
in both medical and surgical patients of all ages, which compromises recovery outcomes. The 
comparison of malnutrition prevalence in older patients at hospital admission and discharge 
from the same hospital in Spain (n=1055; mean age 63 years) yielded alarming results (Alvarez-
Hernandez et al., 2012). Among patients over 70 years of age, the malnutrition prevalence at 
hospital admission was 37% and at discharge 38.1%. This trend is even more important in surgical 
wards, which showed an increase in malnutrition of 2.7% at hospital discharge.
Such results, which unfortunately are the same globally (Freijer et al., 2013; Abizanda et al., 2016), 
raise an important question as to whether recommended lengths of hospitalisation are based 
on economic reasons or medical reasons to ensure an effective recovery. Patients struggle to 
recover from their infections or hip fractures if they suffer from persistent nutritional problems 
which hamper their recovery.
Benefits of enteral nutrition in malnourished patients
Evidence in malnourished care home residents indicates that oral nutritional supplements 
improve quality of life and nutritional intake more effectively than dietary advice alone (Parsons 
et al., 2017) and moreover they are cost effective (Elia et al., 2018).
Postoperative enteral nutrition significantly reduced the rate of postoperative complications, 
decreased the length of hospital stay, with a favourable cost-benefit analysis in malnourished 
subjects (Abunnaja et al., 2013).
Concluding remarks
Recognising and treating malnutrition enhances speed of recover of function and improves 
quality of life. Controlling nutritional issues during the pathway from home to hospital and 
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inappropriate emergency visits and hospital or nursing home admissions. 
The potential to increase quality of care and quality of life, and cut health care costs, is evident.
Policy options
Malnutrition is mainly not diagnosed, remains untreated and leads to major health 
complications. All older inpatients should be systematically screened at hospital 
attendance and admission for malnutrition. Recognising and treating malnutrition 
enhances speed of recovery of function, avoids complications (such as falls, 
fractures and health care associated Infections) and improves quality of life.
3H. AVOIDING POLYPHARMACY AND 
INAPPROPRIATE DRUG PRESCRIPTIONS
Polypharmacy, defined as the use of multiple drugs or more than are medically necessary (n ≥ 
5), is a growing concern for older adults (Maher et al., 2014). Polypharmacy is a safety problem, 
which concerns all patients of all age ranges, but more specifically the old population, whatever 
their place of living. Polypharmacy causes additional health problems from adverse drug effects 
and interactions, and increases direct and indirect health care costs as well as medication non-
adherence (Perez-Jover et al., 2018).
  In Austria, primary care patients over 75 years of age took an average of 9.1 drugs per day, 
and the risk of medication error is higher in this group than in groups taking fewer drugs 
(Koper et al., 2013)
  In Italy, 51.9% of older patients admitted to hospital took more than 5 different drugs; and 67% 
of them were discharged from the hospital ward with more than 5 different drugs.
  The average number of drugs prescribed to French nursing home residents was 6.9, and 
excessive polypharmacy concerned 21.1% of the residents (n = 6468). (Herr et al., 2017).
  Polypharmacy explains why in Spain, people over 65 years were responsible for more than 
30% of total medicine use and 73% of pharmaceutical expenditures, and represent 65% of all 
patients (Diz-Lois Martínez et al., 2012).
These figures explain why it is so important in geriatric medicine to reduce polypharmacy and 
indeed inappropriate drug prescriptions.
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Prescribed drugs in older people are inappropriate when the risk of exposure to potential harm 
from medication is greater than the likelihood of benefit, when medication is prescribed at a 
dose that is not suitable for the condition in question, when medication is prescribed for too 
long or when cheaper alternatives are available. Such medications are referred to as potentially 
inappropriate medications. The other side of inappropriate prescribing is the omission of 
potentially beneficial medications for no valid reason; these instances are referred to as potential 
prescribing omissions. Together, the presence of potentially inappropriate medications and 
potential prescribing omissions represents inappropriate prescribing.
Inappropriate prescribing is highly relevant to older people. This is because inappropriate 
prescribing is the single greatest risk factor for adverse drug reactions which are particularly 
prevalent and present particular health hazards in frail older people with multimorbidity, 
i.e., multiple chronic medical conditions that are present simultaneously (O’Mahony, 2017). 
Multimorbidity is the cause of polypharmacy (Figure 30) and polypharmacy is, in turn, the 
single most important risk factor for inappropriate prescribing. Adverse drug reactions that 
older people experience from polypharmacy are commonly unrecognised and misdiagnosed 
as symptoms of a new condition for which even more medication is prescribed, so-called 
‘prescribing cascades’ (Rochon & Gurwitz, 2017).
Potentially inappropriate medications are highly prevalent in older people in primary care (22%–
40%), in hospital (33%–45%) and in nursing homes (60%–78%). Potential prescribing omissions are 
also highly prevalent among older people in primary care (22.7%–41.8%), in hospital (57.9%–63%) 
and in nursing homes (42.2%–85%) (O’Mahony et al., 2010; Morin et al., 2016; Tommelein et al., 
2015). The presence of potentially inappropriate medications is a consistently strong predictor 
of adverse drug reactions in older people. Use of criteria developed to ascertain inappropriate 
prescribing — the “STOPP/START” criteria — as an intervention improves medication 
appropriateness, reduces adverse drug reactions, reduces drug cost, and lowers the risk of falls 
in older people.
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Prescribing cascades
Adverse 
drug events
Polypharmacy
Multimorbidity
Figure 30. Schematic diagram showing close relationships between multimorbidity, polypharmacy, inappropriate 
medications and adverse drug events. Unrecognised adverse drug events often lead to incorrect new 
diagnoses leading to further prescription medications, so-called ‘prescribing cascades’ (adapted from 
O’Mahony, 2017).
Electronic control of prescription quality
Medication regimens in multimorbid older people are often complex for both patient and 
prescriber. Polypharmacy engenders inappropriate prescribing and has a negative effect on 
older patients’ adherence with appropriate drug therapy. Over the past 25 years, numerous 
computerised systems have been developed and tested with the aim of optimising the 
appropriateness of older people’s medication and minimising medication cost. Criteria for 
optimisation of older people’s medication are numerous and therefore require computer support 
if they are to be deployed effectively in routine clinical practice.
Over the last 20 years, several studies have examined the efficacy of computerised interventions 
designed to improve medication appropriateness in older people, particularly those with 
multimorbid chronic illness with associated polypharmacy. Two recent systematic reviews 
(Cooper et al., 2015; Dalton et al., 2018) have addressed this issue in detail in older people and 
have drawn the following conclusions about routine use of computerised prescribing support for 
older people on multiple medications in whom inappropriate prescribing is highly prevalent in all 
care settings:
  Medication appropriateness is significantly and consistently improved in all care settings.
  Medication review carried out in this way is probably best conducted by pharmacists with 
suitable training and experience in geriatric pharmacotherapy. Physicians are less likely to 
carry out systematic assessment of older patients’ multiple drug therapy.
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There is a need for large-scale clinical trials to examine the effects of customised software 
systems on key clinical outcomes like hospitalisation, hospital length of stay, health care use, 
quality of life and mortality. Nevertheless, it is likely that well-designed software systems will 
improve at least some of these outcomes when assessed by clinical trials. The challenge in 
the future will be to integrate these software systems with patients’ electronic medical records 
in such a way that potentially inappropriate medications and potential prescribing omissions 
are identified and highlighted quickly and accurately. However, implementation of potentially 
inappropriate medications and potential prescribing omission criteria will always require the 
clinical judgement of the prescriber.
Appropriate care for older patients: regular review of medications
Careful regular review of the medications consumed by older people with multimorbidity and 
polypharmacy is an essential part of high-quality medical care and a constituent of the CGA. 
This is because polypharmacy presents a constant risk of inappropriate medication, which in 
turn exposes older multimorbid people to drug-related problems of various kinds. However, 
the steady growth in the numbers of older people in all European populations means that most 
prescriptions for older people will be written by physicians who are not specialised in geriatric 
medicine. Therefore, the increasing challenge as the European population ages is to provide 
regular medication review for older people that minimises their exposure to adverse drug 
reactions.
Application of a structured pharmacist review of medication and subsequent prescriber 
adjustment of medication based on pharmacist advice is recommended. This can take place at 
time of comprehensive geriatric assessment (CGA) or at time of referral, and revised prescription 
at points of care transition (Manias & Hughes, 2015; Spinewine et al., 2012; Dalleur et al., 2014; 
O’Sullivan et al., 2016).
Policy options
It is clear that a high potential exists to both improve health care outcomes and 
reduce health care costs through improving training systems and patient education 
around prescription of medicines. This issue could be considered alongside the 
current debate on access to and availability of medicines at EU level.
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re 3I. REDUCING HEALTH CARE-ASSOCIATED 
INFECTION
Health care-associated infection (HAI) is recognised as an important global health issue due 
to its association with increased morbidity, mortality and health costs, despite being largely 
preventable. The World Health Organisation defines HAI as “infection occurring in a patient 
during the process of care in a hospital or other health care facility which was not present or 
incubating at the time of admission” (WHO, 2019a). This term supersedes older terms including 
“nosocomial” and “hospital” infection, as it recognises that a significant proportion of HAI occurs in 
long-term care facilities such as residential and nursing homes. The care setting is a particularly 
important factor in the transmission of HAI to old patients and one that will become ever more 
significant in an ageing population.
A point prevalence study conducted by the European Centre for Disease Prevention and 
Control (2013) found that 5.7% of inpatients (all ages) in European hospitals were recorded as 
having at least one HAI, equating to over three million cases per year. The median age of the 
study population was 64 years, with 49% of patients being aged 65 and over (11% aged >80), 
demonstrating the importance of older peopke as an at-risk population. In the point prevalence 
study, 14% of HAI present on admission was categorised as originating in a location other than a 
hospital (European Centre for Disease Prevention and Control, 2013). This includes readmissions 
(either to the same or from a different hospital) as well as admissions from long-term care 
facilities.
It is estimated that approximately four million episodes of HAI occur in long-term care facilities 
in Europe annually (many of which are managed within the long-term care facilities setting), 
emphasising the significant burden of HAI in long-term care facilities, rivalling, if not exceeding, 
that of the acute care setting (European Centre for Disease Prevention and Control, 2014).
Due to increasing life expectancy, the number of older people requiring admission to hospital 
continues to increase and is therefore likely to drive up the proportion of inpatients for which 
they account. Increasing age in itself is a recognised risk factor for HAI (Ferreira et al., 2017) and 
specific risk factors for HAI in older people include being bedridden, length of stay, intravenous 
and urinary catheterisation and pressure ulcers (Reunes et al., 2011). Older people with these 
infections can also be challenging to manage: firstly, they may present atypically resulting in 
late diagnosis; secondly, they are prone to greater severity of infection, so may not respond to 
treatment as promptly or effectively as younger populations (Gavazzi & Krause, 2002; Zalacain et 
al., 2003).
The most important HAI among the elderly include pneumonia (HAP)/lower respiratory 
tract infection, urinary tract infections (often catheter-associated), gastrointestinal infections 
(specifically Clostridium difficile) and skin and soft tissue infections (Juthani-Mehta & Quagliarello, 
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2010). Key causative organisms of HAI are different to those causing disease in the community, 
often requiring different and sometimes prolonged treatment. Furthermore, there is an intrinsic 
link between HAI and antimicrobial resistance. These are thought to be synergistic in hospital 
settings, where HAI may drive antimicrobial resistance and therefore in turn the infections 
become more difficult to treat.
The economic burden is also difficult to measure (De Angelis et al., 2010), but a European Centre 
for Disease Prevention and Control report estimated that HAI accounts for approximately 
€7 billion per year (excluding indirect costs), predominantly due to prolonged hospital stays.
Key interventions to date have focused on improving infection prevention and control practices 
of health care workers, as they are recognised as the main source of transmission. These include 
hand hygiene (including hand washing and use of alcohol hand gels), personal protective 
equipment, isolation, and vaccination.
Given their association, policies should incorporate an integrated approach to HAI and 
antimicrobial resistance. Focus on infection prevention and control strategies is not only key to 
reducing incidence of HAI but will also contribute to reducing risk of antimicrobial resistance 
development, complementing antimicrobial stewardship (Dar et al., 2016).
Surveillance is regarded as a key component of control strategy for both HAI and antimicrobial 
resistance. Many European countries now have surveillance systems in place to enable 
monitoring of incidence of HAI. However, there is both paucity of data (Ewan et al., 2017; Lopez-
Alcalde et al., 2015) and lack of publicly available information where data exists (Nunez-Nunez 
et al., 2018). Furthermore, a recent Cochrane review of improving adherence to standard 
precautions for control of HAI concluded that there was lack of standardisation of both 
interventions and outcome measures, meaning it is difficult to accurately evaluate effectiveness 
of infection prevention and control strategies (Moralejo et al., 2018).
Due to the unique environment within long-term care facilities, with many demographic and 
logistical differences to acute care, they are likely to require interventions specific to their setting. 
However, HAI in long-term care facilities is severely under-researched despite the burden 
likely being greater in long-term care facilities than acute care settings. For example, a recent 
Cochrane Review identified only one study that reviewed Methicillin-resistant Staphylococcus 
aureus (MRSA) infection control in nursing homes (Hughes et al., 2013). However, a recent 
randomised clinical trial of a multimodal targeted infection program in long-term care facilities 
showed promise and should encourage a trend towards further research (Mody et al., 2015).
HAI is already recognised as an important cause of preventable morbidity, mortality and costs 
in Europe. However, data are lacking in both quantity and quality (due to both heterogeneity 
and bias), which is n immediate barrier to improving infection prevention and control of HAI. 
There is a need for investment into high quality studies of HAI in both acute care and long-term 
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standardised surveillance system requires implementation in order to accurately monitor HAI 
incidence and subsequently evaluate the impact of intervention.
Policy options
To reduce as much as possible the length of hospital stays of old patients, adapt 
the hospital design (single, double, triple room; number of toilets per patient) and 
enhance hospital global hygiene policy.
Evaluate systematically the nutrition status (including vitamin D) of old patients at 
hospital admission and give nutritional support if needed.
Think of “one health” model and limit antibiotic use (in animals and humans); anti-
microbial and anti-fungal resistance are worrying.
Improve infection prevention and control practices of health care workers: hand 
hygiene (including hand washing and use of alcohol hand gels), personal protective 
equipment, isolation, and vaccination.
Given their association, policies should incorporate an integrated approach to HAI 
and antimicrobial resistance. Focus on infection prevention and control strategies 
is not only key to reducing incidence of HAI but will also contribute to reducing risk 
of antimicrobial resistance development, complementing antimicrobial stewardship. 
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Health care associated infection is a major cause of increased length of stay and 
avoidable death that can be tackled through improved processes.
3J. PROMOTING INTERVENTIONS FOR EARLY 
REHABILITATION
Rehabilitation, defined as “a set of interventions designed to optimise functioning and 
reduce disability in individuals with health conditions in interaction with their environment” 
by the World Health Organisation (WHO, 2017b), is essential in geriatric care due to the 
straightforward relationship between disability and ageing as shown in the World Report 
on Disability (WHO, 2011c). As people get older, the problems in functioning also increase 
resulting in activity limitations and participation restrictions (WHO, 2011c). These need to be 
addressed by rehabilitation incorporating physical and rehabilitation medicine, which might be 
called “medicine of functioning” with the reference point as the International Classification of 
Functioning, Disability and Health (ICF) (WHO, 2011c), the overall objective of both rehabilitation 
and physical and rehabilitation medicine being optimising an individual’s functioning at all ages 
(European Physical and Rehabilitation Medicine Bodies Alliance, 2018). 
Rehabilitation includes:
  multicomponent exercises for those with mobility impairments
  cognitive rehabilitation, including cognitive stimulation, for those with problems in mental 
functions
  uro-gynaecological rehabilitation for those with urinary incontinence
  rehabilitation interventions for risk of falls are recommended within the context of integrated 
care for older people (WHO, 2017b)
  occupational therapy for activities of daily living training, exergaming and virtual reality 
systems, vestibular rehabilitation, tele-rehabilitation, psychosocial interventions for 
depressive symptoms, evidence-based physical rehabilitation medicine interventions 
including physical agents targeting pain relevant to comorbidities frequently encountered in 
older people
  interventions for home modifications (assistive devices, technical aids, and other tools)
  assistive technologies including computer-based and smart technologies along with self-
management educational interventions including nutrition to meet the needs of the specific 
individual and carer support (Oral et al., 2017)
Rehabilitation services for older people can be provided in various settings including hospitals 
(inpatient or day-clinic rehabilitation), rehabilitation centres, home, community and long-term 
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potentially beneficial in improving functioning outcomes as well as preventing nursing home 
admissions and reducing mortality (Bachmann et al., 2010).
Regarding long-term care residents, evidence suggests that disability may be reduced by 
rehabilitation interventions aiming to maintain or improve physical function in individuals aged 
over 60 years living in long-term care facilities, albeit with quite small effects (Crocker et al., 2013).
Assistive technologies are commonplace in rehabilitation. However, there is a need for robust 
research for evidence of efficacy and harms of a variety of new technologies (Giustini et al., 2014). 
Future transdisciplinary research involving relevant scientific disciplines, academic and non-
academic stakeholders shows promise in greater use of technological innovations in ageing 
(Grigorovich et al., 2018).
The insufficient number of rehabilitation professionals can be considered as a current barrier 
to strengthen and extend rehabilitation (WHO, 2017a). The number of physical rehabilitation 
physicians in Europe varies across countries, ranging between 0.23 and 13.46 per 100,000 
inhabitants in 2017 (European Physical and Rehabilitation Medicine Bodies Alliance, 2018). The 
number of other rehabilitation professionals such as physical therapists and occupational 
therapists are below the level needed in most countries (WHO, 2017a).
Policy options
The skilled training and integration of physical rehabilitation workforce within 
community, hospitals and long-term care supports enhanced health outcomes and 
reduced institutionalisation.
3K. PREVENTING HOSPITAL READMISSIONS 
AND DELAYING NURSING HOME 
ADMISSIONS
Preventing hospital readmissions
A systematic review of interventions for reducing hospital readmission at 30 days which included 
42 trials (some extended period of follow-up to 90 days or beyond), found that multi-component 
interventions which involved more individuals in care delivery and supporting capacity for self-
care were 1.3 times more effective than other interventions (Leppin et al., 2014). Interventions 
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supporting the capacity for self-care involved assessing the impact of comorbidities, functional 
status, carer capabilities, socioeconomic factors, and patient and carer goals for care. The 
most successful interventions also coordinated care across inpatient to outpatient settings and 
typically involved patient home visits and reported cost savings.
Another review of randomised controlled trials in the US (Kripalani et al., 2014) also found that 
interventions needed to be multifaceted to successfully reduce readmission rates. Successful 
interventions included using an advanced practice nurse who meets with patient and carer in 
hospital, performs a needs assessment and provides complete discharge planning including 
education and coordination of post-discharge services, followed by home visits (Naylor et 
al., 1999); and the Care Transitions Intervention, which employs a nurse transition coach who 
educates patients on how best to navigate their own care. The latter model emphasises four 
aspects: medication self-management, a patient-owned health record, follow-up with a primary 
care provider or specialist, and awareness of red flags (Coleman et al., 2006). This intervention 
was successful in reducing both 30–day and 90–day readmission rates.
The various multicomponent initiatives have in common that they bridge hospital and post-
discharge periods with dedicated personnel, patient-centred instructions and follow-up. 
Evidence suggests that the greater the number of domains included in the interventions the 
greater the success in reducing readmissions (Burke & Coleman, 2013).
Delaying nursing home admissions
There is evidence that providing home health services delays the transition from community 
living into a nursing home (Segelman et al., 2017; Young et al., 2015). These home health services 
range from help with home management tasks, activities of daily living, to administration of 
medications (Young et al., 2015), with the aim being to promote independence by improving or 
slowing the progression of disability to delay nursing home admission (Rantz et al., 2005).
Policy options
Bridging community care, hospital and post-discharge periods with dedicated 
personnel, patient-centred instructions and follow-up with comprehensive, 
multidomain interventions prevent re-admission.
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TERM CARE FACILITIES
Importance of living conditions within the institution
Long-term care services may be provided in a variety of settings, including home care, 
institutional (nursing homes and hospitals), or residential care, which can be internally or 
externally provided, sometimes under mixed forms (assisted living arrangements other than 
nursing homes, sheltered housing, etc.) (OECD, 2005). Formal care and informal care services 
coexist in many of these institutions, either complementing or substituting for each other and 
depending on the type of dependency of residents. For residents of long-term institutions to 
have a good quality of life, an environment is required where they can have a stimulating and 
homely environment, good medical and psychological support, and adequate nutritional intake.
De-institutionalising of institutions
Moving into a residential care facility requires a great deal of adjustment to a lifestyle and 
environment entirely different from that of one’s previous life. A sense of home in residents is 
important for their quality of life. It is influenced by three main themes (Rijnaard et al., 2016; van 
Hoof et al., 2016):
  psychological factors, including a sense of acknowledgement, preservation of one’s values 
and habits, feeling in control and coping)
  social factors, including interaction and relationship with staff, other residents, family, friends 
and pets
  the built environment, including private space, public space, personal belongings, 
technology, look and feel, outdoors and location
This feeling of home is important to help retain a sense of autonomy, security and wellbeing. 
Good medical and personal care, respect for residents and friendly staff have also been shown 
to be important for the meaning of home (Jaye et al., 2016; Board & McCormack, 2018). The 
carer’s perceptions and attitudes need to shift from task-orientated to person-centred care 
(Klaassens & Meijering, 2015). For dementia sufferers in particular, the design and organisation 
of care homes should be according to the needs of residents and family careers rather than 
according to the priorities of staff and managers (Popham & Orrell, 2012).
Person-centred care
The rights of older people often appear to diminish with age. In the case of old people with 
cognitive impairment, disability or physical or mental illness, the rights of autonomy, dignity and 
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respect face even a greater threat (Cox & Pardasani, 2017). To address this, several philosophical 
approaches have been integrated into health and long-term care practices with older people. 
One such approach is represented by the concept of person-centred care.
‘Person-centred care’ is broadly defined as knowing the person through interpersonal 
relationship, and addressing his or her needs and preferences beyond the clinical or medical 
demands (American Geriatrics Society Expert Panel on Person-Centered Care, 2016). Other 
terms, such as patient-centred care, person-directed care, resident focus or relational care 
roughly address a similar approach, stressing the ‘how’ over the ‘what’ (Fazio et al., 2018). A 
recent systematic review concluded that the most common elements of person-centred care 
include coordination, integration, and focus of care, which is multidisciplinary, involves family and 
fictive kin, and emphasises the individual person and his or her family as significant outcomes 
(Kogan et al., 2016). The overall idea is that relationship, dignity, respect and autonomy are of 
major importance for older adults’ health and wellbeing. Such an approach allows old people 
to maintain their personhood and citizenship, which possibly incorporates both rights and 
responsibilities.
Adequate nutrition
Malnutrition is now recognised as a ‘geriatric syndrome’ and is common in institutionalised 
residents with a prevalence of up to 50% in some studies. Poor food and fluid intake and 
malnutrition are endemic in older people in long-term institutions. It is important that 
policymakers, managers and staff in these institutions are proactive in improving nutrition for 
their residents, and this issue has also been identified as an important area for research in the 
future (Keller et al., 2015).
Risk factors for malnutrition include conditions affecting appetite, dietary intake, oral health, and 
nutrient absorption as well as increasing comorbidities. The syndrome is associated with adverse 
outcomes, including infection risk (such as pneumonia), falls, pressure sores, reduced quality 
of life, hospitalisation, increased mortality and health care costs (Agarwal et al 2016). Conditions 
such as sarcopenia (loss of muscle mass, strength and performance), frailty and wasting 
syndrome (cachexia) can result from protein-energy malnutrition.
A range of screening tools is available for identification of malnutrition, although further research 
is required to identify the most appropriate method in care homes (van Bokhorst-de van der 
Schueren et al., 2014). Earlier identification of nutritional problems in a resident or in the whole 
long-term care facility needs food and nutrition interventions to improve outcomes and quality 
of life. Identifying the problem will allow the food service to be changed, food improvement to 
be favoured, the dining environment to be modified, staff to be trained and feeding assistance to 
be allowed (Abbott et al., 2013).
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and poor oral health (including dental status) and thus ensuring good dentition and appropriate 
wearing of dentures are important in maintaining satisfactory intake of calories (Sadamori et al., 
2012). Dysphagia is a complicating factor in this group of residents (Namasivayam & Steele, 2015), 
which needs modifying of the food texture to improve food intake (Austbø Holteng et al., 2017). 
Residents with dementia are at particularly high risk of malnutrition.
Fortification of foods, variety in menus, frequent low volume nutrient-dense and energy-dense 
small meals, and snacks and oral nutritional supplements are recommended. (Nieuwenhuizen 
et al., 2010; Stange et al., 2013). Oral liquid nutritional supplements can improve nutritional status 
and help prevent weight loss (Hines et al., 2010). Adequate vitamin D supplements (LeBlanc et al., 
2015) and appropriate oral supplementation are often recommended for residents in long-term 
care facilities (Hsieh et al., 2010; Rondanelli et al., 2011).
There are important ethical issues and dilemmas regarding the appropriateness of enteral 
feeding in dementia sufferers in nursing homes (Paccagnella et al., 2016).
Variety in stimulation, leisure and social engagement in long-term care 
facilities
Despite living in care home facilities, some older people can become isolated, with limited 
opportunities for social engagement. As a consequence, their quality of life can suffer and 
psychological and physical consequences can develop, including depression, worsening 
cognitive impairment and frailty.
Proactive interventions are therefore required to improve engagement, physical and cognitive 
stimulation and leisure activities. Physical training to improve strength, balance or function can 
improve functional performance and quality of life (Weening-Dijksterhuis et al., 2011). There 
is accumulating evidence for variations of Yoga and Tai-Chi in improving several outcomes, 
including mood, cognition and sleep quality. Psychosocial interventions empowering care 
staff to encourage lifestyle engagement and a range of leisure activities can benefit residents 
including alleviating depression (Cheng et al., 2012) and reducing cognitive impairment 
progression (Cheng et al., 2014). Studies of cognitive stimulation, reminiscence therapy, music 
therapy, group treatment, movement stimulation, multimodal activation therapy, meaningful 
activity and positive staff engagement have shown potential in improving outcomes in residents 
including those with dementia. Such activities should be encouraged and care staff empowered 
and trained to deliver them.
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Avoiding inappropriate transfers to emergency rooms
Changing demography has resulted in increasing transfers of frail older people to emergency 
departments worldwide, including from long-term institutions. Such transfers often result in 
iatrogenic complications, morbidity, stress and anxiety as well as excessive cost, and some of 
these transfers are potentially avoidable (Marshall et al., 2015). The nature of the acute change in 
health, resources available in the care homes, and the resident’s or family’s preference are some 
of the factors influencing the decision to initiate transfer (Trahan et al., 2016).
Some schemes have shown that interventions could potentially reduce avoidable transfers to 
emergency departments. A programme including a set of tools and transfer-avoiding strategies 
halved transfers (Aizen et al., 2014), and a Canadian “Care by Design” programme that allowed 
increased access and quality of care from family physicians reduced unnecessary transfers 
(Marshall et al., 2015).
Falls are also a common reason for transfers of residents to hospital. The incidence of falls in 
care homes has been reported as 1.7 falls per person-year compared to 0.65 falls per person-
year for community-dwelling older people (Rubenstein, 2006), and a Canadian study showed 
62% of residents fell over at least once over the course of one year in residential care facilities 
(Kennedy et al., 2015). A recent Cochrane review has shown that there is a lack of high quality 
randomised controlled trials on interventions to reduce falls in this environment. There was some 
evidence that vitamin D prescriptions reduced the rate of falls in care homes. Some selected 
trials have shown a reduction in fall rates for individualised multifactorial interventions, although 
the meta-analyses were not conclusive overall for multifactorial interventions. The review 
recommended an urgent need for better quality trials to close this research gap, particularly 
with regards to supervised exercise programs, and interventions targeting staff, organisational 
systems, assistive technologies, medication review and the social environment (Cameron et al., 
2018).
More and more old adults die in long-term care facilities. To avoid the last-minute transfer of 
dying patients to the emergency department, the care facility team needs to be better trained in 
palliative care and advance care planning.
Health care professionals working in long-term care
Worldwide changing demography has resulted in increasing number of frail, disabled and 
demented older people living in long-term care institutions. Age-friendly long-term care 
leadership must be committed to addressing ageism and social cohesion among residents and 
professional staff members. Health care professionals working in long-term care must benefit 
from appropriate multidisciplinary training so that they can acquire the scope of competencies 
needed to provide care improving residents’ health and functional ability and wellbeing.
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Age-friendly long-term care leadership must be committed to addressing ageism. Social 
cohesion and gender justice for residents, and also their formal carers, are major goals.
Implementing a core set of evidence-based actions aims to reduce harm to older adults and 
avoid unwanted or duplicative care. The main goals of the care are improving residents’ health 
and functional ability and wellbeing; favouring reliable use of evidence-based care; helping 
residents to establish advanced care planning and identifying surrogate decision markers; and 
regularly updating previous information and wishes.
A better social and professional recognition of long-term care workers is needed to reduce high 
staff turnover. Specific multidisciplinary training of health professionals is essential to enable 
them to fulfil with their daily duties and adequately care for acute or end of life patients (see 
below), while focusing on both measurable and intangible (dignity and wellbeing of residents) 
outcomes.
3M. DEVELOPING PALLIATIVE MEDICINE AND 
CARE CULTURE
In Europe, three quarters of all death occur at the age of 65 years or older, and more frequently 
in long-term care (Prsic & Teno, 2017). Many older people are now dying from chronic debilitating 
conditions, such as end-stage organ failure and dementia. Although most deaths occur among 
older people, there is relatively little attention to their specific needs toward the end of life (WHO, 
2011b). Palliative care is predominantly afforded to patients with cancer, but even in the field 
of oncology its provision tends to be insufficient, is often limited to end-of-life care and is not 
integrated into standard care pathways. Moreover, cancer patients aged 85 years and older are 
more likely to die from other diseases than from cancer, and the rising incidence of dementia 
has considerably increased the strain on the service.
Alleviation of suffering must be a fundamental goal of health systems, in addition to and 
complementary to the extension and preservation of life. Evidence suggests that older people, 
especially people with dementia, have unmet needs, underdiagnosed and undertreated pain 
(Feast et al., 2018); are subjected to burdensome transitions to acute care hospitals in the last 
few days of life; and may too often die miserably in intensive care, bound to a mechanical 
ventilator (Gavrin, 2007). Older people with multiple health problems are at risk of receiving 
unnecessary treatments and procedures and are not referred to hospice care until the very last 
few days. Particularly problematic is the destiny of people with advanced dementia and of those 
living in long-term care facilities (Beerens et al., 2013).
Palliative care continues to be treated as a silo, operating on its own terms often as a non-
integrated part of treatment, and is limited to end-of-life care in the hospice environment. 
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(Dumanovsky et al., 2016). To better meet the needs of older people, access to palliative care 
should include people with diseases other than cancer and who have multimorbidity. Palliative 
care should be for everybody, in any care setting, and not limited to the last days of life.
There is some evidence that some specific palliative care models are applicable, work well, are 
well received, and are cost-efficient (Pautex et al., 2010). These are:
  hospital-based with mobile teams for consultation, with or without an in-hospital dedicated 
unit with beds
  embedded in homecare services
  provided in nursing homes as an added service
It is clear, however, that a sustainable integration of palliative care requires policies and 
programmes that are culturally sensitive and respectful of each country’s differences, and thus 
are adapted to local settings.
Who should be in charge of palliative medicine: the generalist or a specialist in palliative 
care? While there remains room to distinguish even the representative skill sets for primary 
and specialist palliative care, the basic management of symptoms and the basic elements 
for discussing about prognosis and goal of treatment should be part of all physicians’ job 
requirements. To this end, there are available sets of prognostic indicators — either generic 
indicators of severity or progression, or disease-specific indicators — to correctly identify patients 
with advanced chronic conditions for a progressive palliative care approach (Amblas-Novellas et 
al., 2016).
Concluding remarks
Palliative care as a medical discipline has been one of the major advances in modern medicine. 
The area had previously been seriously neglected, but now forms a major part of patient care.
The de-institutionalisation of long-term care institutions is beneficial as it is associated 
with improved physical and mental health outcomes for resident patients, with improved 
engagement and job satisfaction for long-term care workers.
Policy options
Integrating palliative care into the health care system is essential to take more 
seriously the alleviation of the burden of pain, suffering, and severe distress 
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universal access to palliative care and the implementation of these interventions will 
strengthen the overall performance of any health system.
Promoting advance care planning initiatives
Advance care planning, or ‘living wills’, provide patients with an opportunity to consider, discuss, 
and plan their future care with their health professionals (both GPs and nurses) and inform their 
closest relatives of their end-of-life wishes. The goal is to enable a “dignified end of life”, in the 
event of decisional incapacity (Barnes & Yaffe, 2011).
About two thirds of older patients had views about end of life (becoming care dependent, 
suffering from physical or mental deterioration, dying alone, etc.) and appreciated it if their 
family practitioner initiated a conversation on the subject. Unfortunately, less than a quarter of 
physicians and even fewer nurses have enough knowledge, experience and skills to deal with 
end-of-life discussion (De Vleminck et al., 2017; Silva et al., 2014).
Application of discussions is influenced by a mixture of religious beliefs, attitudes toward death 
and specifically one’s own death. The role of proxies as decision-makers is uncertain. End-of-
life decisions, treatment refusal and ‘do not resuscitate’ policies are complex. The complexity is 
even greater among vulnerable populations including insufficiently informed individuals, such as 
ethnic minorities and patients with limited health literacy (Vyshka & Kruja, 2011). Another frequent 
problem is the considerable reluctance of health care professionals to initiate advance care 
planning discussions as early as possible in patients with pre-dementia (van der Steen et al., 
2016).
Whatever the context, it was proven that patients benefiting from palliative care or advance care 
planning are less likely to receive cardio-pulmonary resuscitation or burdensome, unnecessary 
medical treatments, they enjoy a reduced length of hospital stay and significantly smaller 
number of end-of-life transfers to emergency wards, regardless of whether their place of 
residence is at home or in a nursing home (Abel et al., 2013; Bouwstra et al., 2015).
Concluding remarks
The de-institutionalisation of long-term care institutions is beneficial as it is associated 
with improved physical and mental health outcomes for resident patients, with improved 
engagement and job satisfaction for long-term care workers.
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Policy options
Advance care planning or a “living will”, which state the patient’s wishes and 
preferences for the purpose of preserving dignity and autonomy at the end of 
life, should be a part of the public health agenda and integrated into all health 
professionals’ training programmes.
Informal and family carers must be better supported including training, provision of 
necessary equipment and respite care. Training health care professionals is essential 
to early identify elder abuse and engage clear and fair reporting and whistleblowing 
procedures. There may be lessons that can be transferred from the area of child 
protection policy.
3N. COMBATING ELDER ABUSE
Elder abuse is a single or repeated act, or lack of appropriate action, occurring within any 
relationship where there is an expectation of trust, which causes harm or distress to an older 
person. This type of violence constitutes a violation of human rights and includes physical, 
sexual, psychological, and emotional abuse; financial and material abuse; abandonment; neglect; 
and serious loss of dignity and respect (WHO, 2018a).
Prevalence of elder abuse
Around 1 in 6 older people experience some form of abuse, a figure higher than previously 
estimated and predicted to rise as populations age worldwide. A study supported by WHO 
and published in the Lancet Global Health found that almost 16% of people aged 60 years and 
older were subjected to either psychological abuse (11.6%), financial abuse (6.8%), neglect (4.2%), 
physical abuse (2.6%) or sexual abuse (0.9%) (Yon et al., 2017).
There are numerous risk factors that increase the likelihood of an older person becoming a 
victim of elder abuse, including (Hildreth et al., 2011):
  memory problems (such as dementia)
  mental illness, either long-standing or recent
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  depression, loneliness, or lack of social support
  abuse of alcohol or other substances
  taking prescribed medications that impair judgement
  being verbally or physically combative with the carer
  having a shared living situation
  informal or formal carers’ stress
Elder abuse can take place in both institutional and community settings. As such, some aspects 
of the problem can be addressed through institutional rules and processes for health and care 
institutions. Other aspects of elder abuse are societal and related to the way that older people 
are treated within society. Examples include ageist stereotypes where older adults are depicted 
as frail, weak and dependent, and changes in the bonds between generations of a family.
Relevant considerations and options
It is crucial to proactively identify situations where abuse is suspected to be taking place, in 
order that steps can be taken to liberate those at risk from their abusers. Raising awareness for 
opportunistic screening, for example in the emergency room, is recommended.
At EU level, the most notable elderly abuse-related activity in recent years was the Daphne-
EUSTaCEA programme (European Association for Directors and Providers of Long-Term Care 
Services for the Elderly, 2016), focused on the abuse of elderly women. It was coordinated by 
AGE Platform Europe and funded by the European Commission. The project had the following 
outcomes, intended to launch a call for action on abuse against older women, and to share best 
practice that EU Member States can use to tackle it:
  eleven national workshops
  development of a European Charter
  development of a good practice guide
The Swedish Agency for Health Technology Assessment and Assessment of Social Services 
published systematic reviews on major geriatric topics highlighting lack of evidence, knowledge 
gaps and low-quality research on the oldest patient group (SBU, 2013). Publications on urinary 
incontinence, pressure ulcers (SBU, 2014), depression (SBU, 2015) and fractures management 
(SBU, 2017) indicate clearly that high quality research is needed to favour the development of 
good practice guidelines. In the absence of scientifically-based guidelines, the SBU suggested 
that in many instances care that older people receive may be sub-optimal.
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Concluding remarks
In violation of human rights, elder abuse in multiple forms (financial, psychological and physical) 
all too frequently affect the most vulnerable population at home or in institutions. This linked to a 
general change in societal attitudes to the elderly, who are often seen as being just a vulnerable 
burden which represents an overall cost to society.
Policy options
Informal and family carers must be better supported, including training, provision of 
necessary equipment and respite care. Training health care professionals is essential 
to early identify elder abuse and engage clear and fair reporting and whistleblowing 
procedures.
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Chapter 4. The use of technology to 
promote healthy ageing
Health care technologies offer an opportunity to address some of the health care challenges 
of the 21st century. Telemedicine, smartphone apps, and biosensors for remote diagnosis and 
monitoring, with a focus on prevention, will bring major improvements in patient outcomes. 
Health care technology and other innovative solutions can be harnessed to promote health, 
maintain functional ability, compress morbidity across the life course and extend healthy life 
expectancy.
However, it is critical that adoption any new health care technology is based on scientific 
evidence and that such technologies should redress, not reinforce, health care inequalities. 
If adequate training is provided on the integration of new health care technologies and on 
the interpretation of data from these solutions, such technologies have the potential to 
counterbalance some of the shortfall in health care workforce in future years.
4A. TELEMEDICINE, DIGITAL MEDICINE, 
WEARABLE SENSORS, MOBILE AND 
WIRELESS TECHNOLOGIES
The WHO (2016a) defines telemedicine as the provision of clinical care and preventive care from 
a distance using telecommunication and information technology, including text, audio and video 
consultation. Telemedicine has been used to overcome distance barriers and to improve access 
to medical services that would often not be consistently available in distant rural communities. 
In the UK, the Royal College of Physicians has recommended consultations via the telephone 
and video consultations in order to cope with increased health care demands (Royal College of 
Physicians, 2018). In a recent study evaluating online consultation system for use in primary care, 
it was found that online consultation improved access for some patients, but that in its current 
form, it was not perceived by practices as creating sufficient efficiencies to warrant financial 
investment (Farr et al., 2018).
A 2017 report from the Joint Action to Support the e-health Network, entitled ‘EU state of play 
on telemedicine services and uptake recommendations’, found that adoption of telemedicine 
services across Europe has been uneven, and services represent less than 10% of total health 
care services in Europe (Joint Action to support the e-health Network, 2017).
The term “digital products and services” refers to products that are intended for use in the 
diagnosis, prevention, monitoring and treatment of a disease, condition or syndrome” (Topol et 
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smartphone apps, wearable devices, software used in clinical settings (such as e-prescribing) 
and point-of-care tests.
Wearable sensors and devices have evolved as key technical tools which may dramatically 
revolutionise the next generation of health care solutions and have become health innovation 
drivers (Steinhubl et al., 2013). The miniaturisation of sensors and devices has generated new 
health care solutions (Kher, 2016). By employing mobile and wireless technologies, smartphone 
apps and wearable devices are transforming ‘traditional’ health care services and enhancing 
health outcomes, health quality and health equity (WHO, 2011a). Smartphone apps and wearable 
devices are also included in the domain of m-health (Istepanian & Woodward, 2016). m-health 
can assist in the detection and prevention of age-related diseases, leading towards healthier 
ageing and healthier societies (Vital Wave Consulting, 2009). Existing m-health technologies 
have already shown their potential for improving care, self-management, self-efficacy, behaviour 
promotion and medication adherence (Changizi & Kaveh, 2017). More than 50% of intervention 
studies on m-health relating to healthy eating (McCarroll et al., 2017) or obesity and diabetes 
prevention (Wang et al., 2017) report positive effects based on primary outcomes. A similar trend 
of alcohol and substance abuse prevention via m-health tools is also emerging (Kazemi et al., 
2017).
m-health is still at an early stage of development in many countries (Marcolino et al., 2018). 
Clinical evidence has yet to emerge for many existing or near future solutions (Istepanian 
& Woodward, 2016). However, most importantly, m-health has yet to achieve industry-wide 
deployment of functional, sustainable products and services that consistently meet financial, 
quality, and patient satisfaction benchmarks (Slovensky & Malvey, 2017). A major risk to the future 
perception of m-health is the proliferation of off-the-shelf devices whose scientific foundation is 
questionable (Slovensky & Malvey, 2017).
However, the availability of wearable technologies such as pedometers, smart watches, fitness 
trackers and other types of wearable sensors tracking physical activity provide one measure 
of a healthy lifestyle. Other wearables can record and track blood pressure and temperature. 
Combined with health promotion and early preventive strategies, such measures may enable 
younger European generations to have a healthier later life. Their use and generated data may 
also increase public awareness that some risk factors associated with age-related functional 
decline are modifiable by lifestyle choices at all life stages. Lifelong self-tracking of health 
may offer a new approach for early diagnosis and early interventions (see example later in this 
section).
Health care technologies such as smartphone apps and wearable devices are also important 
facilitators of ageing in place. Wearable technologies, as well as home-based technologies, 
promote the development of integrated closed-loop care and therapeutic systems. The use 
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of such devices has been recognised by other disciplines of medicine, specifically neurology 
(Espay et al., 2016), for their potential to:
  enhance tailoring of symptomatic therapy
  identify objective biomarkers to improve longitudinal tracking of impairments in clinical care 
and research
  encourage the adoption of clinico-pathophysiologic phenotyping and early detection of 
critical health milestones
  improve subgroup targeting of patients for treatments
People are living longer, and overall population levels are increasing (Department of 
Economic and Social Affairs, 2017), but the required medical support personnel and health 
care methodologies are resulting in cost deficits and health personnel shortages. Health care 
technologies such as telemedicine, smartphone apps and wearable devices have the potential 
to address some of these challenges. As mentioned above, scientific evaluation and evidence 
of the clinical benefit as well as sustainable economic models need to be realised first. Also 
required is a health care workforce that is trained to incorporate and interpret data derived 
from these new technologies. The NHS in the UK has recently published an extensive report on 
preparing the health care workforce take advantage of new health care technologies, through 
training and education (Topol et al., 2019). This report concludes that the adoption of new 
technologies should enable staff gain more time to care, promoting deeper interaction with 
patients. This may be most important for older patients.
4B. LIFELONG SELF-TRACKING OF HEALTH
Health booklets can be used to monitor growth and development in children, providing useful 
information on height, weight, immunisations and other common health issues to both carers 
(parents or guardians) and care providers (midwives, nurses, GPs and paediatricians).
We propose the creation of a lifelong self-tracking tool to monitor health, which would be kept 
by every adult throughout early, mid- and older adulthood. Its availability in two different formats, 
a paper booklet and a smartphone app, will allow an adaptation to the level of technology 
literacy of the end user. This lifelong self-tracking of health tool would contain information on key 
health parameters routinely updated by the individual’s care providers at primary care centres 
and hospitals.
Such information may include:
  Anthropometric data: height, weight, waist circumference, body mass index, etc.
  Functional abilities: physical and cognitive basic tests and measurements (average number 
of steps taken per day, balance test, normal/rapid gait speed, etc.
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  Vaccinations: flu, pneumococcus, tetanus, etc.
  Vital signs (especially important for individuals with wearable devices): blood pressure, pulse 
rate, cardiac rhythm, respiration rate, etc.
The parameters mentioned above are examples of what could be encompassed; the exact set of 
parameters, the format of the tool requires development and adoption by the European health 
service authorities.
Our proposal is based on two arguments:
  Life course approach to health: The basic finding in this domain is that health at a specific 
point in time is not based on exposure to risk factors at that time, but over the life course. At 
present, delivery of health care is based on a current snapshot of key health parameters, 
however, integrating all recorded changes over time will enable care to be more appropriate 
and of a higher quality. Functional decline will be detected earlier, allowing for personalised 
primary prevention or intervention to delay or postpone age-related disability.
  Prevention: It is increasingly clear that functioning and lifestyle factors are important 
components used to tackle the increasing burden of chronic diseases. Changes in key 
measurements can help alert individuals (and their health care providers) to increased risk 
of certain diseases before their onset. For example, changes in waist circumference may be 
associated with ischemic heart disease, whereas important functional ability changes may 
reveal a risk of sarcopenia, sarcopenic obesity, frailty and falls.
The proposed long-term and individualised monitoring of key health markers will facilitate 
primary prevention. As is the case with any smartphone app, advice on the use of the tool and 
interpretation of data should be regularly updated, acknowledgement of functional progress 
should be notified, and alerts should be delivered in the case of significant changes
Thus, by combining the use of the tool with proper medical advice, potential decline would 
be detected earlier, and primary prevention or early interventions may then be implemented, 
stopping or even reversing the decline, for example from frailty to pre-frailty or from pre-frailty to 
robustness.
Our proposal is that this lifelong self-tracker of health would be held by the individual or 
authorised person, ensuring data protection and privacy. The data included in the proposed 
health booklets or smartphone apps regarding a particular individual are intended to be under 
the individual’s control as a tool for health self-management and only if he or she agrees to 
include the information collected by health care providers. Development of the tool would 
naturally take into consideration the relevant legal (such as data protection regulation) and 
ethical issues, to ensure all necessary approvals.
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In European countries where universal medical records already exist, this information could 
be regularly downloaded or transferred to complete medical data recordings. For example, 
Denmark’s personal health care card is updated with each medical consultation and 
hospitalisation, and could also include the parameters regularly updated in the proposed 
self-tracker tool. Combined tools of self-management and management of health information 
by professionals will allow for a better and earlier targeted primary prevention or treatment 
intervention in order to delay or postpone age-related disability.
Policy options
New technologies have high potential but often come along with complex legal and 
ethical challenges. Policy should be tailored for health applications, as distinct from 
consumer products, to take account of the specific needs of patients.
There is a knowledge gap in terms of assessing cost-effectiveness of digital 
technologies, which are needed to drive uptake and build business cases for 
investment.
4C. AGEING IN PLACE
Adoption of appropriate technologies can be an important facilitator of ageing in place and 
can play a significant role in the independence of older individuals. These technologies cover a 
multitude of devices and smartphone apps that serve a range of purposes. They may be used to 
promote healthy and active ageing or help people with functional limitations complete everyday 
tasks. The most common examples include text telephones, hearing aids or speech recognition 
software for people with sensory or visual impairments, as well as scooters or motorised 
wheelchairs for people with mobility difficulties. Other examples include wearable battery-
operated emergency alert systems, which detect falls and summon help.
Wearables provide a level of security to the older person, improving their safety at home. Use of 
these devices and aids has been shown to improve quality of life and health outcomes for older 
people and to support independent living. However, little evidence is available to date on cost-
effectiveness (Khosravi & Ghapanchi, 2016).
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Other important assistive technologies include automated pill dispensers or memory prompts 
on smartphones or tablets that provide reminders to those with cognitive impairments to take 
medicines. While there are few studies on their effectiveness or economic benefits, some 
studies suggest these devices improve medication adherence (Paterson et al., 2017). A series of 
recent randomised controlled trial studies have shown that reminders sent via text message can 
encourage people to successfully improve health behaviours. Studies find that text message-
based reminders have led to improvements in remembering to take diabetes drugs (Vervloet 
et al., 2012), following HIV treatment regimens (Pop-Eleches et al), and adhering to asthma 
treatment (Strandbygaard et al.), among others.
Important issues for conventional assistive technology use by older adults include its impact on 
and emotional adjustment regarding self-image, the need for individualised follow-up and close 
collaboration with the social network of the older individuals due to the significant influence 
of sociocultural context (Larsen et al., 2018). Multidisciplinary research involving relevant 
scientific disciplines, academic and non-academic stakeholders show promise in greater use of 
technological innovations in ageing (Grigorovich et al., 2018).
Tablet and computer-based technologies have been developed to slow disease progression. For 
example, some computerised brain-training programmes have reported a slowing in cognitive 
decline. A number of randomised control trials have found that participants in different brain-
training programmes displayed improved reasoning, speed and memory and less decline when 
completing instrumental activities of daily living (IADL) compared to controls (Rebok et al., 2014; 
Shah et al., 2017).
Delivery of health care services by health professionals based on remote monitoring can be 
used to provide timely assessments, support and advice to older people at home. Yet, while 
research suggest these systems may effectively improve care management for older adults 
with chronic health conditions (Flodgren et al., 2015; Salisbury et al., 2017), evidence on cost-
effectiveness is mixed (Henderson et al., 2013; Mistry, 2012).
Home enhancements
One objective of ageing in place is to create a safe zone at home, so that the older person’s 
functional, physical, medical and social needs are maintained through monitoring and 
management of health and wellbeing (Carretero, 2015; Institute of Mechanical Engineers, 2018). 
The viability of technology in the home to meet these needs must be balanced with the older 
person’s declining physical and cognitive heath. These systems are only useful if coupled 
with support services so that closed loop care can be provided. Viable systems require the 
deployment of basic medical and social support services for monitoring and maintaining physical 
and psychological wellbeing, safety, accessibility and mobility.
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Common devices such as mobile phones, tablets or ordinary telephones can be linked though 
an ICT system that monitors the environment or health of an individual (e.g. by monitoring toilet 
visits) and sends alerts when necessary (Carretero, 2015; Institute of Mechanical Engineers, 2018). 
Given that smart homes are a relatively recent development, it is perhaps unsurprising that there 
are scarce studies on their cost effectiveness and potential to prolong ageing in place.
Technologies to promote ageing in place come in different forms, but one distinction that can be 
made is whether they are active or passive:
  Active home monitoring devices capture vital signs, weight or symptoms and report them 
to a remote provider or a home health care agency. Active systems require an individual to 
operate them, whether they are hardware or software in nature.
  Passive monitoring technologies include wearables, such as fitness bands tracking physical 
activity (steps taken), door movement sensors that track activity within the home but 
also include bed sensors that capture restlessness, sleep interruptions, or heartrate and 
respiration during sleep.
The use of technology to adapt housing is a critical component of ageing in place strategies. 
Adapted housing solutions can include installation of practical technology to make everyday 
tasks easier, such as placing ramps at front doors, anti-slip mats or grab-bars in showers and 
baths to assist bathing and improve upkeep of good hygiene standards, or use of toilets with 
adaptable height settings (Carretero, 2015; Powell et al., 2017). Evidence suggests these types of 
aids and devices can prevent falls and reduce accident rates and can lead to improved quality of 
life and health outcomes (Powell et al., 2017).
Technologies can also be introduced to create ‘smart homes’, where sensors and automated 
systems perform various tasks such as switching electrical appliances and lighting and heating 
systems on or off when prompted, or automatically if left on accidentally (Carretero, 2015; 
Institute of Mechanical Engineers, 2018; Liu et al., 2016).
Social connectedness
ICT-based technologies can help promote social connectedness. Evidence shows that provision 
of mobility devices can help older people maintain an active social life and enhances access 
to local resources (Pettersson et al., 2016; Sund et al., 2015). Social networks may also provide 
a means for older people to create or maintain social connections and an active lifestyle. 
Technologies such as tablets and smartphones for social connectivity and emotional health tend 
to focus on older adults’ interactions with their family but can also be useful for carers, whether 
in the form of paid professional assistance or unpaid family, friends or neighbours, as well as 
with the broader community. These technologies may provide social engagement or access to 
information but also employment and volunteer opportunities.
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Technology can encourage or facilitate social interactions and emotional contact either in person 
or via virtual communities, and can delay declines in mental wellbeing. Although poor mental 
health in later life, including anxiety and depression, can be prevalent as a result of genetics, 
social isolation, stressful or traumatic life events, subjective indicators demonstrate that an 
increased sense of purpose and meaning in life can extend longevity (Selwyn et al., 2015).
Policy options
The use of new technologies, including monitoring systems, can support citizens to 
age in place and improve social inclusion but they must facilitate the connection to 
health and care professionals in case of need.
4D. ACCEPTANCE BY OLDER PEOPLE
Developing technical solutions for home monitoring requires consideration of both the older 
person and their care provider (formal or informal).
One factor affecting whether technologies are actually used by older people is how well they 
can be incorporated into the person’s daily life. Technology must be adaptable to individual 
lifestyles and foster individual health goals; those that are too obtrusive are less accepted. 
Acceptance can only be assessed through better design, including human factors engineering, 
as well as usability testing with older people as integral members of the design, development 
and testing process.
Data privacy is very relevant to the acceptance of technology by older adults. Who has access to 
the information generated from technology is an important consideration for technology users 
of all ages? Appropriately designed systems share data only on vital signs or passive activity of 
the individual rather than infringing on privacy, such as recording data from cameras positioned 
around the home.
Technology uptake varies substantially between older people. Knowledge, affordability, ease of 
use, functionality, personal preferences and concerns over privacy all influence whether or not 
an older adult may engage with technologies that can support them to remain living at home 
(Peek et al., 2016; Yusif et al., 2016).
The issue of acceptance will become more acute as wearable devices become increasingly 
hidden through integration into fabrics and textiles. While the data recording and monitoring 
becomes significantly unobtrusive if the clothing itself is the sensor, there needs to be a 
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reminder to the older person and care providers that data is being recorded when wearing the 
garment. Informed consent is crucial, and easy-to-understand explanations must be given.
Current user capacities for smart devices should not be extrapolated to the future. Current older 
people that use smart devices have only learned to use them in old age. Future older people 
may have been using smart devices their whole life, but technology will continually evolve and 
thus usability will always remain an important concern.
Policy options
It is important to establish patient informed consent for use of new technologies, 
which necessitates an explanation of how has access to their data and how it will be 
used.
Current user capacities for smart devices should not be extrapolated to the future. 
Current older people that use smart devices have only learned to use them in old 
age. Future older people may have been using smart devices their whole life, but 
technology will continually evolve and thus usability will always remain an important 
concern.
4E. GLOBAL EFFICIENCY AND PROVEN 
OUTCOMES
Some remote monitoring health models of care have shown clear benefits for patients with 
chronic disease, specifically those that incorporate patients and family members into the care 
team (Darkins et al., 2008). These models of care, which frequently involve remote patient 
monitoring, show promise in getting and maintaining patients to achieve their health care goal 
and, in some cases, lowering the incidence of avoidable hospitalisations and re-hospitalisations 
for patients with chronic conditions (Bartolini & McNeill, 2012; Sorknaes et al., 2013; Polisena et 
al., 2010; Boutwell & Hwu, 2009). Other models have not been able to demonstrate significant 
improvements (Sorknaes et al., 2013).
In Europe, but also in the US, technologies for remote homecare have been shown to be 
effective in small-scale studies of patients with chronic diseases, but adoption of these technical 
199
C
H
A
P
T
E
R
 4
Te
ch
n
o
lo
g
y 
to
 p
ro
m
o
te
 h
e
a
lt
h
y 
a
g
e
in
g
solutions remains limited (Wootton, 2012; Zanaboni & Wootton, 2012; Lindeman, 2010). There are 
several obstacles to achieving widespread adoption:
  acceptance of technologies by patients and clinicians
  economically sustainable reimbursement systems
  interoperability between electronic patient record systems
  financial and technical capability to incorporate bandwidth-heavy telemedicine programs into 
primary care centres, clinics, and small hospitals and into the home
There have been no reported large studies that have explored the efficiency of home care 
delivery that has been supported by technologies in older adult cohorts.
4F. REGULATION AND CERTIFICATION
New types of standardisation and collaboration projects are needed to cope efficiently with 
the rapidly growing new industry of health-based smartphone apps, wearables and in-home 
health care technologies. This lack of standardisation has made it difficult to integrate data into 
electronic patient record systems in primary care centres.
In order to stabilise and accelerate the industrialisation of wearable electronic devices and 
technologies, the International Electro-technical Commission’s Technical Committee 124 
“Wearable electronic devices and technologies” is developing standards in this area. However, it 
will need strong liaisons and collaborations with other bodies to fully standardise such devices. 
The focus on standardisation must also encompass the transmission, processing and storage of 
the data generated from the wearables or from device in the home. With the increasing use of 
cloud-based systems, standards to ensure data privacy and security are urgently required.
As new technologies are constantly being developed, based on different hardware and software 
platforms, there is a need to have a standardised assessment process so that scientific evidence 
is generated to inform both the public but also health care agencies of which devices and 
systems work and which do not. Interoperability of hardware technologies and health care 
services is also lacking.
In 2014, an analysis was undertaken of the use of ICT for health delivery and e-health policy 
initiatives within 27 EU Member States. This influenced the development of an e-health 
roadmap that reflected national, regional, and local conditions focusing on technical imperatives 
but also including personalised telemedicine solutions (Currie & Seddon, 2014). An updated 
communication was published in 2018 (European Commission, 2019).
As health care monitoring in the home is envisaged to play a greater role in health care delivery 
to older adults, it is increasingly important to develop a strong evidence base of successful, 
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innovative solutions that can lead to scalable and sustainable home health care programmes. 
The Transatlantic Tele-health Research Network (Broderick et al., 2017) has developed a 
multinational research agenda to provide a uniform framework for identifying and rapidly 
replicating best practices, while concurrently fostering global collaboration in the development 
and rigorous testing of new and emerging telemedicine and health care technologies. The 
agenda incorporates health care parameters across traditional modes of care for the benefit of 
providers, companies, policymakers, and the international research community:
Transatlantic Telehealth Research Network research agenda 
(Broderick et al., 2017)
Patient
  Assessment of personal engagement in own health through the use of telehealth 
technologies (quantified self)
  Self-determination and motivation with regard to the use of new telehealth technologies
  Health literacy, eHealth literacy, technology literacy, contributions to design features of 
technology, and interaction with telehealth technologies
  Patient-to-patient interventions
Home
  Integration of smart home telehealth technologies (wellness and health devices and 
software, Internet of Things)
Health care professionals
  Communication for and between providers and patients (telehealth through mobile, 
wearable, and remote monitoring)
  Telehealth training and education, including designing communities of knowledge and 
practice
  Health system design, organization, and practice
  Cross-sector integration using telehealth technologies (Accountable Care Organizations, 
bundled care, medical homes
  Telehealth in redesign of chronic disease management
  Adoption of telehealth programs in clinical practice
Technologies
  Use of self-tracking technologies
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  Design of user-friendly technologies
  Development of sensor technologies for detection of fluid in the body, sleep patterns, etc
Data systems and infrastructure
  Integration of telehealth devices with electronic health records and cloud databases
  Integration of personal health records data and telehealth devices and systems
Data analytics
  Algorithms for multimodel data platforms, devices, and sources
  Innovative data analytic approaches for integrating data for precision medicine, including 
predictive, personalized, and customized analytics
Development of new telehealth technologies
  Assessing mobile, intelligent, and individualized telehealth technologies
  Enhancing the matching of patient preferences and telehealth use
  Anticipation of telehealth innovations still to be invented
  International telehealth technology standards
Research methods
  Multidisciplinary assessment of the effectiveness of new telehealth services
  Advances in tracking, data transmission, and storage of telehealth data (real-time analytics vs 
store-and-forward)
  Rapid cycle design evaluation vs traditional randomized controlled trials
Financing
  Assessing innovative payment and reimbursement systems, especially in the emerging 
value-based health care environment
  Global variations in financing and paying for telehealth
Privacy and security policy
  Addressing different cultures of privacy (ethical issues) for patients
  Enhancing telehealth data security (given advances in mobile, wearable, and cloud-based 
system configurations)
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  Local, regional, and international regulatory requirements (licensing, guidelines, standards)
Public policy
  Telehealth across state and international borders
  Professional licensing and standards
  Variation in intergovernmental and international telehealth policies and financing
This model outlines an approach whereby the public and private sectors can address gaps in 
technologies, monitoring and health provision, in order to maximise the potential for ageing at 
home. A global approach is critical, especially when it comes to interoperability.
Policy options
The development of health care technologies must incorporate trustworthiness 
(privacy, security, safety, acceptability) and cost-effectiveness. The focus must be 
on designing age-friendly systems, relevant for all ages. As a principle of design, the 
older person should be considered as a partner of the design team from the outset, 
thus ensuring the system has high levels of usability but also privacy and security. 
Such an approach would also limit uptake of technologies being promoted without 
adequate science underpinning their use. Older people are particularly vulnerable to 
such scams and a trusted development network or certification would foster public 
reassurance.
Digital technologies, especially those on the borderline with consumer or wellness 
products, are a challenge to regulate. Appropriate uptake of technology is 
predicated on health care professionals being able to trust that products and 
services are safe. Clinical evidence, in line with that expected for similar medicines or 
medical devices, should be presented when the product claims demand it.
4G. REIMBURSEMENT AND HEALTH ECONOMICS
While technology plays a crucial role enabling ageing in place, uptake varies substantially 
between older people and between EU member states. Assisting health care provision using 
remote technology has rapidly increased in recent years, as new products are developed and 
consumer demand for instant access to health care increases. Indeed, the telemedicine market 
is expected to grow to $113.1 billion by 2025, at an estimated compound annual growth rate of 
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18.8%. It is expected that at least 7 million patients in the US will access telemedicine services in 
2018, a sharp increase from 2013, when the estimated number of tele-health patients was less 
than 350,000.
Despite this momentous growth, reimbursement continues to be a key obstacle for telemedicine 
providers. However, in the US, reimbursement rules by various health care providers are slowly 
expanding to cover more telemedicine services.
Reimbursement for equipment varies across EU states. In the UK, assistive technology and 
equipment for social (not health) care needs are paid for by local authorities, when items cost 
less than £1000. More expensive equipment is funded on a means-tested basis and according 
to local funding criteria. These items can be provided directly to patients, or, in some local 
authorities, purchased through personal budgets. In order for personal budgets to be used to 
purchase equipment, local authorities must be satisfied that an item is necessary to help support 
social care needs and will help improve specified outcomes. Personal budgets cannot cover 
assistive technologies or equipment items that are eligible for funding from health care budgets 
or housing allowances (NHS). This demonstrates the importance of funding and reimbursement 
schemes being flexible to both new technologies and the needs of the individual.
In cost-effectiveness analyses in health care, Quality-Adjusted Life Years are often used as 
an outcome measure of effectiveness. However, there is an ongoing debate concerning the 
appropriateness of the use of this metric for decision-making in care of older adults. The World 
Economic Forum has reported on the case for investment in, and integration of, innovative 
technologies for health by financial services institutions. It includes recommendations for 
collaboration across the public, private and social sectors to ensure the prosperity of current and 
future generations of older adults and peace of mind for their children (Global Agenda Council 
on Ageing, 2016).
Continued increases in the cost of health care are driving stakeholder interest in reimbursement. 
Investment in new health care technologies is heavily dependent on whether there is coverage, 
coding and reimbursement. Payers increasingly expect new technologies to demonstrate 
better outcomes at equal or lower costs before investment. More hospitals are establishing 
value analysis committees to evaluate all new products prior to entering a hospital or clinic 
setting. Physicians are interested in products that help them meet quality metrics imposed 
by government and private payers. Perhaps most importantly, patients are becoming more 
educated and prefer interventions that improve quality of life at the lowest cost possible.
Most importantly, reimbursement assessment for new technologies should be conducted 
as early in the product design and development phase as possible. Such an assessment is a 
snapshot of the existing coding, coverage and payment landscape for a particular product. 
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It informs potential innovators what reimbursement challenges and opportunities exist for 
adoption of the product under consideration.
As discussed above, there has been a rapidly growing consumer market of digital medicine 
technologies, including smartphone health and wellness apps and health-centred wearable 
devices. This has been a result of the surge in use of connected devices known as the Internet 
of Things. The advantage of this rapidly growing consumer market is that the cost of devices 
will continue to reduce while devices and systems reimbursement become more technically 
advanced.
There is the potential to prescribe devices and apps which may provide information to support 
clinical decision-making and accelerate hospital discharge. The challenge for the acute hospital 
system, but also the longer care of older adults at home, is to put processes in place to ensure 
data from these devices are assessed for validity, that consent to access the data is appropriate, 
that storage of the data is correctly managed including consideration of whether or not there are 
implications for the national electronic health record system.
The private sector needs clearer guidance on what exactly is expected by health care systems, 
in terms of data collected, quality of that data, data privacy and security as well as financial 
reimbursement schemes. Otherwise the development of technologies with no health based 
scientific evidence for their use will continue to increase.
Policy options
There is a great deal of interest around digital technologies, but little widespread 
investment. A major hurdle is that existing reimbursement pathways designed for 
medicines, medical devices and surgical interventions do not facilitate the effective 
assessment and hence uptake of digital technology. They may need to be adapted 
and tailored.
4H. INTEGRATED DIAGNOSTICS AND DATA 
SCIENCE
The use of data science in the diagnosis of disease and management of health care has 
significantly expanded over the past decade. The applications of machine learning (artificial 
intelligence, AI) algorithms within the field of ageing research offer tremendous opportunities. 
Such methods applied to data acquired at a single time point and to data acquired longitudinally 
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can be employed to generate predictors of disease and offer new possibilities to early 
interventions. AI-derived biomarkers of ageing enable a holistic view of biological processes and 
allow for development of new methods to build causal models, extracting the most important 
features and identifying biological targets and mechanisms. These novel methods can be 
combined into a unified, seamless end-to-end biomarker development, target identification, 
drug discovery and real-world evidence pipeline that may help accelerate and improve 
pharmaceutical research and development practices (Zhavoronkov et al., 2019).
Machine learning and big data analytics is considered one of the transformative drivers 
underway for intelligent health care delivery systems (Istepanian & Al-Anzi, 2018). New datasets, 
both structured and unstructured, are beginning to appear that contain formal and informal 
medical knowledge as well as health data. The outcomes are clear: AI will in future perform full, 
descriptive, diagnostic, predictive and prescriptive analytics — paving a new “path” to healthier 
ageing for future older adults.
However, machine learning algorithms are currently far from being useable in the delivery of 
safe health care. They can provide decision support, rather than taking a lead in decision making. 
Algorithms applied to data from wearables are typically designed for people in perfect health. 
People with comorbidities require devices that measure, and account for, relevant parameters, 
and the patients and doctors receiving the data need to be trained in correctly interpreting and 
using it.
Policy options
Artificial intelligence offers tremendous potential for improving standards of 
diagnosis and care. While AI is a policy priority across several sectors, the ethical, 
legal and technical approaches must be tailored for an effective application to 
delivery of health care.
4I. UNIQUE ELECTRONIC HEALTH RECORD: 
INTEROPERABILITY, LEGAL AND ETHICAL 
ASPECTS IN EU COUNTRIES
In Europe, clinical documentation is increasingly carried out in electronic health record systems, 
with huge amounts of data stored in electronic format. Many European countries have invested 
in national e-health infrastructures, which are progressively communicating increasing volumes 
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of electronic health record data to support continuity of care and public health programmes: 
systems are defined (mostly by law) in Denmark, Finland, Israel and the UK (to a limited degree).
The technical capacity to roll out electronic health record systems already exists. However, the 
technical base, systems linking records, and data collected currently differ in content and formal 
description across countries and frequently within one country. Standards are not defined at a 
government level.
A unique electronic medical record within the European Union will improve patient care in 
several ways. As mobility between EU countries becomes more common, access to medical 
records in another country will likely have an impact on citizens’ health.
One of the major hurdles to adoption of electronic health records in a Member State is finding 
an agreement across medical disciplines on the minimum data content of the electronic record. 
At EU level, in order to facilitate the Directive on Patient Rights in Cross-Border Health Care 
(European Commission, 2011), it has been proposed that a summary of a patient’s health record 
could be presented as an extract (European Commission, 2010). The use of different languages 
for an electronic health record, and potential difficulties to understand the record by health care 
professionals in contact with a patient, represent a challenge to widespread coordinated use at 
European level. The European Commission announced in October 2018 that a recommendation 
to establish a European Electronic Health Record is part of its work programme for 2019 
(European Commission, 2018b).
A European electronic health record system could contribute to the flexibility of older people 
to travel or live abroad and still receive somewhat co-ordinated care. Analysis of clinical data 
present in electronic health records across European countries will assist health authorities 
to propose evidence-based public health measures, as well as promote the discovery of new 
knowledge about diseases and effective treatments.
As the society ages, the EU will have a more heterogeneous population. To maximise the use of 
the electronic health record system, medical records should:
  have a common language with a minimum database that can be transferred easily from one 
setting to the next, so the person carries the most relevant social, functional (comprehensive 
geriatric assessment) and medical data between hospitals, countries or settings (including 
nursing homes or long-term care)
  assess treatment effectiveness and outcomes, as well as longitudinal patient monitoring
  ease recruiting of the required number of patients, with specific inclusion and exclusion 
criteria, for clinical studies. This is particularly the case for older people (under-representation 
of frail older patients in clinical trials is commonplace)
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  enhance cross-country studies, improve hypothesis testing and early detection of safety risks 
in different health care systems across the EU
The EU project “Electronic health records for clinical research” has developed a platform that 
can utilise de-identified data from hospital systems, in compliance with the ethical, regulatory 
and data protection policies of the EU General Data Protection Regulation (Council of the 
European Union & European Parliament, 2016) and additional requirements of each participating 
country. The project could enable a scalable and flexible approach to reusing electronic health 
record data, which can bring safe and effective innovative medicines more quickly to the market 
and enrich medical research and knowledge.
Nevertheless, there are many obstacles that have to be addressed. These include:
  guarantees of patient privacy and confidentiality
  unification of legislation related to health in each country
  data storage and centralisation
  differences in clinical practices across the EU of recording data or treatment
These challenges must be carefully considered as the European Commission develops its 
European electronic health record proposal in 2019.
Policy options
It is recognised that transition to an electronic health record is highly challenging 
within health systems, and even more so to coordinate them at EU level. The 
benefits of coordination, not only for receiving care abroad, make it well worth the 
attempt to find an agreement across social and medical disciplines on the minimum 
data content of the electronic record.
4J. EXAMPLES OF THE USE OF TECHNOLOGIES 
IN CARE OF OLDER PEOPLE
Technologies for falls
Technologies are increasingly employed in the detection of falls risk factors (heart rate 
and rhythm), detection of falls and detection of an individual lying on the ground after a 
fall. Technologies can be wearable, implantable (e.g. loop recorder) or ambient in nature. 
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Technologies are further classified by whether they detect falls automatically or need to be 
activated.
Wearable technologies encompass two different types of hardware: inertial sensors (e.g., tri-axial 
accelerometer) and locating systems (GPS), or a combination of both. Ambient technologies 
include vision sensors (e.g., cameras), sound sensors (e.g., microphones), radar sensors (e.g. 
Doppler radar), infrared sensors and pressure sensors (e.g., floor sensors), or a combination of 
them (Lapierre et al., 2018).
Technologies that need to be activated include wall-mounted systems (e.g., warning cord) and 
wearable systems (e.g., wristwatch or pendant alarms linked to a 24/7 call centre). Limitations 
of such technologies are common: if an older adult is unconscious, confused or cognitively 
impairment or injured, he or she cannot activate such alarms. Moreover, 80% of older adults 
do not use their alarm button after a fall, due to difficulty in activating it, or for fear of disturbing 
carers (Fleming & Brayne, 2008; Tinetti et al., 1993). Automatic fall detection technologies (e.g., 
accelerometers) and implantable fall detection technologies may address this issue by detecting 
a fall and automatically sending an alert to a carer or a call centre. The perception of older adults 
toward automatic fall detection technologies is favourable (Hawley-Hague et al., 2014).
Figure 31. Falls prevention technology (Hamm et al., 2016).
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Assistive robotics
In recent decades, assistive robotics has become a theme of research and development. The 
main benefit of implementing robotics is the potential to automate tasks that are often viewed as 
mundane or repetitive. Use of robotics has become very common in minimally invasive surgery, 
specifically in orthopaedic and neurosurgical procedures, and the scope of robotics in health 
care is expanding.
Dahl & Boulos (2014) provide an overview of current and potential applications of robotics 
in health and social care. This report classified robotic systems by applications and tasks, 
experiences, capabilities, commercialisation and platforms. Issues for successful implementation 
of robotics in health and social care include personalisation, user safety, reliability, robustness, 
sustainability, usability and user acceptance, ethical concerns, cost effectiveness, impact on the 
health workforce shortage and issues of liability.
Abdi et al. (2018) report on studies using socially assistive robots in the care of older adults. 
They identified five roles for such robots: affective therapy, cognitive training, social facilitators, 
companionship and physiological therapy. Besides technical challenges, the rise of assistive 
robotics poses ethical and sociological questions. Regulations and standards being developed 
focus on education and dissemination initiatives including robo-ethics and, in particular, on 
human-robot interaction and human dignity in assistive situations (Torras, 2016; Torras, 2018). The 
objective of these guidelines for students and professionals (robot designers, manufacturers and 
programmers) are also valuable for end users and the general public. There are other challenges 
with robotics in social care including acceptance and user-centred design, social impacts and 
issues of autonomy and control (Share & Pender, 2018).
Key needs are to recognise human intentions and build a user model so as to personalise 
robot skills to match the degree of mobility and user preferences (Riek, 2017). An open issue 
shared with other types of robots is their need to semantically ‘understand’ situations, instead 
of just reacting to them in a mere perception-action association. Several European projects 
address these and related technical challenges of assistive robotics (Tzovaras, 2015; European 
Commission, 2018d).
Policy options
Two areas where pilot projects are beneficial, based upon existing evidence, are 
technology to prevent falls and assistive robotics. Such projects should try and 
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identify ethical issues to address through policy before wider adoption in society in 
future.
4K. CONCLUDING REMARKS
The deployment of health care technologies will expand in the next decades and can address 
some of Europe’s health care challenges. While these can assist in the detection and diagnosis 
of disease, they can also be harnessed to promote health, maintain functional ability, and extend 
healthy life expectancy.
Including older individuals and the health care workforce as partners in the design of health care 
technologies will help to offset some of the usability, data privacy and interoperability issues 
that are currently a concern. With increased training and education on the integration of new 
health care technologies and on the interpretation of data from these solutions, health care 
technologies have the potential to counterbalance some of the shortfall in health care workforce 
in future years.
Policy options
It is vital that adoption of any new health care technology is based on scientific 
evidence and that such technology should redress not reinforce health care 
inequalities.
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Chapter 5. Intensifying skilled health 
workforce training
This chapter first identifies the current and near-future shortages in the health care workforce in 
the EU and then explores the many specific and interconnected challenges in addressing these 
shortages, bearing in mind that “without a health workforce, no care is possible” (Campbell et 
al., 2013). The increasing rate of population ageing in the EU highlights how this problem needs 
urgent attention from all EU policymakers and stakeholders as well as a concerted action plan 
from European ministries of education, health, finances and labour.
Solving the problem of workforce shortages starts with youth as well as the general public and 
the media, and requires changing the overall negative perception of ageing. A change in mindset 
is needed to improve how health care professions are valued and to drive a more ethical 
recruitment of health care professionals, free of discrimination on the basis of age, gender or 
race. In addition, education of health care professionals must be transformed by incorporating 
adopting vibrant and attractive training programmes and must be accompanied by the prospect 
of better working conditions. Acting quickly and over the long term on the aforementioned 
issues is essential to provide the substantially increased number of skilled health and social care 
professionals needed in order to care for the ageing population of the EU.
5A. ESTIMATING AND UNDERSTANDING THE 
LACK OF HEALTH AND SOCIAL CARE 
WORKERS IN THE EU
The health workforce embodies “all people engaged in actions whose primary intent is to 
enhance health” (WHO, 2016b) and includes (Eurostat, 2018e, 2018f; Skills Panorama, 2018):
  Health care professionals (physicians, nurses, midwives, paramedical practitioners, dentists, 
pharmacists and veterinarians), who constitute 29.6% of the total EU health workforce.
  In 2016, there were 18 million physicians in the EU; of these, 38% were aged over 55 years, 
and 49% were women.
  The number of nurses varies widely among EU countries; in Luxembourg there is 1 nurse 
for every 86 inhabitants, while in Romania there is one nurse for every 1526 inhabitants.
  Associate health care professionals (medical, laboratory and radiology technicians, as well as 
community health workers), who represent 26.6% of the total EU health workforce.
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  Care workers (mainly health care assistants supervised by health professionals or associate 
professionals), who, together with daily logistical support (cleaning staff, ambulance drivers, 
etc.), correspond to 28.9% of the EU health workforce.
  Allied health professionals (administrators, lawyers, librarians, curators, architects, engineers, 
urban planners, etc.), who make up another 14.9% of the EU health workforce.
It is interesting to note that, in 2017, health professionals in the EU totalled 6.44 million, of 
which 5.3 million of these were health and social workers; moreover, only 1.8% were working 
in education (Skills Panorama, 2019b). Meanwhile, 70% of European health care budgets are 
allocated to salaries and other expenses directly related to health workforce employees 
(European Commission, 2008)
Among OECD countries, the increase in health workforce numbers between 2000 and 2014 
reached 48%, while the agriculture and industry sectors lost a significant number of workers 
(James, 2016). Despite this huge increase, the estimated shortage of health care professionals 
in 2020 at the EU level was estimated in 2012 to reach almost 1 million; similar shortage rates 
concerning physicians, nurses and associated health professionals were also predicted (Insight, 
2012). It was demonstrated that a close relationship exists between health workforce staffing and 
health outcomes, specifically in high-income settings (DeLuca & Soucat, 2013).
Health care is a complex and human resource-intensive sector. To ensure and sustain health 
care, a large, effective and skilled health workforce is required, not just to fulfil both the current 
and future needs and expectations of the population, but also to adapt to the evolving health 
care services provided in the EU (WHO, 2016a).
Without urgent, major and multi-targeted efforts, the shortage in the EU health workforce will 
continue to increase. According to WHO calculations of aggregate density, based on the number 
of physicians, nurses and midwives needed for every 1,000 inhabitants, in 2030 the deficit 
of health care professionals in Europe (51 countries) will reach 4.1 million, broken down into 
0.6 million physicians, 2.3 million nurses and midwives, and 1.2 million dentists, pharmacists and 
associated health specialists/care providers (WHO, 2016a).
The factors shaping the health workforce crisis are well defined. In particular, three 
interconnected groups of factors influence health workforce robustness:
  Internal factors directly related to health care professionals themselves, who have 
grown older and have become overburdened and overstressed by increasingly difficult 
working conditions, changes in care delivery models, and skill mismatches, often without 
opportunities for lifelong learning or career advancement. Moreover, they often experience 
undervalued social status and difficulties trying to adapt their lifelong practice to new 
administrative constraints, leading to burn-out and professional attrition.
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  Other internal factors, linked to changes in patient profiles: patients are older, requiring 
more complex, holistic care as they suffer from chronic diseases, multimorbidity, and loss 
of physical independence and autonomy. Finally, their care demands and expectations 
have risen considerably. Aged multimorbid patients with chronic diseases, frailty or disability 
and polypharmacy require a holistic care strategy consisting of coordinated and integrated 
care that includes polypharmacy management and emerging technology (Busetto, Luijkx, 
Calciolari, González Ortiz, & Vrijhoef, 2017) (Rogers et al., 2018).
  External factors closely related to the financial and management constraints of health care 
systems, which have planned insufficiently for the strong impact of new technology in daily 
care and have underestimated the need for the continuing education of their employees.
All these factors raise the difficult question of how to retain the health care workforce and 
improve its robustness to meet current and future needs.
5B. ADDRESSING THE SHORTAGE OF THE 
HEALTH WORKFORCE: RECRUITMENT 
CHALLENGES
To assure the highest possible quality of care, an optimum quantity of skilled health workers 
is required, which necessitates developing multiple long-term initiatives, keeping in mind that 
nurse accreditation takes 3–4 years of training, while general practitioners need 6–7 years of 
mandatory training, and specialists even more.
EU capacity-building and policy action aimed at the health workforce depends, at the national 
level, on the collaboration among the ministries of health, education, labour and finances of 
member states. Their synergic actions first need to raise sufficient funds and establish public-
private partnerships for job creation, eliminating gender inequities and promoting youth 
employment (High-Level Commission on Health Employment and Economic Growth, 2016).
In addition, transnational collaboration will be required to rethink and adjust health services to 
adapt them to the new needs of the population, the mobility of health professionals and the 
integration of technological progresses in care delivery. In any case, careful monitoring of the 
health labour market is essential for adjusting and evaluating the long-term action needed 
(High-Level Commission on Health Employment and Economic Growth, 2016).
  Without a doubt, the initial steps for building a robust health workforce must begin in 
schools; the ‘whole school, whole community and whole child model’ demonstrated that 
acting on multiple educational components, from health education to health services 
and environment and family–community engagements, is essential for young students to 
develop and maintain healthy behaviours, even up to 15 years after their involvement in such 
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comprehensive programmes (Michael, Merlo, Basch, Wentzel, & Wechsler, 2015). However, 
these programmes failed to demonstrate that participating students will orient their career 
toward health care professions.
  School teachers and counsellors in elementary and middle schools must recognise the 
value of students who tend to the needs of others and exhibit academic excellence and 
enthusiasm for combining knowledge with specialised skills. Once these students have been 
identified, the potential benefits of exploring the health workforce should be suggested to 
them. Waiting until high school to expose students to health care professions may be too 
late. In any case, early exposure to health care responsibilities is a vital step in career choice, 
development and sustainability (Williams, 2018).
  In parallel, family members and the general public should be informed of the current 
evolution in health care systems and the great career opportunities that lie in this multi-
component and promising domain.
  The main determinants of choosing a career in health care are, for general practitioners 
in the UK, firstly, personal social engagement with a holistic approach to health, as well 
as a lifestyle oriented toward a life-work balance. This choice is favoured by the medical 
curriculum of training programmes, which focus on general or family medicine practice. As 
mentioned earlier, the quality and duration of initial exposure to general practice, as well as 
the relationships with general practitioner colleagues, have a strong influence on final career 
decisions (Marchand & Peckham, 2017). As reported below, these criteria are similar for other 
health care professions, including nursing.
  Whichever the health care profession, although career choice and training is a key period, 
initial employment is also a decisive period, as multiple negative factors may intervene. A 
survey conducted among 23,000 nurses in medical and surgical wards in 10 European 
countries showed that 33% of nurses intended to change jobs within the next year, while 
9% intended to permanently leave the profession (Heinen et al., 2013). Such results have 
dramatic consequences: the quality of the care provided by nurses suffering from burnout 
was proven to be deleterious to patient health, resulting in a higher rate of pressure ulcers, 
nosocomial infections and in-hospital mortality. Institutions employing nurses suffering from 
burnout witnessed much higher costs than those that would have been needed to improve 
the working conditions of their health care workers (Buchan & Catton, 2018).
  The ideal way to divert health care attrition (approximately 10% per year) driven by worker 
dissatisfaction is to improve the health care system itself. Reforming health service delivery 
appears essential to increase both the recruitment and retention of health care workers. The 
reform of health care services must:
  prioritise health promotion and disease prevention;
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  optimise scopes of practice, including task shifting, or the rational distribution of tasks 
among health care workforce teams, to allow for accessibility, equity and good quality 
health care services;
  build stronger linkages between health and social sectors;
  favour lifelong learning
  propose career paths with prospects for advancement.  
(High-Level Commission on Health Employment and Economic Growth, 2016).
  Migration of health care workers is not the solution. Often frustrated by a weak health system 
infrastructure and poor living conditions in their home countries, health care workers who 
choose to migrate to higher income countries are attracted by the promise of higher salaries 
and better working conditions. Nevertheless, the loss of health care professionals from poor 
to rich countries is associated with high costs for the poor countries (DeLuca & Soucat, 2013). 
For these reasons, WHO made important efforts to promote single international standards 
in the attempt to regulate the worldwide migration flow of health care professionals. Not 
surprisingly, the recognition of foreign health care credentials appears to be the best way to 
monitor the international migration of health care professionals (WHO, 2014).
5C. ADDRESSING THE SHORTAGE OF THE 
HEALTH WORKFORCE: EDUCATIONAL 
CHALLENGES
Training and support of non-professional carers
Informal caregiving is an essential part of care supply all over Europe, as older adults in many 
countries prefer to receive help at home from their relatives, especially in early stages of care 
dependency (Mair, Quinones, & Pasha, 2016). 
The majority of informal carers across Europe are between 55–65 years old (Colombo et al., 2011), 
and often in a potential “sandwich position” between older parents and younger children and 
grandchildren in need of support (Grundy & Henretta, 2006). Typically, spouses, adult daughters 
or daughters-in-law are the primary carers. Older childless women (often also without partners) 
tend to compensate for a lack of support in older age by drawing on their broader social network 
and formal carers (Deindl & Brandt, 2017).
Informal carers assume many different responsibilities in providing care support for ill or older 
family members. They coordinate logistics, care management, advocacy, medical interpretation, 
and medical decision-making, performing many functions that professional care workers 
perform on a paid basis (Phillips et al., 2016).
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There is a need to provide care-specific information to informal carers. Unfortunately, existing 
print-based carer education materials often fail to adequately match the health literacy 
skills and information needs of their target audience. Patient associations are very useful for 
sharing practical information with informal carers. Individualised, structured multicomponent 
interventions have shown to be a promising approach to relieve the burden of informal carers 
for people with dementia (Berwig et al., 2017). Exchanges and collaboration with health care 
professionals are also highly recommended, as well as education in health care technology, 
which can support in-home care.
Moreover, in order to encourage informal care, it is important to make affordable formal care 
alternatives available to all socioeconomic groups, which would enable an adequate care mix 
and facilitate the reconciliation of care, work and leisure (offering much-needed rest to carers), 
thereby increasing care quality and reducing care burden for all parties involved (Brandt, 2013).
Training of health care professionals
Geriatric medicine is a meta-discipline that transcends and informs all other medical disciplines 
(Tinetti, 2016). Its knowledge base and principles should guide all health care and allied 
professionals involved in caring for older adults. Over the past decades, several important social 
and health care system changes have occurred due to the introduction of new technology, 
including the Internet of Things, smartphones and wearable devices. New concepts in care, 
such as value-based and population-based health care, consider each individual as a consumer 
and decision-maker in every care opportunity available. Despite these changing trends in care, 
unfortunately health care education has not changed (Simpson, Leipzig, & Sauvigne, 2017).
Bearing in mind that ageing represents a major EU health care priority, evidence-based 
geriatric education must move forward quickly to increase global health literacy, offer 
attractive education and training, streamline workforce planning and staffing, and improve 
performance management and working conditions (WHO, 2006). Addressing these domains in a 
comprehensive manner offers the opportunity to overcome the traditionally fragmented health 
care workforce approach and to fully harness the synergies of human resource interventions to 
thereby favour integrating health care systems across the EU.
Perception of ageing and care for older patients
The most urgent need is to effect a major change in the perception of ageing and care for 
older patients in all health care professional schools (medical, nursing, dentistry, pharmacy, 
physiotherapy and social work, among others).
The previous chapters highlight how ageing is an inescapable process and how patient profiles 
change with age. Furthermore, as explained earlier, population ageing is a trend that will 
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continue to increase over the next several decades. In light of such conditions, the fact that many 
European health care schools, some of which are highly recognised, do not provide any training 
in geriatrics is a major omission. Moreover, even when undergraduate training programmes 
in geriatrics exist, they are often limited in hours and discredited by medical specialists who, 
notably, increasingly perform geriatric assessment to enhance the quality of their clinical 
decisions affecting aged patients. This occurs not so much in internal medicine, but increasingly 
in cardiology, cardio-surgery and orthopaedics.
The Geriatric Medicine Section of the Union of European Medical Specialists compiled the 
curricular contents used in European health care schools and performed a modified consensus 
Delphi process to develop a European undergraduate programme in Geriatric Medicine, which 
has been widely endorsed by many European countries (Masud et al., 2014). The curriculum 
outlines ten broad learning domains:
  Graduates should respect patients regardless of their age.
  Graduates should know about and understand normal and abnormal structure and function, 
including the natural history of human diseases, the body’s defence mechanisms, disease 
presentation and responses to illness.
  Graduates should know about common medical conditions in older people.
  Graduates should have the special skills needed to conduct a history and perform an 
assessment in an older patient.
  Graduates should know about and understand the principles of treatment including the 
effective and safe use of medicines as a basis for prescription.
  Graduates should recognise the importance of responses to illness, providing support for 
recovery and reducing or managing impairments, disabilities and handicaps.
  Graduates should know about and understand the main ethical and legal issues in the 
international and national context in which they will encounter them.
  Graduates should know about, understand and respect the roles and expertise of other 
health and social care professionals.
  Graduates should know about care of older patients in different settings.
  Graduates should know about specific aspects relevant for health and social care for older 
persons in their region/country.
These recommendations for undergraduate medical programmes could easily be applied 
in other health care professional schooling programmes (for nurses, pharmacists, dentists, 
social workers, and others). A universal programme in geriatrics bringing medical students 
together with students from different health care professional schools would prove to be an 
excellent option for building competencies in an interdisciplinary way. One of the difficulties in 
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implementing these recommendations is that often the professors themselves lack practical 
clinical experience in geriatrics, and their knowledge is not sufficiently updated in the domains 
they teach; this is especially true in rapidly evolving fields, such as sarcopenia, frailty, early 
diagnosis of dementia, etc.
Lack of academic resources
The lack of faculty and academic resources in geriatrics and gerontology must be addressed 
urgently.
In many EU countries, there is still a lack of available faculty and resources in geriatrics and 
gerontology to support sustainable health education with dynamic, attractive and updated 
curriculums. This shortcoming was partially addressed in the 1990s by the initiative of a few 
academic leaders who decided to ‘train the future leaders in geriatric medicine in Europe’ by 
breaking with traditional classroom teaching and offering hands-on training that built on well-
defined learning objectives and incorporated the use of technological support tools (Michel, 
1997). Fortunately, this initiative is still successful in Europe and continues to expand worldwide 
(Michel & Cha, 2015).
This programme was a precursor of later training in geriatrics, with great impact on not just 
health universities and schools but also on associated professional schools, in fields such as 
architecture, design, engineering, urban planning and management. Training in the field of 
ageing needs a well-balanced education that goes beyond academic knowledge and skills to 
also develop aptitudes for listening to and understanding the life priorities and needs of older 
adults, without prejudice. Mutual respect of professional competencies is absolutely essential 
to create synergies among multidisciplinary care teams. Interpersonal and communication skills 
are fundamental, as well as the ability to cooperate in flexible, competency-driven hierarchies, 
along with a willingness to continuously grow and update skills and knowledge.
An interesting policy option worth exploring is to formalise and support European geriatric 
medicine, both politically and financially. More efforts at the academic level are needed to 
engage general practitioners in continuing education in geriatric medicine and to actively involve 
younger generations in developing new approaches to caring for current and future aged adults.
New teaching techniques
New teaching techniques need to be transversal and interactive. Training platforms offering case 
simulation to learn technical gestures on mannequins represent a first practical model that does 
not involve any risk for patients. Several different models are used in simulation centres that, 
through the repetition of gestures, teach the implementation of technical skills in the context 
of more comprehensive care. The results of a recent meta-analysis of 40 evaluation studies 
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suggest that simulation-based nursing educational interventions have strongly positive effects, 
particularly in the psychomotor domain. However, these need to be complemented by other 
more traditional educational interventions (Kim, Park, & Shin, 2016).
Training platforms involving virtual patients are interactive computer simulations that are 
increasingly used as learning activities in modern health care education, especially in teaching 
clinical decision making (Dafli et al., 2015). The shortage of geriatrician faculties, the declining 
lengths of inpatient hospital stays, and the increasing emphasis on competency-based 
learning argue for the further exploration of the role of virtual patients in geriatrics education. 
Virtual patients are case-based computer programs that combine textual information with 
multimedia elements, such as audio, graphics and animation (Tan, Mulhausen, Smith, & Ruiz, 
2010). Virtual patient activities have been shown to enhance student performance during clinic 
visits, and students felt that virtual patients realistically simulated real patients (Taglieri, Crosby, 
Zimmerman, Schneider, & Patel, 2017).
Complex case simulation scenarios, followed by rigorous debriefings, contribute to patient 
safety, health care worker wellbeing and quality of care. Global analysis applying knowledge, 
skills and attitudes helps determine the major characteristics of the tasks to be simulated; for 
example, assessment of uncontrolled chronic pain in an aged patient implicates optimal timing 
of prescription of adequate medications and follow-up of outcomes when implemented in a 
relevant learning setting (Dieckmann & Krage, 2013). This learning model could greatly benefit 
geriatric medicine, where it has gone unharnessed until now. A preliminary application in clinical 
pharmacy yielded relatively positive results (Gustafsson, Englund, & Gallego, 2017).
When compared with no intervention, virtual patients were found to be superior, with large effect 
sizes seen in knowledge, clinical reasoning, and other skills. However, when compared with 
non-computer instruction (other simulations, standardised patients, lectures, written materials, 
etc.), the effect sizes of studies employing were found to be much smaller for outcomes such 
as satisfaction, knowledge, clinical reasoning, and other skills (Cook, Erwin, & Triola, 2010). The 
paucity of cost comparisons between real patients and virtual patients does not enable any 
conclusions to be drawn yet.
Information and communication technology
The use of ICT effectively complements traditional education.
Distance-learning involves internet delivery of education using a wide variety of instructional 
designs, including synchronous and asynchronous formats (tele-teaching, video transmission, 
and teaching methods based on information and communication technology, including Massive 
Open Online Courses (MOOCS) and Small Private Online Open Courses (SPOOCS) (Wong, 
Greenhalgh, & Pawson, 2010). Many studies indicate that internetɛbased learning can be just as 
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effective as more traditional forms of education and training (WHO, 2017). However, a recent 
WHO-funded review of internet-based training for health care professionals found that engaging 
learners in an online course from start to finish is a far bigger challenge than developing on-line 
course design and content (WHO, 2017).
Blended teaching activities consist of a combination of self-directed learning methods entailing 
traditional knowledge transfer including both e-learning and classroom teaching. It facilitates 
learning content uptake at all stages of life-long learning. Predefining the overall topics and 
learning objectives, as well as detailed objectives for all learning phases, is mandatory for 
blended learning training to be effective. The combination of self-directed and face-to-face 
learning may be supported and enhanced by patient feedback for students. Integrating MOOCS 
into a traditional teaching activity is not so easy and involves specific requirements and training 
of leaders (de Jong et al., 2019). Predefining the overall and detailed learning objectives for each 
professional profile and for each phase of education is mandatory for sustainable educational 
training, in addition to the regular evaluation of support materials. The need for regularly 
updating course contents is exemplified by the 2010 definition of sarcopenia, which became 
outdated when a new definition and diagnostic criteria were published in November 2018 (Cruz-
Jentoft et al., 2019).
Training health professionals in the use of algorithms for machine learning and big data can 
improve decision making and coordinated care. Artificial intelligence can generate relevant 
scientific knowledge but must be applied with operational clarity for collecting data linked with 
online devices while protecting personal data and understanding the rights of patients and other 
ethical concerns. A good example is a supervised machine-learning method that determines a 
“Disease State index” allowing for the prevention of dementia 10 years before its onset (Pekkala 
et al., 2017), or the prediction of cancer survival rate based on the measurement of normal gait 
speed (Sasani et al., 2019).
Multidisciplinary scenarios
The use of multidisciplinary scenarios is the best and most attractive way to train geriatric teams. 
Geriatric care is characterised as teamwork, which is the only way of providing integrated care 
to aged patients. Health care professionals need to be deployed in an efficient manner that 
adequately shares responsibility and accountability for clinical processes and care outcomes. 
Geriatricians who lead and coordinate multidisciplinary teams need to define educational 
requirements, choose a variety of teaching methodologies, enhance competencies, and favour 
inter-professional work without forgetting to promote career pathways. It is the only way to 
prepare the next generation of health care professionals so that they may adapt their knowledge 
to the future care needs of patients. The only way to achieve these goals is to favour the training 
of different categories of health care professionals. (WHO, 2013)
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Multidisciplinary scenarios and role-play training are useful for students, resident doctors 
and health care professionals to learn to work together to face various practical situations, for 
example:
  Adopting the right attitude for responding to clinical situations, e.g. when a pager message is 
received while on call during a nursing home rotation. The effectiveness of structured role-
playing didactic sessions for different learners (geriatric medicine fellows, family medicine 
residents and faculty, and nurse practitioner students) has been demonstrated for all players 
involved (Yuasa et al., 2013).
  Developing a tactful, clear and empathetic style of communication when delivering bad 
news (for example, in the case of an Alzheimer’s disease diagnosis or at the end of life of 
an aged cancer patient). Multidisciplinary training aims at developing skills with authentic, 
real-life applications and improves the ability to speak in terms that both patient and family 
members can understand. These exercises allow for the discussion of ethical questions 
regarding autonomy, dignity and respect of the patient through shared decisions, taking into 
account the patient’s life priorities, fears and expectations (Spear, Guillen, Elliott, Roettger, & 
Zukowsky, 2013).
Co-construction of shared learning between patients and professionals is desirable and 
appreciated. Sharing and understanding patient experiences is an important contribution to 
training health care professionals. Thus, co-teaching joins patients and health care professionals 
to learn together and exchange points of view, feelings and expectations of each other. Such 
innovative programmes must pedagogically address the questions of specific objectives and 
characteristics of the integrated education of health care workers and patients. Research on 
standard and validated methods to obtain and harness the value of patient experiences should 
be developed and assessed (van de Pol et al., 2017).
These new multidisciplinary training methods emerge as the most effective tools for building 
a solid team capable of delivering the best quality care possible to older adult patients with 
complex medico-psycho-social conditions.
Alignment with previously trained professionals
Alignment is needed between new models of care and previously trained health care 
professionals.
The high rate of burnout and attrition among health care professionals is often linked to 
their dissatisfaction or frustration with the health care system in which they work. Alignment 
between the hopes and wishes of the health workforce is often in discordance with increasingly 
compulsory administrative burdens and constant economic constraints. National, regional and 
local health care administrations are not always aware of the numerous changes that health 
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care professionals have had to face during the last few decades: older, complex and dependent 
patients with increasing consumer demands; spectacular advances in medical and scientific 
knowledge; the introduction of high technology in daily care; the development of new treatment 
methods; and the reinforcement of health promotion.
These rapid and continuous changes in the role of health care professionals strongly necessitate 
the need for a lifelong learning programme with regular and mandatory re-certification, at least 
every five years.
Figure 32. Fig ??: Alignment between new models of care and previously trained health care professionals (Prof. 
Jean-Pierre Michel, designed for the TFA report)
The patient needs and demands of today are more and more specific. Complementary training 
enabling task shifting is essential, allowing for career advancement. Among the numerous other 
training opportunities possible in geriatrics, two are briefly described below.
Training of long-term care workforce
Long-term care for all ages is based on the existing geriatric care model, which includes: 
leadership committed to combating ageism, reliable use of evidence-based care in favour of 
advanced care planning, and identification of surrogate decision makers. Furthermore, it includes 
regular evaluation of staff members who are specifically trained and proficient in the care of 
older adults, and, finally, high-performing care teams focused on measurable outcomes.
Older adults accessing long-term care wards should expect a minimum level of knowledge 
from all their providers, and not just from those who provide direct, hands-on care. Care often 
focuses merely on the “basic needs of residents” rather than on their individual preferences so 
as to ensure wellbeing, a meaningful life and respect. This may, for instance, be achieved by 
introducing variety in daily activities and offering stimulating and diverse environments. Moreover, 
long-term care staff members would benefit from cultural competency training. Specific long-
term care issues are often lacking in classical education programmes for physicians and nurses, 
such as elder abuse identification, mouth care, pressure-ulcer prevention and management and 
coping mechanisms for dealing with behavioural and/or psychological disorders in demented 
patients, etc.
The earliest possible integration of such long-term care challenges and more attractive 
transversal training programmes, with multidisciplinary case simulations and greater overall 
involvement of nurse practitioners in medical and nursing education, are urgently needed 
(Donaldson & Vacha-Haase, 2016).
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Training in palliative medicine and end-of-life care
Over the past few decades, the majority of aged populations have experienced prolonged 
burdensome chronic diseases and functional decline at the end of life, necessitating increased 
long-term care. This explains why older adults die more frequently in institutional settings, 
despite their preference for dying at home (Fleming et al., 2017). These changing patterns 
preceding death in older adults require a shift in approaches to care at the end of life (Prsic & 
Teno, 2017).
Integrating palliative care education into all health care systems is essential to respond more 
effectively to alleviate the burden of pain, suffering, and severe distress associated with life-
threatening or life-limiting conditions. A recent survey demonstrated the need for all health care 
professionals to improve management of pain and other physical and psychological symptoms 
in the final hours and days of life, cope with requests to hasten death, handle vital prognosis, 
address spiritual needs, and, in general, better manage the final hours and days of life (Carroll, 
Weisbrod, O’Connor, & Quill, 2018).
5D. ADDRESSING THE SHORTAGE OF THE 
HEALTH WORKFORCE: SUSTAINABILITY AND 
RETENTION
As discussed earlier, the factors that influence the retention of health care workers are complex 
and interrelated. They are shaped by:
  cultural and educational roots
  family background
  financial rewards often linked to the potential benefits of continuing education in institutions 
where career advancement is possible
  employment organisation and human resources management, which play a role even more 
important than clinical infrastructure
  recognition and appreciation of the work performed, as well as the possibility of task sharing 
and shifting, often in close relation with mentoring and relationships with colleagues on the 
team (WHO, 2010).
What appears clear is that worker retention depends on a set of individual factors and choices 
or preferences. Care organisations can only propose a range of administrative options or 
interventions: financial incentives, flexibility of working hours, career ladder, lifelong education, 
etc. Closing the gap between the internal and external factors is left to the management team 
who plays essential roles for retaining the health workforce.
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‘Magnet’ hospitals and care facilities (Buchan & Catton, 2018), in which health care organisations, 
encompassing both administrative and health professionals, attract and retain highly qualified 
health professionals and care workers, thus allowing for the best quality-price ratio possible, are 
based on the criteria of:
  supportive and participatory management
  adequate staffing
  flexible working schedules
  clinical career opportunities
  professional autonomy and responsibility
  in-service continuing education
This section has prioritised many of the workforce problems common to health care institutions 
in all EU countries, over the important topic of geographical regions that are underserved 
in terms of health care. Personal and family choices undoubtedly interact with professional 
decisions. Cultural roots within regions also must be considered, as well as ‘pre-service’ 
education, requiring health care candidates to evaluate whether they have the sufficient personal 
skills and attributes (confidentiality and communication abilities) to cope with the balance 
between work and leisure that awaits them and, at the same time, to serve the care demands 
of the local community. These points are critical, as very often regions that are underserved in 
terms of health care have the poorest community infrastructures and are neglected by central 
governments.
5E. ATTESTING TO THE ROLE OF THE HEALTH 
WORKFORCE AS THE CENTRE OF ROBUST 
HEALTH SYSTEMS
Several strands of evidence demonstrate the truth of the WHO statement that “the health 
workforce is the backbone of strong, resilient health systems” (High-Level Commission on Health 
Employment and Economic Growth, 2016):
  Good health contributes to economic growth; one extra year of life expectancy was shown to 
raise steady-state GDP by about 4% (Bloom, Canning, & Sevilla, 2004)
  Investments in health systems enhance inclusive economic growth, including job creation; an 
additional 2% GDP investment in education, health and social service  
has increased overall employment rates by 2.4 to 6.1% (International Trade Union 
Confederation, 2016).
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  Expenditures on health are associated with productivity gains in other sectors; health sector 
development has had a greater effect on manufacturing than financial development itself 
(Rajan & Zingales, 1998)
For all of those reasons, recruiting, developing and maintaining a skilled health care workforce 
needs a strong political boost, including coordinated actions among the ministries of health, 
education, labour and finances of all EU member states. A new and improved alignment 
between the needs, demands and expectations of the ageing population, and an adequate 
number of skilled health professionals responsible for their care, are absolutely essential.
Changes in the perception of ageing must take place immediately, beginning in primary 
school and continuing through associated professional education in fields such as architecture, 
engineering and urban planning, without neglecting the crucial and positive impact that the 
media may have.
Public perception of ageing constitutes a major priority, keeping in mind that, overall, Europe 
(51 countries) will suffer from a deficit of 4.1 million health workers by 2030. To address this 
impressive challenge, public and private partnerships must be quickly established to develop 
vibrant, blended and sustainable inter-professional workforce education programmes with 
personalised support, lifelong learning, certifications and re-certifications. Furthermore, an 
attractive career ladder and appropriate opportunities for easing the burden of the underserved 
regions in all EU countries are desperately needed.
5F. CONCLUSION
Health care corresponds to a complex and human resource-intensive sector. An adequate 
number of skilled health professionals is needed to assure an optimum functioning of health 
care services. However, the health workforce in Europe is currently facing a shortage linked 
to multiple factors, including the ageing of health care professionals, the new needs and 
expectations of a growing number of aged patients with complex conditions, and difficulties in 
adapting to new health care services, including increasing high technology in management and 
care delivery. Currently, the EU is lacking almost 1 million health care workers, a trend that will 
exponentially worsen until 2030, when a shortage of almost 4.1 million health care professionals 
is expected in the whole Europe. Multiple strategies are required to overcome this crisis:
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Policy options
Without urgent, major and multi-targeted efforts, the shortage in the EU health 
workforce will continue to increase. The attractiveness of a career in health and 
social care for older people is in serious need of a boost to drive an improvement 
in quality and satisfaction while tackling shortages. A new and improved alignment 
between the needs, demands and expectations of the ageing population, and 
an adequate number of skilled health professionals responsible for their care, is 
essential.
Health education should start as early as possible, ideally at primary school, given 
that many habits are formed at a young age that impact our health in later life; 
especially concerning nutrition and exercise.
The most urgent need is to effect a major change in the perception of ageing and 
care for older patients in all health care professional schools (medical, nursing, 
dentistry, pharmacy, physiotherapy and social work, among others).
Transnational collaboration will be required to rethink and adjust health services to 
adapt them to the new needs of the population, the mobility of health professionals 
and the integration of technological progresses in care delivery.
New teaching techniques need to be transversal (medical, dentistry, pharmacy and 
nurses), interactive and make use of e-learning to a greater extent.
All health care workers should receive an education in gerontology considering the 
increasing frequency of exposure to older patients.
A lifelong learning approach to training and education of health care and long-term 
care workers should be put in place as well as the clear establishment of career 
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ladders. Learning can be targeted where appropriate such as updated training for 
GPs on prevention to ensure that public information campaigns and advice offered 
to citizens is up to date.
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Conclusions
Following a period of remarkable demographic transition in Europe, characterised by increased 
life expectancy, decreased fertility and sweeping changes in societal and economic structures, 
the ageing of European populations now demands immediate attention from EU policymakers, 
in order to improve the prospects of current and future ageing for EU citizens. From a broad 
scientific perspective on public health, the present Evidence Review Report has provided 
the most scientifically solid arguments available to help policymakers answer the following 
questions:
  How can public health policy best organise efficient prevention, control and treatment of 
early and midlife risk factors, to ensure that people have good functional ability when they 
enter old age?
  What measures are needed to enable health care systems to face the challenges posed by 
the current generation of aged adults?
In its response to the aforementioned questions, the report highlights various evidences, from 
which the following main conclusions can be drawn:
  Although common processes of ageing appear to be involved in the aetiology of many 
diseases, aged populations exhibit high heterogeneity. The functional approach to ageing 
considers both the various individual determinants of health and the surrounding life 
circumstances of each individual and their interactions. For this reason, “healthy ageing” as 
used by the World Health Organisation, which aims to develop and maintain functional ability, 
serves as a good goal.
  A life course approach, which identifies opportunities throughout life to reduce the risk of 
chronic clinical conditions and age-related disability, proves particularly useful. To counter 
the widening gap in health outcomes over time, comprehensive preventive interventions 
early in life should be complemented with others at each point of the life cycle; midlife 
emerges as a period of particular importance.
  Ageism (age-based stereotypes, prejudice, and discrimination) and adultism (the power that 
the older generations have over the younger generations) are key issues to tackle, bearing in 
mind the growing population of older people in the EU. Fighting against age discrimination 
implies actions at different levels and by different players, including laws and regulations at 
both national and European levels.
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  The all-important concept of costs constrained and the internalisation of costs and benefits 
are essential when developing health and social care policy. In this sense, the potential 
benefits of preventive measures must be considered in the long term.
  Certain global environmental health challenges and lifetime risk factors are common to 
many aspects of healthy ageing and age-related diseases, and many of these risk factors 
are modifiable through intervention, although individual responses may vary. Thus, health 
promotion and preventive strategies need to be assessed for their effectiveness on multiple 
rather than single outcomes, or targeted towards risk factors or protective factors that have a 
wide breadth of effect.
  Health education and health promotion programmes focused on diet, exercise and lifestyle 
are key for reaching a more equitable balance between health promotion, targeted 
intervention, and treatment. Furthermore, such programmes shift the balance of individual 
and societal responsibilities in achieving healthy ageing.
  Health care systems need to effectively measure function in order to prevent its loss during 
ageing, which would also lessen multimorbidity, a major challenge facing older people. This 
would also help reduce the utilisation of health services, as well as hospital admissions and 
stays. The application in acute care settings of a geriatric model of care, with comprehensive 
geriatric assessment, nutritional intervention, reduction of polypharmacy and inappropriate 
drug prescriptions, would prove effective in improving outcomes over the long term.
  Ageing at home is, for many, vastly preferred over long-term care institutions. However, its 
success depends on many things: collaboration between informal (not professional) and 
formal (professional) care networks; all-age communities that support the integrated and 
active lives of aged citizens; non-discriminatory policies for older drivers; and appropriate 
financing models.
  Long-term care institutions emerge as a more attractive alternative if they are properly 
‘de-institutionalised’ to deliver patient-centred care in friendly surroundings. Developing a 
palliative care culture in all care facilities is fundamental, and advance care planning may be 
an effective way to avoid unnecessary transfer to emergency wards.
  Technology will play a revolutionary role in the care delivery systems of the future, and new 
tools, such as those enabling the lifelong tracking of functional health, can help detect and 
diagnose disease, maintain functional ability and improve healthy life expectancy. However, 
the adoption of any new health care technology must be based on scientific evidence, must 
address concerns about usability, data privacy and interoperability and must not reinforce 
health care inequalities.
  Overcoming the increasing shortage of skilled health care professionals in Europe is needed 
to meet the health and social care needs of current and future aged populations, and it 
requires collaboration among ministries of education, health, finances and labour, as well as 
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the private sector. Geriatric care will benefit from promoting health care education early and 
throughout primary and secondary schooling, including principles of geriatric medicine in 
all health care professional education programmes to favour multidisciplinary training, and 
introducing new technology, blended teaching, online learning, virtual patients and case 
simulations in health care education.
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Annex 3: Discussion workshop and 
participants
A key milestone during preparation of this report was a one-day expert workshop that took 
place on 7 December 2018 in Brussels. This workshop brought together the SAPEA Working 
Group members and external experts. The aim of this workshop was to discuss and review 
the key findings of the SAPEA report, and to identify points to prioritise in SAPEA’s report and 
in the Scientific Opinion of the European Commission’s Group of Chief Scientific Advisors. 
The workshop participants discussed the draft report in terms of the feasibility and practical 
applicability of its conclusions to transforming the future of ageing.
The experts were provided with some guiding questions (see below) and the draft report in 
advance of the workshop to familiarise themselves with the content. They were asked to address 
questions raised in the draft report, areas of disagreement, relevant points that may have been 
omitted, inaccuracies that required correction, and evidence which may have been missed in the 
literature presented.
In total, there were 37 participants at the workshop, with twelve external experts invited and 
selected based on their applied knowledge and experience in this field. A workshop report is 
available at sapea.info/ageing.
Guiding questions for external experts
General remarks:
  Does the report/section answer the question in the scoping paper?
  Does it use the appropriate and up-to-date evidence?
  Are there any gaps in terms of the evidence that is covered within the selected topics?
  Are there any crucial omittances in terms of the selected topics?
  Is the report accessible to a wide audience, especially to policy-makers?
Remarks linked to the policy options:
  Are the options presented sufficiently backed up by scientific evidence?
  Can the options presented be implemented at policy level?
  At what scale can the options presented be implemented? At EU level? National levels? And 
within what timeframe?
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  Are there important trade-offs to consider?
  Could part of what is proposed from a scientific evidence perspective be more feasible and 
desirable? Are some options more feasible and desirable than others?
The SAPEA Working Group took into account the comments made and reshaped the report in 
light of them.
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  Ms. Marta Beck-Domzalska, Eurostat, European Commission
  Professor Ilaria Bellantuono, Sheffield University (UK)
  Dr. Mirko de Melis, Medtronic
  Mr. Maarten Eisema, University of Groningen (The Netherlands)
  Professor Chris Hankin, ACM Europe Council, Imperial College London (UK)
  Ms. Barbara Kerstiens, DG Research and Innovation, Unit E4: Noncommunicable diseases and 
the challenge of healthy ageing, European Commission
  Professor Pierre Lefebvre, University of Liège (Belgium)
  Professor Stefania Maggi, Italian National Council for Research (Italy)
  Mr. Ettore Marchetti, DG EMPL, Unit C.2: Modernisation of social protection systems, European 
Commission
  Dr. Jochen Mierau, University of Groningen (The Netherlands)
  Professor Christine Milligan, Lancaster University (UK)
  Ms. Birgit Morlion, DG CNECT, Unit H3: eHealth, Wellbeing and Ageing, European Commission
  Professor Ursula Müller-Werdan, Charité Hospital, Berlin (Germany)
  Dr. Amalia Munoz Pineiro, Joint Research Centre, European Commission
  Ms. Anne Sophie Parent, AGE Platform EU (Belgium)
  Professor José Manuel Ribera Casado, Spanish Academy of Medicine, Universidad 
Complutense de Madrid (Spain)
  Professor John Rowe, Columbia University (USA)
The following experts did not attend the workshop but provided helpful written feedback on the 
draft report:
  Professor Clemens Tesch-Römer, German Centre of Gerontology (Germany)
  Professor Alan Walker, University of Sheffield (United Kingdom)
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Annex 4: Glossary of terms
Amino acids Amino acids are the building blocks of proteins. A large proportion of cells, muscles 
and tissue is made up of amino acids, meaning they carry out many important bodily 
functions, such as giving cells their structure. They also play a key role in the transport 
and the storage of nutrients. Amino acids have an influence on the function of organs, 
glands, tendons and arteries. They are furthermore essential for healing wounds 
and repairing tissue, especially in the muscles, bones, skin and hair as well as for the 
removal of all kinds of waste deposits produced in connection with the metabolism.
Amyloid cascade hypothesis This hypothesis posits that the deposition of the amyloid-ɛ peptide in the brain is a 
central event in Alzheimer's disease pathology
Anaemia A deficiency of red blood cells or haemoglobin in the blood, resulting in pallor and 
weariness
Androgen Deprivation Therapy Also called androgen suppression therapy. It is an antihormone therapy mainly used in 
treating prostate cancer.
Anorexia Anorexia nervosa is a psychiatric illness characterised by maintaining a low body 
weight, caloric restriction, and body dissatisfaction. Often times, people suffering from 
anorexia experience a distorted body image, seeing themselves as overweight even 
when they are significantly underweight. Anorexia nervosa can also be accompanied by 
binge eating and purging.
Antihypertensives Antihypertensive drugs comprise several classes of compound with the therapeutic 
intention of preventing, controlling, or treating hypertension. 
Apolipoprotein E (ApoE) A class of proteins involved in the metabolism of fats in the body. It is important in 
Alzheimer's disease and cardiovascular disease.
Arrhythmia An arrhythmia describes an irregular heartbeat — the heart may beat too fast, too 
slowly, too early, or irregularly
Atherosclerosis A disease in which plaque builds up inside the arteries. Arteries are blood vessels that 
carry oxygen-rich blood to the heart and other parts of the body.
Atrial fibrillation An irregular and often rapid heart rate that can increase the risk of stroke, heart failure 
and other heart-related complications.
Benign paroxysmal positional 
vertigo
Benign paroxysmal positional vertigo (BPPV) is one of the most common causes of 
vertigo — the sudden sensation of spinning or that the inside of the head is spinning. 
Benign paroxysmal positional vertigo causes brief episodes of mild to intense dizziness. 
Benign paroxysmal positional vertigo is usually triggered by specific changes in the 
position of the head.
Benzene Benzene is a colourless, sweet-smelling chemical that can be derived from natural gas, 
crude oil, or coal. Benzene is primarily used as a feedstock to make other industrial 
chemicals. Benzene is also used as a solvent in the chemical and pharmaceutical 
industries.
Beta carotene The yellow/orange pigment that gives vegetables and fruits their rich colours.
Beta-hydroxy-beta-
methylbutyrate (HMB)
Beta-hydroxy beta-methylbutyrate (HMB), a metabolite of the essential amino acid 
leucine, is one of the latest dietary supplements promoted to enhance gains in strength 
and lean body mass associated with resistance training. Unlike anabolic hormones that 
induce muscle hypertrophy by increasing muscle protein synthesis, HMB is claimed to 
influence strength and lean body mass by acting as an anticatabolic agent, minimising 
protein breakdown and damage to cells that may occur with intense exercise. 
Biliary tract Refers to the liver, gall bladder and bile ducts, and how they work together to make, 
store and secrete bile.
Bioimpedance Bioimpedance characterises the electrical properties of the body (or other biomaterials), 
e.g. to what extent the body is a good conductor for electric currents. Bioimpedance is 
a measure of how well the body impedes electric current flow. Fat has high resistivity, 
blood lower resistivity.
Bisphenol A An industrial chemical compound C15H16O2 that is a component especially of hard 
plastics (such as polycarbonate) and epoxy resins.
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Blue Zones Specific geographic areas where an extraordinary number of people live long and 
healthy lives. Inhabitants in these areas routinely live to 100 and beyond. 
Bronchial hyperreactivity A state characterised by easily triggered bronchospasm (contraction of the bronchioles 
or small airways). It is a hallmark of asthma and also occurs frequently in people with 
COPD. 
Bronchopulmonary dysplasia Bronchopulmonary dysplasia (BPD) is a form of chronic lung disease that affects new-
borns (mostly premature) and infants. It results from damage to the lungs caused by 
mechanical ventilation (respirator) and long-term use of oxygen. Most infants recover 
from BPD, but some may have long-term breathing difficulty.
Cachexia Cachexia is a “wasting” disorder that causes extreme weight loss and muscle wasting, 
and can include loss of body fat. This syndrome affects people who are in the late 
stages of serious diseases like cancer, HIV or AIDS, COPD, kidney disease, and 
congestive heart failure (CHF).
cardiometabolic Concerning both heart disease and metabolic disorders such as diabetes
Cardiopulmonary Resuscitation 
(CPR)
Cardiopulmonary resuscitation (CPR) is an emergency technique used to help someone 
whose heart and/or breathing has stopped.
Cardiovascular  1: of, relating to, or involving the heart and blood vessels; 2: used, designed, or 
performed to cause a temporary increase in heart rate.
Cardiovascular disease Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood 
vessels.
Cerebrospinal fluid Is a clear, colourless body fluid found in the brain and spinal cord. It is produced by the 
specialised ependymal cells in the choroid plexuses of the ventricles of the brain, and 
absorbed in the arachnoid granulations.
Cerebrovascular disease Cerebrovascular disease refers to a group of conditions that can lead to a 
cerebrovascular event, such as a stroke. These events affect the blood vessels and 
blood supply to the brain.
Chronic otitis media Chronic otitis media is a chronic infection of the middle ear cavity. It is caused by an 
ongoing inflammatory response within the middle ear, and is typically associated with 
unresolved and resistant bacterial infections.
Clostridium A group of anaerobic bacteria (bacteria that thrive in the absence of oxygen). There are 
100+ species of Clostridium.
Clostridium difficile Clostridium difficile, also known as C. difficile or C. diff, is bacteria that can infect the 
bowel and cause diarrhoea. The infection most commonly affects people who have 
recently been treated with antibiotics. It can spread easily to others. C. difficile infections 
are unpleasant and can sometimes cause serious bowel problems, but they can usually 
be treated with another course of antibiotics.
Cytomegalovirus (CMV) Cytomegalovirus (CMV) is a common virus that can infect almost anyone. Once 
infected, the body retains the virus for life but it remains asymptomatic. CMV is cause 
for concern in pregnant or immunocompromised persons. A woman who develops an 
active CMV infection during pregnancy can pass the virus to her baby, who might then 
experience signs and symptoms. For people with compromised immunity, especially 
due to organ transplantation, CMV infection can be fatal. CMV spreads from person to 
person through body fluids, such as blood, saliva, urine, semen and breast milk. There's 
no cure for the virus. However, medications can help treat new-borns and people with 
weak immune systems.
Demyelination Myelin is an insulating material coating parts of most nerve cells. When it’s worn away 
or damaged, nerves can deteriorate, causing problems in the brain and throughout the 
body. Damage to myelin around nerves is called demyelination.
Diabetes mellitus Diabetes mellitus (or diabetes) is a chronic, lifelong condition that affects the body's 
ability to use the energy found in food. There are three major types of diabetes: type 1 
diabetes, type 2 diabetes, and gestational diabetes.
Diethylstilbestrol Diethylstilbestrol, or DES, is a synthetic (man-made) form of the female hormone 
oestrogen.
Diuretics Diuretics, also called water pills, are medications designed to increase the amount of 
water and salt expelled from the body as urine. There are three types of prescription 
diuretics. They’re often prescribed to help treat high blood pressure, but they're used 
for other conditions as well. 
Dual Energy X-ray Absorptiometry 
(DXA)
Dual X-ray Absorptometry. A technique for scanning bone and measuring bone mineral 
density (BMD). DXA is relatively easy to perform and the amount of radiation exposure is 
considered low. DXA is also called dual energy X-ray absorptometry or DEXA.
Dyslipidaemia Refers to unhealthy levels of one or more kinds of lipid (fat) in the blood. Dyslipidaemia 
usually means that low-density lipoprotein (LDL) levels or triglycerides are too high. It 
can also mean high-density lipoprotein (HDL) levels are too low. 
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Dysphagia Difficulty swallowing (dysphagia) means it takes more time and effort to move food or 
liquid from the mouth to the stomach. Dysphagia may also be associated with pain. 
In some cases, swallowing may be impossible. Persistent dysphagia may indicate a 
serious medical condition requiring treatment. Dysphagia can occur at any age, but is 
more common in older adults. 
Dyspnoea Shortness of breath can be a symptom of health problems, often related to heart or 
lung disease. 
Epigenetics Epigenetics involves genetic control by factors other than an individual's DNA sequence. 
Epigenetic changes can switch genes on or off and determine which proteins are 
transcribed.
Epigenome A multitude of chemical compounds that can tell the genome what to do. The human 
genome is the complete assembly of DNA (deoxyribonucleic acid)-about 3 billion base 
pairs — that makes each individual unique.
Etiologic/ aetiology Assigning or seeking to assign a cause
Focal cerebral ischemia Occurs when a blood clot has blocked a cerebral vessel. Focal cerebral ischemia 
reduces blood flow to the particular brain region, increasing the risk of cell death to that 
area. It can be either caused by thrombosis or embolism.
Gait speed Also known as walking speed. Gait speed is a quick, inexpensive, reliable measure of 
functional capacity with well-documented predictive value for major health-related 
outcomes.
Gastrointestinal Infection Gastrointestinal infections are viral, bacterial or parasitic infections that cause 
gastroenteritis, an inflammation of the gastrointestinal tract involving both the stomach 
and the small intestine. Symptoms include diarrhoea, vomiting, and abdominal pain.
Gerontology Gerontology is the study of the social, cultural, psychological, cognitive, and biological 
aspects of ageing.
Gestational hypertension Also referred to as pregnancy induced hypertension. It is characterised by high blood 
pressure during pregnancy. 
Glaucoma A disease that damages the eye's optic nerve. It usually happens when fluid builds up in 
the front part of the eye and increases the pressure. 
Helicobacter pylori Helicobacter pylori (H. pylori) is a type of bacteria that can cause ulcers in stomach 
lining or the upper part of the small intestine. For some people, an infection can lead to 
stomach cancer.
Homeostatis Any self-regulating process by which biological systems tend to maintain stability while 
adjusting to conditions that are optimal for survival.
Human papillomavirus (HPV) HPV is a group of more than 150 related viruses. HPV is named for the warts 
(papillomas) some HPV types can cause. Some other HPV types can lead to cancer. 
Men and women can get cancer of mouth/ throat, and anus/rectum caused by HPV 
infections. Men can also get penile HPV cancer. In women, HPV infection can also cause 
cervical, vaginal, and vulvar HPV cancers. Vaccines can prevent infection with the types 
of HPV that most commonly cause cancer.
Husbandry The cultivation or production of plants or animals or the scientific control and 
management of a branch of farming and especially of domestic animals
Hyperglycaemia High blood sugar (glucose) level
Hypoperfusion Decreased blood flow through an organ 
Hypotension Low blood pressure
hypothalamic pituitary adrenal 
(HPA) axis
The HPA axis is responsible for the neuroendocrine adaptation component of the stress 
response.
Hypothalamic–pituitary–gonadal 
(HPG) axis
The HPG axis plays a critical part in the development and regulation of a number of the 
body's systems, such as the reproductive and immune systems. Fluctuations in this axis 
cause changes in the hormones produced by each gland and have various local and 
systemic effects on the body.
Hypoxia Lack of oxygen
Iatrogenic Induced inadvertently by a physician or surgeon or by medical treatment or diagnostic 
procedures 
Immunosenescence Refers to the gradual deterioration of the immune system brought on by natural age 
advancement. It involves both the host’s capacity to respond to infections and the 
development of long-term immune memory, especially by vaccination.
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Ischemic A condition in which there is insufficient blood flow to one of the body’s organs, most 
often caused by an atherosclerotic plaque in the artery supplying that organ. An organ 
subjected to ischemia is referred to as being ischemic.
K4Care An integrated knowledge-based intelligent technology is being made available to 
help in the management and provision of health care services to chronically ill patients 
anytime and anywhere through the Web. The K4CARE project involved the joint effort 
of 4 technological institutions and 7 health care centres. This consortium combined 
experiences of old and new EU countries to define a new health care model for care of 
elderly people. New knowledge-based ICT technologies were researched, developed 
and integrated in a final product that implements the health care model as a web 
platform. This is a validated prototype that optimises the safe management of the care 
of chronically ill patients at home.
Leucine Leucine is one of nine essential amino acids in humans (provided by food), Leucine 
is important for protein synthesis and many metabolic functions. Leucine contributes 
to regulation of blood-sugar levels; growth and repair of muscle and bone tissue; 
growth hormone production; and wound healing. Leucine also prevents breakdown of 
muscle proteins after trauma or severe stress and may be beneficial for individuals with 
phenylketonuria. Leucine is available in many foods and deficiency is rare.
Macrophysical Of or relating to the physics of bodies and phenomena on a macroscopic scale.
Macrovascular ischemic disease Involves changes to the small blood vessels in the brain. Changes to these vessels can 
damage white matter — the brain tissue that contains nerve fibres and serves as the 
connection point to other parts of the brain.
Malignancy A term for diseases in which abnormal cells divide without control and can invade 
nearby tissues. Malignant cells can also spread to other parts of the body through the 
blood and lymph systems. There are several main types of malignancy. Carcinoma 
is a malignancy that begins in the skin or in tissues that line or cover internal organs. 
Sarcoma is a malignancy that begins in bone, cartilage, fat, muscle, blood vessels, or 
other connective or supportive tissue. Leukaemia is a malignancy that starts in blood-
forming tissue, such as the bone marrow, and causes large numbers of abnormal 
blood cells to be produced and enter the blood. Lymphoma and multiple myeloma 
are malignancies that begin in the cells of the immune system. Central nervous system 
cancers are malignancies that begin in the tissues of the brain and spinal cord. Also 
called cancer.
Meniere's disease Meniere's disease is a disorder of the inner ear that can lead to dizzy spells (vertigo) and 
hearing loss. In most cases, Meniere's disease affects only one ear. Meniere's disease 
can occur at any age, but it usually starts between young and middle-aged adulthood. 
It's considered a chronic condition, but various treatments can help relieve symptoms 
and minimize the long-term impact on life.
Meningitis Meningitis is a rare infection that affects the delicate membranes — called meninges — 
that cover the brain and spinal cord.
Mesothelioma Malignant mesothelioma is a type of cancer that occurs in the thin layer of tissue that 
covers the majority of the internal organs (mesothelium). Mesothelioma is an aggressive 
and deadly form of cancer. Doctors divide mesothelioma into different types based on 
what part of the mesothelium is affected. Mesothelioma most often affects the tissue 
that surrounds the lungs (pleura). This type is called pleural mesothelioma. Other, rarer 
types of mesothelioma affect tissue in the abdomen (peritoneal mesothelioma), around 
the heart and around the testicles.
Methicillin-resistant 
Staphylococcus aureus (MRSA)
Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by a type of 
Staphylococcus ('staph') bacteria that has become resistant to many of the antibiotics 
used to treat ordinary staph infections. Most MRSA infections occur in people who have 
been in hospitals or other health care settings, such as nursing homes and dialysis 
centres. When it occurs in these settings, it's known as health care-associated MRSA 
(HA-MRSA). HA-MRSA infections typically are associated with invasive procedures or 
devices, such as surgeries, intravenous tubing or artificial joints.
Microangiopathy Disease of the capillaries (very small blood vessels), in which the capillary walls become 
so thick and weak that they bleed, leak protein, and slow the flow of blood.
Microbiome A community of microorganisms (such as bacteria, fungi, and viruses) that inhabit a 
particular environment and especially the collection of microorganisms living in or on 
the human body 
Microvascular complications Include cardiovascular diseases such as heart attacks, strokes and insufficiency in blood 
flow to legs.
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Mitochondrial Disease Result from failures of the mitochondria, specialized compartments present in every 
cell of the body (except red blood cells). Mitochondria are responsible for creating more 
than 90% of the energy needed by the body to sustain life and support organ function. 
When they fail, less and less energy is generated within the cell. Cell injury and even 
cell death follow. If this process is repeated throughout the body, whole organ systems 
begin to fail.
Muscular deconditioning The loss of muscle tone and endurance due to chronic disease, immobility, or loss of 
function.
Myopia Near-sightedness.
Naive B cell A naive B cell is a B cell that has not been exposed to an antigen. Once exposed to an 
antigen, the naive B cell either becomes a memory B cell or a plasma cell that secretes 
antibodies specific to the antigen that was originally bound. Plasma cells do not last 
long in the circulation, this is in contrast to memory cells that last for very long periods 
of time. Memory cells do not secrete antibody until activated by their specific antigen.
Naive T cell T cell that has differentiated in bone marrow. The thymus produces progenitor cells, 
which mature into T-cells (thymus-derived cells). The body uses T-cells help destroy 
infected or cancerous cells. T-cells created by the thymus also help other organs in the 
immune system grow properly. 
Nematode Also known as roundworms. They occur as parasites in animals and plants or as free-
living forms in soil, fresh water and marine environments. 
Nephrovascular Relating to the blood vessels of the kidney
Neurovascular Of, relating to, or involving both nerves and blood vessels
Nonsteroidal anti-inflammatory 
drugs
Are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher 
doses, decrease inflammation. Side-effects depend on the specific drug, but largely 
include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney 
disease.
Nosocomial Originating or taking place in a hospital, acquired in a hospital, especially in reference 
to an infection. The common usage of the term “nosocomial” is now synonymous with 
hospital-acquired. Nosocomial infections are infections that have been caught in a 
hospital and are potentially caused by organisms that are resistant to antibiotics. A 
nosocomial infection is specifically one that was not present or incubating prior to the 
patient’s being admitted to the hospital, but occurring within 72 hours after admittance 
to the hospital.
Nutraceutical The term “nutraceutical” is used to describe these medicinally or nutritionally functional 
foods. Nutraceuticals, which have also been called medical foods, designer foods, 
phytochemicals, functional foods and nutritional supplements, include such everyday 
products as “bio” yoghurts and fortified breakfast cereals, as well as vitamins, herbal 
remedies and even genetically modified foods and supplements.
Nutrient sensing A cell's ability to recognise and respond to fuel substrates such as glucose.
Oncology The branch of science that deals with tumours and cancers. 
Organ of Corti The Organ of Corti is the sensitive element in the inner ear and can be thought of 
as the body's microphone. It is situated on the basilar membrane in one of the three 
compartments of the Cochlea. It contains four rows of hair cells which protrude from its 
surface. Above them is the tectoral membrane which can move in response to pressure 
variations in the fluid- filled tympanic and vestibular canals. There are some 16,000 
-20,000 of the hair cells distributed along the basilar membrane which follows the spiral 
of the cochlea. 
Osteoarthritis Osteoarthritis is the most common form of arthritis. It is a degenerative joint disease that 
involves thinning or destruction of the smooth cartilage that covers the ends of bones, 
as well as changes to the bone underlying the joint cartilage. Osteoarthritis produces 
pain, stiffness and reduced movement of the affected joint, which ultimately affects 
one’s ability to do physical activities, reducing quality of life.
Osteoporosis Osteoporosis is a bone disease. The word “osteoporosis” literally means porous bones. 
It is a bone disorder characterised by decreased bone strength as a result of reduced 
bone quantity and quality. A person with osteoporosis has an increased risk of breaking 
a bone (fracturing) easily.
Otoconia Small crystals of calcium carbonate in the saccule and utricle of the ear that under the 
influence of acceleration in a straight-line cause stimulation of the hair cells by their 
movement relative to the gelatinous supporting substrate containing the embedded 
cilia of the hair cells 
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Oxidative Stress Oxidative stress is well known to be involved in the pathogenesis of lifestyle-related 
diseases, including atherosclerosis, hypertension, diabetes mellitus, ischemic diseases, 
and malignancies. Oxidative stress has been defined as harmful because oxygen 
free radicals attack biological molecules such as lipids, proteins, and DNA. However, 
oxidative stress also has a useful role in physiologic adaptation and in the regulation of 
intracellular signal transduction. 
Palliative care Palliative care is specialized medical care for people living with a serious illness. This 
type of care is focused on relief from the symptoms and stress of a serious illness. 
The goal is to improve quality of life for both the patient and the family. Palliative care 
is provided by a specially-trained team of doctors, nurses and other specialists who 
work together with a patient’s other doctors to provide an extra layer of support. It is 
appropriate at any age and at any stage in a serious illness, and it can be provided along 
with curative treatment.
Pathophysiology the functional changes that accompany a particular syndrome or disease
Phototoxicity Phototoxicity is defined as a toxic response from a substance applied to the body 
which is either elicited or increased (apparent at lower dose levels) after subsequent 
exposure to light, or that is induced by skin irradiation after systemic administration of a 
substance.
Phthalate Phthalate or phthalate esters are esters of phthalic acid. They are mainly used as 
plasticizers, i.e., substances added to plastics to increase their flexibility, transparency, 
durability, and longevity. They are used primarily to soften polyvinyl chloride (PVC).
Pneumococcal Pneumonia There are many types of pneumonia, and the most common type of bacterial 
pneumonia is called pneumococcal pneumonia. Pneumococcal pneumonia is caused 
by bacteria that live in the upper respiratory tract and can be spread through coughing. 
Common symptoms of pneumococcal pneumonia include high fever, excessive 
sweating and shaking chills, coughing, difficulty breathing, shortness of breath and 
chest pain. Certain symptoms, such as cough and fatigue, can appear without warning 
and may last for weeks, or longer. In severe cases, pneumococcal pneumonia may 
necessitate hospitalisation and result in death. 
Pneumococcus Pneumococcus (Streptococcus pneumoniae) is a bacterium that causes human 
diseases such as pneumonia, sinusitis, otitis media, and meningitis. Pneumococci 
normally occur in the upper respiratory tract.
Pneumonia Pneumonia is an infection that inflames the lungs' air sacs (alveoli). The air sacs may 
fill up with fluid or pus, causing symptoms such as a cough, fever, chills and trouble 
breathing.
Polymedication The administration of many drugs at the same time or the administration of an 
excessive number of drugs
Population Attributable Fraction 
(PAF)
The contribution of a risk factor to a disease or a death is quantified using the 
population attributable fraction (PAF). PAF is the proportional reduction in population 
disease or mortality that would occur if exposure to a risk factor were reduced to an 
alternative ideal exposure scenario (e.g. no tobacco use). Many diseases are caused by 
multiple risk factors, and individual risk factors may interact in their impact on overall 
risk of disease. As a result, PAFs for individual risk factors often overlap and add up to 
more than 100%.
Population attributable risk The Population Attributable Risk (or Population Attributable Fraction) indicates the 
number (or proportion) of cases that would not occur in a population if the factor were 
eliminated (e.g. how many lives would be saved if people no longer smoked?) 
Postmitotic A mature cell that is no longer capable of undergoing mitosis (a part of the cell cycle 
when replicated chromosomes are separated into two new nuclei)
Presbyastasis The loss of vestibular and balance functions associated with ageing
Presbycusis Age-related hearing loss
Presenteeism Working while sick
Proprioception/ proprioceptive The process in which nerve endings in the muscles and joints are stimulated when the 
body moves, so that a person is aware of their body's position
Proteostasis Protein homeostasis or ‘proteostasis’ is the process that regulates proteins within the 
cell in order to maintain the health of both the cellular proteome and the organism itself.
Psychomotor Relating to, or characterising movements of the body associated with mental activity
Psychotropic drugs Psychotropic drugs are medications that affect the central nervous system, changing 
how the brain processes information, such as altering mood, thoughts, perceptions, 
emotions, and behaviours.
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Retinopathy Retinopathy means disease of the retina. There are several types of retinopathy, but all 
involve disease of the small retinal blood vessels. 
Sarcopenia The decline of skeletal muscle tissue with age. It is one of the most important causes of 
functional decline and loss of independence in older adults.
Senile miosis A reduction in the size of a person's pupil in old age
STRC Stereocilin is a protein that in humans is encoded by the STRC gene. This gene encodes 
a protein that is associated with the hair bundle of the sensory hair cells in the inner ear. 
The hair bundle is composed of stiff microvilli called stereocilia and is involved with 
mechanoreception of sound waves. Mutations in this gene cause autosomal recessive 
non-syndromic deafness.
Tamoxifen Tamoxifen is the oldest and most-prescribed selective oestrogen receptor modulator 
(SERM) and is used for treatment of: women and men diagnosed with hormone-
receptor-positive, early-stage breast cancer after surgery (or possibly chemotherapy 
and radiation) to reduce the risk of the cancer coming back (recurring); women and 
men diagnosed with advanced-stage or metastatic hormone-receptor-positive disease; 
reduce breast cancer risk in women who haven’t been diagnosed but are at higher-
than-average risk for the disease.
Telomere The natural end of a eukaryotic chromosome composed of a usually repetitive DNA 
sequence and serving to stabilise the chromosome
Tetanus Tetanus is a serious disease caused by a bacterial toxin that affects our nervous system, 
leading to painful muscle contractions, particularly of the jaw and neck muscles. 
Tetanus can interfere with the ability to breathe and can be life-threatening. Tetanus is 
commonly known as "lockjaw." Thanks to the tetanus vaccine, cases of tetanus are rare 
in the developed world. There's no cure for tetanus. Treatment focuses on managing 
complications until the effects of the tetanus toxin resolve.
Thymus The thymus is part of the lymphatic system, along with the tonsils, adenoids and spleen, 
and is also part of the endocrine system. The thymus produces progenitor cells, which 
mature into T-cells (thymus-derived cells). The body uses T-cells help destroy infected 
or cancerous cells. T-cells created by the thymus also help other organs in the immune 
system grow properly. 
Tinnitus Tinnitus is an awareness of sound in the ears or head which is not from an external 
source. There are many different types of tinnitus sounds. Common descriptions are 
that it is a hiss, whistle, whirr, ring or buzz. Occasionally, it can be segments of music. 
The pitch can be high or low and the level can vary over time.
Triaxial Accelerometers Triaxial accelerometers are intended for simultaneous measurement of vibration in 
three perpendicular axes.
Triglyerides A type of fat found in the blood, the most common type of fat in the body. Triglycerides 
are necessary for health but in excess amounts, they may be harmful and may increase 
the risk of heart disease.
Urogynaecology Female pelvic medicine is a new designation for the established field of 
urogynaecology. An urogynecologist cares for women with pelvic floor disorders in a 
blend of gynaecology and reconstructive surgery.
Varicella Zoster Virus (VZV) A type of herpesvirus that causes chicken pox. After initial infection with varicella zoster 
virus (VZV), the inactive (latent) form of the virus can remain in the body. If the latent 
virus becomes active again, it can cause shingles.
Vestibular Relating to empty spaces in the body that are entrances to passages or other spaces
Vestibular Neuritis Vestibular neuritis is a disorder that affects the nerve of the inner ear called the 
vestibulocochlear nerve. The disorder may cause a person to experience such 
symptoms as sudden, severe vertigo (spinning/swaying sensation), dizziness, balance 
difficulties, nausea, vomiting, and concentration difficulties.
West Nile virus West Nile virus (WNV) is a mosquito-borne disease. There are no vaccines to prevent 
or medications to treat WNV in people. Fortunately, most people infected with WNV do 
not feel sick. About 1 in 5 people who are infected develop a fever and other symptoms. 
About 1 out of 150 infected people develop a serious, sometimes fatal, illness.
Yellow fever Yellow fever is an acute viral haemorrhagic disease transmitted by infected mosquitoes. 
The "yellow" in the name refers to the jaundice that affects some patients. Symptoms 
of yellow fever include fever, headache, jaundice, muscle pain, nausea, vomiting and 
fatigue. A small proportion of patients who contract the virus develop severe symptoms 
and approximately half of those die within 7 to 10 days. The virus is endemic in tropical 
areas of Africa and Central and South America. Large epidemics of yellow fever occur 
when infected people introduce the virus into heavily populated areas with high 
mosquito density and where most people have little or no immunity, due to lack of 
vaccination. In these conditions, infected mosquitoes transmit the virus from person to 
person.
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Annex 5: List of abbreviations
AARP American Association of Retired Persons
ACP Advanced Care Planning
AD Alzheimer´s Disease
ADAS Advanced Driver Assistance System
ADL Activities of Daily Living
ADR Adverse Drug Reaction
AF Atrial Fibrillation 
AFH Age-Friendly Hospital
AFM Age-Friendly Manchester
AI Artificial Intelligence
AMD Age-Related Macular Degeneration
AMR Antimicrobial Resistance
APMS Adult Psychiatric Morbidity Survey
APP Application Software
AREDS Age-Related Eye Disease Study
AV Autonomous Vehicle
BCoDE Burden of Communicable Diseases in Europe 
BIA Bioelectrical Impedance Analysis
BMD Bone Mineral Density
BMI Body Mass Index
BP Blood Pressure
CFAS Cognitive Function and Ageing Study
CGA Comprehensive Geriatric Assessment
CIRS-G Cumulative Illness Rating Scale — Geriatrics
CKD Chronic Kidney Disease
CKD Chronic Kidney Disease 
CMD Common Mental Disorder
CMV Cytonegalovirus
CNECT Communications Networks, Content and Technology
COPD Chronic Obstructive Pulmonary Disease 
CRD Chronic Respiratory Disease
CSF Cerebrospinal Fluid
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CSOs Civic Society Organisations
CTI Care Transitions Intervention
CV Cardiovascular
CVD Cardiovascular Disease
DALYs Disability-Adjusted Life Years
DASH Diet Approaches to Stop Hypertension
DFH Dementia Friendly Hospital
DG Directorate General
DG ECFIN Directorate-General for Economic and Financial Affairs
DNR Do Not Resuscitate
DRSs Driving Rehabilitation Specialists
DU Universal Design
DXA Dual Energy X-Ray Absorptiometry
EBD Evidence Based Design
ECDC European Centre for Diseases Control
ECG Electrocardiogram
ECG Electrocardiography 
ED Emergency Department 
EDCs Endocrine-Disrupting Chemicals 
EGE European Group on Ethics in Science and New Technologies
EHR Electronic Health Record
EIP-on-AHA European Innovation Partnership on Active and Healthy Ageing
EMA European Medicine Agency
ERR Evidence Review Report
ESC European Society of Cardiology
ESPEN European Society for Clinical Nutrition and Metabolism
ESPEN European Society for Clinical Nutrition and Metabolism
EU European Union
EVASG Escmid Vaccine Study Group
EWGSOP European Working Group on Sarcopenia in Older People
F-A-C-S Find Cases-Assess-Confirm-Severity
FEV1 Forced Expiratory Pressure In 1 Second
FINGER Finnish Geriatric Intervention Study
FLS Fracture Liaison Services
GD General Director
GDP Growth Domestic Product
GDPR General Data Protection Regulation
GIS Geographic Information System
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GLOW Global Longitudinal Study of Osteoporosis in Women
GNAFCC Global Network on Age-Friendly Cities and Communities
GP General Practitioner
GPS Global Positioning System
HAI Health care-Associated Infection
HAP Hospital-Acquired Pneumonia
HCI Human-Computer Interaction
HCW Health care Workers
HF Heart Failure
HIV Human Immunodeficiency Virus
HMSO Her Majesty’s Stationery Office
HPA Hypothalamic Pituitary Adrenal
HPG Hypothalamic–Pituitary–Gonadal
HPV Human Papillomavirus
HR-pQCT High Resolution Peripheral Quantitative Computed Tomography
IADL Instrumental Activities of Daily Living
ICF International Classification of Functioning, Disability and Health
ICT Information and Communication Technology
IDF International Diabetes Federation
IEEE Institute of Electrical and Electronics Engineers
IOF International Osteoporosis Foundation
IoT Internet of Things
IP Inappropriate Prescription
IPC Infection Prevention and Control
K4Care Knowledge-Based Home-Care Eservices for An Ageing Europe
KSA Knowledge, Skills and Attitudes 
LCT Long-Term Care
LRTI Lower Respiratory Tract Infection
LTC Long-Term Care
LTCF Long-Term Care Facilities
m-health Mobile and Wireless Technologies
MICRA Manchester Institute for Collaborative Research on Ageing
MPI Multidimensional Prognostic Index
MRSA Methicillin-Resistant Staphylococcus Aureus
mTOR Mechanistic Target of Rapamycin
mTOR The Mammalian Target of Rapamycin
NGO Non-Governmental Organisation
NHANES National Health and Nutrition Examination Survey
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NHS National Health Service
NIA National Institute on Ageing
NIH Us National Institutes of Health
NSAIDs Nonsteroidal Anti-Inflammatory Drugs
OA Osteoarthritis
OECD Organisation for Economic Co-Operation and Development
ONS Oral Nutritional Supplements
PAF Population Attributable Fraction
PAR Population Attributable Risk
PDGF-AA Platelet-Derived Growth Factor
PIM´s Potentially Inappropriate Medications
PPO´s Potential Prescribing Omissions 
PPS Point Prevalence Study
PPV Pneumococcal Pneumonia Vaccines
pQCT Quantitative Computed Tomography
PRM Physical and Rehabilitation Medicine 
RCT Randomised Controlled Trial 
SAPEA Science Advice for Policy by European Academies 
SARC-F Questionnaire for Rapid Assessment of Sarcopenia Status
SBU Swedish Agency for Health Technology Assessment and Assessment of 
Social Services
SCOPE The Scorecard for Osteoporosis in Europe
SHARE Survey of Health, Ageing and Retirement in Europe 
SPPB Short Physical Performance Battery
TAVI Transcatheter Aortic Valve Implantation
TFA Trans Fatty Acids
TFR Total Fertility Rate
TILDA The Irish Longitudinal Study on Ageing 
TTRN Transatlantic Telehealth Research Network
TUG Timed Up and Go Test
UEMS European Union of Medical Specialists
UEMS-GMS European Union of Medical Specialists — Geriatric Medicine Section
UN United Nations
UTI Urinary Tract Infection
VP Virtual Patient
VZV Varcella Zoster Virus
WHO World Health Organisation
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Annex 7: Systematic literature 
search method report
Scope
Systematic literature searches were designed and run in the Medline database, and additionally 
in Web of Science if it was a social science topic, using a combination of Subject Heading and 
keyword searching. Subject Heading searching makes use of the National Library of Medicine’s 
controlled vocabulary thesaurus, finding articles in Medline using indexing. Subject heading 
searches can be identified in the search strategies. Here, ‘exp’ indicates that the searched 
Subject Heading was ‘exploded’ and therefore finds articles indexed with this term or narrower 
terms. The subject heading searches were supplemented by textword searching (.tw.), which 
identifies where the searched word or phrase is within the title and abstract of the articles in 
Medline. Textword searches can be identified in the search strategies.
Relevant subjects
Searches were designed in collaboration with Working Group members for a range of different 
topics relating to an ageing population. In total 39 searches were undertaken on topics including:
  interventions for various conditions such as asthma and COPD, cardiovascular disease, 
dementia etc.
  prevention of balance disorder, hearing loss and vision deficiency
  epidemiology of depression, sensory ageing and cardiovascular disease
  health literacy in varying populations
  varying topics related to undernutrition
  varying topics related to care homes
Relevant types of study
Where requested and appropriate, searches were limited to randomised controlled trials and 
observational studies using tested SIGN search filters, to review papers using BMJ Best Practice 
search filters, and to policy documents only using the search filter outlined below:
1. exp Policy/
2. exp Public Policy/
3. exp Health Policy/
4. (policy or policies or policymaker*).tw.
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5. (government* adj3 (intervention* or legislat* or directive* or policy or policies)).tw.
6. Guideline*.tw.
7. OR/1-6
Geographical limits
Where requested and appropriate, a European search filter was applied to searches. The search 
filter used in these instances is outlined below. This filter would identify any studies which 
specifically reference one or several European countries, either mentioned in the title/abstract or 
indexed using Subject Headings.
1. exp European Union/
2. European union.tw.
3. exp Austria/
4. Austria*.tw.
5. exp Belgium/
6. belgi*.tw.
7. exp Bulgaria/
8. Bulgari*.tw.
9. exp Croatia/
10. Croatia*.tw.
11. exp Cyprus/
12. (Cyprus or Cypriot*).tw.
13. exp Czech Republic/
14. Czech*.tw.
15. exp Denmark/
16. (Denmark or Danish).tw.
17. exp Estonia/
18. Estonia*.tw.
19. exp Finland/
20. (Finland or Finnish).tw.
21. exp France/
22. (France of French).tw.
23. exp German/
24. German*.tw.
25. exp Greece/
26. (Greece of Greek*).tw.
27. exp Hungary/
28. (Hungary or Hungarian*).
tw.
29. exp Ireland/
30. (Ireland or Irish).tw.
31. exp Italy/
32. (Italy or Italian*).tw.
33. exp Latvia/
34. Latvia*.tw.
35. exp Lithuania/
36. Lithuania*.tw.
37. exp Luxembourg/
38. Luxembourg*.tw.
39. exp Malta/
40. (Malta or Maltese).tw.
41. exp Netherlands/
42. (Netherlands or Dutch).
tw.
43. exp Polish/
44. (Poland or Polish).tw.
45. exp Portugal/
46. (Portugal or Portugese).
tw.
47. exp Romania/
48. Romania*.tw.
49. exp Slovakia/
50. Slovakia*.tw.
51. exp Slovenia/
52. Slovenia*.tw.
53. exp Spain/
54. (Spain or Spanish).tw.
55. exp Sweden/
56. (Sweden or Swedish).tw.
57. exp United Kingdom/
58. United Kingdom.tw.
59. Great Britain.tw.
60. British.tw.
61. Britain.tw.
62. Or/1-61
Language
All searches were limited to English language studies only. The English language filter was 
applied using the predefined Ovid Medline limit.
Date of publication
All searches were limited to articles from 2010 to current (unless stated otherwise in Table 13).
Method
All searches were undertaken using the same search strategy defining the ageing population 
(unless stated otherwise in Table 13). The search used to define and identify the ageing 
population was:
1. exp Aged/
2. aged.tw.
3. exp Ageing/
4. ageing.tw.
5. ageing.tw.
6. elderly.tw.
7. older adult*.tw.
8. exp Geriatrics/
9. Geriatric*.tw.
10. Or/1-7
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For each of the 39 research questions, this search strategy was used to define the population. 
A further search strategy was then applied relating to each specific research question. Table 13 
outlines the search strategies for each of the 39 searches, which were combined with the ageing 
population search.
Table 13. Search terms used per topic, listed in alphabetical order. Exp = Subject Heading ‘exploded’ to include 
narrower indexed terms; tw = textword searching (title and abstract); adj2 = adjacency searching within 2 
words; adj3 = adjacency searching within 3 words; RCT = randomised controlled trial. Number of results 
are pre-sifting for relevant articles.
Advanced Care Planning
(Medline, 202 results)
1. exp Advanced Care Planning/
2. advance* care plan*.tw.
3. OR/1-2
4. 3 AND ageing population AND EU filter
Asthma and COPD interventions
(Medline, 79 results)
1. exp Asthma/
2. exp Pulmonary Disease, Chronic 
Obstructive/
3. COPD.tw.
4. Asthma*.tw.
5. OR/1-5
6. Intervention*.tw.
7. exp Smoking Cessation/
8. ((stop* or ceas*) adj3 smok*).tw.
9. exp Adrenal Cortez Hormones/
10. (adrenal cortex hormone* or 
corticosteroid*).tw.
11. Beta2-mimetic.tw.
12. OR/6-11
13. 5 AND 12 AND ageing population AND 
EU filter AND policy filter AND RCTs/
Observational studies filters
Balance disorder prevention
(Medline, 25 results)
1. Balance disorder*.tw.
2. (balance* adj3 problem*).tw.
3. OR/1-2
4. prevent*.tw.
5. exp Health Diet/
6. ((healthy or balanced) adj2 diet*).tw.
7. OR/4-6
8. 3 AND 7 AND ageing population
Cardiovascular disease burden
(Medline, 629 results)
1. Coronary Syndrome/
2. acute coronary syndrome*.tw.
3. exp Stroke/
4. ischemic stroke*.tw.
5. exp Myocardial Infarction/
6. myocardial infarction*.tw.
7. atherosclerotic stroke*.tw.
8. OR/1-9
9. exp “Global burden of disease”/
10. burden*.tw.
11. OR/11-12
12. 10 AND 14 AND ageing population AND 
EU filter AND RCTs/Observational studies 
filters
Cardiovascular disease 
epidemiology
(Medline, 402 results)
1. exp Cardiovascular Diseases/
2. cardiovascular disease*.tw.
3. exp Acute Coronary Syndrome/
4. acute coronary syndrome*.tw.
5. exp Stroke/
6. ischemic stroke*.tw.
7. thrombotic stroke*.tw.
8. exp Myocardial Infarction/
9. myocardial infarction*.tw.
10. atherosclerotic stroke*.tw.
11. OR/1-10
12. exp Epidemiology/
13. epidemiology.tw.
14. OR/12-13
15. 11 AND 14 AND EU filter AND RCTs/
Observational studies filters
Cardiovascular disease 
interventions
(Medline, 331 results)
1. exp Cardiovascular Diseases/
2. cardiovascular disease*.tw.
3. exp Coronary Artery Disease/
4. coronary artery disease*.tw.
5. exp Myocardial Infarction/
6. myocardial infarction*.tw.
7. exp Heart Failure/
8. heart failure*.tw.
9. OR/1-8
10. Intervention*.tw.
11. exp Smoking Cessation/
12. smoking cessation.tw.
13. ((stop* or ceas*) adj3 smok*).tw.
14. exp Exercise/
15. exercise*.tw.
16. physical activ*.tw.
17. exp Weight Loss/
18. (weight adj3 los*).tw.
19. exp Diet, Mediterranean/
20. Mediterranean diet*.tw.
21. exp Vegetables/
22. (vegetable* or vegetarian*).tw.
23. exp Fatty Acids, Omega-3/
24. omega 3.tw.
25. omega3.tw.
26. omega 6.tw.
27. omega6.tw.
28. OR/10-27
29. 9 AND 28 AND ageing population AND 
EU filter AND policy filter AND RCTs/
Observational studies filters
Dementia interventions
(Medline, 77 results)
1. exp Dementia/
2. dementia.tw.
3. exp Alzheimer Disease/
4. exp Cognitive Dysfunction/
5. (cognitiv* adj3 impair*).tw.
6. Alzheimer*.tw.
7. (cognitiv* adj3 declin*).tw.
8. OR/1-7
9. Intervention*.tw.
10. exp Education/
11. educat*.tw.
12. exp Employment/
13. employ*.tw.
14. job*.tw.
15. exp Cognitive Reserve/
16. cognitive reserve*.tw.
17. brain reserve*.tw.
18. (memor* adj3 stimulat*).tw.
19. (cogniti* adj3 revalidat*).tw.
20. exp Exercise/
21. exercis*.tw.
22. physical activit*.tw.
23. exp Tai Ji/
24. tai chi.tw.
25. social activit*.tw.
26. leisure activ*.tw.
27. exp Dancing/
28. danc*.tw.
29. exp Diet, Mediterranean/
30. Mediterranean diet*.tw.
31. exp Olive Oil/
32. olive oil.tw.
33. exp Dietary Supplements/
34. dietary supplement*.tw.
35. oral nutritional supplement*.tw.
36. nutritional supplement*.tw.
37. souvenaid.tw.
38. finger.tw.
39. mapt.tw.
40. prediva.tw.
41. statin*.tw.
42. nsaid*.tw.
43. exp Anti-Inflammatory Agents, Non-
Steroidal/
44. ginko biloba.tw.
45. exp Vitamin B 12/
46. vitamin b12.tw.
47. vitamin b 12.tw.
48. exp Adaptation, Psychological/
49. coping behaviour*.tw.
50. coping behavior*.tw.
51. (safe* adj3 home*).tw.
52. Modif* adj3 environ*).tw.
53. Companion robot*.tw.
54. OR/9-53
55. 8 AND 54 AND ageing population AND 
EU filter AND policy filter AND RCTs/
Observational studies filters
Depression epidemiology
(Medline, 249 results)
1. exp Depression/
2. depress*.tw.
3. Depressive disorder/ or depression, 
postpartum/ or depressive disorder, 
major/ or depressive disorder, treatment-
resistant/ or dysthymic disorder/
4. Dysthymi*.tw.
5. OR/1-4
6. Epidemiology.tw.
7. exp Epidemiology/
8. (life adj3 course).tw.
9. OR/6-8
10. 5 AND 9 AND Review filter
Diabetes interventions
(Medline, 158 results)
1. exp Diabetes Mellitus/
2. diabetes.tw.
3. OR/1-2
4. Intervention*.tw.
5. exp Diet, Mediterranean/
6. Mediterranean diet*.tw.
7. exp Dietary Approaches To Stop 
Hypertension/
8. dietary approaches to stop hypertension.
tw.
9. DASH diet*.tw.
10. (lower* adj3 lipid*).tw.
11. exp Blood Pressure/
12. blood pressure.tw.
13. aspirin*.tw.
14. exp Aspirin/
252
15. acetylsalicylic acid*.tw.
16. exp Exercise/
17. exercis*.tw.
18. physical activ*.tw.
19. exp Weight Loss/
20. (weight adj3 los*).tw.
21. exp Wound Healing/
22. (wound* adj3 (manage* or car* or heal*)).
tw.
23. ((foot or feet) adj3 car*).tw.
24. exp Oral Hygiene/
25. ((oral or dental or mouth) adj4 (car* or 
hygien*)).tw.
26. ( tax* adj3 (sugar* or drink* or beverage*)).
tw.
27. OR/4-26
28. 3 AND 27 AND ageing population AND 
EU filter AND policy filter AND RCTs/
Observational studies filters
Global Health education
(Medline, 4 results)
1. exp Global Health/
2. exp Health Education/
3. 1 and 2
4. (global health adj3 educat*).tw.
5. 3 OR 4
6. 5 AND ageing population AND Review 
filter
7. Limit to 2013 — Current
Global Health education and 
health care professionals
(Medline, 9 results)
1. exp Health Personnel/
2. (health professional* or health personnel).
tw.
3. OR/1-2
4. exp Global Health/
5. exp Health Education/
6. 4 AND 5
7. (global health adj3 educat*).tw.
8. OR/6-7
9. 8 AND Review filter
10. Limit to 2013 — Current
Global Health education and 
medical students
(Medline, 3 results)
1. exp Students, Medical/
2. (medical adj3 (student* or 
undergraduate*)).tw.
3. 1 OR 2
4. exp Global Health/
5. exp Health Education/
6. 4 AND 5
7. (global health adj3 educat*).tw.
8. 6 OR 7
9. 3 AND 8 AND Review filter
10. Limit to 2013 — Current
Global Health education and 
young people
(Medline, 20 results)
1. exp Young Adult/
2. (young adult* or young person* or young 
people).tw.
3. 1 OR 2
4. exp Global Health/
5. exp Health Education/
6. 4 AND 5
7. (global health adj3 educat*).tw.
8. 6 OR 7
9. 7 AND Review filter
10. Limit to 2013 — Current
Health literacy
(Medline, 85 results)
1. exp Health Literacy/
2. (health literate or health literacy).tw.
3. OR/1-2
4. 3 AND ageing population AND Review 
filter
5. Limit 4 to 2013 — Current
Health literacy and health care 
professionals
(Medline, 79 results)
1. exp Health Personnel/
2. (health professional* or health personnel).
tw.
3. OR/1-2
4. exp Health Literacy/
5. (health literate or health literacy).tw.
6. OR/4-5
7. 3 AND 6 AND Review filter
8. Limit 7 to 2013 — Current
Health literacy and medical 
students
(Medline, 3 results)
1. exp Students, Medical/
2. (medical adj3 (student* or 
undergraduate*)).tw.
3. OR/1-2
4. exp Health Literacy/
5. (health literate or health literacy).tw.
6. OR/4-5
7. 3 AND 6 AND Review filter
8. Limit 7 to 2013 — Current
Health literacy and young people
(Medline, 71 results)
1. exp Young Adult/
2. (young adult* or young person* or young 
people).tw.
3. exp Adolescent/
4. adolescen*.tw.
5. teen*.tw.
6. OR/1-5
7. exp Health Literacy/
8. (health literate or health literacy).tw.
9. OR/7-8
10. 6 AND 9 AND Review filter
11. Limit 10 to 2013 — Current
Hearing loss prevention
(Medline, 24 results)
1. exp Hearing Loss/
2. ((hear or hearing) adj3 los*).tw.
3. ((hear or hearing) adj3 deficien*).tw.
4. OR/1-3
5. Prevent*.tw.
6. exp Ear Protective Devices/
7. (ear* adj3 protect*).tw.
8. ((avoid* or expos*) adj3 (loud music or 
loud noise*)).tw.
9. Noise cancelling headphone*.tw.
10. Noise cancelling earphone*.tw.
11. OR/5-10
12. 4 AND 11 AND ageing population AND EU 
filter AND RCTs/observational studies/
review filters
Keeping older people in care 
homes stimulated
(Medline, 83 results; Web of Science, 427 
results)
1. Care home*.tw.
2. Nursing home*.tw.
3. exp Nursing Homes/
4. Assisted Living Facilities/
5. Residential home*.tw.
6. exp Homes for the Aged/
7. OR/1-6
8. Activ* provi*.tw.
9. Activit* coordinator*.tw.
10. Meaningful activ*.tw.
11. Leisure activ*.tw.
12. Exercise class*.tw.
13. Physical* exercis*.tw.
14. exp Yoga/
15. yoga.tw.
16. chair yoga.tw.
17. exp Tai Ji/
18. tai ji.tw.
19. tai chi.tw.
20. craft*.tw.
21. puzzle*.tw.
22. jigsaw*.tw.
23. hand massage*.tw.
24. music class*.tw.
25. singing class*.tw.
26. singing group*.tw.
27. choir*.tw.
28. active listen*.tw.
29. (cognitiv* adj3 stimulat*).tw.
30. Engagement intervention*.tw.
31. ((engage* or stimulat*) adj3 activit*).tw.
32. OR/8-31
33. exp Apathy/
34. intervention*.tw.
35. 33 AND 34
36. 32 OR 35
37. 7 AND 36 AND ageing population AND 
RCTs/Observational studies/Review filter
Kidney vascular interventions
(Medline, 54 results)
1. exp Renal Insufficiency, Chronic/
2. chronic renal insufficien*.tw.
3. chronic kidney disease*.tw.
4. chronic renal disease*.tw.
5. OR/1-4
6. Intervention*.tw.
7. exp Blood Glucose/
8. exp Insulin/
9. blood glucose.tw.
10. insulin.tw.
11. glycemic control.tw.
12. exp Blood Pressure/
13. blood pressure.tw.
14. hypoglycemic control.tw.
15. exp Diet, Sodium-Restricted/
16. ((sodium restrict* or low salt* or salt 
restrict*) adj3 diet*).tw.
17. exp Diabetes Mellitus/
18. diabetes.tw.
19. hydrat*.tw.
20. OR/6-19
21. 5 AND 20 AND ageing population AND 
EU filter AND RCTs/Observational studies 
AND policy filter
Making care homes more homely
(Medline, 27 results; Web of Science, 44 
results)
1. exp Nursing Homes/
2. exp Homes for the Aged/
3. exp Assisted Living Facilities/
4. nursing home*.tw.
5. care home*.tw.
6. residential home*.tw.
7. OR/1-6
8. Homely.tw.
9. Home-lie.tw.
10. Homeliness.tw.
11. Sense of home.tw.
12. (nostalgic adj2 décor).tw.
13. (familiar* adj2 (esthetic* or aesthetic*)).tw.
14. High contrast colo?r*.tw.
15. Natural light*.tw.
16. High luminance light*.tw.
17. Intelligent light system*.tw.
18. (discreet adj2 furniture).tw.
19. Interior design.tw.
20. OR/8-19
21. 7 AND 20 AND ageing population
Measure of disability
(Medline, 1684 results)
1. Disabil*.tw.
2. exp Frailty/
3. exp Frail Elderly/
4. frail*.tw.
5. vulnerabl*.tw.
6. (impair* adj3 capab*).tw.
7. (limited adj3 capacit*).tw.
8. (limited adj3 capab*).tw.
9. (functional* adj3 impair*).tw.
10. exp Cognitive Dysfunction/
253
11. (cognitiv* adj3 (dysfunction or impair*)).tw.
12. Psychiatric disorder*.tw.
13. exp “Activities of Daily Living”/
14. activities of daily living.tw.
15. (limit* adj3 activit*).tw.
16. (restrict* adj3 participat*).tw.
17. OR/1-16
18. exp Disability Evaluation/
19. (measure* adj2 method*).tw.
20. (measure* adj3 (disabilit* or frail*)).tw.
21. (evaluat* adj3 disabil*).tw.
22. Short performance physical battery.tw.
23. Frailty assessment method*.tw.
24. Frieds frailty phenotype.tw.
25. Fraily index.tw.
26. Study of osteoporotic fractures index.tw.
27. Edmonton frailty scale.tw.
28. “fatigue resistance ambulation and loss 
of weight index”.tw.
29. Clinical frailty scale.tw.
30. Multidimensional prognostic index.tw.
31. Tilburg frailty indicator.tw.
32. Prisma-7.tw.
33. Groningen frailty indicator.tw.
34. Sherbrooke postal questionnaire.tw.
35. Gerontopole frailty screening tool.tw.
36. Kihon checklist.tw.
37. OR/18-36
38. 17 AND 37 AND ageing population AND 
Review filter
Mobility interventions
(Medline, 142 results)
1. exp Walking Speed/
2. (walk* adj3 speed*).tw.
3. (gait adj3 speed*).tw.
4. (physical* adj3 (perform* or function*)).tw.
5. (function* adj3 (capacit* or ageing or 
ageing)).tw.
6. Mobilit*.tw.
7. Locomoto*.tw.
8. exp Accidental Falls/
9. (fall or falls or falling).tw.
10. OR/1-9
11. Intervention*.tw.
12. Chair stand*.tw.
13. Chair rise*.tw.
14. TUG test.tw.
15. “timed up and go”.tw.
16. (strength* adj3 test*).tw.
17. (flexibil* adj3 (test* or exercis*)).tw.
18. exp Walkers/
19. (walking aid* or walker*).tw.
20. exp Exercise/
21. exercis*.tw.
22. physical* activ*.tw.
23. exp Physical Therapy Modalities/
24. physical therap*.tw.
25. ((chang* or modif*) adj3 (home* or 
house*)).tw.
26. ((chang* or modif*) adj3 (footwear or 
shoe*)).tw.
27. exp Vitamin D/
28. vitamin d.tw.
29. (cataract* adj3 (surg* or operat*)).tw.
30. OR/11-29
31. 10 AND 30 AND ageing population AND 
EU filter AND observational studies/
review filter and policy filter
Muscle strength interventions
(Medline, 12 results)
1. exp Muscle Strength/
2. (muscl* adj3 strength*).tw.
3. exp Hand Strength/
4. ((hand* or grip*) adj3 strength*).tw.
5. OR/1-4
6. Intervention*.tw.
7. exp Exercise/
8. exercis*.tw.
9. physical* activ*.tw.
10. OR/6-9
11. 5 AND 10 AND ageing population AND 
EU filter AND observational studies/
review filters AND policy filter
Musculoskeletal interventions
(Medline, 75 results)
1. exp Musculoskeletal Diseases/
2. exp Musculoskeletal Pain/
3. musculoskeletal disease*.tw.
4. exp Bone Density/
5. bone dens*.tw.
6. bone mass*.tw.
7. OR/1-6
8. Intervention*.tw.
9. Bisphosphonate*.tw.
10. exp Strontium/
11. strontium.tw.
12. exp Vitamin D/
13. vitamin d.tw.
14. exp Calcium/
15. calcium.tw.
16. cathepsin k.tw.
17. exp Denosumab/
18. denosumab.tw.
19. exp Exercise/
20. exercis*.tw.
21. physical* activ*.tw.
22. exp Hydrotherapy/
23. hydrotherap*.tw.
24. OR/8-23
25. 7 AND 24 AND ageing population AND 
EU filter AND observational studies/
review filter AND policy filter
Neurovascular interventions
(Medline, 88 results)
1. Neurovascular disease*.tw.
2. exp Stroke/
3. stroke*.tw.
4. exp Ischemic Attack, Transient/
5. transient ischemic attack*.tw.
6. exp Carotid Stenosis/
7. carotid stenosis.tw.
8. exp Dementia, Vascular/
9. vascular dementia.tw.
10. mixed dementia.tw.
11. OR/1-10
12. Intervention*.tw.
13. exp Blood Pressure/
14. blood pressure.tw.
15. exp Aspirin/
16. aspirin.tw.
17. acetylsalicylic acid.tw.
18. exp Diet, Sodium-Restricted/
19. ((sodium restrict* or low salt* or salt 
restrict*) adj3 diet*).tw.
20. exp Exercise/
21. exercis*.tw.
22. physical activ*.tw.
23. exp Diet, Mediterranean/
24. Mediterranean diet*.tw.
25. exp Dietary Approaches To Stop 
Hypertension/
26. dietary approaches to stop hypertension.
tw.
27. DASH diet*.tw.
28. Mid diet.tw.
29. OR/12-28
30. 11 AND 30 AND ageing population AND 
EU filter AND RCTs/observational studies 
filter AND policy filter
Nutritional status of patients in 
nursing homes
(Medline, 322 results)
1. exp Malnutrition/
2. malnutrition.tw.
3. nutrition*.tw.
4. OR/1-3
5. exp Nursing Homes/
6. exp Homes for the Aged/
7. exp Assisted Living Facilities/
8. nursing home*.tw.
9. care home*.tw.
10. residential home*.tw.
11. OR/5-10
12. 4 AND 11 AND ageing population AND 
RCTs/observational studies/review filter
Obesity interventions
(Medline, 66 results)
1. exp Obesity/
2. obes*.tw.
3. overweight*.tw.
4. OR/1-3
5. Intervention*.tw.
6. exp Exercise/
7. exercis*.tw.
8. physical* activ*.tw.
9. (weight adj3 los*).tw.
10. exp Bariatric Surgery/
11. (bariatric adj3 (surg* or operat*)).tw.
12. OR/5-11
13. 4 AND 12 AND ageing population AND 
EU filter AND RCTs/Observational studies 
filter
Osteoarthritis interventions
(Medline, 19 results)
1. exp Osteoarthritis/
2. osteoarthritis.tw.
3. OR/1-2
4. Intervention*.tw.
5. exp Weight Loss/
6. ((los* or reduc*) adj3 weight).tw.
7. exp Micronutrients/
8. micronutrient*.tw.
9. exp Vitamin D/
10. vitamin d.tw.
11. exp Antioxidants/
12. antioxidant*.tw.
13. exp Smoking/
14. smoking.tw.
15. exp Occupational Diseases/
16. ((occupation* or work* or employ*) adj3 
(condition* or disease*)).tw.
17. exp Swimming/
18. (aquatic exercis* or swim* or water 
aerobics).tw.
19. Aerobic*.tw.
20. exp Resistance Training/
21. (resistance training or strength training).
tw.
22. exp Hydrotherapy/
23. hydrotherap*.tw.
24. exp Tai Ji/
25. tai chi.tw.
26. exp Yoga/
27. yoga.tw.
28. exp Stem Cells/
29. stem cell*.tw.
30. OR/4-29
31. 3 AND 30 AND ageing population AND 
EU filter AND RCTs/Observational studies 
filter AND policy filter
Osteoporosis interventions
(Medline, 37 results)
1. exp Osteoporosis/
2. osteoporosis.tw.
3. OR/1-2
4. Intervention*.tw.
5. exp Smoking Cessation/
6. ((stop* or ceas*) adj3 smok*).tw.
7. exp Exercise/
8. exercis*.tw.
9. physical* activ*.tw.
10. exp Resistance Training/
11. ((strength or resistance or balance) adj3 
training).tw.
12. exp Dietary Proteins/
13. (protein* adj3 diet*).tw.
14. exp Vitamin D/
15. vitamin d.tw.
16. exp Calcium/
17. calcium.tw.
18. OR/4-17
19. 3 AND 18 AND ageing population AND 
EU filter AND RCTs/observational studies 
filter AND policy filter
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Sarcopenia interventions
(Medline, 10 results)
1. exp Sarcopenia/
2. sarcopenia.tw.
3. OR/1-2
4. exp Social Class/
5. (social status* or social class* or 
socioeconomic status* or socioeconomic 
status*).tw.
6. exp Exercise/
7. exercis*.tw.
8. physical* activ*.tw.
9. exp Resistance Training/
10. ((resistance or strength) adj3 training).tw.
11. exp Dietary Proteins/
12. (protein* adj3 (diet* or intak*)).tw.
13. ((adequate or good) adj3 (nutrition* or 
diet*)).tw.
14. exp Leucine/
15. Leucine.tw.
16. Beta methyl butyrate.tw.
17. Beta hydroxyl.tw.
18. OR/4-17
19. 3 AND 18 AND ageing population AND 
RCTs/observational studies filter AND 
policy filter
Sensory ageing epidemiology
(Medline, 47 results)
1. (sens* adj3 (ageing or ageing or aged)).tw.
2. exp Hearing Loss/
3. ((hear or hearing) adj3 (los* or deficien*)).
tw.
4. exp Deafness/
5. deaf*.tw.
6. ((eyesight or vision or visual) adj3 (los* or 
deficien*)).tw.
7. Balance disorder*.tw.
8. (balanc* adj3 problem*).tw.
9. exp Vertigo/
10. OR/1-10
11. exp Epidemiology/
12. epidemiology.tw.
13. (life adj3 course).tw.
14. OR/11-13
15. 10 AND 14 AND EU filter
Sensory interventions
(Medline, 13 results)
1. exp Macular Degeneration/
2. macular degenera*.tw.
3. exp Hearing Loss/
4. (hearing adj3 los*).tw.
5. exp Presbycusis/
6. OR/1-5
7. Intervention*.tw.
8. exp Diabetes Mellitus/
9. diabet*.tw.
10. exp Blood Glucose/
11. blood glucose.tw.
12. exp Insulin/
13. insulin.tw.
14. glycemic control.tw.
15. exp Blood Pressure/
16. blood pressure.tw.
17. exp Vitamin A/
18. vitamin a.tw.
19. vitamin c.tw.
20. exp Vitamin E/
21. vitamin e.tw.
22. exp Selenium/
23. selenium.tw.
24. exp Zinc/
25. zinc.tw.
26. exp Smoking Cessation/
27. ((stop* or ceas*) adj3 smok*).tw.
28. exp Sunscreening Agents/
29. ((sun or UVA or UVB) adj3 protect*).tw.
30. exp Fatty Acids, Omega-3/
31. omega 3.tw.
32. omega3.tw.
33. (sensory adj3 stimul*).tw.
34. (sensory adj3 activ*).tw.
35. exp Mindfulness/
36. mindfulness.tw.
37. exp Noise/
38. noise.tw.
39. exp Hearing Loss, Noise-Induced/
40. chronic acoustic trauma.tw.
41. music concert*.tw.
42. ((headphone* or head phone*) adj3 
music*).tw.
43. exp “Drug-Related Side-effects and 
Adverse Reactions”/
44. drug toxicit*.tw.
45. OR/7-44
46. 6 AND 45 AND ageing population AND 
EU filter AND RCTs/observational studies 
filter AND policy
Undernutrition and hospital 
admissions
(Medline, 182 results)
1. exp Hospitalisation/
2. (hospital* adj3 admission*).tw.
3. Hospitalisation*.tw.
4. Hospitalisation*.tw.
5. OR/1-4
6. exp Malnutrition/
7. malnutrition.tw.
8. undernutrition.tw.
9. under nutrition.tw.
10. OR/6-9
11. 5 AND 10 AND EU filter
Undernutrition and hospital 
discharge
(Medline, 36 results)
1. exp Patient Discharge/
2. (patient* adj3 discharg*).tw.
3. (hospital* adj3 discharg*).tw.
4. OR/1-3
5. exp Malnutrition/
6. malnutrition.tw.
7. undernutrition.tw.
8. under nutrition.tw.
9. OR/5-8
10. 4 AND 10 AND ageing population AND 
EU filter
Undernutrition and independent 
living
(Medline, 99 results)
1. exp Independent Living/
2. (independent* adj3 (living or live)).tw.
3. Community dwelling.tw.
4. OR/1-3
5. exp Malnutrition/
6. malnutrition.tw.
7. undernutrition.tw.
8. under nutrition.tw.
9. OR/5-8
10. 4 AND 9 AND EU filter
Undernutrition and nursing homes
(Medline, 146 results)
1. exp Nursing Homes/
2. nursing home*.tw.
3. OR/1-2
4. exp Malnutrition/
5. malnutrition.tw.
6. undernutrition.tw.
7. under nutrition.tw.
8. OR/4-7
9. 3 AND 8 AND ageing population AND 
EU filter
Unnecessary transfers of 
older patients to emergency 
departments
(Medline, 19 results)
1. exp Nursing Homes/
2. exp Homes for the Aged/
3. exp Assisted Living Facilities/
4. nursing home*.tw.
5. care home*.tw.
6. residential home*.tw.
7. OR/1-6
8. “accident and emergency”.tw.
9. A&e.tw.
10. exp Emergency Service, Hospital/
11. emergency department*.tw.
12. emergency room*.tw.
13. OR/8-12
14. ((avoid* or unnecessary) adj3 (transfer* or 
admission* or admit*)).tw.
15. 7 AND 13 AND 14 AND ageing population
Vision deficiency prevention
(Medline, 22 results)
1. ((eyesight or vision or visual) adj3 (los* or 
deficien*)).tw.
2. Prevent*.tw.
3. exp Healthy Diet/
4. ((healthy or balance) adj2 diet*).tw.
5. exp Vitamin A/
6. vitamin a.tw.
7. exp Fatty Acids, Omega-3/
8. omega 3.tw.
9. ((regular* or frequent* or annual*) adj3 
eye exam*).tw.
10. exp Smoking Cessation/
11. smoking cessation.tw.
12. ((stop* or ceas*) adj3 smok*).tw.
13. exp Eye Protection Devices/
14. sunglasses.tw.
15. OR/2-14
16. 1 AND 15 AND ageing population AND EU 
filter AND observational studies/review 
filter
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